data_1wqk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wqk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.268 0.556 . . . . 1.1299999999999999 111.385 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.7 m -103.27 126.86 50.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.1200000000000001 109.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.13 127.3 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.334 0.588 . . . . 1.01 110.9 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -91.38 119.46 31.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.491 . . . . 1.1799999999999999 110.812 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -94.8 104.24 16.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.112 -0.699 . . . . 1.2 109.112 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.12 -96.47 0.61 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.511 -0.852 . . . . 1.01 111.075 -173.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -128.84 0.33 5.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 3.6499999999999999 110.638 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -92.35 130.68 37.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.352 -0.386 . . . . 0.81999999999999995 110.608 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -79.53 114.31 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 1.0600000000000001 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.41 165.91 12.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.656 -0.702 . . . . 0.81999999999999995 111.862 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.56 134.19 54.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.278 0.561 . . . . 0.81999999999999995 109.866 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -87.29 106.13 17.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.472 -0.786 . . . . 1.1200000000000001 111.168 -175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.403 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -88.47 108.39 19.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.814 -0.63 . . . . 0.81999999999999995 110.618 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -96.88 114.29 25.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.83999999999999997 109.815 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.86 -16.58 6.13 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.271 -0.966 . . . . 1.0700000000000001 113.08 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.4 t -135.55 156.66 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.81999999999999995 110.87 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.42 0.63 23.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 3.98 109.878 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 m -116.76 118.99 34.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 1.6000000000000001 111.144 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 71.7 m -61.29 120.51 55.71 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 47.6 Cg_exo -53.43 108.24 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.652 2.235 . . . . 0.81999999999999995 111.116 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -79.18 36.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.916 -0.584 . . . . 2.3700000000000001 111.896 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -123.89 13.68 9.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.386 0.612 . . . . 1.8300000000000001 109.47 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -108.75 -74.37 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.481 -0.781 . . . . 3.3900000000000001 110.831 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.1 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.356 -0.838 . . . . 1.1000000000000001 111.63 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.58 149.58 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 3.7599999999999998 110.566 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 m -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.091 -0.504 . . . . 1.3300000000000001 110.549 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.67 160.72 22.81 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.442 -0.885 . . . . 0.81999999999999995 112.072 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 36' ' ' ILE . 33.0 p -142.1 136.34 30.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.101 0.476 . . . . 1.4399999999999999 111.746 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 61.2 m -107.16 128.16 54.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.624 -0.716 . . . . 1.01 109.986 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 105.87 1.69 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.692 -0.766 . . . . 0.81999999999999995 111.334 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -105.74 173.14 6.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.173 -0.306 . . . . 1.97 110.173 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -54.35 102.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.445 -0.343 . . . . 2.3599999999999999 111.615 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp 58.33 28.41 16.68 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.019 0.824 . . . . 1.75 111.143 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.27 -173.4 33.81 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.039 -0.601 . . . . 0.81999999999999995 111.687 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 29' ' ' SER . 16.0 tt -136.25 128.51 45.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.282 0.563 . . . . 0.81999999999999995 111.416 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 22.1 m -92.05 102.8 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 110.378 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.3 m -97.92 125.37 42.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.477 -0.329 . . . . 1.1399999999999999 110.532 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -128.46 156.41 77.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 1.1499999999999999 111.111 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.16 162.56 83.66 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.669 -1.388 . . . . 0.81999999999999995 112.377 -2.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 C--O 1.234 0.241 0 CA-C-N 116.238 -0.437 . . . . 1.45 110.385 175.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.607 0.718 . . . . 1.1299999999999999 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m -146.43 136.39 23.44 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.439 -0.801 . . . . 1.1200000000000001 109.398 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 p -129.26 161.61 29.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.024 0.44 . . . . 1.01 110.716 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -111.67 93.43 4.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 1.1799999999999999 109.598 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.72 107.82 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.89 -100.87 0.73 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.446 -0.662 . . . . 1.01 111.446 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.88 23.18 5.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 110.16 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -124.2 127.79 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.81999999999999995 110.778 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tt -83.97 124.24 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.537 0.684 . . . . 1.0600000000000001 110.683 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -130.67 161.2 23.33 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.464 -0.789 . . . . 0.81999999999999995 111.864 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.31 132.02 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.81999999999999995 109.739 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 10.3 t80 -86.92 106.58 17.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 1.1200000000000001 111.104 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -84.49 107.74 16.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.81999999999999995 110.121 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -90.35 119.35 30.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.486 -0.561 . . . . 0.83999999999999997 109.486 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.01 -60.63 0.46 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 1.0700000000000001 111.862 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -91.89 134.24 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.106 0.479 . . . . 0.81999999999999995 110.288 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -108.65 23.63 14.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.642 0.734 . . . . 3.98 109.455 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.8 p -124.11 130.18 52.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.875 -1.057 . . . . 1.6000000000000001 109.916 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.9 m -78.7 125.3 84.52 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.576 -0.284 . . . . 0.91000000000000003 111.054 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.09 110.5 1.76 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.878 2.386 . . . . 0.81999999999999995 111.272 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -79.6 66.08 4.96 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.315 0.579 . . . . 2.3700000000000001 110.981 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -157.66 23.74 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 1.8300000000000001 110.357 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -130.21 -49.82 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 3.3900000000000001 111.538 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.01 10.01 1.4 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.981 -0.628 . . . . 1.1000000000000001 111.971 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 23.5 m-85 -69.62 120.83 15.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.919 -0.4 . . . . 3.7599999999999998 109.919 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -115.68 -24.19 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.099 0.476 . . . . 1.3300000000000001 110.889 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 158.48 22.55 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.942 -0.863 . . . . 0.81999999999999995 110.942 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.03 139.4 48.56 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.313 0.556 . . . . 1.4399999999999999 111.738 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -115.77 95.3 5.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.447 -0.946 . . . . 1.01 108.447 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.67 131.17 39.69 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.407 -0.425 . . . . 0.81999999999999995 112.317 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -132.42 169.11 17.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.961 0.41 . . . . 1.97 111.066 -173.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -59.67 111.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 2.3599999999999999 111.118 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.2 mt 64.88 24.44 12.74 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.748 0.655 . . . . 1.75 111.57 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.8 -159.76 23.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.704 -1.236 . . . . 0.81999999999999995 112.936 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.45 125.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.81999999999999995 110.85 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 t -92.43 94.66 9.22 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.744 -0.836 . . . . 1.1100000000000001 108.744 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 1.5 t -93.48 136.53 33.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.161 -0.472 . . . . 1.1399999999999999 110.405 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 36.1 p90 -134.03 161.14 65.52 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 111.232 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 2.3 Cg_endo -82.32 154.94 77.39 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.613 -1.411 . . . . 0.81999999999999995 111.555 -3.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 122.211 1.005 . . . . 1.45 109.437 175.194 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.28 0.562 . . . . 1.1299999999999999 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 m -106.15 127.77 53.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.1200000000000001 111.368 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 p -145.82 136.08 23.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.972 0.415 . . . . 1.01 110.9 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.42 136.42 38.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 1.1799999999999999 111.66 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.8 m -119.14 105.05 11.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.316 -0.856 . . . . 1.2 108.737 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.95 -115.36 7.16 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.806 -0.917 . . . . 1.01 110.806 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -102.0 -12.89 17.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.654 -0.499 . . . . 3.6499999999999999 109.654 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.471 HG21 ' HB2' ' A' ' 39' ' ' TYR . 7.3 m -83.21 119.65 24.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.523 -0.762 . . . . 0.81999999999999995 111.241 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' A' ' 41' ' ' VAL . 4.1 tp -73.98 121.86 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0600000000000001 110.286 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.05 159.07 15.15 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.667 -0.697 . . . . 0.81999999999999995 112.011 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.1 130.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.478 0.656 . . . . 0.81999999999999995 109.741 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -84.36 97.67 9.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.207 -0.906 . . . . 1.1200000000000001 110.88 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -79.9 88.98 5.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.694 -0.684 . . . . 0.81999999999999995 110.181 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -84.17 104.13 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.186 -0.672 . . . . 0.83999999999999997 109.186 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.86 -48.33 0.64 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.953 -0.642 . . . . 1.0700000000000001 111.707 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -107.57 165.73 11.2 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.907 -0.405 . . . . 0.81999999999999995 109.907 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -122.22 11.05 10.06 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.975 -0.75 . . . . 3.98 108.975 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -127.44 125.29 40.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.431 -0.804 . . . . 1.6000000000000001 110.55 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.5 m -67.9 123.58 87.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.109 -0.33 . . . . 0.91000000000000003 110.109 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 108.05 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.589 2.192 . . . . 0.81999999999999995 111.275 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.4 m -79.75 58.62 2.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.03 0.443 . . . . 2.3700000000000001 111.888 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -149.23 22.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 1.8300000000000001 111.153 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -133.46 -49.17 0.84 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.862 0.363 . . . . 3.3900000000000001 111.323 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.99 22.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.738 -0.744 . . . . 1.1000000000000001 112.718 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -70.23 111.8 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.841 -0.429 . . . . 3.7599999999999998 109.841 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 m -93.33 -28.52 16.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.0 -0.546 . . . . 1.3300000000000001 110.94 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.22 167.48 24.68 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.55 -0.833 . . . . 0.81999999999999995 112.33 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.5 p -144.41 144.47 31.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.143 0.496 . . . . 1.4399999999999999 110.908 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 76.0 m -121.32 129.18 52.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 1.01 109.719 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.39 115.26 6.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.896 -0.882 . . . . 0.81999999999999995 110.896 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -117.78 167.74 11.1 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.724 -0.473 . . . . 1.97 109.724 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -54.39 101.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.93 -0.577 . . . . 2.3599999999999999 111.408 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.3 mt 63.77 22.29 13.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.522 -0.763 . . . . 1.75 111.905 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.89 -178.98 35.35 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.573 -0.822 . . . . 0.81999999999999995 112.123 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.9 126.58 62.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.214 0.531 . . . . 0.81999999999999995 111.128 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 57.2 m -90.25 107.61 19.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.559 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.1 125.77 46.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.939 -0.393 . . . . 1.1399999999999999 109.939 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HB2' HG21 ' A' ' 9' ' ' THR . 45.1 p90 -128.62 155.37 79.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.528 -0.306 . . . . 1.1499999999999999 110.82 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.38 161.66 92.09 Favored 'Cis proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.996 -1.252 . . . . 0.81999999999999995 112.568 -1.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' CG2' HG13 ' A' ' 10' ' ' ILE . 97.9 t . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.023 0.439 . . . . 1.45 111.262 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.04 0.448 . . . . 1.1299999999999999 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 m -76.37 117.9 18.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.764 -0.458 . . . . 1.1200000000000001 109.764 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.1 t -121.77 109.09 14.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.137 0.494 . . . . 1.01 111.754 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 55.4 m-85 -85.77 109.7 18.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.174 -0.466 . . . . 1.1799999999999999 110.2 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.51 101.86 13.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.2 108.09 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.51 -118.12 8.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.613 -0.803 . . . . 1.01 111.102 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -107.04 10.33 30.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.857 0.361 . . . . 3.6499999999999999 110.997 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 39' ' ' TYR . 11.9 m -108.82 117.23 33.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.362 -0.535 . . . . 0.81999999999999995 110.476 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.4 tt -81.27 123.28 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.679 . . . . 1.0600000000000001 110.851 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -131.39 -172.83 13.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 111.706 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.2 131.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.399 0.618 . . . . 0.81999999999999995 109.843 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -86.4 106.75 17.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.296 -0.865 . . . . 1.1200000000000001 110.833 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -88.17 112.8 23.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 110.049 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -89.91 135.98 33.32 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.964 -0.384 . . . . 0.83999999999999997 109.964 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.5 -53.51 0.77 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 1.0700000000000001 112.654 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -83.36 154.11 24.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.81999999999999995 110.422 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.5 mptt -109.63 -2.88 17.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 3.98 109.257 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -130.24 159.0 38.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.524 -0.762 . . . . 1.6000000000000001 110.012 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.5 m -88.07 121.83 70.33 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.536 -0.302 . . . . 0.91000000000000003 110.941 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -63.11 105.75 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.078 1.852 . . . . 0.81999999999999995 110.459 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.5 m -79.08 68.72 5.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.987 -0.551 . . . . 2.3700000000000001 111.128 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.56 13.46 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 1.8300000000000001 111.341 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -128.64 -82.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 3.3900000000000001 110.958 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.67 27.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.621 -0.718 . . . . 1.1000000000000001 111.924 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -70.48 153.2 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.145 -0.317 . . . . 3.7599999999999998 110.145 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.1 m -129.66 -55.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.012 -0.275 . . . . 1.3300000000000001 111.504 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.68 17.4 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.799 . . . . 0.81999999999999995 111.716 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 p -138.18 140.14 39.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.281 0.562 . . . . 1.4399999999999999 111.655 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.679 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 61.1 m -116.92 136.95 52.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.631 -0.713 . . . . 1.01 109.473 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.44 127.15 28.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.684 -0.77 . . . . 0.81999999999999995 111.506 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -129.29 171.37 12.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.804 -0.443 . . . . 1.97 109.804 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -54.48 103.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.455 0.472 . . . . 2.3599999999999999 111.49 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 56.92 25.35 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.391 -0.822 . . . . 1.75 111.857 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.53 177.15 37.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.075 -1.059 . . . . 0.81999999999999995 112.604 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 tt -118.37 124.2 72.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.579 0.704 . . . . 0.81999999999999995 110.94 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.8 t -88.43 95.51 10.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.414 -0.812 . . . . 1.1100000000000001 109.694 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.1 t -101.11 124.49 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.907 0.384 . . . . 1.1399999999999999 111.056 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.679 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 28.3 p90 -126.46 162.04 48.93 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 1.1499999999999999 110.571 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -82.66 167.0 68.05 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 124.481 -1.05 . . . . 0.81999999999999995 112.835 -1.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 1.45 110.832 175.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.084 0.469 . . . . 1.1299999999999999 110.69 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.1 m -75.76 124.99 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.484 -0.78 . . . . 1.1200000000000001 111.516 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t -138.55 154.53 48.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.697 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -133.42 129.0 36.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 1.1799999999999999 111.563 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -112.33 102.53 10.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.607 -0.724 . . . . 1.2 109.202 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.8 -86.79 0.45 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -138.1 -0.51 2.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 3.6499999999999999 109.937 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -85.7 124.97 32.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.81999999999999995 110.381 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.405 HG13 ' CG1' ' A' ' 41' ' ' VAL . 3.6 tp -79.75 121.84 33.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.491 0.662 . . . . 1.0600000000000001 110.827 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.1 -176.01 14.26 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.49 -0.777 . . . . 0.81999999999999995 111.708 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.5 134.04 61.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.479 0.657 . . . . 0.81999999999999995 110.238 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 16.4 t80 -89.6 102.51 15.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.364 -0.835 . . . . 1.1200000000000001 111.176 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -83.2 98.23 9.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.025 -0.534 . . . . 0.81999999999999995 110.777 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.61 102.35 14.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.896 0.379 . . . . 0.83999999999999997 110.184 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.84 -51.22 0.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.782 -0.723 . . . . 1.0700000000000001 111.708 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 t -90.44 158.1 17.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.899 0.381 . . . . 0.81999999999999995 110.337 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.6 mptt -116.52 17.99 15.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.646 . . . . 3.98 109.502 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -147.17 146.94 30.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.114 -0.493 . . . . 1.6000000000000001 110.553 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.0 m -80.11 124.33 82.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.148 -0.478 . . . . 0.91000000000000003 110.685 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.12 130.13 29.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.87 2.38 . . . . 0.81999999999999995 112.012 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 m -83.74 55.3 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.299 -0.41 . . . . 2.3700000000000001 111.548 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -141.8 0.53 1.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.741 0.305 . . . . 1.8300000000000001 111.476 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -44.78 3.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.983 0.42 . . . . 3.3900000000000001 111.627 -174.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 38.46 1.68 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.464 -0.654 . . . . 1.1000000000000001 111.464 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -71.09 138.39 49.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.622 0.248 . . . . 3.7599999999999998 110.69 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.5 t -106.78 -12.87 15.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.442 -0.344 . . . . 1.3300000000000001 110.713 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.67 170.47 38.23 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.745 -1.217 . . . . 0.81999999999999995 113.027 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 9.3 p -143.05 144.78 32.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.936 0.398 . . . . 1.4399999999999999 111.013 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 63.1 m -125.28 134.61 52.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.026 -0.534 . . . . 1.01 110.173 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 121.76 7.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.638 -0.792 . . . . 0.81999999999999995 112.119 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.12 171.94 9.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.455 0.169 . . . . 1.97 110.722 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -56.2 104.32 0.14 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 2.3599999999999999 111.714 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.95 27.09 14.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.307 -0.86 . . . . 1.75 112.028 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.56 170.68 35.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.374 -0.917 . . . . 0.81999999999999995 112.761 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 tt -116.55 130.81 70.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.81999999999999995 110.339 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.7 t -96.23 102.23 13.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.05 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.05 122.19 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.816 0.341 . . . . 1.1399999999999999 110.681 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -122.18 151.19 58.39 Favored Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.225 -0.443 . . . . 1.1499999999999999 110.321 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -86.16 160.41 56.81 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.063 -1.641 . . . . 0.81999999999999995 112.045 0.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.405 ' CG1' HG13 ' A' ' 10' ' ' ILE . 5.6 p . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.734 0.778 . . . . 1.45 110.723 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.069 0.461 . . . . 1.1299999999999999 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.1 m -74.38 121.91 22.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.5 . . . . 1.1200000000000001 110.742 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 t -121.82 157.27 31.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.657 -0.701 . . . . 1.01 110.068 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -132.05 124.5 29.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.936 0.398 . . . . 1.1799999999999999 111.344 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -100.53 92.56 5.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.69 -95.31 0.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.97 -0.852 . . . . 1.01 110.97 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -121.71 -2.03 9.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.829 0.347 . . . . 3.6499999999999999 110.33 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -87.46 129.34 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.81999999999999995 110.717 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 tt -86.36 113.45 24.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.885 0.85 . . . . 1.0600000000000001 111.669 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.0 -174.22 14.58 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.029 -0.987 . . . . 0.81999999999999995 111.528 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.93 134.48 66.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.43 0.633 . . . . 0.81999999999999995 110.204 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -83.77 104.4 13.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.262 -0.881 . . . . 1.1200000000000001 111.174 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.473 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 90.0 m95 -89.16 98.36 11.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.81999999999999995 110.822 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.939 -0.573 . . . . 0.83999999999999997 109.949 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.89 14.79 6.51 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.358 -0.925 . . . . 1.0700000000000001 113.387 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -151.42 146.12 25.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.81999999999999995 110.664 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -97.51 -8.67 28.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.378 -0.828 . . . . 3.98 109.603 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 p -118.75 139.43 51.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.679 . . . . 1.6000000000000001 111.404 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 72.8 m -75.9 129.06 82.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 109.75 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 31.3 Cg_exo -58.11 97.59 0.09 OUTLIER 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.555 2.17 . . . . 0.81999999999999995 110.782 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -79.61 51.92 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.524 0.678 . . . . 2.3700000000000001 111.316 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.87 0.39 1.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.934 -1.03 . . . . 1.8300000000000001 109.785 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -103.99 -46.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 3.3900000000000001 110.906 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.07 14.95 0.94 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.747 -0.739 . . . . 1.1000000000000001 112.683 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -70.7 137.92 50.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 3.7599999999999998 110.385 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 m -115.23 -32.78 5.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.92 0.39 . . . . 1.3300000000000001 110.659 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.48 176.97 18.61 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.858 -0.687 . . . . 0.81999999999999995 111.796 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.463 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.4 p -162.66 148.89 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.116 0.484 . . . . 1.4399999999999999 111.598 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 58.3 m -125.53 151.13 46.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.506 -0.77 . . . . 1.01 109.426 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.46 125.89 7.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.81999999999999995 111.659 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.98 162.97 24.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.97 110.469 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 106.61 0.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 2.3599999999999999 111.545 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 63.53 20.48 12.26 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.929 0.768 . . . . 1.75 112.087 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.92 175.73 39.26 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.28 -0.962 . . . . 0.81999999999999995 112.85 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.58 133.69 68.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.199 0.523 . . . . 0.81999999999999995 110.285 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 29' ' ' SER . 52.2 t -95.02 95.69 8.76 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.813 -0.44 . . . . 1.1100000000000001 109.813 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.41 128.29 40.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.397 -0.365 . . . . 1.1399999999999999 110.752 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 41.0 p90 -129.54 159.74 67.94 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.512 -0.313 . . . . 1.1499999999999999 110.759 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 83.7 Cg_endo -91.41 162.6 28.71 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.677 -1.384 . . . . 0.81999999999999995 112.789 -1.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.235 0.332 0 CA-C-N 116.099 -0.5 . . . . 1.45 109.78 173.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.548 0.69 . . . . 1.1299999999999999 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 m -76.88 109.02 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.145 -0.934 . . . . 1.1200000000000001 110.303 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.67 151.23 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.694 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -129.06 115.51 17.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 1.1799999999999999 111.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.7 m -99.88 95.54 6.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.85 -107.34 2.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.62 -0.8 . . . . 1.01 111.268 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -107.78 -5.03 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.042 0.448 . . . . 3.6499999999999999 110.524 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -99.95 117.38 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.81999999999999995 110.788 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tt -82.23 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.514 0.673 . . . . 1.0600000000000001 110.996 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.55 -170.28 11.85 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.201 -0.909 . . . . 0.81999999999999995 111.204 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.92 137.7 52.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.295 0.569 . . . . 0.81999999999999995 109.553 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HE1' ' HB3' ' A' ' 32' ' ' TYR . 36.8 t80 -87.56 107.27 18.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 1.1200000000000001 111.475 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.489 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 82.0 m95 -90.64 100.51 13.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.129 -0.487 . . . . 0.81999999999999995 109.861 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.7 t80 -83.76 132.54 34.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.491 -0.322 . . . . 0.83999999999999997 110.303 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.01 -18.69 39.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.639 -0.791 . . . . 1.0700000000000001 113.233 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -118.29 151.83 36.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.581 . . . . 0.81999999999999995 111.359 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -102.32 3.1 37.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.303 -0.862 . . . . 3.98 110.527 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -134.87 146.27 49.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.224 0.535 . . . . 1.6000000000000001 111.368 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 94.5 m -80.9 127.99 72.93 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.702 -0.681 . . . . 0.91000000000000003 111.208 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 17.1 Cg_exo -62.54 116.18 3.36 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.514 2.143 . . . . 0.81999999999999995 110.553 173.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.1 m -84.08 24.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 2.3700000000000001 112.12 -170.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.27 16.32 24.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.135 0.493 . . . . 1.8300000000000001 110.147 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -119.38 -60.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.714 -0.676 . . . . 3.3900000000000001 110.943 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.02 40.54 0.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.828 -0.624 . . . . 1.1000000000000001 111.678 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -70.39 132.58 45.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 3.7599999999999998 111.245 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -89.16 -27.8 20.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.537 -0.756 . . . . 1.3300000000000001 110.592 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.62 171.68 34.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.37 -0.919 . . . . 0.81999999999999995 112.337 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 17.6 p -140.68 151.97 44.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.898 0.38 . . . . 1.4399999999999999 111.505 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -124.02 140.93 52.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.01 109.778 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.91 126.49 7.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.785 -0.722 . . . . 0.81999999999999995 111.783 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -129.13 169.02 15.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 1.97 109.058 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -62.55 97.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 2.3599999999999999 111.924 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.4 mp 63.5 27.32 15.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.337 -0.847 . . . . 1.75 111.266 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . -154.11 165.71 31.82 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.81999999999999995 111.566 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.34 129.35 74.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.359 0.599 . . . . 0.81999999999999995 110.559 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.7 t -92.53 105.86 17.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.325 -0.62 . . . . 1.1100000000000001 109.325 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.8 m -103.76 123.08 46.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.922 0.391 . . . . 1.1399999999999999 110.807 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -125.32 153.86 72.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.978 -0.556 . . . . 1.1499999999999999 110.634 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.38 158.72 73.68 Favored 'Cis proline' 0 C--O 1.235 0.331 0 C-N-CA 123.518 -1.451 . . . . 0.81999999999999995 111.852 -1.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.849 0.833 . . . . 1.45 110.612 178.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.09 0.471 . . . . 1.1299999999999999 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -96.14 139.82 31.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.44 -0.345 . . . . 1.1200000000000001 110.532 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.58 161.05 30.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.303 -0.408 . . . . 1.01 110.707 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.37 106.72 10.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.565 -0.289 . . . . 1.1799999999999999 110.558 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.2 m -85.04 93.28 8.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.24 -0.652 . . . . 1.2 109.24 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.27 -93.1 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.442 -0.799 . . . . 1.01 111.865 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.56 0.29 8.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.645 0.259 . . . . 3.6499999999999999 110.805 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 m -106.42 122.94 47.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.81999999999999995 110.774 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 9.6 tt -76.31 123.26 32.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.405 -0.816 . . . . 1.0600000000000001 111.256 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.02 171.77 18.6 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.81999999999999995 111.653 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.95 131.55 65.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.201 0.524 . . . . 0.81999999999999995 109.776 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 7.6 t80 -87.34 100.6 12.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.541 -0.754 . . . . 1.1200000000000001 110.66 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -79.51 88.53 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.673 -0.694 . . . . 0.81999999999999995 109.679 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 78.1 t80 -70.48 122.14 19.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.677 -0.692 . . . . 0.83999999999999997 109.782 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.07 -32.58 5.06 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.698 -0.763 . . . . 1.0700000000000001 112.847 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -125.25 151.24 46.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.81999999999999995 111.194 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.2 tptm -109.76 21.76 16.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.047 0.927 . . . . 3.98 108.615 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -119.44 122.86 42.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 1.6000000000000001 110.303 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.1 m -72.6 118.96 72.38 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.848 0.356 . . . . 0.91000000000000003 110.392 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.6 75.86 4.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.745 2.297 . . . . 0.81999999999999995 109.858 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -78.34 53.12 1.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.865 -1.061 . . . . 2.3700000000000001 112.913 -168.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -88.36 1.37 54.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.219 -0.66 . . . . 1.8300000000000001 109.219 170.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -97.12 -73.44 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.073 -0.967 . . . . 3.3900000000000001 109.857 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.8 28.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.455 -0.793 . . . . 1.1000000000000001 112.194 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.02 138.66 43.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 3.7599999999999998 110.978 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -109.11 -45.98 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.209 0.528 . . . . 1.3300000000000001 111.027 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.1 -179.48 16.06 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.83 -0.908 . . . . 0.81999999999999995 110.83 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -157.71 164.29 37.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.655 0.728 . . . . 1.4399999999999999 111.655 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -133.17 125.12 28.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.83 . . . . 1.01 109.74 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' HE3' ' A' ' 18' ' ' LYS . . . -66.88 127.15 27.63 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.818 -0.706 . . . . 0.81999999999999995 112.082 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -123.11 165.14 17.33 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.734 -0.274 . . . . 1.97 111.235 -176.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -39.23 -55.78 1.62 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.359 1.037 . . . . 2.3599999999999999 113.021 -168.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 5.8 mp -134.27 45.71 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.951 -0.389 . . . . 1.75 109.951 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.6 -164.7 33.4 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.702 -1.237 . . . . 0.81999999999999995 112.7 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 18' ' ' LYS . 16.1 tt -133.89 130.08 55.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.093 0.473 . . . . 0.81999999999999995 111.146 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.8 t -95.88 92.44 6.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.201 -0.454 . . . . 1.1100000000000001 109.971 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.7 124.51 33.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 1.1399999999999999 110.55 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -126.97 153.48 76.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 1.1499999999999999 111.036 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 2.4 Cg_endo -82.82 172.13 50.23 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.621 -1.408 . . . . 0.81999999999999995 111.3 -3.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG21 HG12 ' A' ' 10' ' ' ILE . 3.0 t . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.137 0.494 . . . . 1.45 110.771 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 15.4 p . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.464 0.649 . . . . 1.1299999999999999 110.371 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.6 m -104.27 123.79 48.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.416 -0.811 . . . . 1.1200000000000001 110.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.0 p -135.65 159.96 40.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.873 0.368 . . . . 1.01 111.316 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.61 143.91 47.41 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.78 -0.452 . . . . 1.1799999999999999 109.78 175.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.3 t -119.91 101.75 8.08 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.49 -91.54 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.778 -0.646 . . . . 1.01 111.872 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -122.49 -9.95 8.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.887 0.375 . . . . 3.6499999999999999 110.684 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -95.6 128.53 42.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.117 -0.492 . . . . 0.81999999999999995 111.067 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 tp -82.22 132.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.978 -0.555 . . . . 1.0600000000000001 110.003 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.46 179.78 19.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.13 -0.557 . . . . 0.81999999999999995 112.627 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.62 137.71 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.228 0.537 . . . . 0.81999999999999995 109.76 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 2.0 t80 -89.64 101.09 13.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.724 -0.671 . . . . 1.1200000000000001 111.443 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -82.85 83.28 7.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.871 -0.604 . . . . 0.81999999999999995 109.42 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -73.37 96.91 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.178 -0.465 . . . . 0.83999999999999997 110.337 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.33 -61.37 0.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.725 -0.67 . . . . 1.0700000000000001 111.903 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -87.11 161.82 17.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.729 0.299 . . . . 0.81999999999999995 110.627 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -113.51 11.18 18.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.165 -0.68 . . . . 3.98 109.165 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -128.77 135.78 49.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.595 . . . . 1.6000000000000001 110.562 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.9 m -80.01 127.41 77.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.745 0.307 . . . . 0.91000000000000003 111.292 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.23 78.32 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.558 2.172 . . . . 0.81999999999999995 110.194 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -78.62 63.04 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.556 0.693 . . . . 2.3700000000000001 111.141 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.43 4.71 10.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.33 -0.85 . . . . 1.8300000000000001 109.687 171.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.04 -81.77 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.29 -0.633 . . . . 3.3900000000000001 109.29 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.49 4.23 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.977 -0.63 . . . . 1.1000000000000001 113.146 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -62.06 127.31 30.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.077 0.438 . . . . 3.7599999999999998 110.273 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 p -114.74 -39.07 3.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.933 0.397 . . . . 1.3300000000000001 110.888 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.91 157.85 14.95 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.956 -0.64 . . . . 0.81999999999999995 112.188 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.596 ' HB2' HD12 ' A' ' 36' ' ' ILE . 16.2 p -124.55 149.97 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.376 . . . . 1.4399999999999999 111.103 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.9 t -133.4 114.66 13.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.119 -0.491 . . . . 1.01 109.969 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 127.16 42.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.416 -0.421 . . . . 0.81999999999999995 113.196 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -128.21 174.43 9.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.644 0.259 . . . . 1.97 110.56 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -65.52 95.41 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 2.3599999999999999 111.506 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt 64.42 27.31 13.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.745 -0.661 . . . . 1.75 110.536 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.34 -175.83 29.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.822 -0.704 . . . . 0.81999999999999995 111.874 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 29' ' ' SER . 12.3 tt -136.44 130.09 46.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.233 0.539 . . . . 0.81999999999999995 110.958 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 45.0 t -93.3 103.52 15.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.062 -0.718 . . . . 1.1100000000000001 109.062 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.1 m -91.76 124.43 35.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 1.1399999999999999 110.928 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 47.0 p90 -127.08 150.11 71.24 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.025 -0.534 . . . . 1.1499999999999999 111.117 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 16.5 Cg_exo -68.49 165.78 71.56 Favored 'Cis proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.56 -1.433 . . . . 0.81999999999999995 111.933 -4.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 122.32 1.057 . . . . 1.45 110.712 178.489 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.723 0.297 . . . . 1.1299999999999999 111.43 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -69.69 115.83 9.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 1.1200000000000001 110.023 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -122.51 154.7 37.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.451 . . . . 1.01 110.651 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 54.7 m-85 -131.67 121.94 25.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.755 0.312 . . . . 1.1799999999999999 110.941 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -102.92 99.47 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.979 -0.749 . . . . 1.2 108.979 171.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.75 -97.55 0.35 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.921 -0.657 . . . . 1.01 111.767 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -106.84 -25.15 11.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.694 0.283 . . . . 3.6499999999999999 110.825 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -88.39 123.68 33.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.209 0.528 . . . . 0.81999999999999995 111.64 -170.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 tt -78.73 131.84 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.706 -0.679 . . . . 1.0600000000000001 110.615 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.68 -174.06 13.33 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.702 -0.681 . . . . 0.81999999999999995 111.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.16 133.19 64.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.353 0.596 . . . . 0.81999999999999995 109.928 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.406 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 15.3 t80 -84.44 100.1 11.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 1.1200000000000001 110.928 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -80.17 94.37 6.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.81999999999999995 110.373 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.5 t80 -79.56 109.87 14.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.523 -0.547 . . . . 0.83999999999999997 109.523 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.26 -21.32 4.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.453 -0.88 . . . . 1.0700000000000001 112.884 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -135.05 151.99 51.27 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.765 -0.256 . . . . 0.81999999999999995 110.497 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -115.94 8.08 14.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.386 -0.598 . . . . 3.98 109.386 174.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 p -120.98 126.73 50.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 1.6000000000000001 109.786 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 36' ' ' ILE . 88.9 m -74.52 136.25 74.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.91000000000000003 111.686 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 6.0 Cg_exo -79.48 100.69 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.091 2.527 . . . . 0.81999999999999995 110.126 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 t -80.97 20.4 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 2.3700000000000001 111.2 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -86.84 -8.7 57.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.471 -0.566 . . . . 1.8300000000000001 109.471 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.41 -58.15 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 3.3900000000000001 109.98 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.9 30.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.588 -0.733 . . . . 1.1000000000000001 112.149 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -72.17 152.2 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 3.7599999999999998 111.256 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -118.37 -41.09 2.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.118 -0.492 . . . . 1.3300000000000001 111.149 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.5 165.41 23.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.71 -0.757 . . . . 0.81999999999999995 111.959 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 p -143.09 143.72 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.093 0.473 . . . . 1.4399999999999999 111.888 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 42.8 m -122.49 125.6 46.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 1.01 109.764 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.04 132.44 45.95 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.531 -0.842 . . . . 0.81999999999999995 111.585 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.34 166.36 21.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.97 0.385 . . . . 1.97 110.884 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -59.0 100.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 2.3599999999999999 111.197 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp 64.36 29.33 13.61 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.767 0.667 . . . . 1.75 111.207 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.57 -168.87 33.75 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.394 -0.907 . . . . 0.81999999999999995 112.306 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.533 HD12 ' SG ' ' A' ' 20' ' ' CYS . 15.0 tt -136.28 130.3 47.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.437 0.637 . . . . 0.81999999999999995 111.166 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 47.5 t -89.26 96.36 10.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.751 . . . . 1.1100000000000001 108.971 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -100.27 130.9 46.44 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.66 -0.416 . . . . 1.1399999999999999 110.146 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.406 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 55.1 p90 -131.27 157.91 76.75 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.455 . . . . 1.1499999999999999 110.787 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.6 Cg_exo -74.0 157.2 99.5 Favored 'Cis proline' 0 C--O 1.231 0.152 0 C-N-CA 123.611 -1.412 . . . . 0.81999999999999995 111.674 -2.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.711 0.767 . . . . 1.45 110.144 177.667 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 11.9 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.33 0.586 . . . . 1.1299999999999999 110.861 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -107.09 128.09 54.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.865 -0.607 . . . . 1.1200000000000001 110.719 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -135.17 119.07 17.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.01 111.132 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.415 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 45.6 m-85 -80.7 117.81 21.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 1.1799999999999999 111.182 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.1 m -91.53 87.55 6.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.102 -0.703 . . . . 1.2 109.102 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.03 -102.87 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.868 -0.605 . . . . 1.01 112.047 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -100.38 -19.98 16.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.569 0.223 . . . . 3.6499999999999999 111.327 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -97.16 118.37 33.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.898 0.38 . . . . 0.81999999999999995 110.732 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.415 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 7.4 tt -79.82 131.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 1.0600000000000001 110.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.33 173.75 19.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.736 -0.745 . . . . 0.81999999999999995 112.608 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.97 135.04 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.513 -0.551 . . . . 0.81999999999999995 109.513 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.791 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 25.4 t80 -87.28 113.78 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 1.1200000000000001 111.701 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -92.68 102.81 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.469 -0.787 . . . . 0.81999999999999995 109.596 173.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -73.15 130.83 41.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.033 -0.358 . . . . 0.83999999999999997 110.033 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.39 -82.62 0.31 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.031 -0.604 . . . . 1.0700000000000001 111.995 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.5 t -63.81 151.63 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.81999999999999995 111.67 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -112.44 12.08 19.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.883 -0.784 . . . . 3.98 108.883 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -127.93 130.09 47.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.114 -0.948 . . . . 1.6000000000000001 110.108 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.7 m -68.28 128.15 93.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.508 -0.314 . . . . 0.91000000000000003 111.022 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 109.7 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.477 2.118 . . . . 0.81999999999999995 110.454 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -83.42 48.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.432 0.634 . . . . 2.3700000000000001 111.093 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -144.39 25.82 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 1.8300000000000001 110.262 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.42 -54.67 2.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.901 -0.591 . . . . 3.3900000000000001 111.016 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.81 22.28 1.05 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.507 -0.769 . . . . 1.1000000000000001 111.851 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -63.78 147.82 50.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.849 0.357 . . . . 3.7599999999999998 110.916 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -108.76 -43.35 4.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 110.832 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -133.85 175.23 20.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.798 -0.715 . . . . 0.81999999999999995 112.288 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 36' ' ' ILE . 16.4 p -152.1 140.73 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.986 0.422 . . . . 1.4399999999999999 111.817 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.436 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 59.3 m -116.69 133.51 55.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.243 -0.651 . . . . 1.01 109.243 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.59 133.09 17.05 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.532 -0.842 . . . . 0.81999999999999995 111.177 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -130.21 165.22 22.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.626 -0.509 . . . . 1.97 109.626 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -37.53 -69.43 0.12 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.177 0.806 . . . . 2.3599999999999999 113.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -120.76 43.52 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.735 -0.386 . . . . 1.75 110.157 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.0 -158.08 22.77 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.146 -1.026 . . . . 0.81999999999999995 112.694 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.632 HD12 ' HB2' ' A' ' 29' ' ' SER . 13.3 tt -137.37 133.92 46.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.39 0.614 . . . . 0.81999999999999995 111.133 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -93.46 101.26 13.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.1100000000000001 110.135 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -94.1 130.35 40.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.076 -0.511 . . . . 1.1399999999999999 110.907 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.436 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.8 p90 -130.14 157.98 75.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.263 -0.426 . . . . 1.1499999999999999 110.314 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.2 Cg_exo -74.85 153.03 98.95 Favored 'Cis proline' 0 C--O 1.231 0.154 0 C-N-CA 123.863 -1.307 . . . . 0.81999999999999995 111.944 -0.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 41' ' ' VAL . 6.2 p . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.472 0.653 . . . . 1.45 111.078 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.1 p . . . . . 0 C--O 1.234 0.277 0 CA-C-O 121.038 0.447 . . . . 1.1299999999999999 111.86 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m -69.7 131.28 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 110.012 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -135.3 153.26 51.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.797 0.332 . . . . 1.01 110.903 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -136.44 125.3 24.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 1.1799999999999999 110.463 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.22 86.93 2.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.201 -1.037 . . . . 1.2 108.201 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.93 -102.12 1.11 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.224 -0.898 . . . . 1.01 111.654 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.42 -11.39 17.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.468 0.175 . . . . 3.6499999999999999 110.678 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -95.91 118.03 31.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.81999999999999995 110.993 -175.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.0 tt -79.7 130.43 36.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.312 0.577 . . . . 1.0600000000000001 111.189 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -173.45 12.9 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 111.934 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.67 136.1 60.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.142 0.496 . . . . 0.81999999999999995 109.942 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 1.6 t80 -86.28 105.91 16.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.831 -0.622 . . . . 1.1200000000000001 110.516 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.38 104.48 13.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.81999999999999995 109.982 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 61.2 t80 -94.31 103.58 15.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.662 -0.699 . . . . 0.83999999999999997 109.192 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.33 -6.7 5.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.412 -0.899 . . . . 1.0700000000000001 112.242 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -143.54 152.48 41.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.955 -0.387 . . . . 0.81999999999999995 109.955 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.82 12.54 19.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.331 0.586 . . . . 3.98 109.584 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 p -134.35 146.33 49.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 1.6000000000000001 110.055 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 77.5 m -79.58 116.59 61.85 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.91000000000000003 110.364 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.75 126.29 16.42 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.485 2.123 . . . . 0.81999999999999995 111.697 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.0 m -76.06 110.39 10.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 2.3700000000000001 110.517 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.403 HD21 ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -169.95 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.8300000000000001 111.922 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -122.27 -69.38 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.795 -0.362 . . . . 3.3900000000000001 111.583 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.77 36.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.237 -0.982 . . . . 1.1000000000000001 112.959 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.08 130.58 44.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.859 0.361 . . . . 3.7599999999999998 110.178 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.2 m -101.2 -40.35 7.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.228 -0.442 . . . . 1.3300000000000001 110.78 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -124.4 169.92 16.48 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.581 -0.818 . . . . 0.81999999999999995 112.229 -177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.461 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 12.3 p -154.06 133.19 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.39 0.615 . . . . 1.4399999999999999 111.87 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 65.3 m -115.3 120.85 41.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.42 -0.809 . . . . 1.01 109.68 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.24 133.42 48.54 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.81999999999999995 111.842 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -129.92 164.44 24.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.864 0.332 . . . . 1.97 110.865 -176.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -39.37 -59.66 1.04 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.863 1.06 . . . . 2.3599999999999999 113.863 -170.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 3.1 mm? -123.34 28.47 7.05 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.439 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.98 -151.31 9.23 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.514 -1.327 . . . . 0.81999999999999995 113.246 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.25 135.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.81999999999999995 111.178 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 42.5 t -94.2 101.65 13.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.681 -0.69 . . . . 1.1100000000000001 109.576 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.5 m -95.58 129.19 42.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 1.1399999999999999 110.817 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.462 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 42.4 p90 -130.22 157.39 77.34 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 1.1499999999999999 110.468 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.4 Cg_exo -81.89 171.63 55.41 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 123.707 -1.372 . . . . 0.81999999999999995 111.931 -1.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 1.45 110.962 174.719 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.097 0.475 . . . . 1.1299999999999999 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.7 m -110.25 127.83 55.19 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.611 . . . . 1.1200000000000001 109.349 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.36 139.14 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.125 0.488 . . . . 1.01 111.887 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 62.5 m-85 -103.26 111.74 24.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.073 -0.512 . . . . 1.1799999999999999 110.019 173.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.04 100.47 12.58 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.479 -0.563 . . . . 1.2 109.479 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.97 -85.29 0.38 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 1.01 112.003 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -134.23 -0.71 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.799 0.333 . . . . 3.6499999999999999 111.065 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 m -108.39 135.09 50.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.805 0.336 . . . . 0.81999999999999995 110.887 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.403 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.9 tt -93.87 128.11 45.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.601 0.715 . . . . 1.0600000000000001 111.654 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 -178.4 15.95 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.471 -0.786 . . . . 0.81999999999999995 111.826 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.423 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.52 136.78 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.439 -0.578 . . . . 0.81999999999999995 109.439 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -89.85 115.92 27.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 1.1200000000000001 111.648 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -99.12 110.68 23.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.842 -0.617 . . . . 0.81999999999999995 110.427 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -103.22 122.13 44.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.189 -0.671 . . . . 0.83999999999999997 109.189 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 125.4 -32.1 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.183 -0.767 . . . . 1.0700000000000001 111.183 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 t -121.4 146.39 46.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.951 -0.389 . . . . 0.81999999999999995 109.951 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -108.73 14.78 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.348 0.594 . . . . 3.98 109.885 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -128.91 137.07 51.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.532 -0.758 . . . . 1.6000000000000001 109.527 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.3 m -80.34 125.75 80.44 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.612 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.11 97.53 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.726 2.284 . . . . 0.81999999999999995 110.766 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -71.74 4.16 3.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.23 0.538 . . . . 2.3700000000000001 112.329 -173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -79.73 -16.59 55.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.827 -0.624 . . . . 1.8300000000000001 109.358 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -87.19 -11.95 48.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.51 -0.768 . . . . 3.3900000000000001 110.931 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.31 33.23 23.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.944 -0.646 . . . . 1.1000000000000001 113.202 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -70.82 137.29 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.84 0.352 . . . . 3.7599999999999998 110.224 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.7 m -100.32 -43.1 6.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 1.3300000000000001 111.078 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.93 165.99 24.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.742 -0.742 . . . . 0.81999999999999995 112.21 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -137.05 160.74 38.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.879 0.371 . . . . 1.4399999999999999 111.26 -176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 97.8 m -141.77 145.48 34.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.026 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.59 131.33 11.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.008 -0.615 . . . . 0.81999999999999995 112.337 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -127.75 174.06 9.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.331 -0.618 . . . . 1.97 109.331 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.61 92.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.674 0.609 . . . . 2.3599999999999999 111.972 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt 59.67 33.08 21.84 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.566 -0.743 . . . . 1.75 110.657 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.99 178.26 36.13 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 0.81999999999999995 111.583 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.47 135.28 64.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.379 0.609 . . . . 0.81999999999999995 111.039 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.76 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.721 -0.672 . . . . 1.1100000000000001 109.367 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.3 m -105.82 121.96 45.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.612 -0.267 . . . . 1.1399999999999999 111.049 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.58 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.3 p90 -129.27 157.11 77.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 1.1499999999999999 110.982 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.0 Cg_exo -65.28 151.51 76.99 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 123.774 -1.344 . . . . 0.81999999999999995 112.323 -1.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.6 p . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.123 0.487 . . . . 1.45 111.486 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.12 0.486 . . . . 1.1299999999999999 110.959 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -142.97 141.88 31.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 109.905 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.6 p -131.45 159.64 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 1.01 110.819 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.66 102.23 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 1.1799999999999999 110.574 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -89.28 90.49 8.36 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.755 -0.831 . . . . 1.2 108.755 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.68 -117.07 7.36 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 1.01 111.49 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -88.63 -18.38 28.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.552 0.215 . . . . 3.6499999999999999 110.534 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.46 117.23 29.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.142 0.496 . . . . 0.81999999999999995 111.18 -170.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.7 tt -86.81 129.75 37.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.579 -0.737 . . . . 1.0600000000000001 110.028 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.77 162.48 22.9 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.021 -0.609 . . . . 0.81999999999999995 112.131 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.84 132.81 41.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.364 -0.606 . . . . 0.81999999999999995 109.364 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.1 t80 -89.04 103.45 16.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.064 -0.516 . . . . 1.1200000000000001 111.283 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.509 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 97.6 m95 -84.44 81.24 8.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.773 -0.648 . . . . 0.81999999999999995 110.337 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -75.25 118.16 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.738 -0.664 . . . . 0.83999999999999997 109.895 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.01 8.14 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.443 -0.884 . . . . 1.0700000000000001 112.414 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -132.5 153.6 50.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.62 0.248 . . . . 0.81999999999999995 110.571 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 6.88 23.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.208 0.527 . . . . 3.98 109.615 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.0 m -107.23 118.11 35.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.618 -0.719 . . . . 1.6000000000000001 110.393 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -68.48 116.63 42.08 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.91000000000000003 109.531 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 Cg_exo -56.92 120.22 7.99 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.804 2.336 . . . . 0.81999999999999995 111.41 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -84.86 49.39 1.71 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.638 0.732 . . . . 2.3700000000000001 110.732 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -128.22 13.36 6.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.586 -0.734 . . . . 1.8300000000000001 110.007 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -117.94 -55.84 2.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 3.3900000000000001 110.988 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.72 38.2 0.67 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.69 -0.686 . . . . 1.1000000000000001 111.677 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -67.49 141.95 56.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.408 . . . . 3.7599999999999998 110.869 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -112.38 -35.32 5.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.066 -0.516 . . . . 1.3300000000000001 110.63 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.97 175.27 21.21 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.586 -0.816 . . . . 0.81999999999999995 111.494 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 p -156.73 158.28 36.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.946 0.403 . . . . 1.4399999999999999 111.509 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 74.3 m -123.45 114.69 20.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.104 -0.702 . . . . 1.01 109.104 174.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.88 131.52 25.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.766 -0.73 . . . . 0.81999999999999995 111.936 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -135.71 -178.96 5.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.472 0.136 . . . . 1.97 110.933 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -57.66 102.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.632 0.605 . . . . 2.3599999999999999 112.632 -172.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.83 26.27 15.44 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.562 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.93 173.42 35.82 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.508 -0.853 . . . . 0.81999999999999995 111.975 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.61 124.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.445 0.64 . . . . 0.81999999999999995 110.241 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 8.0 t -94.74 98.55 10.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.123 -0.695 . . . . 1.1100000000000001 109.123 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 m -93.76 140.33 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 1.1399999999999999 111.365 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 15.1 p90 -134.23 159.63 71.58 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 116.372 -0.377 . . . . 1.1499999999999999 111.165 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 33.6 Cg_exo -63.32 154.59 70.84 Favored 'Cis proline' 0 N--CA 1.479 0.643 0 C-N-CA 124.107 -1.205 . . . . 0.81999999999999995 112.494 -0.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.418 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.1 p . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.504 0.668 . . . . 1.45 111.853 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.96 -0.385 . . . . 1.1299999999999999 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 m -102.1 142.0 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.546 -0.297 . . . . 1.1200000000000001 110.42 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.57 152.42 51.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.437 . . . . 1.01 111.086 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.0 m-85 -113.6 138.71 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.057 0.456 . . . . 1.1799999999999999 110.581 174.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.3 t -121.57 102.21 8.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.615 -0.883 . . . . 1.2 108.615 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -101.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.151 -0.78 . . . . 1.01 111.151 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' C ' ' HD2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -119.64 -1.88 10.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.576 0.227 . . . . 3.6499999999999999 111.094 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -97.96 136.38 38.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.81999999999999995 111.006 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 tt -96.31 125.15 49.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.689 0.757 . . . . 1.0600000000000001 111.475 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.01 178.65 17.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.16 -0.927 . . . . 0.81999999999999995 112.131 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 135.96 49.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.659 -0.496 . . . . 0.81999999999999995 109.659 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.414 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 11.7 t80 -87.59 104.58 16.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.446 -0.797 . . . . 1.1200000000000001 111.21 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.402 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 94.6 m95 -87.36 90.11 8.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.81999999999999995 110.522 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.414 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.2 t80 -79.5 123.46 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.398 -0.593 . . . . 0.83999999999999997 109.398 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.31 -24.72 8.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.415 -0.898 . . . . 1.0700000000000001 112.597 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -126.08 155.04 42.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.99 0.424 . . . . 0.81999999999999995 110.667 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 15.94 16.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.644 -0.707 . . . . 3.98 109.806 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -131.76 128.08 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.6000000000000001 110.7 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -72.38 126.35 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.258 -0.428 . . . . 0.91000000000000003 111.159 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 12.4 Cg_exo -67.4 101.39 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.763 2.309 . . . . 0.81999999999999995 110.905 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 p -79.27 26.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 2.3700000000000001 111.805 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -91.27 -11.07 39.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.331 -0.395 . . . . 1.8300000000000001 110.649 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -102.35 -74.06 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.418 -0.355 . . . . 3.3900000000000001 111.185 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.22 33.07 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.531 -0.842 . . . . 1.1000000000000001 112.392 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -71.9 125.73 27.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.384 -0.228 . . . . 3.7599999999999998 110.384 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 m -100.86 -49.44 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.085 -0.507 . . . . 1.3300000000000001 110.842 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.426 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -112.4 157.13 15.15 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.622 -0.799 . . . . 0.81999999999999995 112.061 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.493 ' HB3' HD12 ' A' ' 36' ' ' ILE . 11.6 m -139.64 136.29 34.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.858 0.361 . . . . 1.4399999999999999 110.907 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.611 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 81.8 m -129.64 132.88 46.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 1.01 109.689 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 145.78 49.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.149 -0.548 . . . . 0.81999999999999995 112.99 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -136.48 165.46 25.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.886 -0.783 . . . . 1.97 108.886 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -60.26 99.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.052 0.22 . . . . 2.3599999999999999 110.725 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.0 mt 63.09 32.15 15.44 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.825 0.703 . . . . 1.75 111.102 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.22 178.21 39.64 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.89 -0.671 . . . . 0.81999999999999995 111.707 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 29' ' ' SER . 16.8 tt -128.93 131.57 68.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.294 0.569 . . . . 0.81999999999999995 110.93 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.14 105.29 17.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 109.308 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -101.93 123.37 45.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 1.1399999999999999 110.869 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.611 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 42.6 p90 -128.44 158.06 72.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.485 -0.325 . . . . 1.1499999999999999 111.248 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.8 Cg_exo -78.77 161.16 89.64 Favored 'Cis proline' 0 C--O 1.233 0.267 0 C-N-CA 124.058 -1.226 . . . . 0.81999999999999995 112.204 -2.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.142 -0.481 . . . . 1.45 111.105 176.459 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.216 0.531 . . . . 1.1299999999999999 110.58 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.5 m -87.61 137.29 32.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.739 -0.664 . . . . 1.1200000000000001 112.055 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 p -140.07 155.72 46.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.702 -0.481 . . . . 1.01 109.702 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 1.1799999999999999 111.268 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.9 m -110.92 87.67 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.807 -0.812 . . . . 1.2 108.807 170.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.81 -97.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.361 -0.836 . . . . 1.01 111.479 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -108.51 -18.88 13.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.49 0.186 . . . . 3.6499999999999999 111.109 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.411 HG21 ' HB2' ' A' ' 39' ' ' TYR . 7.0 m -90.09 119.31 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.434 -0.506 . . . . 0.81999999999999995 110.731 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tt -82.26 128.29 38.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.603 . . . . 1.0600000000000001 110.379 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.61 -171.53 12.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.933 -0.576 . . . . 0.81999999999999995 112.294 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -121.88 132.7 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.81999999999999995 109.785 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -89.99 109.38 20.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.672 -0.695 . . . . 1.1200000000000001 110.972 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.04 119.34 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.477 -0.783 . . . . 0.81999999999999995 110.456 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -104.13 118.02 35.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.003 -0.74 . . . . 0.83999999999999997 109.003 170.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.72 -21.37 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.284 -0.726 . . . . 1.0700000000000001 111.284 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 t -141.12 161.9 36.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.336 -0.616 . . . . 0.81999999999999995 109.336 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -121.09 20.7 11.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.184 -0.462 . . . . 3.98 110.06 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -135.95 152.83 51.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 1.6000000000000001 109.789 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 83.9 m -84.79 116.37 64.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.502 -0.317 . . . . 0.91000000000000003 111.022 -177.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.94 134.79 44.82 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.684 2.256 . . . . 0.81999999999999995 111.562 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 t -85.9 45.06 1.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.75 0.786 . . . . 2.3700000000000001 110.037 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -97.2 -16.38 20.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 110.091 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -121.18 -80.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 3.3900000000000001 111.211 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 1.1000000000000001 111.053 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 49.2 m-85 -67.87 112.06 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 3.7599999999999998 110.021 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -100.53 -26.32 13.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 1.3300000000000001 110.721 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.538 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -124.41 157.33 18.73 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.263 -0.97 . . . . 0.81999999999999995 111.859 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.554 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 30.0 p -145.05 137.27 25.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.205 0.526 . . . . 1.4399999999999999 111.716 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 74.3 m -117.46 129.41 55.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.616 -0.72 . . . . 1.01 109.448 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.3 118.08 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.736 -0.745 . . . . 0.81999999999999995 111.759 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -116.79 172.92 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.435 -0.209 . . . . 1.97 110.435 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -54.46 104.58 0.11 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 2.3599999999999999 111.542 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.2 mp 56.65 26.92 11.78 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.812 0.695 . . . . 1.75 111.432 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.36 -173.5 32.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.551 -0.833 . . . . 0.81999999999999995 112.225 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -135.38 132.03 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.147 0.499 . . . . 0.81999999999999995 111.387 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.5 t -93.74 106.99 18.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.277 -0.638 . . . . 1.1100000000000001 109.277 176.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 99.7 m -104.34 126.9 51.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.365 -0.38 . . . . 1.1399999999999999 111.166 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 44.1 p90 -124.84 155.68 69.8 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 116.048 -0.524 . . . . 1.1499999999999999 110.852 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 21.1 Cg_exo -67.45 161.22 78.59 Favored 'Cis proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.958 -1.268 . . . . 0.81999999999999995 112.882 -1.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.4 p . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 115.82 -0.627 . . . . 1.45 112.211 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.894 -0.41 . . . . 1.1299999999999999 109.894 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -127.59 144.15 51.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.799 0.333 . . . . 1.1200000000000001 111.556 -171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.64 164.15 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.85 115.97 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.918 0.39 . . . . 1.1799999999999999 110.619 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.19 103.49 15.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.986 -0.746 . . . . 1.2 108.986 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 -93.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.334 -1.106 . . . . 1.01 110.334 -171.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -133.22 5.02 3.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.033 0.444 . . . . 3.6499999999999999 110.249 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 m -87.38 129.17 35.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.886 -0.597 . . . . 0.81999999999999995 110.281 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tt -85.08 115.85 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.37 0.605 . . . . 1.0600000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.71 173.66 16.13 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.548 -0.751 . . . . 0.81999999999999995 112.042 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -111.27 127.0 68.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.408 0.623 . . . . 0.81999999999999995 109.738 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t80 -86.2 109.34 18.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 1.1200000000000001 111.005 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 91.9 m95 -89.83 117.02 28.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.516 -0.765 . . . . 0.81999999999999995 110.266 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -112.52 114.19 26.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.491 -0.559 . . . . 0.83999999999999997 109.491 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.5 -9.53 6.51 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.871 -0.68 . . . . 1.0700000000000001 111.976 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 t -133.06 160.43 37.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.795 0.331 . . . . 0.81999999999999995 110.563 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -116.71 8.61 13.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.474 -0.565 . . . . 3.98 109.474 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.8 m -134.93 132.74 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 1.6000000000000001 111.302 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 86.6 m -67.79 120.62 74.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.91000000000000003 110.315 174.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 43.9 Cg_exo -55.75 116.1 2.92 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.915 2.41 . . . . 0.81999999999999995 111.97 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.8 t -84.84 14.92 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.457 0.646 . . . . 2.3700000000000001 111.3 -174.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -97.35 -1.96 43.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.459 0.647 . . . . 1.8300000000000001 109.267 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -100.0 -59.94 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 3.3900000000000001 110.436 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.43 40.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.86 -0.686 . . . . 1.1000000000000001 112.564 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -69.88 146.36 51.32 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.883 -0.186 . . . . 3.7599999999999998 110.74 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 p -106.98 -14.41 14.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.906 0.384 . . . . 1.3300000000000001 111.061 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.39 170.74 36.46 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.884 -0.674 . . . . 0.81999999999999995 111.74 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.449 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 57.4 p -145.77 150.05 35.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 1.4399999999999999 111.386 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.8 m -123.45 118.29 27.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.838 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.67 111.17 3.91 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.437 -0.665 . . . . 0.81999999999999995 111.437 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.1 178.22 4.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.064 -0.347 . . . . 1.97 110.064 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -52.31 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.201 0.313 . . . . 2.3599999999999999 111.541 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 57.04 25.4 10.7 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.703 -0.681 . . . . 1.75 111.655 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.07 26.93 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.534 -0.841 . . . . 0.81999999999999995 112.281 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 tt -136.11 122.84 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.232 0.539 . . . . 0.81999999999999995 110.616 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 14.0 t -99.76 109.51 21.94 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.618 -0.512 . . . . 1.1100000000000001 109.618 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.3 m -97.66 130.87 44.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.147 -0.479 . . . . 1.1399999999999999 110.369 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -122.81 154.67 63.97 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.52 -0.309 . . . . 1.1499999999999999 110.779 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.42 174.43 48.42 Favored 'Cis proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.604 -1.415 . . . . 0.81999999999999995 112.036 -1.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.8 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.748 0.785 . . . . 1.45 110.849 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.7 p . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.433 0.635 . . . . 1.1299999999999999 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -101.92 136.85 41.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.783 -0.644 . . . . 1.1200000000000001 109.928 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 149.72 35.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 1.01 111.347 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.33 127.64 53.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 1.1799999999999999 110.047 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 t -97.79 95.88 7.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.333 -0.988 . . . . 1.2 108.333 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.98 -92.95 0.56 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.75 -0.94 . . . . 1.01 110.75 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -120.18 -14.28 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.582 0.23 . . . . 3.6499999999999999 110.577 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -78.3 115.19 17.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.88 0.372 . . . . 0.81999999999999995 110.913 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.7 tp -74.71 125.44 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.902 -0.59 . . . . 1.0600000000000001 110.862 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.29 -176.39 17.29 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.899 -0.667 . . . . 0.81999999999999995 112.126 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 134.13 62.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.304 0.573 . . . . 0.81999999999999995 109.699 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.563 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 10.4 t80 -85.38 101.76 12.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 1.1200000000000001 110.612 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.427 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m95 -82.22 107.6 15.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.715 -0.675 . . . . 0.81999999999999995 109.921 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -96.65 101.31 12.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.179 -0.464 . . . . 0.83999999999999997 109.854 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.15 -41.57 1.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.728 -0.748 . . . . 1.0700000000000001 112.83 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -96.44 155.0 16.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.81999999999999995 110.61 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -102.36 -4.94 24.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.791 . . . . 3.98 109.713 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -126.37 133.36 51.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 111.145 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.0 m -70.58 121.15 82.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.824 -0.626 . . . . 0.91000000000000003 110.469 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 53.0 Cg_exo -53.06 108.6 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.96 2.44 . . . . 0.81999999999999995 111.934 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.1 t -74.88 -0.89 20.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.516 0.675 . . . . 2.3700000000000001 111.452 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.05 -13.37 57.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.364 -0.834 . . . . 1.8300000000000001 109.808 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -89.28 -55.26 3.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.81 -0.632 . . . . 3.3900000000000001 110.162 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.12 1.84 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.851 -0.69 . . . . 1.1000000000000001 112.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -63.36 132.66 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.378 . . . . 3.7599999999999998 110.357 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 m -93.65 -26.62 16.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.848 -0.615 . . . . 1.3300000000000001 110.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.34 170.18 27.48 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.708 -0.758 . . . . 0.81999999999999995 111.848 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.604 ' HB2' HD13 ' A' ' 36' ' ' ILE . 13.9 p -139.16 133.9 32.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.44 0.638 . . . . 1.4399999999999999 111.227 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 2.4 t -110.52 106.61 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.568 -0.742 . . . . 1.01 109.458 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.99 123.85 33.78 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.147 -0.549 . . . . 0.81999999999999995 111.876 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.45 170.75 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.04 -0.355 . . . . 1.97 110.04 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -54.42 104.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.664 0.386 . . . . 2.3599999999999999 111.758 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 56.1 28.81 13.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.791 0.682 . . . . 1.75 111.64 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -172.44 34.29 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.759 -0.734 . . . . 0.81999999999999995 111.798 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.604 HD13 ' HB2' ' A' ' 29' ' ' SER . 15.2 tt -138.8 121.45 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.422 0.63 . . . . 0.81999999999999995 111.581 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 15.1 m -83.43 96.3 8.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 1.1100000000000001 110.254 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.61 130.15 34.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.262 -0.426 . . . . 1.1399999999999999 110.924 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -135.63 157.43 76.3 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.123 -0.49 . . . . 1.1499999999999999 111.063 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.79 151.11 93.86 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.603 -1.415 . . . . 0.81999999999999995 111.577 -2.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 122.021 0.915 . . . . 1.45 111.099 -179.171 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 111.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.1 m -134.6 140.04 45.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.385 -0.371 . . . . 1.1200000000000001 110.426 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.77 175.49 9.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.764 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 70.9 m-85 -134.76 132.55 38.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 1.1799999999999999 110.893 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.07 106.86 14.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.152 -0.685 . . . . 1.2 109.152 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.33 -97.06 0.66 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.752 -0.939 . . . . 1.01 110.752 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -130.47 3.4 4.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.924 0.392 . . . . 3.6499999999999999 110.424 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.7 m -93.18 133.08 36.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.216 -0.447 . . . . 0.81999999999999995 110.341 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 tt -85.48 126.0 40.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.438 0.637 . . . . 1.0600000000000001 110.628 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.19 162.3 16.03 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.351 -0.84 . . . . 0.81999999999999995 111.386 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 131.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.382 -0.599 . . . . 0.81999999999999995 109.382 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -86.84 98.07 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.434 -0.803 . . . . 1.1200000000000001 110.911 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.515 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 99.9 m95 -82.83 98.86 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.81 -0.632 . . . . 0.81999999999999995 110.075 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -81.26 127.77 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.603 -0.517 . . . . 0.83999999999999997 109.603 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.28 -68.5 0.25 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.689 -0.767 . . . . 1.0700000000000001 111.886 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 t -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.81999999999999995 110.518 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.61 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.3 tmtt? -97.3 -0.68 46.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.237 -1.023 . . . . 3.98 108.237 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -96.64 107.31 19.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.664 -0.698 . . . . 1.6000000000000001 110.337 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.6 m -59.75 113.4 7.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.872 -0.418 . . . . 0.91000000000000003 109.872 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 77.4 Cg_exo -49.89 114.28 1.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.762 2.308 . . . . 0.81999999999999995 112.252 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -76.95 47.99 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.057 0.932 . . . . 2.3700000000000001 109.604 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 21' ' ' PRO . 54.4 t-20 -111.75 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.304 -1.316 . . . . 1.8300000000000001 108.927 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -52.38 10.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.795 -1.093 . . . . 3.3900000000000001 111.111 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.0 25.15 0.83 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.566 -0.826 . . . . 1.1000000000000001 113.133 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -56.81 131.32 49.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.997 -0.371 . . . . 3.7599999999999998 109.997 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -114.03 -37.18 4.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 111.346 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -102.94 151.46 18.02 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.422 -0.894 . . . . 0.81999999999999995 111.524 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . 19.8 p -143.46 137.33 28.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.093 0.473 . . . . 1.4399999999999999 111.788 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 59.1 m -123.87 132.44 53.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.708 . . . . 1.01 109.687 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.11 134.33 34.13 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.81999999999999995 112.232 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 171.66 14.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.887 0.343 . . . . 1.97 110.99 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -60.66 96.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.9 -0.591 . . . . 2.3599999999999999 111.473 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.991 -0.549 . . . . 1.75 110.697 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.76 -176.16 35.39 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.332 -0.937 . . . . 0.81999999999999995 112.073 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 18' ' ' LYS . 19.2 tt -136.53 137.02 48.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.27 0.557 . . . . 0.81999999999999995 110.872 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 25.3 t -93.3 99.94 12.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.661 -0.699 . . . . 1.1100000000000001 109.32 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.77 119.29 36.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.966 0.412 . . . . 1.1399999999999999 110.642 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 51.5 p90 -122.33 160.74 46.7 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.048 -0.524 . . . . 1.1499999999999999 110.423 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.4 Cg_exo -79.01 156.37 91.69 Favored 'Cis proline' 0 CA--C 1.523 -0.07 0 C-N-CA 124.232 -1.153 . . . . 0.81999999999999995 111.945 -3.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.624 -0.262 . . . . 1.45 110.615 173.656 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.183 0.516 . . . . 1.1299999999999999 111.186 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 m -86.0 134.58 33.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.898 -0.592 . . . . 1.1200000000000001 110.182 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 26.3 p -130.92 165.91 22.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.842 0.353 . . . . 1.01 110.705 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -127.86 112.69 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 1.1799999999999999 110.826 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.25 99.38 12.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.956 -0.757 . . . . 1.2 108.956 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.44 0.9 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.472 -1.051 . . . . 1.01 110.472 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.44 10.62 2.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 109.995 170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.2 m -94.58 119.63 33.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.679 . . . . 0.81999999999999995 109.615 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.5 tt -74.85 129.01 37.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.444 0.64 . . . . 1.0600000000000001 111.418 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.17 -175.37 13.88 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.52 -0.764 . . . . 0.81999999999999995 111.926 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.46 132.63 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.327 0.584 . . . . 0.81999999999999995 109.46 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 15.6 t80 -88.35 112.49 22.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.668 -0.696 . . . . 1.1200000000000001 111.353 -173.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.454 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -97.41 103.74 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.873 -0.603 . . . . 0.81999999999999995 110.357 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -86.95 135.31 33.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.557 -0.292 . . . . 0.83999999999999997 110.229 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.6 -10.81 59.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.525 -0.845 . . . . 1.0700000000000001 113.334 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -123.92 150.46 44.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.003 0.43 . . . . 0.81999999999999995 111.022 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.23 4.58 29.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 3.98 110.425 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -135.51 140.71 44.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 1.6000000000000001 110.14 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.2 m -74.66 139.13 73.96 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.91000000000000003 110.142 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 6.2 Cg_exo -75.37 84.46 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.431 2.088 . . . . 0.81999999999999995 109.7 172.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -71.68 71.73 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.507 0.67 . . . . 2.3700000000000001 111.799 -172.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.434 ' HB2' HH11 ' A' ' 24' ' ' ARG . 40.6 m-80 -130.97 20.93 4.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.038 -0.983 . . . . 1.8300000000000001 108.544 172.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.434 HH11 ' HB2' ' A' ' 23' ' ' ASN . 10.8 mpt_? -129.71 -2.57 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.043 -0.98 . . . . 3.3900000000000001 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.97 30.12 52.35 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.524 -0.846 . . . . 1.1000000000000001 112.516 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -54.52 133.18 46.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.732 0.301 . . . . 3.7599999999999998 110.755 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.9 m -103.43 -45.41 4.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.013 -0.54 . . . . 1.3300000000000001 111.423 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -133.04 171.79 21.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.169 -1.015 . . . . 0.81999999999999995 112.452 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB3' HD13 ' A' ' 36' ' ' ILE . 14.8 m -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 1.4399999999999999 111.546 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -120.09 108.31 14.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.72 -0.673 . . . . 1.01 109.359 172.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.18 138.57 45.31 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.973 -0.632 . . . . 0.81999999999999995 112.099 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.05 -178.28 5.13 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.641 -0.329 . . . . 1.97 110.48 -176.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -65.04 95.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 2.3599999999999999 111.766 -172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 62.28 28.07 16.77 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.533 -0.758 . . . . 1.75 110.707 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.65 -176.26 28.53 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.542 -0.837 . . . . 0.81999999999999995 111.922 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 29' ' ' SER . 15.0 tt -141.35 128.12 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.113 0.483 . . . . 0.81999999999999995 110.626 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -87.78 101.86 14.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 1.1100000000000001 109.447 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.9 m -99.06 120.59 39.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.1399999999999999 110.742 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.511 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 53.3 p90 -119.87 156.56 54.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.259 -0.428 . . . . 1.1499999999999999 109.981 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 31.7 Cg_exo -61.18 158.71 50.65 Favored 'Cis proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.167 -1.18 . . . . 0.81999999999999995 114.033 1.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.31 -0.859 . . . . 1.45 111.036 172.119 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.303 0.573 . . . . 1.1299999999999999 110.579 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.2 m -133.4 139.63 46.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 1.1200000000000001 111.014 -177.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 p -125.99 171.28 10.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.106 -0.702 . . . . 1.01 109.106 176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -127.55 106.6 9.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 1.1799999999999999 110.479 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m -88.2 104.0 16.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.523 -0.917 . . . . 1.2 108.523 174.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.18 -112.46 4.37 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.978 -1.249 . . . . 1.01 109.978 -167.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -114.74 3.15 14.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.26 0.553 . . . . 3.6499999999999999 109.701 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -86.26 119.29 26.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.81999999999999995 110.567 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.98 124.98 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.578 -0.737 . . . . 1.0600000000000001 111.027 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.48 151.03 16.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.852 -0.613 . . . . 0.81999999999999995 111.976 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.55 130.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.284 0.564 . . . . 0.81999999999999995 109.532 -178.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 20.0 t80 -87.95 120.6 29.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.75 -0.659 . . . . 1.1200000000000001 111.426 -174.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -102.9 125.28 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.81999999999999995 110.405 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -116.7 119.11 34.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.689 -0.687 . . . . 0.83999999999999997 109.736 178.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.12 12.81 13.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.513 -0.851 . . . . 1.0700000000000001 112.198 -178.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -155.55 143.27 19.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.81999999999999995 110.669 177.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -90.54 -12.36 37.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 3.98 110.077 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -122.45 141.96 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.209 0.528 . . . . 1.6000000000000001 111.064 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.5 m -72.28 134.71 82.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.631 -0.713 . . . . 0.91000000000000003 109.981 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.24 95.36 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.562 2.175 . . . . 0.81999999999999995 110.294 173.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 t -79.85 66.86 5.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 2.3700000000000001 111.355 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -141.26 15.04 2.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 1.8300000000000001 110.76 173.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -108.53 -54.87 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 3.3900000000000001 109.608 174.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.97 -5.42 0.79 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.282 -0.872 . . . . 1.1000000000000001 112.049 -175.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' HE1' ' HA ' ' A' ' 41' ' ' VAL . 17.7 m-85 -52.2 139.19 24.35 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.596 0.358 . . . . 3.7599999999999998 111.003 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.1 m -132.23 -48.61 0.92 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.291 -0.413 . . . . 1.3300000000000001 111.163 -176.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.68 159.56 25.93 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.822 -0.704 . . . . 0.81999999999999995 112.01 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 m -142.38 154.04 44.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.004 0.431 . . . . 1.4399999999999999 111.282 -177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.3 120.9 20.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.73 . . . . 1.01 109.138 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.96 124.79 37.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.81999999999999995 111.333 177.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -127.49 177.86 6.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.994 0.397 . . . . 1.97 110.547 -173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -53.23 101.74 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 123.56 0.537 . . . . 2.3599999999999999 112.177 -176.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.7 tp 56.76 29.51 16.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.249 -0.887 . . . . 1.75 110.986 176.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -169.05 -163.75 23.6 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.689 -0.767 . . . . 0.81999999999999995 112.129 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -136.02 128.56 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.144 0.497 . . . . 0.81999999999999995 110.702 -177.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 4.9 t -99.2 116.25 30.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.769 -0.826 . . . . 1.1100000000000001 108.769 178.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.56 133.45 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.538 -0.301 . . . . 1.1399999999999999 110.996 -171.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 54.9 p90 -133.5 162.79 55.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.59 -0.277 . . . . 1.1499999999999999 110.549 -177.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.3 Cg_exo -81.68 150.55 75.48 Favored 'Cis proline' 0 C--N 1.342 0.232 0 C-N-CA 124.47 -1.054 . . . . 0.81999999999999995 112.306 -3.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HA ' ' HE1' ' A' ' 26' ' ' TYR . 87.4 t . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.193 0.52 . . . . 1.45 111.077 177.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.3 p . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.1299999999999999 111.521 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 m -99.21 129.64 45.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 1.1200000000000001 110.302 177.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.4 p -132.08 153.6 50.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.877 0.37 . . . . 1.01 111.337 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 39.7 m-85 -120.61 129.78 53.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 1.1799999999999999 110.515 175.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.9 t -123.3 115.81 22.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.585 -0.524 . . . . 1.2 109.585 174.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.85 -91.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.271 -0.732 . . . . 1.01 111.271 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -133.71 -2.31 3.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.975 0.417 . . . . 3.6499999999999999 110.094 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -100.44 134.97 42.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.81999999999999995 111.46 -171.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.532 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -93.64 130.18 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 1.0600000000000001 110.218 177.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.29 -171.32 12.14 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.035 -0.602 . . . . 0.81999999999999995 112.196 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.25 130.44 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.369 0.604 . . . . 0.81999999999999995 109.42 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 6.8 t80 -87.6 109.8 19.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.609 -0.723 . . . . 1.1200000000000001 111.145 -176.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -87.79 102.51 14.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.73 -0.668 . . . . 0.81999999999999995 110.379 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -83.07 105.91 14.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.83999999999999997 109.727 174.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.49 -61.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.638 -0.792 . . . . 1.0700000000000001 112.046 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t -86.77 161.03 18.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.003 0.43 . . . . 0.81999999999999995 110.655 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.1 tmtp? -116.78 11.56 14.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.9 -0.778 . . . . 3.98 108.9 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -139.34 141.06 37.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.694 -0.685 . . . . 1.6000000000000001 110.278 178.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 90.5 m -77.27 117.98 68.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.477 -0.329 . . . . 0.91000000000000003 111.079 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.11 85.24 0.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.073 1.848 . . . . 0.81999999999999995 109.896 172.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -82.15 52.42 2.0 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.746 0.784 . . . . 2.3700000000000001 110.681 -172.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.54 24.19 8.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.99 -1.004 . . . . 1.8300000000000001 108.773 172.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -132.74 -76.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.895 -1.048 . . . . 3.3900000000000001 110.22 -178.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.55 27.59 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.554 -0.831 . . . . 1.1000000000000001 113.162 176.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -71.43 135.83 47.39 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 122.6 -0.353 . . . . 3.7599999999999998 110.886 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -104.67 -38.32 6.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.987 0.423 . . . . 1.3300000000000001 111.071 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 176.26 24.7 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.764 -0.731 . . . . 0.81999999999999995 112.219 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 43.7 p -139.44 171.57 14.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.925 0.393 . . . . 1.4399999999999999 111.251 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 5.5 t -149.75 131.28 14.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.01 109.06 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.21 129.04 34.3 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.599 -0.81 . . . . 0.81999999999999995 111.855 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.98 168.99 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.858 0.329 . . . . 1.97 110.474 -176.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -53.98 102.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.106 -0.497 . . . . 2.3599999999999999 111.393 -178.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.92 26.39 14.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.506 0.504 . . . . 1.75 111.621 177.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.29 -170.13 30.8 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.254 -0.974 . . . . 0.81999999999999995 112.499 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 29' ' ' SER . 14.7 tt -132.62 132.69 59.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.81999999999999995 111.014 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 52.4 t -92.73 111.56 23.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.4 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.3 m -103.07 120.62 41.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.766 0.317 . . . . 1.1399999999999999 111.442 -175.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 24.0 p90 -124.92 155.55 70.26 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.343 -0.39 . . . . 1.1499999999999999 110.905 -177.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.9 Cg_exo -66.75 163.12 72.27 Favored 'Cis proline' 0 N--CA 1.474 0.342 0 C-N-CA 123.697 -1.376 . . . . 0.81999999999999995 111.947 -2.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.702 0.763 . . . . 1.45 110.203 176.173 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 19.3 p . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 121.328 0.585 . . . . 1.1299999999999999 110.619 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -141.16 139.27 33.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.614 -0.721 . . . . 1.1200000000000001 110.877 -174.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.9 p -122.72 172.05 8.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.26 93.27 3.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.66 -0.496 . . . . 1.1799999999999999 109.66 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.64 101.47 5.75 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.27 -104.48 1.51 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.799 -1.32 . . . . 1.01 109.799 -168.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -122.36 6.5 9.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.802 0.334 . . . . 3.6499999999999999 110.205 171.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.37 121.15 31.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.81999999999999995 110.836 -178.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tt -71.75 121.45 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.695 -0.684 . . . . 1.0600000000000001 110.738 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.77 154.33 16.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.526 -0.761 . . . . 0.81999999999999995 111.474 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.45 132.04 56.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.212 0.53 . . . . 0.81999999999999995 109.691 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.752 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 18.1 t80 -85.12 112.1 20.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 1.1200000000000001 111.602 -173.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -95.97 131.51 42.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.81999999999999995 110.095 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -112.35 138.12 49.53 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.649 -0.5 . . . . 0.83999999999999997 109.649 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.18 -50.38 0.9 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.668 -0.777 . . . . 1.0700000000000001 111.903 -178.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -87.17 149.8 24.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.929 0.395 . . . . 0.81999999999999995 110.428 176.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.3 8.8 16.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 3.98 109.459 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -130.23 141.13 50.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.309 -0.859 . . . . 1.6000000000000001 110.177 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -72.38 114.74 32.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.089 -0.337 . . . . 0.91000000000000003 110.089 177.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.31 135.95 52.88 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.521 2.148 . . . . 0.81999999999999995 112.416 -176.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 56.03 2.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.567 -0.742 . . . . 2.3700000000000001 110.213 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -119.2 -16.62 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.718 -0.674 . . . . 1.8300000000000001 111.131 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -124.97 -26.8 3.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 3.3900000000000001 110.99 175.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 31.29 7.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.418 -0.896 . . . . 1.1000000000000001 112.202 -177.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -51.17 125.87 15.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.813 0.339 . . . . 3.7599999999999998 110.458 177.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -106.89 -4.04 19.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.122 0.486 . . . . 1.3300000000000001 111.183 -169.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -148.46 158.21 27.59 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.704 -0.76 . . . . 0.81999999999999995 111.678 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.49 ' HB2' HD13 ' A' ' 36' ' ' ILE . 50.3 p -137.44 138.43 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.17 0.51 . . . . 1.4399999999999999 111.766 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 94.0 m -120.84 114.02 20.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.174 172.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.01 141.55 47.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.174 -0.466 . . . . 0.81999999999999995 113.086 -177.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.81 175.72 9.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.952 -0.388 . . . . 1.97 109.952 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -56.72 98.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.575 0.547 . . . . 2.3599999999999999 111.724 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt 60.39 18.37 8.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.026 -0.534 . . . . 1.75 111.198 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.63 -174.37 17.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.992 -0.623 . . . . 0.81999999999999995 111.893 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 29' ' ' SER . 14.8 tt -143.86 126.57 11.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.279 0.561 . . . . 0.81999999999999995 110.662 -178.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.08 106.27 18.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.983 -0.747 . . . . 1.1100000000000001 108.983 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.52 136.08 38.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.087 0.47 . . . . 1.1399999999999999 111.349 -173.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.3 p90 -129.08 159.9 66.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 1.1499999999999999 110.286 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 86.6 Cg_endo -90.66 156.74 28.58 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.421 -1.491 . . . . 0.81999999999999995 112.349 -2.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.065 -0.717 . . . . 1.45 109.065 173.432 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.436 0.636 . . . . 1.1299999999999999 109.999 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -91.82 128.62 37.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 1.1200000000000001 112.151 -168.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.83 148.72 34.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.588 -0.523 . . . . 1.01 109.588 172.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.2 125.04 52.91 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.184 -0.206 . . . . 1.1799999999999999 110.623 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.2 m -89.63 95.42 10.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.386 -0.968 . . . . 1.2 108.386 171.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -83.48 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.053 -0.594 . . . . 1.01 111.795 -177.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -141.76 19.76 2.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 3.6499999999999999 110.104 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -116.35 131.26 56.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.81999999999999995 110.586 178.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 tp -82.5 115.26 24.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.533 0.683 . . . . 1.0600000000000001 111.751 -175.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.62 173.62 17.03 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.384 -0.826 . . . . 0.81999999999999995 112.234 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.87 130.33 63.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.493 -0.558 . . . . 0.81999999999999995 109.493 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -84.07 108.99 17.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.775 . . . . 1.1200000000000001 111.378 -174.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.24 102.08 14.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.569 -0.741 . . . . 0.81999999999999995 110.389 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -89.38 121.26 31.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.24 -0.437 . . . . 0.83999999999999997 110.006 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.56 -29.94 5.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.489 -0.862 . . . . 1.0700000000000001 112.916 178.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -107.41 149.79 27.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.154 0.502 . . . . 0.81999999999999995 110.732 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -100.88 1.62 40.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.359 -0.837 . . . . 3.98 110.091 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -139.85 152.56 46.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.882 -0.599 . . . . 1.6000000000000001 110.407 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.3 m -83.66 119.86 74.36 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.91000000000000003 110.666 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.22 96.85 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.88 1.72 . . . . 0.81999999999999995 109.589 170.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 t -82.17 63.05 6.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.555 0.693 . . . . 2.3700000000000001 110.631 -172.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -107.67 -1.46 21.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 1.8300000000000001 110.078 177.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HD2' ' OH ' ' A' ' 26' ' ' TYR . 91.3 mtt180 -125.98 21.25 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 3.3900000000000001 110.611 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.75 38.08 89.34 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.031 -0.604 . . . . 1.1000000000000001 113.311 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 24' ' ' ARG . 20.9 m-85 -68.35 120.21 14.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.032 0.416 . . . . 3.7599999999999998 110.014 177.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 m -94.76 -33.81 12.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.851 -0.613 . . . . 1.3300000000000001 111.345 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.73 174.07 25.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.218 -0.991 . . . . 0.81999999999999995 112.311 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.24 159.03 35.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.961 0.41 . . . . 1.4399999999999999 111.185 -178.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 29.8 p -134.45 142.44 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.247 -0.649 . . . . 1.01 109.247 174.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.36 132.57 27.77 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.059 -0.591 . . . . 0.81999999999999995 112.122 -177.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.27 16.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.816 0.341 . . . . 1.97 110.697 -175.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -56.9 106.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.624 . . . . 2.3599999999999999 111.233 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 58.88 21.86 9.59 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.754 0.659 . . . . 1.75 111.898 177.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -173.08 32.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.436 -0.888 . . . . 0.81999999999999995 112.134 -177.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.5 134.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.807 0.337 . . . . 0.81999999999999995 110.65 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 44.1 t -98.86 108.88 21.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.495 -0.558 . . . . 1.1100000000000001 109.495 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.9 m -104.97 127.3 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.385 -0.37 . . . . 1.1399999999999999 111.081 -174.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.447 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.7 p90 -120.29 159.69 46.62 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.287 -0.415 . . . . 1.1499999999999999 111.061 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 95.1 Cg_endo -92.04 160.49 25.79 Favored 'Cis proline' 0 C--N 1.344 0.303 0 C-N-CA 124.005 -1.248 . . . . 0.81999999999999995 113.006 -0.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.45 110.422 173.856 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.066 0.46 . . . . 1.1299999999999999 111.084 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -76.71 148.69 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.068 0.461 . . . . 1.1200000000000001 110.075 178.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.22 115.4 5.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.914 0.388 . . . . 1.01 110.618 -175.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 35.7 m-85 -97.33 109.19 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.479 -0.328 . . . . 1.1799999999999999 111.041 -178.001 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.2 m -86.81 98.2 11.05 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.545 -0.909 . . . . 1.2 108.545 171.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.81 -111.77 4.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.395 -0.821 . . . . 1.01 111.499 -172.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -89.83 -22.86 21.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.518 0.199 . . . . 3.6499999999999999 111.287 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -91.82 118.61 30.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.18 0.514 . . . . 0.81999999999999995 111.639 -168.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 5.4 tt -78.32 123.56 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 1.0600000000000001 110.859 177.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.23 -169.44 12.56 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 111.06 -0.816 . . . . 0.81999999999999995 111.06 176.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 132.91 68.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.178 0.513 . . . . 0.81999999999999995 110.02 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 6.7 t80 -88.82 106.17 18.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.554 -0.748 . . . . 1.1200000000000001 111.068 -176.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.427 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 89.8 m95 -87.15 95.91 10.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.81999999999999995 110.329 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.1 t80 -78.79 109.82 13.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.422 -0.584 . . . . 0.83999999999999997 109.422 175.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.39 -61.45 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.88 -0.676 . . . . 1.0700000000000001 112.143 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -86.79 160.19 18.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.88 0.372 . . . . 0.81999999999999995 110.578 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.39 11.5 14.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 3.98 109.589 178.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.3 t -129.47 145.93 51.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 1.6000000000000001 110.3 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 70.9 m -82.87 124.76 76.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.91000000000000003 110.105 178.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 33.5 Cg_exo -57.36 113.47 1.51 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.638 2.225 . . . . 0.81999999999999995 111.104 176.098 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -77.01 43.42 0.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 2.3700000000000001 111.947 -172.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -128.44 16.75 6.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.928 0.394 . . . . 1.8300000000000001 110.789 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -123.09 -42.25 2.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.84 0.352 . . . . 3.3900000000000001 111.102 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.28 32.11 3.57 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.752 -0.737 . . . . 1.1000000000000001 112.044 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -56.25 131.42 47.89 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.879 0.371 . . . . 3.7599999999999998 110.557 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -85.2 -40.66 16.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.087 -0.506 . . . . 1.3300000000000001 110.943 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.23 165.31 26.35 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.672 -0.775 . . . . 0.81999999999999995 111.651 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.495 ' HB2' HD12 ' A' ' 36' ' ' ILE . 69.0 p -140.66 134.47 30.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 1.4399999999999999 110.989 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 57.0 m -106.07 110.93 23.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.567 -0.742 . . . . 1.01 109.496 178.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.6 113.47 3.89 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.171 -0.772 . . . . 0.81999999999999995 111.171 176.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -112.84 164.47 13.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.041 -0.355 . . . . 1.97 110.041 -172.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -56.9 104.9 0.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.082 -0.508 . . . . 2.3599999999999999 110.675 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt 65.03 28.62 12.42 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.683 0.614 . . . . 1.75 111.307 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.79 -168.72 35.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.496 -0.859 . . . . 0.81999999999999995 112.268 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 29' ' ' SER . 17.4 tt -138.13 132.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.81999999999999995 111.071 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 48.6 t -94.77 100.58 12.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.674 -0.694 . . . . 1.1100000000000001 109.751 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.03 121.05 39.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.464 -0.334 . . . . 1.1399999999999999 110.933 -176.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -128.1 153.52 78.56 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 1.1499999999999999 110.927 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.83 154.05 46.45 Favored 'Cis proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.286 -1.547 . . . . 0.81999999999999995 112.498 -1.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.048 -0.524 . . . . 1.45 110.165 177.272 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 111.999 -0.44 . . . . 2.96 111.999 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.4 41.55 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.268 0.556 . . . . 1.1299999999999999 111.385 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.7 m -103.27 126.86 50.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.1200000000000001 109.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.13 127.3 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.334 0.588 . . . . 1.01 110.9 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -91.38 119.46 31.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.491 . . . . 1.1799999999999999 110.812 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -94.8 104.24 16.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.112 -0.699 . . . . 1.2 109.112 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.12 -96.47 0.61 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.511 -0.852 . . . . 1.01 111.075 -173.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -128.84 0.33 5.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 3.6499999999999999 110.638 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -92.35 130.68 37.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.352 -0.386 . . . . 0.81999999999999995 110.608 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -79.53 114.31 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 1.0600000000000001 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.41 165.91 12.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.656 -0.702 . . . . 0.81999999999999995 111.862 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.56 134.19 54.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.278 0.561 . . . . 0.81999999999999995 109.866 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -87.29 106.13 17.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.472 -0.786 . . . . 1.1200000000000001 111.168 -175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.403 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -88.47 108.39 19.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.814 -0.63 . . . . 0.81999999999999995 110.618 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -96.88 114.29 25.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.83999999999999997 109.815 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.86 -16.58 6.13 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.271 -0.966 . . . . 1.0700000000000001 113.08 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.4 t -135.55 156.66 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.81999999999999995 110.87 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.42 0.63 23.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 3.98 109.878 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 m -116.76 118.99 34.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 1.6000000000000001 111.144 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 71.7 m -61.29 120.51 55.71 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 47.6 Cg_exo -53.43 108.24 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.652 2.235 . . . . 0.81999999999999995 111.116 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -79.18 36.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.916 -0.584 . . . . 2.3700000000000001 111.896 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -123.89 13.68 9.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.386 0.612 . . . . 1.8300000000000001 109.47 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -108.75 -74.37 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.481 -0.781 . . . . 3.3900000000000001 110.831 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.1 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.356 -0.838 . . . . 1.1000000000000001 111.63 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.58 149.58 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 3.7599999999999998 110.566 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 m -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.091 -0.504 . . . . 1.3300000000000001 110.549 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.67 160.72 22.81 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.442 -0.885 . . . . 0.81999999999999995 112.072 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 36' ' ' ILE . 33.0 p -142.1 136.34 30.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.101 0.476 . . . . 1.4399999999999999 111.746 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 61.2 m -107.16 128.16 54.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.624 -0.716 . . . . 1.01 109.986 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 105.87 1.69 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.692 -0.766 . . . . 0.81999999999999995 111.334 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -105.74 173.14 6.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.173 -0.306 . . . . 1.97 110.173 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -54.35 102.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.445 -0.343 . . . . 2.3599999999999999 111.615 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp 58.33 28.41 16.68 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.019 0.824 . . . . 1.75 111.143 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.27 -173.4 33.81 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.039 -0.601 . . . . 0.81999999999999995 111.687 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 29' ' ' SER . 16.0 tt -136.25 128.51 45.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.282 0.563 . . . . 0.81999999999999995 111.416 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 22.1 m -92.05 102.8 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 110.378 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.3 m -97.92 125.37 42.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.477 -0.329 . . . . 1.1399999999999999 110.532 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -128.46 156.41 77.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 1.1499999999999999 111.111 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.16 162.56 83.66 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.669 -1.388 . . . . 0.81999999999999995 112.377 -2.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.74 96.09 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.238 -0.437 . . . . 1.45 110.385 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.476 -0.773 . . . . 3.0800000000000001 110.155 -179.515 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.28 -0.328 . . . . 2.96 112.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -84.42 65.3 8.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.607 0.718 . . . . 1.1299999999999999 111.07 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m -146.43 136.39 23.44 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.439 -0.801 . . . . 1.1200000000000001 109.398 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 p -129.26 161.61 29.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.024 0.44 . . . . 1.01 110.716 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -111.67 93.43 4.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 1.1799999999999999 109.598 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.72 107.82 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.89 -100.87 0.73 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.446 -0.662 . . . . 1.01 111.446 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.88 23.18 5.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 110.16 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -124.2 127.79 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.81999999999999995 110.778 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tt -83.97 124.24 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.537 0.684 . . . . 1.0600000000000001 110.683 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -130.67 161.2 23.33 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.464 -0.789 . . . . 0.81999999999999995 111.864 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.31 132.02 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.81999999999999995 109.739 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 10.3 t80 -86.92 106.58 17.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 1.1200000000000001 111.104 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -84.49 107.74 16.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.81999999999999995 110.121 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -90.35 119.35 30.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.486 -0.561 . . . . 0.83999999999999997 109.486 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.01 -60.63 0.46 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 1.0700000000000001 111.862 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -91.89 134.24 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.106 0.479 . . . . 0.81999999999999995 110.288 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -108.65 23.63 14.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.642 0.734 . . . . 3.98 109.455 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.8 p -124.11 130.18 52.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.875 -1.057 . . . . 1.6000000000000001 109.916 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.9 m -78.7 125.3 84.52 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.576 -0.284 . . . . 0.91000000000000003 111.054 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.09 110.5 1.76 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.878 2.386 . . . . 0.81999999999999995 111.272 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -79.6 66.08 4.96 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.315 0.579 . . . . 2.3700000000000001 110.981 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -157.66 23.74 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 1.8300000000000001 110.357 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -130.21 -49.82 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 3.3900000000000001 111.538 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.01 10.01 1.4 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.981 -0.628 . . . . 1.1000000000000001 111.971 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 23.5 m-85 -69.62 120.83 15.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.919 -0.4 . . . . 3.7599999999999998 109.919 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -115.68 -24.19 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.099 0.476 . . . . 1.3300000000000001 110.889 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 158.48 22.55 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.942 -0.863 . . . . 0.81999999999999995 110.942 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.03 139.4 48.56 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.313 0.556 . . . . 1.4399999999999999 111.738 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -115.77 95.3 5.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.447 -0.946 . . . . 1.01 108.447 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.67 131.17 39.69 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.407 -0.425 . . . . 0.81999999999999995 112.317 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -132.42 169.11 17.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.961 0.41 . . . . 1.97 111.066 -173.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -59.67 111.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 2.3599999999999999 111.118 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.2 mt 64.88 24.44 12.74 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.748 0.655 . . . . 1.75 111.57 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.8 -159.76 23.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.704 -1.236 . . . . 0.81999999999999995 112.936 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.45 125.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.81999999999999995 110.85 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 t -92.43 94.66 9.22 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.744 -0.836 . . . . 1.1100000000000001 108.744 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 1.5 t -93.48 136.53 33.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.161 -0.472 . . . . 1.1399999999999999 110.405 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 36.1 p90 -134.03 161.14 65.52 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 111.232 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 2.3 Cg_endo -82.32 154.94 77.39 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.613 -1.411 . . . . 0.81999999999999995 111.555 -3.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.07 61.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 122.211 1.005 . . . . 1.45 109.437 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 114.796 -1.093 . . . . 3.0800000000000001 110.672 -173.184 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 112.02 -0.432 . . . . 2.96 112.02 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.2 p -90.04 48.73 1.61 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.28 0.562 . . . . 1.1299999999999999 110.938 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 m -106.15 127.77 53.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.1200000000000001 111.368 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 p -145.82 136.08 23.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.972 0.415 . . . . 1.01 110.9 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.42 136.42 38.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 1.1799999999999999 111.66 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.8 m -119.14 105.05 11.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.316 -0.856 . . . . 1.2 108.737 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.95 -115.36 7.16 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.806 -0.917 . . . . 1.01 110.806 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -102.0 -12.89 17.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.654 -0.499 . . . . 3.6499999999999999 109.654 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.471 HG21 ' HB2' ' A' ' 39' ' ' TYR . 7.3 m -83.21 119.65 24.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.523 -0.762 . . . . 0.81999999999999995 111.241 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' A' ' 41' ' ' VAL . 4.1 tp -73.98 121.86 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0600000000000001 110.286 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.05 159.07 15.15 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.667 -0.697 . . . . 0.81999999999999995 112.011 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.1 130.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.478 0.656 . . . . 0.81999999999999995 109.741 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -84.36 97.67 9.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.207 -0.906 . . . . 1.1200000000000001 110.88 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -79.9 88.98 5.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.694 -0.684 . . . . 0.81999999999999995 110.181 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -84.17 104.13 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.186 -0.672 . . . . 0.83999999999999997 109.186 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.86 -48.33 0.64 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.953 -0.642 . . . . 1.0700000000000001 111.707 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -107.57 165.73 11.2 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.907 -0.405 . . . . 0.81999999999999995 109.907 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -122.22 11.05 10.06 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.975 -0.75 . . . . 3.98 108.975 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -127.44 125.29 40.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.431 -0.804 . . . . 1.6000000000000001 110.55 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.5 m -67.9 123.58 87.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.109 -0.33 . . . . 0.91000000000000003 110.109 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 108.05 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.589 2.192 . . . . 0.81999999999999995 111.275 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.4 m -79.75 58.62 2.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.03 0.443 . . . . 2.3700000000000001 111.888 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -149.23 22.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 1.8300000000000001 111.153 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 62.4 mtt180 -133.46 -49.17 0.84 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.862 0.363 . . . . 3.3900000000000001 111.323 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.99 22.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.738 -0.744 . . . . 1.1000000000000001 112.718 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -70.23 111.8 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.841 -0.429 . . . . 3.7599999999999998 109.841 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 m -93.33 -28.52 16.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.0 -0.546 . . . . 1.3300000000000001 110.94 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.22 167.48 24.68 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.55 -0.833 . . . . 0.81999999999999995 112.33 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.5 p -144.41 144.47 31.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.143 0.496 . . . . 1.4399999999999999 110.908 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 76.0 m -121.32 129.18 52.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 1.01 109.719 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.39 115.26 6.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.896 -0.882 . . . . 0.81999999999999995 110.896 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -117.78 167.74 11.1 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.724 -0.473 . . . . 1.97 109.724 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -54.39 101.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.93 -0.577 . . . . 2.3599999999999999 111.408 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.3 mt 63.77 22.29 13.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.522 -0.763 . . . . 1.75 111.905 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.89 -178.98 35.35 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.573 -0.822 . . . . 0.81999999999999995 112.123 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.9 126.58 62.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.214 0.531 . . . . 0.81999999999999995 111.128 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 57.2 m -90.25 107.61 19.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.559 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.1 125.77 46.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.939 -0.393 . . . . 1.1399999999999999 109.939 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HB2' HG21 ' A' ' 9' ' ' THR . 45.1 p90 -128.62 155.37 79.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.528 -0.306 . . . . 1.1499999999999999 110.82 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.38 161.66 92.09 Favored 'Cis proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.996 -1.252 . . . . 0.81999999999999995 112.568 -1.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' CG2' HG13 ' A' ' 10' ' ' ILE . 97.9 t -61.05 104.21 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 121.023 0.439 . . . . 1.45 111.262 174.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 22.6 t70 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.223 -0.894 . . . . 3.0800000000000001 109.248 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.197 -0.361 . . . . 2.96 112.197 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -93.29 23.82 4.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.04 0.448 . . . . 1.1299999999999999 111.926 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 m -76.37 117.9 18.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.764 -0.458 . . . . 1.1200000000000001 109.764 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.1 t -121.77 109.09 14.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.137 0.494 . . . . 1.01 111.754 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 55.4 m-85 -85.77 109.7 18.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.174 -0.466 . . . . 1.1799999999999999 110.2 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.51 101.86 13.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.2 108.09 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.51 -118.12 8.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.613 -0.803 . . . . 1.01 111.102 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -107.04 10.33 30.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.857 0.361 . . . . 3.6499999999999999 110.997 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 39' ' ' TYR . 11.9 m -108.82 117.23 33.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.362 -0.535 . . . . 0.81999999999999995 110.476 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.4 tt -81.27 123.28 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.679 . . . . 1.0600000000000001 110.851 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -131.39 -172.83 13.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 111.706 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.2 131.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.399 0.618 . . . . 0.81999999999999995 109.843 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -86.4 106.75 17.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.296 -0.865 . . . . 1.1200000000000001 110.833 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -88.17 112.8 23.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 110.049 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -89.91 135.98 33.32 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.964 -0.384 . . . . 0.83999999999999997 109.964 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.5 -53.51 0.77 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 1.0700000000000001 112.654 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -83.36 154.11 24.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.81999999999999995 110.422 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.5 mptt -109.63 -2.88 17.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 3.98 109.257 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -130.24 159.0 38.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.524 -0.762 . . . . 1.6000000000000001 110.012 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.5 m -88.07 121.83 70.33 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.536 -0.302 . . . . 0.91000000000000003 110.941 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -63.11 105.75 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.078 1.852 . . . . 0.81999999999999995 110.459 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.5 m -79.08 68.72 5.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.987 -0.551 . . . . 2.3700000000000001 111.128 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.56 13.46 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 1.8300000000000001 111.341 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 3.5 mpt_? -128.64 -82.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 3.3900000000000001 110.958 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.67 27.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.621 -0.718 . . . . 1.1000000000000001 111.924 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -70.48 153.2 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.145 -0.317 . . . . 3.7599999999999998 110.145 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.1 m -129.66 -55.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.012 -0.275 . . . . 1.3300000000000001 111.504 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.68 17.4 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.799 . . . . 0.81999999999999995 111.716 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 p -138.18 140.14 39.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.281 0.562 . . . . 1.4399999999999999 111.655 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.679 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 61.1 m -116.92 136.95 52.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.631 -0.713 . . . . 1.01 109.473 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.44 127.15 28.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.684 -0.77 . . . . 0.81999999999999995 111.506 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -129.29 171.37 12.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.804 -0.443 . . . . 1.97 109.804 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -54.48 103.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.455 0.472 . . . . 2.3599999999999999 111.49 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 56.92 25.35 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.391 -0.822 . . . . 1.75 111.857 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.53 177.15 37.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.075 -1.059 . . . . 0.81999999999999995 112.604 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 tt -118.37 124.2 72.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.579 0.704 . . . . 0.81999999999999995 110.94 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.8 t -88.43 95.51 10.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.414 -0.812 . . . . 1.1100000000000001 109.694 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.1 t -101.11 124.49 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.907 0.384 . . . . 1.1399999999999999 111.056 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.679 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 28.3 p90 -126.46 162.04 48.93 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 1.1499999999999999 110.571 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -82.66 167.0 68.05 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 124.481 -1.05 . . . . 0.81999999999999995 112.835 -1.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.29 101.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 1.45 110.832 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 25.9 t70 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.526 -0.916 . . . . 3.0800000000000001 108.526 169.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.747 -0.541 . . . . 2.96 111.747 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -69.13 115.87 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.469 . . . . 1.1299999999999999 110.69 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.1 m -75.76 124.99 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.484 -0.78 . . . . 1.1200000000000001 111.516 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.4 t -138.55 154.53 48.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.697 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -133.42 129.0 36.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 1.1799999999999999 111.563 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -112.33 102.53 10.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.607 -0.724 . . . . 1.2 109.202 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.8 -86.79 0.45 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -138.1 -0.51 2.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 3.6499999999999999 109.937 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -85.7 124.97 32.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.81999999999999995 110.381 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.405 HG13 ' CG1' ' A' ' 41' ' ' VAL . 3.6 tp -79.75 121.84 33.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.491 0.662 . . . . 1.0600000000000001 110.827 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.1 -176.01 14.26 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.49 -0.777 . . . . 0.81999999999999995 111.708 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.5 134.04 61.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.479 0.657 . . . . 0.81999999999999995 110.238 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 16.4 t80 -89.6 102.51 15.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.364 -0.835 . . . . 1.1200000000000001 111.176 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -83.2 98.23 9.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.025 -0.534 . . . . 0.81999999999999995 110.777 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.61 102.35 14.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.896 0.379 . . . . 0.83999999999999997 110.184 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.84 -51.22 0.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.782 -0.723 . . . . 1.0700000000000001 111.708 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 t -90.44 158.1 17.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.899 0.381 . . . . 0.81999999999999995 110.337 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.6 mptt -116.52 17.99 15.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.646 . . . . 3.98 109.502 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -147.17 146.94 30.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.114 -0.493 . . . . 1.6000000000000001 110.553 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.0 m -80.11 124.33 82.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.148 -0.478 . . . . 0.91000000000000003 110.685 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.12 130.13 29.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.87 2.38 . . . . 0.81999999999999995 112.012 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 m -83.74 55.3 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.299 -0.41 . . . . 2.3700000000000001 111.548 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -141.8 0.53 1.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.741 0.305 . . . . 1.8300000000000001 111.476 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.942 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.6 -44.78 3.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.983 0.42 . . . . 3.3900000000000001 111.627 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 38.46 1.68 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.464 -0.654 . . . . 1.1000000000000001 111.464 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -71.09 138.39 49.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.622 0.248 . . . . 3.7599999999999998 110.69 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.5 t -106.78 -12.87 15.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.442 -0.344 . . . . 1.3300000000000001 110.713 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.67 170.47 38.23 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.745 -1.217 . . . . 0.81999999999999995 113.027 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 9.3 p -143.05 144.78 32.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.936 0.398 . . . . 1.4399999999999999 111.013 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 63.1 m -125.28 134.61 52.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.026 -0.534 . . . . 1.01 110.173 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 121.76 7.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.638 -0.792 . . . . 0.81999999999999995 112.119 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.12 171.94 9.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.455 0.169 . . . . 1.97 110.722 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -56.2 104.32 0.14 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 2.3599999999999999 111.714 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.95 27.09 14.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.307 -0.86 . . . . 1.75 112.028 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.56 170.68 35.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.374 -0.917 . . . . 0.81999999999999995 112.761 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 tt -116.55 130.81 70.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.81999999999999995 110.339 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.7 t -96.23 102.23 13.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.05 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.05 122.19 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.816 0.341 . . . . 1.1399999999999999 110.681 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -122.18 151.19 58.39 Favored Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.225 -0.443 . . . . 1.1499999999999999 110.321 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -86.16 160.41 56.81 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.063 -1.641 . . . . 0.81999999999999995 112.045 0.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.405 ' CG1' HG13 ' A' ' 10' ' ' ILE . 5.6 p -73.2 91.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.734 0.778 . . . . 1.45 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.942 ' HB3' ' HG3' ' A' ' 24' ' ' ARG . 24.6 t70 . . . . . 0 C--O 1.246 0.87 0 CA-C-N 115.208 -0.906 . . . . 3.0800000000000001 110.442 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 111.853 -0.499 . . . . 2.96 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p -112.41 30.64 6.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.069 0.461 . . . . 1.1299999999999999 111.129 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.1 m -74.38 121.91 22.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.5 . . . . 1.1200000000000001 110.742 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 t -121.82 157.27 31.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.657 -0.701 . . . . 1.01 110.068 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -132.05 124.5 29.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.936 0.398 . . . . 1.1799999999999999 111.344 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -100.53 92.56 5.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.69 -95.31 0.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.97 -0.852 . . . . 1.01 110.97 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -121.71 -2.03 9.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.829 0.347 . . . . 3.6499999999999999 110.33 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -87.46 129.34 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.81999999999999995 110.717 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 tt -86.36 113.45 24.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.885 0.85 . . . . 1.0600000000000001 111.669 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.0 -174.22 14.58 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.029 -0.987 . . . . 0.81999999999999995 111.528 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.93 134.48 66.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.43 0.633 . . . . 0.81999999999999995 110.204 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -83.77 104.4 13.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.262 -0.881 . . . . 1.1200000000000001 111.174 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.473 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 90.0 m95 -89.16 98.36 11.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.81999999999999995 110.822 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.939 -0.573 . . . . 0.83999999999999997 109.949 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.89 14.79 6.51 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.358 -0.925 . . . . 1.0700000000000001 113.387 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -151.42 146.12 25.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.81999999999999995 110.664 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -97.51 -8.67 28.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.378 -0.828 . . . . 3.98 109.603 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 p -118.75 139.43 51.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.679 . . . . 1.6000000000000001 111.404 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 72.8 m -75.9 129.06 82.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 109.75 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 31.3 Cg_exo -58.11 97.59 0.09 OUTLIER 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.555 2.17 . . . . 0.81999999999999995 110.782 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -79.61 51.92 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.524 0.678 . . . . 2.3700000000000001 111.316 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.87 0.39 1.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.934 -1.03 . . . . 1.8300000000000001 109.785 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -103.99 -46.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 3.3900000000000001 110.906 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.07 14.95 0.94 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.747 -0.739 . . . . 1.1000000000000001 112.683 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -70.7 137.92 50.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 3.7599999999999998 110.385 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 m -115.23 -32.78 5.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.92 0.39 . . . . 1.3300000000000001 110.659 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.48 176.97 18.61 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.858 -0.687 . . . . 0.81999999999999995 111.796 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.463 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.4 p -162.66 148.89 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.116 0.484 . . . . 1.4399999999999999 111.598 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 58.3 m -125.53 151.13 46.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.506 -0.77 . . . . 1.01 109.426 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.46 125.89 7.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.81999999999999995 111.659 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.98 162.97 24.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.97 110.469 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 106.61 0.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 2.3599999999999999 111.545 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 63.53 20.48 12.26 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.929 0.768 . . . . 1.75 112.087 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.92 175.73 39.26 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.28 -0.962 . . . . 0.81999999999999995 112.85 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.58 133.69 68.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.199 0.523 . . . . 0.81999999999999995 110.285 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 29' ' ' SER . 52.2 t -95.02 95.69 8.76 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.813 -0.44 . . . . 1.1100000000000001 109.813 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.41 128.29 40.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.397 -0.365 . . . . 1.1399999999999999 110.752 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 41.0 p90 -129.54 159.74 67.94 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.512 -0.313 . . . . 1.1499999999999999 110.759 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 83.7 Cg_endo -91.41 162.6 28.71 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.677 -1.384 . . . . 0.81999999999999995 112.789 -1.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.53 92.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.099 -0.5 . . . . 1.45 109.78 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.306 -0.854 . . . . 3.0800000000000001 109.916 -177.89 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.982 0 N-CA-C 111.494 -0.643 . . . . 2.96 111.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 p -86.68 42.32 1.01 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.548 0.69 . . . . 1.1299999999999999 110.165 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 m -76.88 109.02 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.145 -0.934 . . . . 1.1200000000000001 110.303 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.67 151.23 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.694 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -129.06 115.51 17.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 1.1799999999999999 111.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.7 m -99.88 95.54 6.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.85 -107.34 2.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.62 -0.8 . . . . 1.01 111.268 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -107.78 -5.03 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.042 0.448 . . . . 3.6499999999999999 110.524 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -99.95 117.38 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.81999999999999995 110.788 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tt -82.23 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.514 0.673 . . . . 1.0600000000000001 110.996 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.55 -170.28 11.85 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.201 -0.909 . . . . 0.81999999999999995 111.204 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.92 137.7 52.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.295 0.569 . . . . 0.81999999999999995 109.553 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HE1' ' HB3' ' A' ' 32' ' ' TYR . 36.8 t80 -87.56 107.27 18.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 1.1200000000000001 111.475 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.489 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 82.0 m95 -90.64 100.51 13.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.129 -0.487 . . . . 0.81999999999999995 109.861 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.7 t80 -83.76 132.54 34.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.491 -0.322 . . . . 0.83999999999999997 110.303 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.01 -18.69 39.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.639 -0.791 . . . . 1.0700000000000001 113.233 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -118.29 151.83 36.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.581 . . . . 0.81999999999999995 111.359 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -102.32 3.1 37.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.303 -0.862 . . . . 3.98 110.527 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -134.87 146.27 49.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.224 0.535 . . . . 1.6000000000000001 111.368 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 94.5 m -80.9 127.99 72.93 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.702 -0.681 . . . . 0.91000000000000003 111.208 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 17.1 Cg_exo -62.54 116.18 3.36 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.514 2.143 . . . . 0.81999999999999995 110.553 173.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.1 m -84.08 24.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 2.3700000000000001 112.12 -170.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.27 16.32 24.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.135 0.493 . . . . 1.8300000000000001 110.147 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -119.38 -60.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.714 -0.676 . . . . 3.3900000000000001 110.943 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.02 40.54 0.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.828 -0.624 . . . . 1.1000000000000001 111.678 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -70.39 132.58 45.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 3.7599999999999998 111.245 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -89.16 -27.8 20.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.537 -0.756 . . . . 1.3300000000000001 110.592 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.62 171.68 34.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.37 -0.919 . . . . 0.81999999999999995 112.337 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 17.6 p -140.68 151.97 44.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.898 0.38 . . . . 1.4399999999999999 111.505 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -124.02 140.93 52.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.01 109.778 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.91 126.49 7.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.785 -0.722 . . . . 0.81999999999999995 111.783 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -129.13 169.02 15.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 1.97 109.058 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -62.55 97.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 2.3599999999999999 111.924 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.4 mp 63.5 27.32 15.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.337 -0.847 . . . . 1.75 111.266 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . -154.11 165.71 31.82 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.81999999999999995 111.566 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.34 129.35 74.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.359 0.599 . . . . 0.81999999999999995 110.559 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.7 t -92.53 105.86 17.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.325 -0.62 . . . . 1.1100000000000001 109.325 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.8 m -103.76 123.08 46.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.922 0.391 . . . . 1.1399999999999999 110.807 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -125.32 153.86 72.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.978 -0.556 . . . . 1.1499999999999999 110.634 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.38 158.72 73.68 Favored 'Cis proline' 0 C--O 1.235 0.331 0 C-N-CA 123.518 -1.451 . . . . 0.81999999999999995 111.852 -1.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.8 p -75.76 86.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.849 0.833 . . . . 1.45 110.612 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.288 -0.863 . . . . 3.0800000000000001 110.503 -179.468 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.088 -0.405 . . . . 2.96 112.088 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p -100.93 30.8 3.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.09 0.471 . . . . 1.1299999999999999 111.433 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -96.14 139.82 31.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.44 -0.345 . . . . 1.1200000000000001 110.532 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.58 161.05 30.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.303 -0.408 . . . . 1.01 110.707 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.37 106.72 10.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.565 -0.289 . . . . 1.1799999999999999 110.558 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.2 m -85.04 93.28 8.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.24 -0.652 . . . . 1.2 109.24 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.27 -93.1 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.442 -0.799 . . . . 1.01 111.865 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.56 0.29 8.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.645 0.259 . . . . 3.6499999999999999 110.805 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 m -106.42 122.94 47.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.81999999999999995 110.774 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 9.6 tt -76.31 123.26 32.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.405 -0.816 . . . . 1.0600000000000001 111.256 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.02 171.77 18.6 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.81999999999999995 111.653 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.95 131.55 65.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.201 0.524 . . . . 0.81999999999999995 109.776 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 7.6 t80 -87.34 100.6 12.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.541 -0.754 . . . . 1.1200000000000001 110.66 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -79.51 88.53 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.673 -0.694 . . . . 0.81999999999999995 109.679 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 78.1 t80 -70.48 122.14 19.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.677 -0.692 . . . . 0.83999999999999997 109.782 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.07 -32.58 5.06 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.698 -0.763 . . . . 1.0700000000000001 112.847 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -125.25 151.24 46.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.81999999999999995 111.194 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.2 tptm -109.76 21.76 16.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.047 0.927 . . . . 3.98 108.615 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -119.44 122.86 42.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 1.6000000000000001 110.303 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.1 m -72.6 118.96 72.38 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.848 0.356 . . . . 0.91000000000000003 110.392 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.6 75.86 4.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.745 2.297 . . . . 0.81999999999999995 109.858 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -78.34 53.12 1.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.865 -1.061 . . . . 2.3700000000000001 112.913 -168.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -88.36 1.37 54.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.219 -0.66 . . . . 1.8300000000000001 109.219 170.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HB3' ' OXT' ' A' ' 42' ' ' ASP . 9.7 mpt_? -97.12 -73.44 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.073 -0.967 . . . . 3.3900000000000001 109.857 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.8 28.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.455 -0.793 . . . . 1.1000000000000001 112.194 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.02 138.66 43.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 3.7599999999999998 110.978 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -109.11 -45.98 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.209 0.528 . . . . 1.3300000000000001 111.027 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.1 -179.48 16.06 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.83 -0.908 . . . . 0.81999999999999995 110.83 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -157.71 164.29 37.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.655 0.728 . . . . 1.4399999999999999 111.655 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -133.17 125.12 28.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.83 . . . . 1.01 109.74 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' HE3' ' A' ' 18' ' ' LYS . . . -66.88 127.15 27.63 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.818 -0.706 . . . . 0.81999999999999995 112.082 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -123.11 165.14 17.33 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.734 -0.274 . . . . 1.97 111.235 -176.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -39.23 -55.78 1.62 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.359 1.037 . . . . 2.3599999999999999 113.021 -168.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 5.8 mp -134.27 45.71 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.951 -0.389 . . . . 1.75 109.951 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.6 -164.7 33.4 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.702 -1.237 . . . . 0.81999999999999995 112.7 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 18' ' ' LYS . 16.1 tt -133.89 130.08 55.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.093 0.473 . . . . 0.81999999999999995 111.146 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.8 t -95.88 92.44 6.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.201 -0.454 . . . . 1.1100000000000001 109.971 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.7 124.51 33.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 1.1399999999999999 110.55 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -126.97 153.48 76.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 1.1499999999999999 111.036 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 2.4 Cg_endo -82.82 172.13 50.23 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.621 -1.408 . . . . 0.81999999999999995 111.3 -3.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG21 HG12 ' A' ' 10' ' ' ILE . 3.0 t -77.14 46.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.137 0.494 . . . . 1.45 110.771 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.516 ' OXT' ' HB3' ' A' ' 24' ' ' ARG . 18.4 m-20 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.263 -0.875 . . . . 3.0800000000000001 109.596 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 111.752 -0.539 . . . . 2.96 111.752 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 15.4 p -84.29 59.03 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.464 0.649 . . . . 1.1299999999999999 110.371 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.6 m -104.27 123.79 48.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.416 -0.811 . . . . 1.1200000000000001 110.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.0 p -135.65 159.96 40.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.873 0.368 . . . . 1.01 111.316 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.61 143.91 47.41 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.78 -0.452 . . . . 1.1799999999999999 109.78 175.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.3 t -119.91 101.75 8.08 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.49 -91.54 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.778 -0.646 . . . . 1.01 111.872 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -122.49 -9.95 8.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.887 0.375 . . . . 3.6499999999999999 110.684 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -95.6 128.53 42.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.117 -0.492 . . . . 0.81999999999999995 111.067 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 tp -82.22 132.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.978 -0.555 . . . . 1.0600000000000001 110.003 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.46 179.78 19.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.13 -0.557 . . . . 0.81999999999999995 112.627 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.62 137.71 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.228 0.537 . . . . 0.81999999999999995 109.76 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 2.0 t80 -89.64 101.09 13.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.724 -0.671 . . . . 1.1200000000000001 111.443 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -82.85 83.28 7.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.871 -0.604 . . . . 0.81999999999999995 109.42 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -73.37 96.91 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.178 -0.465 . . . . 0.83999999999999997 110.337 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.33 -61.37 0.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.725 -0.67 . . . . 1.0700000000000001 111.903 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -87.11 161.82 17.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.729 0.299 . . . . 0.81999999999999995 110.627 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -113.51 11.18 18.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.165 -0.68 . . . . 3.98 109.165 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -128.77 135.78 49.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.595 . . . . 1.6000000000000001 110.562 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.9 m -80.01 127.41 77.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.745 0.307 . . . . 0.91000000000000003 111.292 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.23 78.32 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.558 2.172 . . . . 0.81999999999999995 110.194 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -78.62 63.04 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.556 0.693 . . . . 2.3700000000000001 111.141 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.43 4.71 10.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.33 -0.85 . . . . 1.8300000000000001 109.687 171.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.04 -81.77 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.29 -0.633 . . . . 3.3900000000000001 109.29 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.49 4.23 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.977 -0.63 . . . . 1.1000000000000001 113.146 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -62.06 127.31 30.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.077 0.438 . . . . 3.7599999999999998 110.273 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 p -114.74 -39.07 3.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.933 0.397 . . . . 1.3300000000000001 110.888 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.91 157.85 14.95 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.956 -0.64 . . . . 0.81999999999999995 112.188 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.596 ' HB2' HD12 ' A' ' 36' ' ' ILE . 16.2 p -124.55 149.97 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.376 . . . . 1.4399999999999999 111.103 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.9 t -133.4 114.66 13.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.119 -0.491 . . . . 1.01 109.969 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 127.16 42.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.416 -0.421 . . . . 0.81999999999999995 113.196 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -128.21 174.43 9.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.644 0.259 . . . . 1.97 110.56 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -65.52 95.41 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 2.3599999999999999 111.506 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt 64.42 27.31 13.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.745 -0.661 . . . . 1.75 110.536 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.34 -175.83 29.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.822 -0.704 . . . . 0.81999999999999995 111.874 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 29' ' ' SER . 12.3 tt -136.44 130.09 46.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.233 0.539 . . . . 0.81999999999999995 110.958 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 45.0 t -93.3 103.52 15.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.062 -0.718 . . . . 1.1100000000000001 109.062 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.1 m -91.76 124.43 35.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 1.1399999999999999 110.928 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.427 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 47.0 p90 -127.08 150.11 71.24 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.025 -0.534 . . . . 1.1499999999999999 111.117 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 16.5 Cg_exo -68.49 165.78 71.56 Favored 'Cis proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.56 -1.433 . . . . 0.81999999999999995 111.933 -4.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.5 68.65 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 122.32 1.057 . . . . 1.45 110.712 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.199 -0.91 . . . . 3.0800000000000001 109.996 -179.281 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.889 -0.485 . . . . 2.96 111.889 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.8 p -92.43 18.07 9.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.723 0.297 . . . . 1.1299999999999999 111.43 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -69.69 115.83 9.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 1.1200000000000001 110.023 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -122.51 154.7 37.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.451 . . . . 1.01 110.651 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 54.7 m-85 -131.67 121.94 25.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.755 0.312 . . . . 1.1799999999999999 110.941 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -102.92 99.47 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.979 -0.749 . . . . 1.2 108.979 171.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.75 -97.55 0.35 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.921 -0.657 . . . . 1.01 111.767 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -106.84 -25.15 11.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.694 0.283 . . . . 3.6499999999999999 110.825 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -88.39 123.68 33.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.209 0.528 . . . . 0.81999999999999995 111.64 -170.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 tt -78.73 131.84 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.706 -0.679 . . . . 1.0600000000000001 110.615 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.68 -174.06 13.33 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.702 -0.681 . . . . 0.81999999999999995 111.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.16 133.19 64.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.353 0.596 . . . . 0.81999999999999995 109.928 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.406 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 15.3 t80 -84.44 100.1 11.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 1.1200000000000001 110.928 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -80.17 94.37 6.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.81999999999999995 110.373 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.5 t80 -79.56 109.87 14.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.523 -0.547 . . . . 0.83999999999999997 109.523 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.26 -21.32 4.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.453 -0.88 . . . . 1.0700000000000001 112.884 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -135.05 151.99 51.27 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.765 -0.256 . . . . 0.81999999999999995 110.497 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -115.94 8.08 14.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.386 -0.598 . . . . 3.98 109.386 174.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 p -120.98 126.73 50.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 1.6000000000000001 109.786 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 36' ' ' ILE . 88.9 m -74.52 136.25 74.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.91000000000000003 111.686 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 6.0 Cg_exo -79.48 100.69 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.091 2.527 . . . . 0.81999999999999995 110.126 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 t -80.97 20.4 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 2.3700000000000001 111.2 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -86.84 -8.7 57.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.471 -0.566 . . . . 1.8300000000000001 109.471 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.41 -58.15 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 3.3900000000000001 109.98 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.9 30.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.588 -0.733 . . . . 1.1000000000000001 112.149 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -72.17 152.2 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 3.7599999999999998 111.256 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -118.37 -41.09 2.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.118 -0.492 . . . . 1.3300000000000001 111.149 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.5 165.41 23.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.71 -0.757 . . . . 0.81999999999999995 111.959 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 p -143.09 143.72 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.093 0.473 . . . . 1.4399999999999999 111.888 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 42.8 m -122.49 125.6 46.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 1.01 109.764 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.04 132.44 45.95 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.531 -0.842 . . . . 0.81999999999999995 111.585 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.34 166.36 21.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.97 0.385 . . . . 1.97 110.884 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -59.0 100.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 2.3599999999999999 111.197 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp 64.36 29.33 13.61 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.767 0.667 . . . . 1.75 111.207 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.57 -168.87 33.75 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.394 -0.907 . . . . 0.81999999999999995 112.306 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.533 HD12 ' SG ' ' A' ' 20' ' ' CYS . 15.0 tt -136.28 130.3 47.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.437 0.637 . . . . 0.81999999999999995 111.166 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 47.5 t -89.26 96.36 10.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.751 . . . . 1.1100000000000001 108.971 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -100.27 130.9 46.44 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.66 -0.416 . . . . 1.1399999999999999 110.146 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.406 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 55.1 p90 -131.27 157.91 76.75 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.455 . . . . 1.1499999999999999 110.787 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.6 Cg_exo -74.0 157.2 99.5 Favored 'Cis proline' 0 C--O 1.231 0.152 0 C-N-CA 123.611 -1.412 . . . . 0.81999999999999995 111.674 -2.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.14 97.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.711 0.767 . . . . 1.45 110.144 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.395 -0.82 . . . . 3.0800000000000001 110.444 -177.151 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 N-CA-C 112.015 -0.434 . . . . 2.96 112.015 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 11.9 p -80.79 77.27 7.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 1.1299999999999999 110.861 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -107.09 128.09 54.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.865 -0.607 . . . . 1.1200000000000001 110.719 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -135.17 119.07 17.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.01 111.132 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.415 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 45.6 m-85 -80.7 117.81 21.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 1.1799999999999999 111.182 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.1 m -91.53 87.55 6.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.102 -0.703 . . . . 1.2 109.102 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.03 -102.87 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.868 -0.605 . . . . 1.01 112.047 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -100.38 -19.98 16.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.569 0.223 . . . . 3.6499999999999999 111.327 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -97.16 118.37 33.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.898 0.38 . . . . 0.81999999999999995 110.732 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.415 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 7.4 tt -79.82 131.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 1.0600000000000001 110.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.33 173.75 19.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.736 -0.745 . . . . 0.81999999999999995 112.608 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.97 135.04 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.513 -0.551 . . . . 0.81999999999999995 109.513 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.791 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 25.4 t80 -87.28 113.78 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 1.1200000000000001 111.701 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -92.68 102.81 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.469 -0.787 . . . . 0.81999999999999995 109.596 173.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -73.15 130.83 41.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.033 -0.358 . . . . 0.83999999999999997 110.033 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.39 -82.62 0.31 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.031 -0.604 . . . . 1.0700000000000001 111.995 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.5 t -63.81 151.63 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.81999999999999995 111.67 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -112.44 12.08 19.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.883 -0.784 . . . . 3.98 108.883 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -127.93 130.09 47.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.114 -0.948 . . . . 1.6000000000000001 110.108 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.7 m -68.28 128.15 93.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.508 -0.314 . . . . 0.91000000000000003 111.022 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 109.7 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.477 2.118 . . . . 0.81999999999999995 110.454 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -83.42 48.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.432 0.634 . . . . 2.3700000000000001 111.093 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -144.39 25.82 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 1.8300000000000001 110.262 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.42 -54.67 2.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.901 -0.591 . . . . 3.3900000000000001 111.016 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.81 22.28 1.05 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.507 -0.769 . . . . 1.1000000000000001 111.851 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -63.78 147.82 50.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.849 0.357 . . . . 3.7599999999999998 110.916 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -108.76 -43.35 4.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 110.832 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -133.85 175.23 20.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.798 -0.715 . . . . 0.81999999999999995 112.288 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 36' ' ' ILE . 16.4 p -152.1 140.73 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.986 0.422 . . . . 1.4399999999999999 111.817 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 59.3 m -116.69 133.51 55.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.243 -0.651 . . . . 1.01 109.243 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.59 133.09 17.05 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.532 -0.842 . . . . 0.81999999999999995 111.177 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -130.21 165.22 22.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.626 -0.509 . . . . 1.97 109.626 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -37.53 -69.43 0.12 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.177 0.806 . . . . 2.3599999999999999 113.177 -167.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -120.76 43.52 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.735 -0.386 . . . . 1.75 110.157 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.0 -158.08 22.77 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.146 -1.026 . . . . 0.81999999999999995 112.694 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.632 HD12 ' HB2' ' A' ' 29' ' ' SER . 13.3 tt -137.37 133.92 46.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.39 0.614 . . . . 0.81999999999999995 111.133 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 m -93.46 101.26 13.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.1100000000000001 110.135 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -94.1 130.35 40.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.076 -0.511 . . . . 1.1399999999999999 110.907 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.436 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.8 p90 -130.14 157.98 75.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.263 -0.426 . . . . 1.1499999999999999 110.314 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.2 Cg_exo -74.85 153.03 98.95 Favored 'Cis proline' 0 C--O 1.231 0.154 0 C-N-CA 123.863 -1.307 . . . . 0.81999999999999995 111.944 -0.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 41' ' ' VAL . 6.2 p -72.02 98.35 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.472 0.653 . . . . 1.45 111.078 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.023 -0.99 . . . . 3.0800000000000001 111.117 177.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.161 -0.376 . . . . 2.96 112.161 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.1 p -90.69 48.19 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.038 0.447 . . . . 1.1299999999999999 111.86 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m -69.7 131.28 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 110.012 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -135.3 153.26 51.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.797 0.332 . . . . 1.01 110.903 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -136.44 125.3 24.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 1.1799999999999999 110.463 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.22 86.93 2.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.201 -1.037 . . . . 1.2 108.201 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.93 -102.12 1.11 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.224 -0.898 . . . . 1.01 111.654 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.42 -11.39 17.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.468 0.175 . . . . 3.6499999999999999 110.678 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -95.91 118.03 31.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.81999999999999995 110.993 -175.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.0 tt -79.7 130.43 36.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.312 0.577 . . . . 1.0600000000000001 111.189 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -173.45 12.9 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 111.934 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.67 136.1 60.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.142 0.496 . . . . 0.81999999999999995 109.942 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 1.6 t80 -86.28 105.91 16.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.831 -0.622 . . . . 1.1200000000000001 110.516 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.38 104.48 13.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.81999999999999995 109.982 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 61.2 t80 -94.31 103.58 15.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.662 -0.699 . . . . 0.83999999999999997 109.192 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.33 -6.7 5.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.412 -0.899 . . . . 1.0700000000000001 112.242 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -143.54 152.48 41.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.955 -0.387 . . . . 0.81999999999999995 109.955 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.82 12.54 19.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.331 0.586 . . . . 3.98 109.584 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 p -134.35 146.33 49.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 1.6000000000000001 110.055 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 77.5 m -79.58 116.59 61.85 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.91000000000000003 110.364 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.75 126.29 16.42 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.485 2.123 . . . . 0.81999999999999995 111.697 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.0 m -76.06 110.39 10.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 2.3700000000000001 110.517 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.403 HD21 ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -169.95 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.8300000000000001 111.922 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HD3' ' OXT' ' A' ' 42' ' ' ASP . 72.4 mtt180 -122.27 -69.38 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.795 -0.362 . . . . 3.3900000000000001 111.583 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.77 36.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.237 -0.982 . . . . 1.1000000000000001 112.959 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.08 130.58 44.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.859 0.361 . . . . 3.7599999999999998 110.178 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.2 m -101.2 -40.35 7.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.228 -0.442 . . . . 1.3300000000000001 110.78 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -124.4 169.92 16.48 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.581 -0.818 . . . . 0.81999999999999995 112.229 -177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.461 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 12.3 p -154.06 133.19 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.39 0.615 . . . . 1.4399999999999999 111.87 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 65.3 m -115.3 120.85 41.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.42 -0.809 . . . . 1.01 109.68 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.24 133.42 48.54 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.81999999999999995 111.842 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -129.92 164.44 24.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.864 0.332 . . . . 1.97 110.865 -176.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -39.37 -59.66 1.04 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.863 1.06 . . . . 2.3599999999999999 113.863 -170.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 3.1 mm? -123.34 28.47 7.05 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.439 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.98 -151.31 9.23 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.514 -1.327 . . . . 0.81999999999999995 113.246 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.25 135.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.81999999999999995 111.178 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 42.5 t -94.2 101.65 13.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.681 -0.69 . . . . 1.1100000000000001 109.576 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.5 m -95.58 129.19 42.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 1.1399999999999999 110.817 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.462 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 42.4 p90 -130.22 157.39 77.34 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 1.1499999999999999 110.468 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.4 Cg_exo -81.89 171.63 55.41 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 123.707 -1.372 . . . . 0.81999999999999995 111.931 -1.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.3 t -62.94 95.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 1.45 110.962 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.612 ' OXT' ' HD3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.632 -0.699 . . . . 3.0800000000000001 109.406 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.993 -0.443 . . . . 2.96 111.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p -96.26 53.98 1.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 1.1299999999999999 111.43 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.7 m -110.25 127.83 55.19 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.611 . . . . 1.1200000000000001 109.349 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.36 139.14 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.125 0.488 . . . . 1.01 111.887 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 62.5 m-85 -103.26 111.74 24.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.073 -0.512 . . . . 1.1799999999999999 110.019 173.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.04 100.47 12.58 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.479 -0.563 . . . . 1.2 109.479 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.97 -85.29 0.38 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 1.01 112.003 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -134.23 -0.71 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.799 0.333 . . . . 3.6499999999999999 111.065 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 m -108.39 135.09 50.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.805 0.336 . . . . 0.81999999999999995 110.887 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.9 tt -93.87 128.11 45.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.601 0.715 . . . . 1.0600000000000001 111.654 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 -178.4 15.95 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.471 -0.786 . . . . 0.81999999999999995 111.826 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.423 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.52 136.78 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.439 -0.578 . . . . 0.81999999999999995 109.439 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -89.85 115.92 27.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 1.1200000000000001 111.648 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -99.12 110.68 23.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.842 -0.617 . . . . 0.81999999999999995 110.427 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -103.22 122.13 44.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.189 -0.671 . . . . 0.83999999999999997 109.189 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 125.4 -32.1 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.183 -0.767 . . . . 1.0700000000000001 111.183 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 t -121.4 146.39 46.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.951 -0.389 . . . . 0.81999999999999995 109.951 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -108.73 14.78 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.348 0.594 . . . . 3.98 109.885 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -128.91 137.07 51.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.532 -0.758 . . . . 1.6000000000000001 109.527 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.3 m -80.34 125.75 80.44 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.612 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.11 97.53 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.726 2.284 . . . . 0.81999999999999995 110.766 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -71.74 4.16 3.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.23 0.538 . . . . 2.3700000000000001 112.329 -173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -79.73 -16.59 55.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.827 -0.624 . . . . 1.8300000000000001 109.358 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -87.19 -11.95 48.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.51 -0.768 . . . . 3.3900000000000001 110.931 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.31 33.23 23.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.944 -0.646 . . . . 1.1000000000000001 113.202 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -70.82 137.29 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.84 0.352 . . . . 3.7599999999999998 110.224 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.7 m -100.32 -43.1 6.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 1.3300000000000001 111.078 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.93 165.99 24.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.742 -0.742 . . . . 0.81999999999999995 112.21 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -137.05 160.74 38.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.879 0.371 . . . . 1.4399999999999999 111.26 -176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 97.8 m -141.77 145.48 34.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.026 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.59 131.33 11.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.008 -0.615 . . . . 0.81999999999999995 112.337 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -127.75 174.06 9.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.331 -0.618 . . . . 1.97 109.331 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.61 92.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.674 0.609 . . . . 2.3599999999999999 111.972 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt 59.67 33.08 21.84 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.566 -0.743 . . . . 1.75 110.657 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.99 178.26 36.13 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 0.81999999999999995 111.583 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.47 135.28 64.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.379 0.609 . . . . 0.81999999999999995 111.039 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.76 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.721 -0.672 . . . . 1.1100000000000001 109.367 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.3 m -105.82 121.96 45.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.612 -0.267 . . . . 1.1399999999999999 111.049 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.3 p90 -129.27 157.11 77.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 1.1499999999999999 110.982 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.0 Cg_exo -65.28 151.51 76.99 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 123.774 -1.344 . . . . 0.81999999999999995 112.323 -1.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.6 p -61.59 96.84 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.123 0.487 . . . . 1.45 111.486 178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--O 1.245 0.862 0 CA-C-N 115.044 -0.98 . . . . 3.0800000000000001 111.857 176.582 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.265 -0.334 . . . . 2.96 112.265 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -80.99 61.86 4.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.12 0.486 . . . . 1.1299999999999999 110.959 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -142.97 141.88 31.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 109.905 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.6 p -131.45 159.64 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 1.01 110.819 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.66 102.23 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 1.1799999999999999 110.574 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -89.28 90.49 8.36 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.755 -0.831 . . . . 1.2 108.755 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.68 -117.07 7.36 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 1.01 111.49 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -88.63 -18.38 28.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.552 0.215 . . . . 3.6499999999999999 110.534 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.46 117.23 29.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.142 0.496 . . . . 0.81999999999999995 111.18 -170.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.7 tt -86.81 129.75 37.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.579 -0.737 . . . . 1.0600000000000001 110.028 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.77 162.48 22.9 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.021 -0.609 . . . . 0.81999999999999995 112.131 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.84 132.81 41.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.364 -0.606 . . . . 0.81999999999999995 109.364 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.1 t80 -89.04 103.45 16.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.064 -0.516 . . . . 1.1200000000000001 111.283 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.509 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 97.6 m95 -84.44 81.24 8.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.773 -0.648 . . . . 0.81999999999999995 110.337 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -75.25 118.16 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.738 -0.664 . . . . 0.83999999999999997 109.895 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.01 8.14 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.443 -0.884 . . . . 1.0700000000000001 112.414 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -132.5 153.6 50.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.62 0.248 . . . . 0.81999999999999995 110.571 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 6.88 23.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.208 0.527 . . . . 3.98 109.615 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.0 m -107.23 118.11 35.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.618 -0.719 . . . . 1.6000000000000001 110.393 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -68.48 116.63 42.08 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.91000000000000003 109.531 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 Cg_exo -56.92 120.22 7.99 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.804 2.336 . . . . 0.81999999999999995 111.41 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -84.86 49.39 1.71 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.638 0.732 . . . . 2.3700000000000001 110.732 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -128.22 13.36 6.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.586 -0.734 . . . . 1.8300000000000001 110.007 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.649 ' HG2' ' HA ' ' A' ' 42' ' ' ASP . 8.6 mpt_? -117.94 -55.84 2.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 3.3900000000000001 110.988 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.72 38.2 0.67 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.69 -0.686 . . . . 1.1000000000000001 111.677 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -67.49 141.95 56.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.408 . . . . 3.7599999999999998 110.869 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -112.38 -35.32 5.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.066 -0.516 . . . . 1.3300000000000001 110.63 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.97 175.27 21.21 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.586 -0.816 . . . . 0.81999999999999995 111.494 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 p -156.73 158.28 36.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.946 0.403 . . . . 1.4399999999999999 111.509 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 74.3 m -123.45 114.69 20.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.104 -0.702 . . . . 1.01 109.104 174.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.88 131.52 25.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.766 -0.73 . . . . 0.81999999999999995 111.936 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -135.71 -178.96 5.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.472 0.136 . . . . 1.97 110.933 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -57.66 102.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.632 0.605 . . . . 2.3599999999999999 112.632 -172.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 59.83 26.27 15.44 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.562 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.93 173.42 35.82 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.508 -0.853 . . . . 0.81999999999999995 111.975 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.61 124.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.445 0.64 . . . . 0.81999999999999995 110.241 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 8.0 t -94.74 98.55 10.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.123 -0.695 . . . . 1.1100000000000001 109.123 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 m -93.76 140.33 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 1.1399999999999999 111.365 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 15.1 p90 -134.23 159.63 71.58 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 116.372 -0.377 . . . . 1.1499999999999999 111.165 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 33.6 Cg_exo -63.32 154.59 70.84 Favored 'Cis proline' 0 N--CA 1.479 0.643 0 C-N-CA 124.107 -1.205 . . . . 0.81999999999999995 112.494 -0.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.418 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.1 p -64.41 98.35 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.504 0.668 . . . . 1.45 111.853 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.649 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 26.2 t70 . . . . . 0 C--O 1.243 0.746 0 CA-C-N 114.758 -1.11 . . . . 3.0800000000000001 111.274 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.601 0 N-CA-C 112.177 -0.369 . . . . 2.96 112.177 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m -94.23 125.36 38.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.96 -0.385 . . . . 1.1299999999999999 109.96 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 m -102.1 142.0 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.546 -0.297 . . . . 1.1200000000000001 110.42 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.57 152.42 51.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.437 . . . . 1.01 111.086 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.0 m-85 -113.6 138.71 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.057 0.456 . . . . 1.1799999999999999 110.581 174.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.3 t -121.57 102.21 8.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.615 -0.883 . . . . 1.2 108.615 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -101.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.151 -0.78 . . . . 1.01 111.151 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' C ' ' HD2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -119.64 -1.88 10.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.576 0.227 . . . . 3.6499999999999999 111.094 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -97.96 136.38 38.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.81999999999999995 111.006 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 tt -96.31 125.15 49.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.689 0.757 . . . . 1.0600000000000001 111.475 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.01 178.65 17.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.16 -0.927 . . . . 0.81999999999999995 112.131 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 135.96 49.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.659 -0.496 . . . . 0.81999999999999995 109.659 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 11.7 t80 -87.59 104.58 16.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.446 -0.797 . . . . 1.1200000000000001 111.21 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.402 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 94.6 m95 -87.36 90.11 8.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.81999999999999995 110.522 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.414 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.2 t80 -79.5 123.46 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.398 -0.593 . . . . 0.83999999999999997 109.398 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.31 -24.72 8.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.415 -0.898 . . . . 1.0700000000000001 112.597 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -126.08 155.04 42.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.99 0.424 . . . . 0.81999999999999995 110.667 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 15.94 16.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.644 -0.707 . . . . 3.98 109.806 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -131.76 128.08 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.6000000000000001 110.7 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -72.38 126.35 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.258 -0.428 . . . . 0.91000000000000003 111.159 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 12.4 Cg_exo -67.4 101.39 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.763 2.309 . . . . 0.81999999999999995 110.905 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 p -79.27 26.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 2.3700000000000001 111.805 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -91.27 -11.07 39.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.331 -0.395 . . . . 1.8300000000000001 110.649 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -102.35 -74.06 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.418 -0.355 . . . . 3.3900000000000001 111.185 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.22 33.07 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.531 -0.842 . . . . 1.1000000000000001 112.392 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -71.9 125.73 27.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.384 -0.228 . . . . 3.7599999999999998 110.384 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 m -100.86 -49.44 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.085 -0.507 . . . . 1.3300000000000001 110.842 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.426 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -112.4 157.13 15.15 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.622 -0.799 . . . . 0.81999999999999995 112.061 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.493 ' HB3' HD12 ' A' ' 36' ' ' ILE . 11.6 m -139.64 136.29 34.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.858 0.361 . . . . 1.4399999999999999 110.907 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.611 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 81.8 m -129.64 132.88 46.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 1.01 109.689 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 145.78 49.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.149 -0.548 . . . . 0.81999999999999995 112.99 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -136.48 165.46 25.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.886 -0.783 . . . . 1.97 108.886 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -60.26 99.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.052 0.22 . . . . 2.3599999999999999 110.725 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.0 mt 63.09 32.15 15.44 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.825 0.703 . . . . 1.75 111.102 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.22 178.21 39.64 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.89 -0.671 . . . . 0.81999999999999995 111.707 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 29' ' ' SER . 16.8 tt -128.93 131.57 68.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.294 0.569 . . . . 0.81999999999999995 110.93 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.14 105.29 17.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 109.308 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -101.93 123.37 45.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 1.1399999999999999 110.869 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.611 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 42.6 p90 -128.44 158.06 72.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.485 -0.325 . . . . 1.1499999999999999 111.248 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.8 Cg_exo -78.77 161.16 89.64 Favored 'Cis proline' 0 C--O 1.233 0.267 0 C-N-CA 124.058 -1.226 . . . . 0.81999999999999995 112.204 -2.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.7 97.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.142 -0.481 . . . . 1.45 111.105 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.494 -0.765 . . . . 3.0800000000000001 109.563 174.129 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.3 -0.72 . . . . 2.96 111.3 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.9 m -80.13 105.32 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.216 0.531 . . . . 1.1299999999999999 110.58 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.5 m -87.61 137.29 32.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.739 -0.664 . . . . 1.1200000000000001 112.055 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 p -140.07 155.72 46.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.702 -0.481 . . . . 1.01 109.702 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 1.1799999999999999 111.268 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.9 m -110.92 87.67 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.807 -0.812 . . . . 1.2 108.807 170.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.81 -97.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.361 -0.836 . . . . 1.01 111.479 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -108.51 -18.88 13.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.49 0.186 . . . . 3.6499999999999999 111.109 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.411 HG21 ' HB2' ' A' ' 39' ' ' TYR . 7.0 m -90.09 119.31 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.434 -0.506 . . . . 0.81999999999999995 110.731 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tt -82.26 128.29 38.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.603 . . . . 1.0600000000000001 110.379 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.61 -171.53 12.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.933 -0.576 . . . . 0.81999999999999995 112.294 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -121.88 132.7 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.81999999999999995 109.785 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -89.99 109.38 20.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.672 -0.695 . . . . 1.1200000000000001 110.972 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.04 119.34 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.477 -0.783 . . . . 0.81999999999999995 110.456 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -104.13 118.02 35.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.003 -0.74 . . . . 0.83999999999999997 109.003 170.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.72 -21.37 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.284 -0.726 . . . . 1.0700000000000001 111.284 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 t -141.12 161.9 36.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.336 -0.616 . . . . 0.81999999999999995 109.336 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -121.09 20.7 11.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.184 -0.462 . . . . 3.98 110.06 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -135.95 152.83 51.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 1.6000000000000001 109.789 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 83.9 m -84.79 116.37 64.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.502 -0.317 . . . . 0.91000000000000003 111.022 -177.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.94 134.79 44.82 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.684 2.256 . . . . 0.81999999999999995 111.562 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 t -85.9 45.06 1.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.75 0.786 . . . . 2.3700000000000001 110.037 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -97.2 -16.38 20.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 110.091 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HG2' ' HA ' ' A' ' 42' ' ' ASP . 1.2 mpt_? -121.18 -80.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 3.3900000000000001 111.211 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 1.1000000000000001 111.053 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' HE1' ' H ' ' A' ' 42' ' ' ASP . 49.2 m-85 -67.87 112.06 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 3.7599999999999998 110.021 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -100.53 -26.32 13.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 1.3300000000000001 110.721 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.538 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -124.41 157.33 18.73 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.263 -0.97 . . . . 0.81999999999999995 111.859 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.554 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 30.0 p -145.05 137.27 25.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.205 0.526 . . . . 1.4399999999999999 111.716 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 74.3 m -117.46 129.41 55.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.616 -0.72 . . . . 1.01 109.448 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.3 118.08 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.736 -0.745 . . . . 0.81999999999999995 111.759 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -116.79 172.92 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.435 -0.209 . . . . 1.97 110.435 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -54.46 104.58 0.11 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 2.3599999999999999 111.542 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.2 mp 56.65 26.92 11.78 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.812 0.695 . . . . 1.75 111.432 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.36 -173.5 32.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.551 -0.833 . . . . 0.81999999999999995 112.225 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -135.38 132.03 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.147 0.499 . . . . 0.81999999999999995 111.387 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.5 t -93.74 106.99 18.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.277 -0.638 . . . . 1.1100000000000001 109.277 176.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 99.7 m -104.34 126.9 51.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.365 -0.38 . . . . 1.1399999999999999 111.166 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 44.1 p90 -124.84 155.68 69.8 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 116.048 -0.524 . . . . 1.1499999999999999 110.852 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 21.1 Cg_exo -67.45 161.22 78.59 Favored 'Cis proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.958 -1.268 . . . . 0.81999999999999995 112.882 -1.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.4 p -66.67 95.27 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.82 -0.627 . . . . 1.45 112.211 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.513 ' H ' ' HE1' ' A' ' 26' ' ' TYR . 22.9 t70 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.001 -0.999 . . . . 3.0800000000000001 111.867 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.875 -0.49 . . . . 2.96 111.875 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -97.72 112.87 24.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.894 -0.41 . . . . 1.1299999999999999 109.894 178.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -127.59 144.15 51.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.799 0.333 . . . . 1.1200000000000001 111.556 -171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.64 164.15 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.85 115.97 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.918 0.39 . . . . 1.1799999999999999 110.619 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.19 103.49 15.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.986 -0.746 . . . . 1.2 108.986 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 -93.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.334 -1.106 . . . . 1.01 110.334 -171.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -133.22 5.02 3.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.033 0.444 . . . . 3.6499999999999999 110.249 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 m -87.38 129.17 35.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.886 -0.597 . . . . 0.81999999999999995 110.281 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tt -85.08 115.85 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.37 0.605 . . . . 1.0600000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.71 173.66 16.13 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.548 -0.751 . . . . 0.81999999999999995 112.042 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -111.27 127.0 68.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.408 0.623 . . . . 0.81999999999999995 109.738 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t80 -86.2 109.34 18.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 1.1200000000000001 111.005 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 91.9 m95 -89.83 117.02 28.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.516 -0.765 . . . . 0.81999999999999995 110.266 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -112.52 114.19 26.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.491 -0.559 . . . . 0.83999999999999997 109.491 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.5 -9.53 6.51 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.871 -0.68 . . . . 1.0700000000000001 111.976 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 t -133.06 160.43 37.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.795 0.331 . . . . 0.81999999999999995 110.563 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -116.71 8.61 13.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.474 -0.565 . . . . 3.98 109.474 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.8 m -134.93 132.74 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 1.6000000000000001 111.302 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 86.6 m -67.79 120.62 74.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.91000000000000003 110.315 174.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 43.9 Cg_exo -55.75 116.1 2.92 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.915 2.41 . . . . 0.81999999999999995 111.97 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.8 t -84.84 14.92 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.457 0.646 . . . . 2.3700000000000001 111.3 -174.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -97.35 -1.96 43.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.459 0.647 . . . . 1.8300000000000001 109.267 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -100.0 -59.94 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 3.3900000000000001 110.436 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.43 40.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.86 -0.686 . . . . 1.1000000000000001 112.564 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -69.88 146.36 51.32 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.883 -0.186 . . . . 3.7599999999999998 110.74 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 p -106.98 -14.41 14.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.906 0.384 . . . . 1.3300000000000001 111.061 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.39 170.74 36.46 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.884 -0.674 . . . . 0.81999999999999995 111.74 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.449 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 57.4 p -145.77 150.05 35.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 1.4399999999999999 111.386 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.8 m -123.45 118.29 27.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.838 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.67 111.17 3.91 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.437 -0.665 . . . . 0.81999999999999995 111.437 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.1 178.22 4.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.064 -0.347 . . . . 1.97 110.064 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -52.31 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.201 0.313 . . . . 2.3599999999999999 111.541 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 57.04 25.4 10.7 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.703 -0.681 . . . . 1.75 111.655 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.07 26.93 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.534 -0.841 . . . . 0.81999999999999995 112.281 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 tt -136.11 122.84 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.232 0.539 . . . . 0.81999999999999995 110.616 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 14.0 t -99.76 109.51 21.94 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.618 -0.512 . . . . 1.1100000000000001 109.618 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.3 m -97.66 130.87 44.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.147 -0.479 . . . . 1.1399999999999999 110.369 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -122.81 154.67 63.97 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.52 -0.309 . . . . 1.1499999999999999 110.779 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.42 174.43 48.42 Favored 'Cis proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.604 -1.415 . . . . 0.81999999999999995 112.036 -1.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.8 p -67.72 95.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.748 0.785 . . . . 1.45 110.849 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.245 0.833 0 CA-C-N 115.383 -0.826 . . . . 3.0800000000000001 110.323 178.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.136 -0.386 . . . . 2.96 112.136 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.7 p -89.0 85.0 6.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.433 0.635 . . . . 1.1299999999999999 111.462 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -101.92 136.85 41.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.783 -0.644 . . . . 1.1200000000000001 109.928 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 149.72 35.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 1.01 111.347 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.33 127.64 53.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 1.1799999999999999 110.047 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 t -97.79 95.88 7.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.333 -0.988 . . . . 1.2 108.333 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.98 -92.95 0.56 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.75 -0.94 . . . . 1.01 110.75 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -120.18 -14.28 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.582 0.23 . . . . 3.6499999999999999 110.577 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -78.3 115.19 17.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.88 0.372 . . . . 0.81999999999999995 110.913 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.7 tp -74.71 125.44 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.902 -0.59 . . . . 1.0600000000000001 110.862 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.29 -176.39 17.29 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.899 -0.667 . . . . 0.81999999999999995 112.126 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 134.13 62.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.304 0.573 . . . . 0.81999999999999995 109.699 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.563 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 10.4 t80 -85.38 101.76 12.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 1.1200000000000001 110.612 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.427 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m95 -82.22 107.6 15.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.715 -0.675 . . . . 0.81999999999999995 109.921 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -96.65 101.31 12.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.179 -0.464 . . . . 0.83999999999999997 109.854 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.15 -41.57 1.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.728 -0.748 . . . . 1.0700000000000001 112.83 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -96.44 155.0 16.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.81999999999999995 110.61 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -102.36 -4.94 24.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.791 . . . . 3.98 109.713 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -126.37 133.36 51.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 111.145 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.0 m -70.58 121.15 82.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.824 -0.626 . . . . 0.91000000000000003 110.469 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 53.0 Cg_exo -53.06 108.6 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.96 2.44 . . . . 0.81999999999999995 111.934 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.1 t -74.88 -0.89 20.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.516 0.675 . . . . 2.3700000000000001 111.452 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.05 -13.37 57.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.364 -0.834 . . . . 1.8300000000000001 109.808 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -89.28 -55.26 3.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.81 -0.632 . . . . 3.3900000000000001 110.162 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.12 1.84 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.851 -0.69 . . . . 1.1000000000000001 112.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -63.36 132.66 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.378 . . . . 3.7599999999999998 110.357 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 m -93.65 -26.62 16.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.848 -0.615 . . . . 1.3300000000000001 110.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.34 170.18 27.48 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.708 -0.758 . . . . 0.81999999999999995 111.848 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.604 ' HB2' HD13 ' A' ' 36' ' ' ILE . 13.9 p -139.16 133.9 32.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.44 0.638 . . . . 1.4399999999999999 111.227 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 2.4 t -110.52 106.61 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.568 -0.742 . . . . 1.01 109.458 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.99 123.85 33.78 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.147 -0.549 . . . . 0.81999999999999995 111.876 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.45 170.75 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.04 -0.355 . . . . 1.97 110.04 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -54.42 104.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.664 0.386 . . . . 2.3599999999999999 111.758 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 56.1 28.81 13.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.791 0.682 . . . . 1.75 111.64 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -172.44 34.29 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.759 -0.734 . . . . 0.81999999999999995 111.798 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.604 HD13 ' HB2' ' A' ' 29' ' ' SER . 15.2 tt -138.8 121.45 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.422 0.63 . . . . 0.81999999999999995 111.581 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 15.1 m -83.43 96.3 8.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 1.1100000000000001 110.254 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.61 130.15 34.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.262 -0.426 . . . . 1.1399999999999999 110.924 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -135.63 157.43 76.3 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.123 -0.49 . . . . 1.1499999999999999 111.063 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.79 151.11 93.86 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.603 -1.415 . . . . 0.81999999999999995 111.577 -2.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.15 96.63 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 122.021 0.915 . . . . 1.45 111.099 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.244 0.793 0 CA-C-N 115.242 -0.89 . . . . 3.0800000000000001 109.292 178.213 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 112.119 -0.392 . . . . 2.96 112.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p -109.05 55.36 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 111.361 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.1 m -134.6 140.04 45.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.385 -0.371 . . . . 1.1200000000000001 110.426 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.77 175.49 9.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.764 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 70.9 m-85 -134.76 132.55 38.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 1.1799999999999999 110.893 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.07 106.86 14.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.152 -0.685 . . . . 1.2 109.152 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.33 -97.06 0.66 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.752 -0.939 . . . . 1.01 110.752 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -130.47 3.4 4.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.924 0.392 . . . . 3.6499999999999999 110.424 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.7 m -93.18 133.08 36.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.216 -0.447 . . . . 0.81999999999999995 110.341 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 tt -85.48 126.0 40.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.438 0.637 . . . . 1.0600000000000001 110.628 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.19 162.3 16.03 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.351 -0.84 . . . . 0.81999999999999995 111.386 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 131.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.382 -0.599 . . . . 0.81999999999999995 109.382 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -86.84 98.07 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.434 -0.803 . . . . 1.1200000000000001 110.911 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.515 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 99.9 m95 -82.83 98.86 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.81 -0.632 . . . . 0.81999999999999995 110.075 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -81.26 127.77 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.603 -0.517 . . . . 0.83999999999999997 109.603 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.28 -68.5 0.25 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.689 -0.767 . . . . 1.0700000000000001 111.886 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 t -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.81999999999999995 110.518 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.61 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.3 tmtt? -97.3 -0.68 46.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.237 -1.023 . . . . 3.98 108.237 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -96.64 107.31 19.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.664 -0.698 . . . . 1.6000000000000001 110.337 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.6 m -59.75 113.4 7.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.872 -0.418 . . . . 0.91000000000000003 109.872 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 77.4 Cg_exo -49.89 114.28 1.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.762 2.308 . . . . 0.81999999999999995 112.252 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -76.95 47.99 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.057 0.932 . . . . 2.3700000000000001 109.604 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 21' ' ' PRO . 54.4 t-20 -111.75 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.304 -1.316 . . . . 1.8300000000000001 108.927 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.88 -52.38 10.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.795 -1.093 . . . . 3.3900000000000001 111.111 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.0 25.15 0.83 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.566 -0.826 . . . . 1.1000000000000001 113.133 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -56.81 131.32 49.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.997 -0.371 . . . . 3.7599999999999998 109.997 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -114.03 -37.18 4.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 111.346 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -102.94 151.46 18.02 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.422 -0.894 . . . . 0.81999999999999995 111.524 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB2' ' CD1' ' A' ' 36' ' ' ILE . 19.8 p -143.46 137.33 28.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.093 0.473 . . . . 1.4399999999999999 111.788 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 59.1 m -123.87 132.44 53.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.708 . . . . 1.01 109.687 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.11 134.33 34.13 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.81999999999999995 112.232 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 171.66 14.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.887 0.343 . . . . 1.97 110.99 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -60.66 96.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.9 -0.591 . . . . 2.3599999999999999 111.473 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.991 -0.549 . . . . 1.75 110.697 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.76 -176.16 35.39 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.332 -0.937 . . . . 0.81999999999999995 112.073 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 18' ' ' LYS . 19.2 tt -136.53 137.02 48.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.27 0.557 . . . . 0.81999999999999995 110.872 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 25.3 t -93.3 99.94 12.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.661 -0.699 . . . . 1.1100000000000001 109.32 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.77 119.29 36.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.966 0.412 . . . . 1.1399999999999999 110.642 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 51.5 p90 -122.33 160.74 46.7 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.048 -0.524 . . . . 1.1499999999999999 110.423 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.4 Cg_exo -79.01 156.37 91.69 Favored 'Cis proline' 0 CA--C 1.523 -0.07 0 C-N-CA 124.232 -1.153 . . . . 0.81999999999999995 111.945 -3.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.92 101.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.624 -0.262 . . . . 1.45 110.615 173.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 13.2 m-20 . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.772 -0.632 . . . . 3.0800000000000001 110.265 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.5 0 N-CA-C 111.934 -0.466 . . . . 2.96 111.934 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 7.9 p -90.59 77.74 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.183 0.516 . . . . 1.1299999999999999 111.186 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 m -86.0 134.58 33.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.898 -0.592 . . . . 1.1200000000000001 110.182 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 26.3 p -130.92 165.91 22.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.842 0.353 . . . . 1.01 110.705 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -127.86 112.69 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 1.1799999999999999 110.826 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.25 99.38 12.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.956 -0.757 . . . . 1.2 108.956 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.44 0.9 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.472 -1.051 . . . . 1.01 110.472 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.44 10.62 2.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 109.995 170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.2 m -94.58 119.63 33.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.679 . . . . 0.81999999999999995 109.615 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.5 tt -74.85 129.01 37.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.444 0.64 . . . . 1.0600000000000001 111.418 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.17 -175.37 13.88 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.52 -0.764 . . . . 0.81999999999999995 111.926 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.46 132.63 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.327 0.584 . . . . 0.81999999999999995 109.46 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 15.6 t80 -88.35 112.49 22.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.668 -0.696 . . . . 1.1200000000000001 111.353 -173.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.454 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -97.41 103.74 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.873 -0.603 . . . . 0.81999999999999995 110.357 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -86.95 135.31 33.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.557 -0.292 . . . . 0.83999999999999997 110.229 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.6 -10.81 59.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.525 -0.845 . . . . 1.0700000000000001 113.334 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -123.92 150.46 44.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.003 0.43 . . . . 0.81999999999999995 111.022 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.23 4.58 29.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 3.98 110.425 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -135.51 140.71 44.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 1.6000000000000001 110.14 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.2 m -74.66 139.13 73.96 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.91000000000000003 110.142 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 6.2 Cg_exo -75.37 84.46 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.431 2.088 . . . . 0.81999999999999995 109.7 172.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -71.68 71.73 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.507 0.67 . . . . 2.3700000000000001 111.799 -172.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.434 ' HB2' HH11 ' A' ' 24' ' ' ARG . 40.6 m-80 -130.97 20.93 4.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.038 -0.983 . . . . 1.8300000000000001 108.544 172.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.434 HH11 ' HB2' ' A' ' 23' ' ' ASN . 10.8 mpt_? -129.71 -2.57 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.043 -0.98 . . . . 3.3900000000000001 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.97 30.12 52.35 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.524 -0.846 . . . . 1.1000000000000001 112.516 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -54.52 133.18 46.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.732 0.301 . . . . 3.7599999999999998 110.755 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.9 m -103.43 -45.41 4.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.013 -0.54 . . . . 1.3300000000000001 111.423 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -133.04 171.79 21.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.169 -1.015 . . . . 0.81999999999999995 112.452 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.432 ' HB3' HD13 ' A' ' 36' ' ' ILE . 14.8 m -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 1.4399999999999999 111.546 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -120.09 108.31 14.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.72 -0.673 . . . . 1.01 109.359 172.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.18 138.57 45.31 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.973 -0.632 . . . . 0.81999999999999995 112.099 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.05 -178.28 5.13 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.641 -0.329 . . . . 1.97 110.48 -176.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -65.04 95.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 2.3599999999999999 111.766 -172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 62.28 28.07 16.77 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.533 -0.758 . . . . 1.75 110.707 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.65 -176.26 28.53 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.542 -0.837 . . . . 0.81999999999999995 111.922 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 29' ' ' SER . 15.0 tt -141.35 128.12 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.113 0.483 . . . . 0.81999999999999995 110.626 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -87.78 101.86 14.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 1.1100000000000001 109.447 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.9 m -99.06 120.59 39.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.1399999999999999 110.742 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.511 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 53.3 p90 -119.87 156.56 54.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.259 -0.428 . . . . 1.1499999999999999 109.981 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 31.7 Cg_exo -61.18 158.71 50.65 Favored 'Cis proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.167 -1.18 . . . . 0.81999999999999995 114.033 1.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 p -57.79 111.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.31 -0.859 . . . . 1.45 111.036 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 24' ' ' ARG . 7.5 t70 . . . . . 0 C--O 1.25 1.084 0 CA-C-N 114.31 -1.314 . . . . 3.0800000000000001 111.452 171.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.07 -0.412 . . . . 2.96 112.07 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 p -99.08 68.69 1.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.303 0.573 . . . . 1.1299999999999999 110.579 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.2 m -133.4 139.63 46.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 1.1200000000000001 111.014 -177.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 p -125.99 171.28 10.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.106 -0.702 . . . . 1.01 109.106 176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -127.55 106.6 9.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 1.1799999999999999 110.479 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m -88.2 104.0 16.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.523 -0.917 . . . . 1.2 108.523 174.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.18 -112.46 4.37 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.978 -1.249 . . . . 1.01 109.978 -167.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -114.74 3.15 14.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.26 0.553 . . . . 3.6499999999999999 109.701 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -86.26 119.29 26.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.81999999999999995 110.567 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.98 124.98 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.578 -0.737 . . . . 1.0600000000000001 111.027 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.48 151.03 16.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.852 -0.613 . . . . 0.81999999999999995 111.976 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.55 130.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.284 0.564 . . . . 0.81999999999999995 109.532 -178.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 20.0 t80 -87.95 120.6 29.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.75 -0.659 . . . . 1.1200000000000001 111.426 -174.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -102.9 125.28 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.81999999999999995 110.405 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -116.7 119.11 34.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.689 -0.687 . . . . 0.83999999999999997 109.736 178.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.12 12.81 13.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.513 -0.851 . . . . 1.0700000000000001 112.198 -178.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -155.55 143.27 19.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.81999999999999995 110.669 177.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -90.54 -12.36 37.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 3.98 110.077 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -122.45 141.96 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.209 0.528 . . . . 1.6000000000000001 111.064 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.5 m -72.28 134.71 82.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.631 -0.713 . . . . 0.91000000000000003 109.981 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.24 95.36 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.562 2.175 . . . . 0.81999999999999995 110.294 173.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 t -79.85 66.86 5.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 2.3700000000000001 111.355 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -141.26 15.04 2.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 1.8300000000000001 110.76 173.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -108.53 -54.87 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 3.3900000000000001 109.608 174.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.97 -5.42 0.79 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.282 -0.872 . . . . 1.1000000000000001 112.049 -175.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.446 ' HE1' ' HA ' ' A' ' 41' ' ' VAL . 17.7 m-85 -52.2 139.19 24.35 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.596 0.358 . . . . 3.7599999999999998 111.003 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.1 m -132.23 -48.61 0.92 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.291 -0.413 . . . . 1.3300000000000001 111.163 -176.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.68 159.56 25.93 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.822 -0.704 . . . . 0.81999999999999995 112.01 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 m -142.38 154.04 44.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.004 0.431 . . . . 1.4399999999999999 111.282 -177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.3 120.9 20.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.73 . . . . 1.01 109.138 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.96 124.79 37.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.81999999999999995 111.333 177.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -127.49 177.86 6.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.994 0.397 . . . . 1.97 110.547 -173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -53.23 101.74 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 123.56 0.537 . . . . 2.3599999999999999 112.177 -176.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.7 tp 56.76 29.51 16.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.249 -0.887 . . . . 1.75 110.986 176.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -169.05 -163.75 23.6 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.689 -0.767 . . . . 0.81999999999999995 112.129 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -136.02 128.56 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.144 0.497 . . . . 0.81999999999999995 110.702 -177.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 4.9 t -99.2 116.25 30.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.769 -0.826 . . . . 1.1100000000000001 108.769 178.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.56 133.45 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.538 -0.301 . . . . 1.1399999999999999 110.996 -171.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 54.9 p90 -133.5 162.79 55.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.59 -0.277 . . . . 1.1499999999999999 110.549 -177.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.3 Cg_exo -81.68 150.55 75.48 Favored 'Cis proline' 0 C--N 1.342 0.232 0 C-N-CA 124.47 -1.054 . . . . 0.81999999999999995 112.306 -3.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HA ' ' HE1' ' A' ' 26' ' ' TYR . 87.4 t -63.13 97.69 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.193 0.52 . . . . 1.45 111.077 177.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.253 1.256 0 CA-C-N 115.331 -0.849 . . . . 3.0800000000000001 109.531 177.837 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.607 -0.597 . . . . 2.96 111.607 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.3 p -84.83 81.67 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.251 0.548 . . . . 1.1299999999999999 111.521 -178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 m -99.21 129.64 45.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 1.1200000000000001 110.302 177.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.4 p -132.08 153.6 50.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.877 0.37 . . . . 1.01 111.337 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 39.7 m-85 -120.61 129.78 53.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 1.1799999999999999 110.515 175.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.9 t -123.3 115.81 22.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.585 -0.524 . . . . 1.2 109.585 174.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.85 -91.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.271 -0.732 . . . . 1.01 111.271 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -133.71 -2.31 3.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.975 0.417 . . . . 3.6499999999999999 110.094 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -100.44 134.97 42.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.81999999999999995 111.46 -171.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.532 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -93.64 130.18 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 1.0600000000000001 110.218 177.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.29 -171.32 12.14 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.035 -0.602 . . . . 0.81999999999999995 112.196 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.25 130.44 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.369 0.604 . . . . 0.81999999999999995 109.42 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 6.8 t80 -87.6 109.8 19.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.609 -0.723 . . . . 1.1200000000000001 111.145 -176.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -87.79 102.51 14.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.73 -0.668 . . . . 0.81999999999999995 110.379 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -83.07 105.91 14.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.83999999999999997 109.727 174.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.49 -61.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.638 -0.792 . . . . 1.0700000000000001 112.046 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t -86.77 161.03 18.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.003 0.43 . . . . 0.81999999999999995 110.655 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.1 tmtp? -116.78 11.56 14.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.9 -0.778 . . . . 3.98 108.9 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -139.34 141.06 37.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.694 -0.685 . . . . 1.6000000000000001 110.278 178.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 90.5 m -77.27 117.98 68.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.477 -0.329 . . . . 0.91000000000000003 111.079 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.11 85.24 0.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.073 1.848 . . . . 0.81999999999999995 109.896 172.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -82.15 52.42 2.0 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.746 0.784 . . . . 2.3700000000000001 110.681 -172.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.54 24.19 8.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.99 -1.004 . . . . 1.8300000000000001 108.773 172.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 83.1 mtt85 -132.74 -76.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.895 -1.048 . . . . 3.3900000000000001 110.22 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.55 27.59 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.554 -0.831 . . . . 1.1000000000000001 113.162 176.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -71.43 135.83 47.39 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 122.6 -0.353 . . . . 3.7599999999999998 110.886 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -104.67 -38.32 6.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.987 0.423 . . . . 1.3300000000000001 111.071 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 176.26 24.7 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.764 -0.731 . . . . 0.81999999999999995 112.219 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 43.7 p -139.44 171.57 14.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.925 0.393 . . . . 1.4399999999999999 111.251 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 5.5 t -149.75 131.28 14.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.01 109.06 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.21 129.04 34.3 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.599 -0.81 . . . . 0.81999999999999995 111.855 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.98 168.99 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.858 0.329 . . . . 1.97 110.474 -176.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -53.98 102.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.106 -0.497 . . . . 2.3599999999999999 111.393 -178.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.92 26.39 14.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.506 0.504 . . . . 1.75 111.621 177.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.29 -170.13 30.8 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.254 -0.974 . . . . 0.81999999999999995 112.499 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 29' ' ' SER . 14.7 tt -132.62 132.69 59.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.81999999999999995 111.014 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 52.4 t -92.73 111.56 23.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.4 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.3 m -103.07 120.62 41.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.766 0.317 . . . . 1.1399999999999999 111.442 -175.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 24.0 p90 -124.92 155.55 70.26 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.343 -0.39 . . . . 1.1499999999999999 110.905 -177.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.9 Cg_exo -66.75 163.12 72.27 Favored 'Cis proline' 0 N--CA 1.474 0.342 0 C-N-CA 123.697 -1.376 . . . . 0.81999999999999995 111.947 -2.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.3 96.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.702 0.763 . . . . 1.45 110.203 176.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 28.0 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.346 -0.843 . . . . 3.0800000000000001 110.611 -175.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.994 -0.443 . . . . 2.96 111.994 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 19.3 p -82.07 93.41 7.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.328 0.585 . . . . 1.1299999999999999 110.619 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -141.16 139.27 33.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.614 -0.721 . . . . 1.1200000000000001 110.877 -174.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.9 p -122.72 172.05 8.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.26 93.27 3.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.66 -0.496 . . . . 1.1799999999999999 109.66 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.64 101.47 5.75 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.27 -104.48 1.51 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.799 -1.32 . . . . 1.01 109.799 -168.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -122.36 6.5 9.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.802 0.334 . . . . 3.6499999999999999 110.205 171.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.37 121.15 31.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.81999999999999995 110.836 -178.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tt -71.75 121.45 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.695 -0.684 . . . . 1.0600000000000001 110.738 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.77 154.33 16.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.526 -0.761 . . . . 0.81999999999999995 111.474 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.45 132.04 56.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.212 0.53 . . . . 0.81999999999999995 109.691 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.752 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 18.1 t80 -85.12 112.1 20.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 1.1200000000000001 111.602 -173.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -95.97 131.51 42.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.81999999999999995 110.095 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -112.35 138.12 49.53 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.649 -0.5 . . . . 0.83999999999999997 109.649 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.18 -50.38 0.9 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.668 -0.777 . . . . 1.0700000000000001 111.903 -178.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -87.17 149.8 24.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.929 0.395 . . . . 0.81999999999999995 110.428 176.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.3 8.8 16.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 3.98 109.459 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -130.23 141.13 50.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.309 -0.859 . . . . 1.6000000000000001 110.177 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -72.38 114.74 32.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.089 -0.337 . . . . 0.91000000000000003 110.089 177.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.31 135.95 52.88 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.521 2.148 . . . . 0.81999999999999995 112.416 -176.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 56.03 2.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.567 -0.742 . . . . 2.3700000000000001 110.213 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -119.2 -16.62 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.718 -0.674 . . . . 1.8300000000000001 111.131 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -124.97 -26.8 3.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 3.3900000000000001 110.99 175.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 31.29 7.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.418 -0.896 . . . . 1.1000000000000001 112.202 -177.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -51.17 125.87 15.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.813 0.339 . . . . 3.7599999999999998 110.458 177.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -106.89 -4.04 19.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.122 0.486 . . . . 1.3300000000000001 111.183 -169.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -148.46 158.21 27.59 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.704 -0.76 . . . . 0.81999999999999995 111.678 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.49 ' HB2' HD13 ' A' ' 36' ' ' ILE . 50.3 p -137.44 138.43 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.17 0.51 . . . . 1.4399999999999999 111.766 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 94.0 m -120.84 114.02 20.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.174 172.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.01 141.55 47.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.174 -0.466 . . . . 0.81999999999999995 113.086 -177.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.81 175.72 9.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.952 -0.388 . . . . 1.97 109.952 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -56.72 98.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.575 0.547 . . . . 2.3599999999999999 111.724 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt 60.39 18.37 8.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.026 -0.534 . . . . 1.75 111.198 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.63 -174.37 17.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.992 -0.623 . . . . 0.81999999999999995 111.893 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 29' ' ' SER . 14.8 tt -143.86 126.57 11.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.279 0.561 . . . . 0.81999999999999995 110.662 -178.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.08 106.27 18.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.983 -0.747 . . . . 1.1100000000000001 108.983 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.52 136.08 38.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.087 0.47 . . . . 1.1399999999999999 111.349 -173.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.3 p90 -129.08 159.9 66.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 1.1499999999999999 110.286 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 86.6 Cg_endo -90.66 156.74 28.58 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.421 -1.491 . . . . 0.81999999999999995 112.349 -2.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.6 74.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.065 -0.717 . . . . 1.45 109.065 173.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.483 -0.77 . . . . 3.0800000000000001 110.214 -177.908 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.926 -0.47 . . . . 2.96 111.926 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -69.36 99.39 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.436 0.636 . . . . 1.1299999999999999 109.999 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.5 m -91.82 128.62 37.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 1.1200000000000001 112.151 -168.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.83 148.72 34.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.588 -0.523 . . . . 1.01 109.588 172.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.2 125.04 52.91 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.184 -0.206 . . . . 1.1799999999999999 110.623 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.2 m -89.63 95.42 10.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.386 -0.968 . . . . 1.2 108.386 171.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -83.48 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.053 -0.594 . . . . 1.01 111.795 -177.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -141.76 19.76 2.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 3.6499999999999999 110.104 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -116.35 131.26 56.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.81999999999999995 110.586 178.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 tp -82.5 115.26 24.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.533 0.683 . . . . 1.0600000000000001 111.751 -175.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.62 173.62 17.03 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.384 -0.826 . . . . 0.81999999999999995 112.234 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.87 130.33 63.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.493 -0.558 . . . . 0.81999999999999995 109.493 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -84.07 108.99 17.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.775 . . . . 1.1200000000000001 111.378 -174.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.24 102.08 14.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.569 -0.741 . . . . 0.81999999999999995 110.389 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -89.38 121.26 31.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.24 -0.437 . . . . 0.83999999999999997 110.006 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.56 -29.94 5.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.489 -0.862 . . . . 1.0700000000000001 112.916 178.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -107.41 149.79 27.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.154 0.502 . . . . 0.81999999999999995 110.732 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -100.88 1.62 40.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.359 -0.837 . . . . 3.98 110.091 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -139.85 152.56 46.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.882 -0.599 . . . . 1.6000000000000001 110.407 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.3 m -83.66 119.86 74.36 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.91000000000000003 110.666 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.22 96.85 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.88 1.72 . . . . 0.81999999999999995 109.589 170.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 t -82.17 63.05 6.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.555 0.693 . . . . 2.3700000000000001 110.631 -172.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -107.67 -1.46 21.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 1.8300000000000001 110.078 177.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HD2' ' OH ' ' A' ' 26' ' ' TYR . 91.3 mtt180 -125.98 21.25 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 3.3900000000000001 110.611 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.75 38.08 89.34 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.031 -0.604 . . . . 1.1000000000000001 113.311 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 24' ' ' ARG . 20.9 m-85 -68.35 120.21 14.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.032 0.416 . . . . 3.7599999999999998 110.014 177.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 m -94.76 -33.81 12.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.851 -0.613 . . . . 1.3300000000000001 111.345 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.73 174.07 25.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.218 -0.991 . . . . 0.81999999999999995 112.311 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.24 159.03 35.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.961 0.41 . . . . 1.4399999999999999 111.185 -178.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 29.8 p -134.45 142.44 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.247 -0.649 . . . . 1.01 109.247 174.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.36 132.57 27.77 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.059 -0.591 . . . . 0.81999999999999995 112.122 -177.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.27 16.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.816 0.341 . . . . 1.97 110.697 -175.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -56.9 106.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.624 . . . . 2.3599999999999999 111.233 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 58.88 21.86 9.59 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.754 0.659 . . . . 1.75 111.898 177.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -173.08 32.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.436 -0.888 . . . . 0.81999999999999995 112.134 -177.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.5 134.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.807 0.337 . . . . 0.81999999999999995 110.65 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 44.1 t -98.86 108.88 21.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.495 -0.558 . . . . 1.1100000000000001 109.495 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.9 m -104.97 127.3 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.385 -0.37 . . . . 1.1399999999999999 111.081 -174.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.447 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.7 p90 -120.29 159.69 46.62 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.287 -0.415 . . . . 1.1499999999999999 111.061 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 95.1 Cg_endo -92.04 160.49 25.79 Favored 'Cis proline' 0 C--N 1.344 0.303 0 C-N-CA 124.005 -1.248 . . . . 0.81999999999999995 113.006 -0.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.29 96.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.45 110.422 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.659 -0.686 . . . . 3.0800000000000001 110.121 175.419 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.723 -0.551 . . . . 2.96 111.723 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -84.08 85.19 7.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 1.1299999999999999 111.084 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -76.71 148.69 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.068 0.461 . . . . 1.1200000000000001 110.075 178.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.22 115.4 5.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.914 0.388 . . . . 1.01 110.618 -175.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 35.7 m-85 -97.33 109.19 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.479 -0.328 . . . . 1.1799999999999999 111.041 -178.001 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.2 m -86.81 98.2 11.05 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.545 -0.909 . . . . 1.2 108.545 171.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.81 -111.77 4.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.395 -0.821 . . . . 1.01 111.499 -172.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -89.83 -22.86 21.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.518 0.199 . . . . 3.6499999999999999 111.287 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -91.82 118.61 30.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.18 0.514 . . . . 0.81999999999999995 111.639 -168.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 5.4 tt -78.32 123.56 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 1.0600000000000001 110.859 177.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.23 -169.44 12.56 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 111.06 -0.816 . . . . 0.81999999999999995 111.06 176.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 132.91 68.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.178 0.513 . . . . 0.81999999999999995 110.02 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 6.7 t80 -88.82 106.17 18.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.554 -0.748 . . . . 1.1200000000000001 111.068 -176.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.427 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 89.8 m95 -87.15 95.91 10.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.81999999999999995 110.329 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.1 t80 -78.79 109.82 13.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.422 -0.584 . . . . 0.83999999999999997 109.422 175.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.39 -61.45 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.88 -0.676 . . . . 1.0700000000000001 112.143 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -86.79 160.19 18.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.88 0.372 . . . . 0.81999999999999995 110.578 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.39 11.5 14.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 3.98 109.589 178.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.3 t -129.47 145.93 51.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 1.6000000000000001 110.3 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 70.9 m -82.87 124.76 76.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.91000000000000003 110.105 178.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 33.5 Cg_exo -57.36 113.47 1.51 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.638 2.225 . . . . 0.81999999999999995 111.104 176.098 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -77.01 43.42 0.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 2.3700000000000001 111.947 -172.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -128.44 16.75 6.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.928 0.394 . . . . 1.8300000000000001 110.789 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -123.09 -42.25 2.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.84 0.352 . . . . 3.3900000000000001 111.102 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.28 32.11 3.57 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.752 -0.737 . . . . 1.1000000000000001 112.044 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -56.25 131.42 47.89 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.879 0.371 . . . . 3.7599999999999998 110.557 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -85.2 -40.66 16.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.087 -0.506 . . . . 1.3300000000000001 110.943 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.23 165.31 26.35 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.672 -0.775 . . . . 0.81999999999999995 111.651 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.495 ' HB2' HD12 ' A' ' 36' ' ' ILE . 69.0 p -140.66 134.47 30.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 1.4399999999999999 110.989 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 57.0 m -106.07 110.93 23.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.567 -0.742 . . . . 1.01 109.496 178.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.6 113.47 3.89 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.171 -0.772 . . . . 0.81999999999999995 111.171 176.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -112.84 164.47 13.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.041 -0.355 . . . . 1.97 110.041 -172.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -56.9 104.9 0.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.082 -0.508 . . . . 2.3599999999999999 110.675 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt 65.03 28.62 12.42 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.683 0.614 . . . . 1.75 111.307 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.79 -168.72 35.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.496 -0.859 . . . . 0.81999999999999995 112.268 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 29' ' ' SER . 17.4 tt -138.13 132.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.81999999999999995 111.071 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 48.6 t -94.77 100.58 12.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.674 -0.694 . . . . 1.1100000000000001 109.751 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.03 121.05 39.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.464 -0.334 . . . . 1.1399999999999999 110.933 -176.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -128.1 153.52 78.56 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 1.1499999999999999 110.927 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.83 154.05 46.45 Favored 'Cis proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.286 -1.547 . . . . 0.81999999999999995 112.498 -1.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 p -85.2 98.2 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.048 -0.524 . . . . 1.45 110.165 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.161 -0.927 . . . . 3.0800000000000001 110.733 178.577 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.268 0.556 . . . . 1.13 111.385 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.7 m -103.27 126.86 50.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.12 109.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.13 127.3 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.334 0.588 . . . . 1.01 110.9 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -91.38 119.46 31.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.491 . . . . 0.85 110.812 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -94.8 104.24 16.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.112 -0.699 . . . . 1.2 109.112 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.12 -96.47 0.61 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.511 -0.852 . . . . 1.01 111.075 -173.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -128.84 0.33 5.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 3.65 110.638 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -92.35 130.68 37.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.352 -0.386 . . . . 0.72 110.608 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -79.53 114.31 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 1.06 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.41 165.91 12.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.656 -0.702 . . . . 0.36 111.862 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.56 134.19 54.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.278 0.561 . . . . 0.33 109.866 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -87.29 106.13 17.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.472 -0.786 . . . . 0.8 111.168 -175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -88.47 108.39 19.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.814 -0.63 . . . . 0.47 110.618 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -96.88 114.29 25.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.75 109.815 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.86 -16.58 6.13 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.271 -0.966 . . . . 1.07 113.08 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.4 t -135.55 156.66 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.57 110.87 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.42 0.63 23.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 3.98 109.878 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 m -116.76 118.99 34.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 1.6 111.144 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 71.7 m -61.29 120.51 55.71 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.702 -0.481 . . . . 0.91 109.702 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 47.6 Cg_exo -53.43 108.24 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.652 2.235 . . . . 0.82 111.116 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -79.18 36.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.916 -0.584 . . . . 2.07 111.896 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -123.89 13.68 9.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.386 0.612 . . . . 1.83 109.47 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -108.75 -74.37 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.481 -0.781 . . . . 3.39 110.831 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.1 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.356 -0.838 . . . . 1.1 111.63 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.58 149.58 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 3.45 110.566 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 m -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.091 -0.504 . . . . 1.33 110.549 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.67 160.72 22.81 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.442 -0.885 . . . . 0.35 112.072 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.551 ' HB2' HD11 ' A' ' 36' ' ' ILE . 33.0 p -142.1 136.34 30.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.101 0.476 . . . . 0.96 111.746 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 61.2 m -107.16 128.16 54.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.624 -0.716 . . . . 1.01 109.986 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 105.87 1.69 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.692 -0.766 . . . . 0.49 111.334 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -105.74 173.14 6.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.173 -0.306 . . . . 1.75 110.173 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -54.35 102.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.445 -0.343 . . . . 1.96 111.615 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp 58.33 28.41 16.68 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.019 0.824 . . . . 1.75 111.143 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.27 -173.4 33.81 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.039 -0.601 . . . . 0.34 111.687 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 29' ' ' SER . 16.0 tt -136.25 128.51 45.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.282 0.563 . . . . 0.37 111.416 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 22.1 m -92.05 102.8 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.942 -0.572 . . . . 1.11 110.378 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.3 m -97.92 125.37 42.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.477 -0.329 . . . . 1.14 110.532 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.441 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 45.0 p90 -128.46 156.41 77.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.57 111.111 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -80.16 162.56 83.66 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.669 -1.388 . . . . 0.48 112.377 -2.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 C--O 1.234 0.241 0 CA-C-N 116.238 -0.437 . . . . 1.31 110.385 175.774 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.607 0.718 . . . . 1.13 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m -146.43 136.39 23.44 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.439 -0.801 . . . . 1.12 109.398 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 p -129.26 161.61 29.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.024 0.44 . . . . 1.01 110.716 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -111.67 93.43 4.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.85 109.598 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.72 107.82 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.89 -100.87 0.73 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.446 -0.662 . . . . 1.01 111.446 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.88 23.18 5.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 3.65 110.16 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -124.2 127.79 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.72 110.778 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tt -83.97 124.24 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.537 0.684 . . . . 1.06 110.683 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -130.67 161.2 23.33 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.464 -0.789 . . . . 0.36 111.864 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.31 132.02 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.33 109.739 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 10.3 t80 -86.92 106.58 17.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 0.8 111.104 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -84.49 107.74 16.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.47 110.121 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -90.35 119.35 30.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.486 -0.561 . . . . 0.75 109.486 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.01 -60.63 0.46 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 1.07 111.862 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -91.89 134.24 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.106 0.479 . . . . 0.57 110.288 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -108.65 23.63 14.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.642 0.734 . . . . 3.98 109.455 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.8 p -124.11 130.18 52.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.875 -1.057 . . . . 1.6 109.916 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 73.9 m -78.7 125.3 84.52 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.576 -0.284 . . . . 0.91 111.054 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.3 Cg_exo -66.09 110.5 1.76 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.878 2.386 . . . . 0.82 111.272 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -79.6 66.08 4.96 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.315 0.579 . . . . 2.07 110.981 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -157.66 23.74 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 1.83 110.357 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.2 mmp_? -130.21 -49.82 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 3.39 111.538 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.01 10.01 1.4 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.981 -0.628 . . . . 1.1 111.971 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.591 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 23.5 m-85 -69.62 120.83 15.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.919 -0.4 . . . . 3.45 109.919 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -115.68 -24.19 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.099 0.476 . . . . 1.33 110.889 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 158.48 22.55 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.942 -0.863 . . . . 0.35 110.942 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.806 ' HB3' HD11 ' A' ' 36' ' ' ILE . 13.3 m -132.03 139.4 48.56 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.313 0.556 . . . . 0.96 111.738 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -115.77 95.3 5.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.447 -0.946 . . . . 1.01 108.447 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.67 131.17 39.69 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.407 -0.425 . . . . 0.49 112.317 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -132.42 169.11 17.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.961 0.41 . . . . 1.75 111.066 -173.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -59.67 111.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 1.96 111.118 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.2 mt 64.88 24.44 12.74 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.748 0.655 . . . . 1.75 111.57 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.8 -159.76 23.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.704 -1.236 . . . . 0.34 112.936 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 29' ' ' SER . 17.0 tt -144.45 125.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.37 110.85 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 t -92.43 94.66 9.22 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.744 -0.836 . . . . 1.11 108.744 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 1.5 t -93.48 136.53 33.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.161 -0.472 . . . . 1.14 110.405 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 36.1 p90 -134.03 161.14 65.52 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.57 111.232 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 2.3 Cg_endo -82.32 154.94 77.39 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.613 -1.411 . . . . 0.48 111.555 -3.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 122.211 1.005 . . . . 1.31 109.437 175.194 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.28 0.562 . . . . 1.13 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 10' ' ' ILE . 53.0 m -106.15 127.77 53.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.12 111.368 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 7.2 p -145.82 136.08 23.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.972 0.415 . . . . 1.01 110.9 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.42 136.42 38.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.85 111.66 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.8 m -119.14 105.05 11.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.316 -0.856 . . . . 1.2 108.737 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.95 -115.36 7.16 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.806 -0.917 . . . . 1.01 110.806 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -102.0 -12.89 17.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.654 -0.499 . . . . 3.65 109.654 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 39' ' ' TYR . 7.3 m -83.21 119.65 24.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.523 -0.762 . . . . 0.72 111.241 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 3' ' ' THR . 4.1 tp -73.98 121.86 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.06 110.286 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.05 159.07 15.15 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.667 -0.697 . . . . 0.36 112.011 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.1 130.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.478 0.656 . . . . 0.33 109.741 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.406 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 12.0 t80 -84.36 97.67 9.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.207 -0.906 . . . . 0.8 110.88 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -79.9 88.98 5.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.694 -0.684 . . . . 0.47 110.181 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -84.17 104.13 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.186 -0.672 . . . . 0.75 109.186 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.86 -48.33 0.64 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.953 -0.642 . . . . 1.07 111.707 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -107.57 165.73 11.2 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.907 -0.405 . . . . 0.57 109.907 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -122.22 11.05 10.06 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.975 -0.75 . . . . 3.98 108.975 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -127.44 125.29 40.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.431 -0.804 . . . . 1.6 110.55 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.5 m -67.9 123.58 87.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.109 -0.33 . . . . 0.91 110.109 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 108.05 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.589 2.192 . . . . 0.82 111.275 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.4 m -79.75 58.62 2.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.03 0.443 . . . . 2.07 111.888 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -149.23 22.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 1.83 111.153 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -133.46 -49.17 0.84 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.862 0.363 . . . . 3.39 111.323 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.99 22.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.738 -0.744 . . . . 1.1 112.718 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -70.23 111.8 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.841 -0.429 . . . . 3.45 109.841 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 m -93.33 -28.52 16.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.0 -0.546 . . . . 1.33 110.94 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.22 167.48 24.68 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.55 -0.833 . . . . 0.35 112.33 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 44.5 p -144.41 144.47 31.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.143 0.496 . . . . 0.96 110.908 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 76.0 m -121.32 129.18 52.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 1.01 109.719 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.39 115.26 6.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.896 -0.882 . . . . 0.49 110.896 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -117.78 167.74 11.1 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.724 -0.473 . . . . 1.75 109.724 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -54.39 101.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.93 -0.577 . . . . 1.96 111.408 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.3 mt 63.77 22.29 13.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.522 -0.763 . . . . 1.75 111.905 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.89 -178.98 35.35 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.573 -0.822 . . . . 0.34 112.123 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.9 126.58 62.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.214 0.531 . . . . 0.37 111.128 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 57.2 m -90.25 107.61 19.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.1 -0.5 . . . . 1.11 110.559 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.1 125.77 46.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.939 -0.393 . . . . 1.14 109.939 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 9' ' ' THR . 45.1 p90 -128.62 155.37 79.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.528 -0.306 . . . . 0.57 110.82 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.38 161.66 92.09 Favored 'Cis proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.996 -1.252 . . . . 0.48 112.568 -1.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 10' ' ' ILE . 97.9 t . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.023 0.439 . . . . 1.31 111.262 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.04 0.448 . . . . 1.13 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 m -76.37 117.9 18.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.764 -0.458 . . . . 1.12 109.764 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 34.1 t -121.77 109.09 14.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.137 0.494 . . . . 1.01 111.754 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 55.4 m-85 -85.77 109.7 18.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.85 110.2 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.51 101.86 13.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.2 108.09 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.51 -118.12 8.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.613 -0.803 . . . . 1.01 111.102 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -107.04 10.33 30.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.857 0.361 . . . . 3.65 110.997 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 39' ' ' TYR . 11.9 m -108.82 117.23 33.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.362 -0.535 . . . . 0.72 110.476 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.4 tt -81.27 123.28 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.679 . . . . 1.06 110.851 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -131.39 -172.83 13.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.723 -0.671 . . . . 0.36 111.706 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.2 131.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.399 0.618 . . . . 0.33 109.843 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HE1' ' HA3' ' A' ' 35' ' ' GLY . 11.2 t80 -86.4 106.75 17.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.296 -0.865 . . . . 0.8 110.833 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.432 ' HB2' HG23 ' A' ' 36' ' ' ILE . 98.8 m95 -88.17 112.8 23.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.47 110.049 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.407 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 91.7 t80 -89.91 135.98 33.32 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.964 -0.384 . . . . 0.75 109.964 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.5 -53.51 0.77 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 1.07 112.654 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -83.36 154.11 24.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.57 110.422 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.5 mptt -109.63 -2.88 17.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 3.98 109.257 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -130.24 159.0 38.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.524 -0.762 . . . . 1.6 110.012 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.5 m -88.07 121.83 70.33 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.536 -0.302 . . . . 0.91 110.941 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -63.11 105.75 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.078 1.852 . . . . 0.82 110.459 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.5 m -79.08 68.72 5.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.987 -0.551 . . . . 2.07 111.128 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.56 13.46 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 1.83 111.341 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -128.64 -82.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 3.39 110.958 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.67 27.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.621 -0.718 . . . . 1.1 111.924 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 18.3 m-85 -70.48 153.2 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.145 -0.317 . . . . 3.45 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.1 m -129.66 -55.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.012 -0.275 . . . . 1.33 111.504 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.68 17.4 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.799 . . . . 0.35 111.716 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 p -138.18 140.14 39.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.281 0.562 . . . . 0.96 111.655 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 61.1 m -116.92 136.95 52.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.631 -0.713 . . . . 1.01 109.473 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.44 127.15 28.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.684 -0.77 . . . . 0.49 111.506 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -129.29 171.37 12.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.804 -0.443 . . . . 1.75 109.804 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -54.48 103.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.455 0.472 . . . . 1.96 111.49 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 56.92 25.35 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.391 -0.822 . . . . 1.75 111.857 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . -161.53 177.15 37.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.075 -1.059 . . . . 0.34 112.604 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 14' ' ' TRP . 11.8 tt -118.37 124.2 72.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.579 0.704 . . . . 0.37 110.94 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 49.8 t -88.43 95.51 10.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.414 -0.812 . . . . 1.11 109.694 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 3.1 t -101.11 124.49 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.907 0.384 . . . . 1.14 111.056 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.696 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 28.3 p90 -126.46 162.04 48.93 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.57 110.571 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -82.66 167.0 68.05 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 124.481 -1.05 . . . . 0.48 112.835 -1.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 93.8 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 1.31 110.832 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.084 0.469 . . . . 1.13 110.69 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.1 m -75.76 124.99 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.484 -0.78 . . . . 1.12 111.516 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 50.4 t -138.55 154.53 48.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.697 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -133.42 129.0 36.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.85 111.563 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -112.33 102.53 10.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.607 -0.724 . . . . 1.2 109.202 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.8 -86.79 0.45 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -138.1 -0.51 2.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 3.65 109.937 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -85.7 124.97 32.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.72 110.381 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG13 ' CG1' ' A' ' 41' ' ' VAL . 3.6 tp -79.75 121.84 33.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.491 0.662 . . . . 1.06 110.827 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.1 -176.01 14.26 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.49 -0.777 . . . . 0.36 111.708 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.5 134.04 61.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.479 0.657 . . . . 0.33 110.238 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 16.4 t80 -89.6 102.51 15.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.364 -0.835 . . . . 0.8 111.176 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -83.2 98.23 9.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.025 -0.534 . . . . 0.47 110.777 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.61 102.35 14.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.896 0.379 . . . . 0.75 110.184 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.84 -51.22 0.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.782 -0.723 . . . . 1.07 111.708 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 t -90.44 158.1 17.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.899 0.381 . . . . 0.57 110.337 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.6 mptt -116.52 17.99 15.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.646 . . . . 3.98 109.502 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -147.17 146.94 30.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.114 -0.493 . . . . 1.6 110.553 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 71.0 m -80.11 124.33 82.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.148 -0.478 . . . . 0.91 110.685 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 24.3 Cg_exo -62.12 130.13 29.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.87 2.38 . . . . 0.82 112.012 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 m -83.74 55.3 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.299 -0.41 . . . . 2.07 111.548 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -141.8 0.53 1.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.741 0.305 . . . . 1.83 111.476 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -44.78 3.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.983 0.42 . . . . 3.39 111.627 -174.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 38.46 1.68 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.464 -0.654 . . . . 1.1 111.464 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -71.09 138.39 49.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.622 0.248 . . . . 3.45 110.69 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.516 HG22 ' HD3' ' A' ' 40' ' ' PRO . 14.5 t -106.78 -12.87 15.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.442 -0.344 . . . . 1.33 110.713 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.67 170.47 38.23 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.745 -1.217 . . . . 0.35 113.027 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 9.3 p -143.05 144.78 32.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.936 0.398 . . . . 0.96 111.013 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 63.1 m -125.28 134.61 52.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.026 -0.534 . . . . 1.01 110.173 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 121.76 7.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.638 -0.792 . . . . 0.49 112.119 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.12 171.94 9.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.455 0.169 . . . . 1.75 110.722 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -56.2 104.32 0.14 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 1.96 111.714 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.95 27.09 14.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.307 -0.86 . . . . 1.75 112.028 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.56 170.68 35.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.374 -0.917 . . . . 0.34 112.761 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 tt -116.55 130.81 70.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.37 110.339 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.7 t -96.23 102.23 13.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.113 -0.494 . . . . 1.11 110.05 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.05 122.19 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.816 0.341 . . . . 1.14 110.681 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -122.18 151.19 58.39 Favored Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.225 -0.443 . . . . 0.57 110.321 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 27' ' ' THR . 73.1 Cg_endo -86.16 160.41 56.81 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.063 -1.641 . . . . 0.48 112.045 0.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' CG1' HG13 ' A' ' 10' ' ' ILE . 5.6 p . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.734 0.778 . . . . 1.31 110.723 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.069 0.461 . . . . 1.13 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.1 m -74.38 121.91 22.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.5 . . . . 1.12 110.742 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 t -121.82 157.27 31.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.657 -0.701 . . . . 1.01 110.068 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -132.05 124.5 29.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.936 0.398 . . . . 0.85 111.344 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -100.53 92.56 5.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.69 -95.31 0.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.97 -0.852 . . . . 1.01 110.97 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -121.71 -2.03 9.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.829 0.347 . . . . 3.65 110.33 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.466 HG21 ' CD1' ' A' ' 39' ' ' TYR . 6.0 m -87.46 129.34 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.72 110.717 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 tt -86.36 113.45 24.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.885 0.85 . . . . 1.06 111.669 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.0 -174.22 14.58 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.029 -0.987 . . . . 0.36 111.528 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.93 134.48 66.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.43 0.633 . . . . 0.33 110.204 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -83.77 104.4 13.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.262 -0.881 . . . . 0.8 111.174 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 90.0 m95 -89.16 98.36 11.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.47 110.822 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.939 -0.573 . . . . 0.75 109.949 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.89 14.79 6.51 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.358 -0.925 . . . . 1.07 113.387 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -151.42 146.12 25.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.57 110.664 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -97.51 -8.67 28.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.378 -0.828 . . . . 3.98 109.603 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 p -118.75 139.43 51.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.679 . . . . 1.6 111.404 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 72.8 m -75.9 129.06 82.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.131 -0.486 . . . . 0.91 109.75 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 31.3 Cg_exo -58.11 97.59 0.09 OUTLIER 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.555 2.17 . . . . 0.82 110.782 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -79.61 51.92 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.524 0.678 . . . . 2.07 111.316 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.87 0.39 1.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.934 -1.03 . . . . 1.83 109.785 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -103.99 -46.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 3.39 110.906 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.07 14.95 0.94 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.747 -0.739 . . . . 1.1 112.683 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -70.7 137.92 50.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 3.45 110.385 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 m -115.23 -32.78 5.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.92 0.39 . . . . 1.33 110.659 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.48 176.97 18.61 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.858 -0.687 . . . . 0.35 111.796 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.4 p -162.66 148.89 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.116 0.484 . . . . 0.96 111.598 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 58.3 m -125.53 151.13 46.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.506 -0.77 . . . . 1.01 109.426 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.46 125.89 7.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.49 111.659 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.98 162.97 24.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.75 110.469 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 106.61 0.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 1.96 111.545 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 63.53 20.48 12.26 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.929 0.768 . . . . 1.75 112.087 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.92 175.73 39.26 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.28 -0.962 . . . . 0.34 112.85 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.58 133.69 68.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.199 0.523 . . . . 0.37 110.285 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' SER . 52.2 t -95.02 95.69 8.76 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.813 -0.44 . . . . 1.11 109.813 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.41 128.29 40.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.397 -0.365 . . . . 1.14 110.752 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 41.0 p90 -129.54 159.74 67.94 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.512 -0.313 . . . . 0.57 110.759 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 83.7 Cg_endo -91.41 162.6 28.71 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.677 -1.384 . . . . 0.48 112.789 -1.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.235 0.332 0 CA-C-N 116.099 -0.5 . . . . 1.31 109.78 173.987 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.8 p . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.548 0.69 . . . . 1.13 110.165 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 m -76.88 109.02 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.145 -0.934 . . . . 1.12 110.303 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.67 151.23 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.694 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -129.06 115.51 17.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.85 111.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.7 m -99.88 95.54 6.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.85 -107.34 2.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.62 -0.8 . . . . 1.01 111.268 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -107.78 -5.03 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.042 0.448 . . . . 3.65 110.524 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -99.95 117.38 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.72 110.788 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tt -82.23 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.514 0.673 . . . . 1.06 110.996 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.55 -170.28 11.85 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.201 -0.909 . . . . 0.36 111.204 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.92 137.7 52.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.295 0.569 . . . . 0.33 109.553 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 36.8 t80 -87.56 107.27 18.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.8 111.475 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.531 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 82.0 m95 -90.64 100.51 13.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.129 -0.487 . . . . 0.47 109.861 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.7 t80 -83.76 132.54 34.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.491 -0.322 . . . . 0.75 110.303 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.01 -18.69 39.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.639 -0.791 . . . . 1.07 113.233 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -118.29 151.83 36.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.581 . . . . 0.57 111.359 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -102.32 3.1 37.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.303 -0.862 . . . . 3.98 110.527 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -134.87 146.27 49.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.224 0.535 . . . . 1.6 111.368 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 94.5 m -80.9 127.99 72.93 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.702 -0.681 . . . . 0.91 111.208 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 17.1 Cg_exo -62.54 116.18 3.36 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.514 2.143 . . . . 0.82 110.553 173.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.1 m -84.08 24.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 2.07 112.12 -170.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.27 16.32 24.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.135 0.493 . . . . 1.83 110.147 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -119.38 -60.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.714 -0.676 . . . . 3.39 110.943 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.02 40.54 0.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.828 -0.624 . . . . 1.1 111.678 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 48.3 m-85 -70.39 132.58 45.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 3.45 111.245 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -89.16 -27.8 20.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.537 -0.756 . . . . 1.33 110.592 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.62 171.68 34.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.37 -0.919 . . . . 0.35 112.337 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.518 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 17.6 p -140.68 151.97 44.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.898 0.38 . . . . 0.96 111.505 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -124.02 140.93 52.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.01 109.778 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.91 126.49 7.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.785 -0.722 . . . . 0.49 111.783 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -129.13 169.02 15.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 1.75 109.058 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -62.55 97.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 1.96 111.924 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.4 mp 63.5 27.32 15.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.337 -0.847 . . . . 1.75 111.266 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . -154.11 165.71 31.82 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.34 111.566 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.34 129.35 74.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.359 0.599 . . . . 0.37 110.559 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.7 t -92.53 105.86 17.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.325 -0.62 . . . . 1.11 109.325 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.8 m -103.76 123.08 46.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.922 0.391 . . . . 1.14 110.807 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -125.32 153.86 72.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.978 -0.556 . . . . 0.57 110.634 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.38 158.72 73.68 Favored 'Cis proline' 0 C--O 1.235 0.331 0 C-N-CA 123.518 -1.451 . . . . 0.48 111.852 -1.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 41' ' ' VAL . 5.8 p . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.849 0.833 . . . . 1.31 110.612 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.09 0.471 . . . . 1.13 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -96.14 139.82 31.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.44 -0.345 . . . . 1.12 110.532 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.58 161.05 30.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.303 -0.408 . . . . 1.01 110.707 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.37 106.72 10.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.565 -0.289 . . . . 0.85 110.558 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.2 m -85.04 93.28 8.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.24 -0.652 . . . . 1.2 109.24 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.27 -93.1 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.442 -0.799 . . . . 1.01 111.865 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.56 0.29 8.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.645 0.259 . . . . 3.65 110.805 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 m -106.42 122.94 47.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.72 110.774 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 9.6 tt -76.31 123.26 32.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.405 -0.816 . . . . 1.06 111.256 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.02 171.77 18.6 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.36 111.653 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.95 131.55 65.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.201 0.524 . . . . 0.33 109.776 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 7.6 t80 -87.34 100.6 12.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.541 -0.754 . . . . 0.8 110.66 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -79.51 88.53 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.673 -0.694 . . . . 0.47 109.679 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 78.1 t80 -70.48 122.14 19.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.677 -0.692 . . . . 0.75 109.782 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.07 -32.58 5.06 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.698 -0.763 . . . . 1.07 112.847 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -125.25 151.24 46.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.57 111.194 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.2 tptm -109.76 21.76 16.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.047 0.927 . . . . 3.98 108.615 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -119.44 122.86 42.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 1.6 110.303 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.1 m -72.6 118.96 72.38 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.848 0.356 . . . . 0.91 110.392 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.6 75.86 4.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.745 2.297 . . . . 0.82 109.858 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -78.34 53.12 1.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.865 -1.061 . . . . 2.07 112.913 -168.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -88.36 1.37 54.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.219 -0.66 . . . . 1.83 109.219 170.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -97.12 -73.44 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.073 -0.967 . . . . 3.39 109.857 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.8 28.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.455 -0.793 . . . . 1.1 112.194 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.02 138.66 43.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 3.45 110.978 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -109.11 -45.98 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.209 0.528 . . . . 1.33 111.027 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.1 -179.48 16.06 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.83 -0.908 . . . . 0.35 110.83 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.461 ' OG ' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -157.71 164.29 37.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.655 0.728 . . . . 0.96 111.655 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -133.17 125.12 28.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.83 . . . . 1.01 109.74 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HE3' ' A' ' 18' ' ' LYS . . . -66.88 127.15 27.63 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.818 -0.706 . . . . 0.49 112.082 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -123.11 165.14 17.33 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.734 -0.274 . . . . 1.75 111.235 -176.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -39.23 -55.78 1.62 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.359 1.037 . . . . 1.96 113.021 -168.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 5.8 mp -134.27 45.71 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.951 -0.389 . . . . 1.75 109.951 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.6 -164.7 33.4 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.702 -1.237 . . . . 0.34 112.7 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 18' ' ' LYS . 16.1 tt -133.89 130.08 55.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.093 0.473 . . . . 0.37 111.146 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.8 t -95.88 92.44 6.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.201 -0.454 . . . . 1.11 109.971 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.7 124.51 33.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 1.14 110.55 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -126.97 153.48 76.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.57 111.036 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 2.4 Cg_endo -82.82 172.13 50.23 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.621 -1.408 . . . . 0.48 111.3 -3.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.137 0.494 . . . . 1.31 110.771 178.236 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 15.4 p . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.464 0.649 . . . . 1.13 110.371 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 10' ' ' ILE . 3.6 m -104.27 123.79 48.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.416 -0.811 . . . . 1.12 110.195 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' O ' HD12 ' A' ' 10' ' ' ILE . 8.0 p -135.65 159.96 40.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.873 0.368 . . . . 1.01 111.316 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.471 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 88.6 m-85 -119.61 143.91 47.41 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.78 -0.452 . . . . 0.85 109.78 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.3 t -119.91 101.75 8.08 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.49 -91.54 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.778 -0.646 . . . . 1.01 111.872 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -122.49 -9.95 8.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.887 0.375 . . . . 3.65 110.684 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -95.6 128.53 42.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.117 -0.492 . . . . 0.72 111.067 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 3' ' ' THR . 5.1 tp -82.22 132.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.978 -0.555 . . . . 1.06 110.003 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.46 179.78 19.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.13 -0.557 . . . . 0.36 112.627 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.871 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.62 137.71 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.228 0.537 . . . . 0.33 109.76 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 2.0 t80 -89.64 101.09 13.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.724 -0.671 . . . . 0.8 111.443 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -82.85 83.28 7.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.871 -0.604 . . . . 0.47 109.42 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -73.37 96.91 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.178 -0.465 . . . . 0.75 110.337 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.33 -61.37 0.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.725 -0.67 . . . . 1.07 111.903 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -87.11 161.82 17.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.729 0.299 . . . . 0.57 110.627 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -113.51 11.18 18.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.165 -0.68 . . . . 3.98 109.165 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -128.77 135.78 49.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.595 . . . . 1.6 110.562 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 93.9 m -80.01 127.41 77.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.745 0.307 . . . . 0.91 111.292 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 2.9 Cg_exo -74.23 78.32 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.558 2.172 . . . . 0.82 110.194 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -78.62 63.04 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.556 0.693 . . . . 2.07 111.141 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.43 4.71 10.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.33 -0.85 . . . . 1.83 109.687 171.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.04 -81.77 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.29 -0.633 . . . . 3.39 109.29 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.49 4.23 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.977 -0.63 . . . . 1.1 113.146 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -62.06 127.31 30.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.077 0.438 . . . . 3.45 110.273 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 p -114.74 -39.07 3.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.933 0.397 . . . . 1.33 110.888 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.91 157.85 14.95 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.956 -0.64 . . . . 0.35 112.188 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.2 p -124.55 149.97 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.376 . . . . 0.96 111.103 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.9 t -133.4 114.66 13.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.119 -0.491 . . . . 1.01 109.969 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 127.16 42.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.416 -0.421 . . . . 0.49 113.196 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -128.21 174.43 9.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.644 0.259 . . . . 1.75 110.56 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -65.52 95.41 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 1.96 111.506 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt 64.42 27.31 13.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.745 -0.661 . . . . 1.75 110.536 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.34 -175.83 29.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.822 -0.704 . . . . 0.34 111.874 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 29' ' ' SER . 12.3 tt -136.44 130.09 46.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.233 0.539 . . . . 0.37 110.958 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 45.0 t -93.3 103.52 15.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.062 -0.718 . . . . 1.11 109.062 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.1 m -91.76 124.43 35.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 1.14 110.928 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 47.0 p90 -127.08 150.11 71.24 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.025 -0.534 . . . . 0.57 111.117 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 16.5 Cg_exo -68.49 165.78 71.56 Favored 'Cis proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.56 -1.433 . . . . 0.48 111.933 -4.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' HB ' ' A' ' 12' ' ' ILE . 7.3 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 122.32 1.057 . . . . 1.31 110.712 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.723 0.297 . . . . 1.13 111.43 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -69.69 115.83 9.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 1.12 110.023 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -122.51 154.7 37.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.451 . . . . 1.01 110.651 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 54.7 m-85 -131.67 121.94 25.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.755 0.312 . . . . 0.85 110.941 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -102.92 99.47 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.979 -0.749 . . . . 1.2 108.979 171.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.75 -97.55 0.35 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.921 -0.657 . . . . 1.01 111.767 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -106.84 -25.15 11.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.694 0.283 . . . . 3.65 110.825 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -88.39 123.68 33.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.209 0.528 . . . . 0.72 111.64 -170.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 tt -78.73 131.84 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.706 -0.679 . . . . 1.06 110.615 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.68 -174.06 13.33 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.702 -0.681 . . . . 0.36 111.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -117.16 133.19 64.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.353 0.596 . . . . 0.33 109.928 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 15.3 t80 -84.44 100.1 11.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.8 110.928 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -80.17 94.37 6.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.47 110.373 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.5 t80 -79.56 109.87 14.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.523 -0.547 . . . . 0.75 109.523 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.26 -21.32 4.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.453 -0.88 . . . . 1.07 112.884 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -135.05 151.99 51.27 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.765 -0.256 . . . . 0.57 110.497 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -115.94 8.08 14.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.386 -0.598 . . . . 3.98 109.386 174.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 p -120.98 126.73 50.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 1.6 109.786 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 88.9 m -74.52 136.25 74.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.91 111.686 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 6.0 Cg_exo -79.48 100.69 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.091 2.527 . . . . 0.82 110.126 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 t -80.97 20.4 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 2.07 111.2 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -86.84 -8.7 57.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.471 -0.566 . . . . 1.83 109.471 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 11.0 mmt180 -89.41 -58.15 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 3.39 109.98 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.9 30.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.588 -0.733 . . . . 1.1 112.149 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -72.17 152.2 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 3.45 111.256 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -118.37 -41.09 2.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.118 -0.492 . . . . 1.33 111.149 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.5 165.41 23.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.71 -0.757 . . . . 0.35 111.959 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.826 ' HB2' HD11 ' A' ' 36' ' ' ILE . 34.5 p -143.09 143.72 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.093 0.473 . . . . 0.96 111.888 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 42.8 m -122.49 125.6 46.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 1.01 109.764 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.04 132.44 45.95 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.531 -0.842 . . . . 0.49 111.585 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.34 166.36 21.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.97 0.385 . . . . 1.75 110.884 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -59.0 100.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.96 111.197 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp 64.36 29.33 13.61 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.767 0.667 . . . . 1.75 111.207 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.57 -168.87 33.75 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.394 -0.907 . . . . 0.34 112.306 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.0 tt -136.28 130.3 47.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.437 0.637 . . . . 0.37 111.166 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 47.5 t -89.26 96.36 10.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.751 . . . . 1.11 108.971 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -100.27 130.9 46.44 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.66 -0.416 . . . . 1.14 110.146 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 55.1 p90 -131.27 157.91 76.75 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.787 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.6 Cg_exo -74.0 157.2 99.5 Favored 'Cis proline' 0 C--O 1.231 0.152 0 C-N-CA 123.611 -1.412 . . . . 0.48 111.674 -2.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.7 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.711 0.767 . . . . 1.31 110.144 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 11.9 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.33 0.586 . . . . 1.13 110.861 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -107.09 128.09 54.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.865 -0.607 . . . . 1.12 110.719 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -135.17 119.07 17.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.01 111.132 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 45.6 m-85 -80.7 117.81 21.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.85 111.182 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.1 m -91.53 87.55 6.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.102 -0.703 . . . . 1.2 109.102 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.03 -102.87 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.868 -0.605 . . . . 1.01 112.047 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -100.38 -19.98 16.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.569 0.223 . . . . 3.65 111.327 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -97.16 118.37 33.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.898 0.38 . . . . 0.72 110.732 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 7.4 tt -79.82 131.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 1.06 110.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.33 173.75 19.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.736 -0.745 . . . . 0.36 112.608 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.97 135.04 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.513 -0.551 . . . . 0.33 109.513 -178.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.87 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 25.4 t80 -87.28 113.78 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.8 111.701 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.403 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 88.1 m95 -92.68 102.81 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.469 -0.787 . . . . 0.47 109.596 173.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -73.15 130.83 41.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.033 -0.358 . . . . 0.75 110.033 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.39 -82.62 0.31 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.031 -0.604 . . . . 1.07 111.995 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.5 t -63.81 151.63 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.57 111.67 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -112.44 12.08 19.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.883 -0.784 . . . . 3.98 108.883 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -127.93 130.09 47.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.114 -0.948 . . . . 1.6 110.108 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.7 m -68.28 128.15 93.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.508 -0.314 . . . . 0.91 111.022 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 52.4 Cg_exo -53.36 109.7 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.477 2.118 . . . . 0.82 110.454 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -83.42 48.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.432 0.634 . . . . 2.07 111.093 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -144.39 25.82 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 1.83 110.262 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.42 -54.67 2.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.901 -0.591 . . . . 3.39 111.016 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.81 22.28 1.05 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.507 -0.769 . . . . 1.1 111.851 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -63.78 147.82 50.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.849 0.357 . . . . 3.45 110.916 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -108.76 -43.35 4.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.86 -0.609 . . . . 1.33 110.832 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -133.85 175.23 20.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.798 -0.715 . . . . 0.35 112.288 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.709 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.4 p -152.1 140.73 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.986 0.422 . . . . 0.96 111.817 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 59.3 m -116.69 133.51 55.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.243 -0.651 . . . . 1.01 109.243 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.59 133.09 17.05 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.532 -0.842 . . . . 0.49 111.177 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -130.21 165.22 22.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.626 -0.509 . . . . 1.75 109.626 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HB3' HD12 ' A' ' 34' ' ' LEU . 54.6 m-85 -37.53 -69.43 0.12 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.177 0.806 . . . . 1.96 113.177 -167.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 33' ' ' PHE . 7.2 mp -120.76 43.52 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.735 -0.386 . . . . 1.75 110.157 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.0 -158.08 22.77 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.146 -1.026 . . . . 0.34 112.694 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' SER . 13.3 tt -137.37 133.92 46.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.39 0.614 . . . . 0.37 111.133 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 28.0 m -93.46 101.26 13.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.11 110.135 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -94.1 130.35 40.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.076 -0.511 . . . . 1.14 110.907 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.8 p90 -130.14 157.98 75.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.263 -0.426 . . . . 0.57 110.314 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.2 Cg_exo -74.85 153.03 98.95 Favored 'Cis proline' 0 C--O 1.231 0.154 0 C-N-CA 123.863 -1.307 . . . . 0.48 111.944 -0.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.2 p . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.472 0.653 . . . . 1.31 111.078 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.1 p . . . . . 0 C--O 1.234 0.277 0 CA-C-O 121.038 0.447 . . . . 1.13 111.86 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m -69.7 131.28 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 1.12 110.012 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -135.3 153.26 51.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.797 0.332 . . . . 1.01 110.903 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -136.44 125.3 24.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 0.85 110.463 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.22 86.93 2.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.201 -1.037 . . . . 1.2 108.201 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.93 -102.12 1.11 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.224 -0.898 . . . . 1.01 111.654 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.42 -11.39 17.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.468 0.175 . . . . 3.65 110.678 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -95.91 118.03 31.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.72 110.993 -175.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 41' ' ' VAL . 11.0 tt -79.7 130.43 36.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.312 0.577 . . . . 1.06 111.189 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -173.45 12.9 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.543 -0.753 . . . . 0.36 111.934 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.67 136.1 60.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.142 0.496 . . . . 0.33 109.942 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 1.6 t80 -86.28 105.91 16.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.831 -0.622 . . . . 0.8 110.516 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.38 104.48 13.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.47 109.982 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 61.2 t80 -94.31 103.58 15.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.662 -0.699 . . . . 0.75 109.192 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.33 -6.7 5.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.412 -0.899 . . . . 1.07 112.242 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -143.54 152.48 41.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.955 -0.387 . . . . 0.57 109.955 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.82 12.54 19.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.331 0.586 . . . . 3.98 109.584 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 p -134.35 146.33 49.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 1.6 110.055 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 77.5 m -79.58 116.59 61.85 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.91 110.364 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.75 126.29 16.42 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.485 2.123 . . . . 0.82 111.697 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.0 m -76.06 110.39 10.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 2.07 110.517 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -169.95 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.83 111.922 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -122.27 -69.38 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.795 -0.362 . . . . 3.39 111.583 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.77 36.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.237 -0.982 . . . . 1.1 112.959 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.08 130.58 44.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.859 0.361 . . . . 3.45 110.178 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.2 m -101.2 -40.35 7.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.228 -0.442 . . . . 1.33 110.78 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -124.4 169.92 16.48 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.581 -0.818 . . . . 0.35 112.229 -177.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.3 p -154.06 133.19 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.39 0.615 . . . . 0.96 111.87 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 65.3 m -115.3 120.85 41.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.42 -0.809 . . . . 1.01 109.68 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.24 133.42 48.54 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.49 111.842 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -129.92 164.44 24.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.864 0.332 . . . . 1.75 110.865 -176.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HB3' HD22 ' A' ' 34' ' ' LEU . 70.7 m-85 -39.37 -59.66 1.04 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.863 1.06 . . . . 1.96 113.863 -170.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 33' ' ' PHE . 3.1 mm? -123.34 28.47 7.05 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.439 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.98 -151.31 9.23 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.514 -1.327 . . . . 0.34 113.246 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.817 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.1 tt -139.25 135.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.37 111.178 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 42.5 t -94.2 101.65 13.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.681 -0.69 . . . . 1.11 109.576 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.5 m -95.58 129.19 42.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 1.14 110.817 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 42.4 p90 -130.22 157.39 77.34 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.57 110.468 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.4 Cg_exo -81.89 171.63 55.41 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 123.707 -1.372 . . . . 0.48 111.931 -1.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 77.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 1.31 110.962 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.097 0.475 . . . . 1.13 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.7 m -110.25 127.83 55.19 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.611 . . . . 1.12 109.349 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.36 139.14 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.125 0.488 . . . . 1.01 111.887 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 62.5 m-85 -103.26 111.74 24.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.073 -0.512 . . . . 0.85 110.019 173.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.04 100.47 12.58 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.479 -0.563 . . . . 1.2 109.479 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.97 -85.29 0.38 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 1.01 112.003 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -134.23 -0.71 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.799 0.333 . . . . 3.65 111.065 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 m -108.39 135.09 50.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.805 0.336 . . . . 0.72 110.887 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.9 tt -93.87 128.11 45.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.601 0.715 . . . . 1.06 111.654 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 -178.4 15.95 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.471 -0.786 . . . . 0.36 111.826 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.816 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.52 136.78 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.439 -0.578 . . . . 0.33 109.439 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 26.4 t80 -89.85 115.92 27.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.8 111.648 -173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HZ2' ' HH ' ' A' ' 26' ' ' TYR . 87.1 m95 -99.12 110.68 23.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.842 -0.617 . . . . 0.47 110.427 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -103.22 122.13 44.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.189 -0.671 . . . . 0.75 109.189 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 125.4 -32.1 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.183 -0.767 . . . . 1.07 111.183 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 t -121.4 146.39 46.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.951 -0.389 . . . . 0.57 109.951 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 18' ' ' LYS . 14.2 ptmt -108.73 14.78 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.348 0.594 . . . . 3.98 109.885 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -128.91 137.07 51.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.532 -0.758 . . . . 1.6 109.527 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.3 m -80.34 125.75 80.44 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.91 110.612 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.11 97.53 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.726 2.284 . . . . 0.82 110.766 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -71.74 4.16 3.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.23 0.538 . . . . 2.07 112.329 -173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -79.73 -16.59 55.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.827 -0.624 . . . . 1.83 109.358 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 16.7 mmt180 -87.19 -11.95 48.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.51 -0.768 . . . . 3.39 110.931 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.31 33.23 23.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.944 -0.646 . . . . 1.1 113.202 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 35.8 m-85 -70.82 137.29 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.84 0.352 . . . . 3.45 110.224 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.7 m -100.32 -43.1 6.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 1.33 111.078 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.93 165.99 24.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.742 -0.742 . . . . 0.35 112.21 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -137.05 160.74 38.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.879 0.371 . . . . 0.96 111.26 -176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.593 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 97.8 m -141.77 145.48 34.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.026 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.59 131.33 11.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.008 -0.615 . . . . 0.49 112.337 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 2.0 t80 -127.75 174.06 9.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.331 -0.618 . . . . 1.75 109.331 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.61 92.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.674 0.609 . . . . 1.96 111.972 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt 59.67 33.08 21.84 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.566 -0.743 . . . . 1.75 110.657 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.99 178.26 36.13 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 0.34 111.583 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.47 135.28 64.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.379 0.609 . . . . 0.37 111.039 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.76 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.721 -0.672 . . . . 1.11 109.367 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.3 m -105.82 121.96 45.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.612 -0.267 . . . . 1.14 111.049 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.3 p90 -129.27 157.11 77.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.57 110.982 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.0 Cg_exo -65.28 151.51 76.99 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 123.774 -1.344 . . . . 0.48 112.323 -1.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.816 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.6 p . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.123 0.487 . . . . 1.31 111.486 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.12 0.486 . . . . 1.13 110.959 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -142.97 141.88 31.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.775 -0.648 . . . . 1.12 109.905 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.6 p -131.45 159.64 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 1.01 110.819 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.66 102.23 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.85 110.574 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -89.28 90.49 8.36 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.755 -0.831 . . . . 1.2 108.755 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.68 -117.07 7.36 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 1.01 111.49 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -88.63 -18.38 28.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.552 0.215 . . . . 3.65 110.534 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.46 117.23 29.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.142 0.496 . . . . 0.72 111.18 -170.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 41' ' ' VAL . 6.7 tt -86.81 129.75 37.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.579 -0.737 . . . . 1.06 110.028 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.77 162.48 22.9 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.021 -0.609 . . . . 0.36 112.131 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.858 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.84 132.81 41.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.364 -0.606 . . . . 0.33 109.364 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.1 t80 -89.04 103.45 16.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.064 -0.516 . . . . 0.8 111.283 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 97.6 m95 -84.44 81.24 8.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.773 -0.648 . . . . 0.47 110.337 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -75.25 118.16 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.738 -0.664 . . . . 0.75 109.895 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.01 8.14 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.443 -0.884 . . . . 1.07 112.414 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 36' ' ' ILE . 10.2 t -132.5 153.6 50.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.62 0.248 . . . . 0.57 110.571 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 6.88 23.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.208 0.527 . . . . 3.98 109.615 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.0 m -107.23 118.11 35.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.618 -0.719 . . . . 1.6 110.393 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -68.48 116.63 42.08 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.91 109.531 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 Cg_exo -56.92 120.22 7.99 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.804 2.336 . . . . 0.82 111.41 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -84.86 49.39 1.71 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.638 0.732 . . . . 2.07 110.732 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -128.22 13.36 6.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.586 -0.734 . . . . 1.83 110.007 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -117.94 -55.84 2.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 3.39 110.988 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.72 38.2 0.67 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.69 -0.686 . . . . 1.1 111.677 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -67.49 141.95 56.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.408 . . . . 3.45 110.869 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -112.38 -35.32 5.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.066 -0.516 . . . . 1.33 110.63 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.97 175.27 21.21 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.586 -0.816 . . . . 0.35 111.494 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 p -156.73 158.28 36.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.96 111.509 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 74.3 m -123.45 114.69 20.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.104 -0.702 . . . . 1.01 109.104 174.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.88 131.52 25.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.766 -0.73 . . . . 0.49 111.936 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 32.6 m-85 -135.71 -178.96 5.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.472 0.136 . . . . 1.75 110.933 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -57.66 102.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.632 0.605 . . . . 1.96 112.632 -172.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.0 mm? 59.83 26.27 15.44 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.562 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.93 173.42 35.82 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.508 -0.853 . . . . 0.34 111.975 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 17' ' ' THR . 16.6 tt -132.61 124.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.445 0.64 . . . . 0.37 110.241 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 8.0 t -94.74 98.55 10.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.123 -0.695 . . . . 1.11 109.123 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 m -93.76 140.33 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 1.14 111.365 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 15.1 p90 -134.23 159.63 71.58 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 116.372 -0.377 . . . . 0.57 111.165 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 33.6 Cg_exo -63.32 154.59 70.84 Favored 'Cis proline' 0 N--CA 1.479 0.643 0 C-N-CA 124.107 -1.205 . . . . 0.48 112.494 -0.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.1 p . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.504 0.668 . . . . 1.31 111.853 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.1 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.96 -0.385 . . . . 1.13 109.96 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 m -102.1 142.0 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.546 -0.297 . . . . 1.12 110.42 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.57 152.42 51.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.437 . . . . 1.01 111.086 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.0 m-85 -113.6 138.71 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.057 0.456 . . . . 0.85 110.581 174.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.3 t -121.57 102.21 8.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.615 -0.883 . . . . 1.2 108.615 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -101.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.151 -0.78 . . . . 1.01 111.151 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -119.64 -1.88 10.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.576 0.227 . . . . 3.65 111.094 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 39' ' ' TYR . 3.5 m -97.96 136.38 38.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.72 111.006 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 tt -96.31 125.15 49.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.689 0.757 . . . . 1.06 111.475 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.01 178.65 17.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.16 -0.927 . . . . 0.36 112.131 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 135.96 49.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.659 -0.496 . . . . 0.33 109.659 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 11.7 t80 -87.59 104.58 16.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.446 -0.797 . . . . 0.8 111.21 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 94.6 m95 -87.36 90.11 8.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.47 110.522 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.435 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.2 t80 -79.5 123.46 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.398 -0.593 . . . . 0.75 109.398 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.31 -24.72 8.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.415 -0.898 . . . . 1.07 112.597 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 6.9 t -126.08 155.04 42.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.99 0.424 . . . . 0.57 110.667 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 15.94 16.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.644 -0.707 . . . . 3.98 109.806 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -131.76 128.08 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.6 110.7 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 99.7 m -72.38 126.35 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.258 -0.428 . . . . 0.91 111.159 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 12.4 Cg_exo -67.4 101.39 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.763 2.309 . . . . 0.82 110.905 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 p -79.27 26.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 2.07 111.805 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -91.27 -11.07 39.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.331 -0.395 . . . . 1.83 110.649 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -102.35 -74.06 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.418 -0.355 . . . . 3.39 111.185 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.22 33.07 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.531 -0.842 . . . . 1.1 112.392 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -71.9 125.73 27.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.384 -0.228 . . . . 3.45 110.384 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 m -100.86 -49.44 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.085 -0.507 . . . . 1.33 110.842 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -112.4 157.13 15.15 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.622 -0.799 . . . . 0.35 112.061 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.543 ' HB3' HD11 ' A' ' 36' ' ' ILE . 11.6 m -139.64 136.29 34.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.858 0.361 . . . . 0.96 110.907 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 81.8 m -129.64 132.88 46.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 1.01 109.689 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 145.78 49.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.149 -0.548 . . . . 0.49 112.99 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -136.48 165.46 25.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.886 -0.783 . . . . 1.75 108.886 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -60.26 99.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.052 0.22 . . . . 1.96 110.725 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.0 mt 63.09 32.15 15.44 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.825 0.703 . . . . 1.75 111.102 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.22 178.21 39.64 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.89 -0.671 . . . . 0.34 111.707 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 29' ' ' SER . 16.8 tt -128.93 131.57 68.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.294 0.569 . . . . 0.37 110.93 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.14 105.29 17.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 1.11 109.308 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -101.93 123.37 45.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 1.14 110.869 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 42.6 p90 -128.44 158.06 72.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.485 -0.325 . . . . 0.57 111.248 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.8 Cg_exo -78.77 161.16 89.64 Favored 'Cis proline' 0 C--O 1.233 0.267 0 C-N-CA 124.058 -1.226 . . . . 0.48 112.204 -2.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.142 -0.481 . . . . 1.31 111.105 176.459 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 13' ' ' TYR . 3.9 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.216 0.531 . . . . 1.13 110.58 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.5 m -87.61 137.29 32.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.739 -0.664 . . . . 1.12 112.055 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 p -140.07 155.72 46.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.702 -0.481 . . . . 1.01 109.702 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 0.85 111.268 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.9 m -110.92 87.67 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.807 -0.812 . . . . 1.2 108.807 170.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.81 -97.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.361 -0.836 . . . . 1.01 111.479 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -108.51 -18.88 13.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.49 0.186 . . . . 3.65 111.109 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -90.09 119.31 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.434 -0.506 . . . . 0.72 110.731 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tt -82.26 128.29 38.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.603 . . . . 1.06 110.379 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.61 -171.53 12.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.933 -0.576 . . . . 0.36 112.294 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.728 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -121.88 132.7 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.33 109.785 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.414 ' HD2' HG21 ' A' ' 2' ' ' THR . 14.4 t80 -89.99 109.38 20.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.8 110.972 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.04 119.34 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.477 -0.783 . . . . 0.47 110.456 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 44.0 t80 -104.13 118.02 35.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.003 -0.74 . . . . 0.75 109.003 170.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.72 -21.37 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.284 -0.726 . . . . 1.07 111.284 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 t -141.12 161.9 36.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.336 -0.616 . . . . 0.57 109.336 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -121.09 20.7 11.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.184 -0.462 . . . . 3.98 110.06 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -135.95 152.83 51.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 1.6 109.789 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 83.9 m -84.79 116.37 64.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.502 -0.317 . . . . 0.91 111.022 -177.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 18.9 Cg_endo -63.94 134.79 44.82 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.684 2.256 . . . . 0.82 111.562 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 t -85.9 45.06 1.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.75 0.786 . . . . 2.07 110.037 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -97.2 -16.38 20.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.295 -0.866 . . . . 1.83 110.091 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -121.18 -80.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 3.39 111.211 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 1.1 111.053 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 49.2 m-85 -67.87 112.06 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 3.45 110.021 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HD3' ' A' ' 40' ' ' PRO . 8.9 t -100.53 -26.32 13.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 1.33 110.721 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -124.41 157.33 18.73 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.263 -0.97 . . . . 0.35 111.859 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.643 ' HB2' HD11 ' A' ' 36' ' ' ILE . 30.0 p -145.05 137.27 25.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.205 0.526 . . . . 0.96 111.716 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 74.3 m -117.46 129.41 55.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.616 -0.72 . . . . 1.01 109.448 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.3 118.08 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.736 -0.745 . . . . 0.49 111.759 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -116.79 172.92 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.435 -0.209 . . . . 1.75 110.435 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -54.46 104.58 0.11 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.96 111.542 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.2 mp 56.65 26.92 11.78 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.812 0.695 . . . . 1.75 111.432 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.36 -173.5 32.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.551 -0.833 . . . . 0.34 112.225 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.5 tt -135.38 132.03 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.147 0.499 . . . . 0.37 111.387 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.5 t -93.74 106.99 18.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.277 -0.638 . . . . 1.11 109.277 176.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 99.7 m -104.34 126.9 51.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.365 -0.38 . . . . 1.14 111.166 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 44.1 p90 -124.84 155.68 69.8 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.852 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD3' HG22 ' A' ' 27' ' ' THR . 21.1 Cg_exo -67.45 161.22 78.59 Favored 'Cis proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.958 -1.268 . . . . 0.48 112.882 -1.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.4 p . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 115.82 -0.627 . . . . 1.31 112.211 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.894 -0.41 . . . . 1.13 109.894 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -127.59 144.15 51.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.799 0.333 . . . . 1.12 111.556 -171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.64 164.15 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.85 115.97 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.918 0.39 . . . . 0.85 110.619 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.19 103.49 15.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.986 -0.746 . . . . 1.2 108.986 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 -93.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.334 -1.106 . . . . 1.01 110.334 -171.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 20.8 ptmt -133.22 5.02 3.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.033 0.444 . . . . 3.65 110.249 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 m -87.38 129.17 35.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.886 -0.597 . . . . 0.72 110.281 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tt -85.08 115.85 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.37 0.605 . . . . 1.06 110.754 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.71 173.66 16.13 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.548 -0.751 . . . . 0.36 112.042 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.27 127.0 68.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.408 0.623 . . . . 0.33 109.738 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t80 -86.2 109.34 18.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 0.8 111.005 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.495 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 91.9 m95 -89.83 117.02 28.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.516 -0.765 . . . . 0.47 110.266 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -112.52 114.19 26.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.491 -0.559 . . . . 0.75 109.491 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.5 -9.53 6.51 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.871 -0.68 . . . . 1.07 111.976 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 t -133.06 160.43 37.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.795 0.331 . . . . 0.57 110.563 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -116.71 8.61 13.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.474 -0.565 . . . . 3.98 109.474 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.8 m -134.93 132.74 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 1.6 111.302 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 86.6 m -67.79 120.62 74.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.91 110.315 174.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 43.9 Cg_exo -55.75 116.1 2.92 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.915 2.41 . . . . 0.82 111.97 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.8 t -84.84 14.92 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.457 0.646 . . . . 2.07 111.3 -174.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -97.35 -1.96 43.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.459 0.647 . . . . 1.83 109.267 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -100.0 -59.94 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 3.39 110.436 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.43 40.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.86 -0.686 . . . . 1.1 112.564 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.47 ' HE2' ' HD2' ' A' ' 21' ' ' PRO . 57.4 m-85 -69.88 146.36 51.32 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.883 -0.186 . . . . 3.45 110.74 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.406 ' OG1' ' HD3' ' A' ' 40' ' ' PRO . 46.6 p -106.98 -14.41 14.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.906 0.384 . . . . 1.33 111.061 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.39 170.74 36.46 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.884 -0.674 . . . . 0.35 111.74 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 57.4 p -145.77 150.05 35.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 0.96 111.386 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.8 m -123.45 118.29 27.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.838 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.67 111.17 3.91 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.437 -0.665 . . . . 0.49 111.437 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.1 178.22 4.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.064 -0.347 . . . . 1.75 110.064 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -52.31 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.201 0.313 . . . . 1.96 111.541 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 57.04 25.4 10.7 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.703 -0.681 . . . . 1.75 111.655 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.07 26.93 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.534 -0.841 . . . . 0.34 112.281 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 tt -136.11 122.84 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.232 0.539 . . . . 0.37 110.616 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 14.0 t -99.76 109.51 21.94 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.618 -0.512 . . . . 1.11 109.618 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.3 m -97.66 130.87 44.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.147 -0.479 . . . . 1.14 110.369 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.5 p90 -122.81 154.67 63.97 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.52 -0.309 . . . . 0.57 110.779 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 8.3 Cg_exo -72.42 174.43 48.42 Favored 'Cis proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.604 -1.415 . . . . 0.48 112.036 -1.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.8 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.748 0.785 . . . . 1.31 110.849 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.7 p . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.433 0.635 . . . . 1.13 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -101.92 136.85 41.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.783 -0.644 . . . . 1.12 109.928 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 9.3 p -145.44 149.72 35.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 1.01 111.347 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 78.2 m-85 -107.33 127.64 53.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.85 110.047 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 t -97.79 95.88 7.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.333 -0.988 . . . . 1.2 108.333 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.98 -92.95 0.56 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.75 -0.94 . . . . 1.01 110.75 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -120.18 -14.28 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.582 0.23 . . . . 3.65 110.577 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' CD1' ' A' ' 39' ' ' TYR . 1.3 m -78.3 115.19 17.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.88 0.372 . . . . 0.72 110.913 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.517 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 5.7 tp -74.71 125.44 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.902 -0.59 . . . . 1.06 110.862 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.29 -176.39 17.29 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.899 -0.667 . . . . 0.36 112.126 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 134.13 62.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.304 0.573 . . . . 0.33 109.699 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.611 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 10.4 t80 -85.38 101.76 12.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.8 110.612 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m95 -82.22 107.6 15.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.715 -0.675 . . . . 0.47 109.921 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -96.65 101.31 12.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.179 -0.464 . . . . 0.75 109.854 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.15 -41.57 1.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.728 -0.748 . . . . 1.07 112.83 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -96.44 155.0 16.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.57 110.61 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -102.36 -4.94 24.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.791 . . . . 3.98 109.713 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -126.37 133.36 51.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.6 111.145 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.0 m -70.58 121.15 82.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.824 -0.626 . . . . 0.91 110.469 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 53.0 Cg_exo -53.06 108.6 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.96 2.44 . . . . 0.82 111.934 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.1 t -74.88 -0.89 20.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.516 0.675 . . . . 2.07 111.452 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.05 -13.37 57.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.364 -0.834 . . . . 1.83 109.808 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -89.28 -55.26 3.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.81 -0.632 . . . . 3.39 110.162 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.12 1.84 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.851 -0.69 . . . . 1.1 112.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 63.9 m-85 -63.36 132.66 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.378 . . . . 3.45 110.357 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 m -93.65 -26.62 16.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.848 -0.615 . . . . 1.33 110.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.34 170.18 27.48 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.708 -0.758 . . . . 0.35 111.848 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.667 ' HB2' HD11 ' A' ' 36' ' ' ILE . 13.9 p -139.16 133.9 32.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.44 0.638 . . . . 0.96 111.227 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 2.4 t -110.52 106.61 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.568 -0.742 . . . . 1.01 109.458 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.99 123.85 33.78 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.147 -0.549 . . . . 0.49 111.876 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.45 170.75 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.04 -0.355 . . . . 1.75 110.04 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -54.42 104.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.664 0.386 . . . . 1.96 111.758 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 56.1 28.81 13.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.791 0.682 . . . . 1.75 111.64 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -172.44 34.29 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.759 -0.734 . . . . 0.34 111.798 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.2 tt -138.8 121.45 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.422 0.63 . . . . 0.37 111.581 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 15.1 m -83.43 96.3 8.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 1.11 110.254 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 83.7 m -86.61 130.15 34.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.262 -0.426 . . . . 1.14 110.924 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 9' ' ' THR . 34.1 p90 -135.63 157.43 76.3 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.123 -0.49 . . . . 0.57 111.063 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.1 Cg_exo -76.79 151.11 93.86 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.603 -1.415 . . . . 0.48 111.577 -2.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 10' ' ' ILE . 7.5 p . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 122.021 0.915 . . . . 1.31 111.099 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.244 0.545 . . . . 1.13 111.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.1 m -134.6 140.04 45.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.385 -0.371 . . . . 1.12 110.426 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.77 175.49 9.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.764 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 70.9 m-85 -134.76 132.55 38.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.85 110.893 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.07 106.86 14.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.152 -0.685 . . . . 1.2 109.152 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.33 -97.06 0.66 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.752 -0.939 . . . . 1.01 110.752 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -130.47 3.4 4.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.924 0.392 . . . . 3.65 110.424 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.7 m -93.18 133.08 36.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.216 -0.447 . . . . 0.72 110.341 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.5 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 tt -85.48 126.0 40.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.438 0.637 . . . . 1.06 110.628 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.19 162.3 16.03 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.351 -0.84 . . . . 0.36 111.386 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 131.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.382 -0.599 . . . . 0.33 109.382 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -86.84 98.07 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.8 110.911 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 99.9 m95 -82.83 98.86 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.81 -0.632 . . . . 0.47 110.075 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -81.26 127.77 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.603 -0.517 . . . . 0.75 109.603 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.28 -68.5 0.25 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.689 -0.767 . . . . 1.07 111.886 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 t -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.57 110.518 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.637 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.3 tmtt? -97.3 -0.68 46.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.237 -1.023 . . . . 3.98 108.237 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -96.64 107.31 19.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.664 -0.698 . . . . 1.6 110.337 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.6 m -59.75 113.4 7.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.872 -0.418 . . . . 0.91 109.872 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 77.4 Cg_exo -49.89 114.28 1.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.762 2.308 . . . . 0.82 112.252 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -76.95 47.99 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.057 0.932 . . . . 2.07 109.604 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -111.75 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.304 -1.316 . . . . 1.83 108.927 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -75.88 -52.38 10.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.795 -1.093 . . . . 3.39 111.111 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.0 25.15 0.83 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.566 -0.826 . . . . 1.1 113.133 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -56.81 131.32 49.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.997 -0.371 . . . . 3.45 109.997 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -114.03 -37.18 4.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 1.33 111.346 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -102.94 151.46 18.02 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.422 -0.894 . . . . 0.35 111.524 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.873 ' HB2' HD11 ' A' ' 36' ' ' ILE . 19.8 p -143.46 137.33 28.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.093 0.473 . . . . 0.96 111.788 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 59.1 m -123.87 132.44 53.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.708 . . . . 1.01 109.687 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.11 134.33 34.13 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.49 112.232 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 171.66 14.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.887 0.343 . . . . 1.75 110.99 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -60.66 96.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.473 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.991 -0.549 . . . . 1.75 110.697 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.76 -176.16 35.39 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.332 -0.937 . . . . 0.34 112.073 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 29' ' ' SER . 19.2 tt -136.53 137.02 48.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.27 0.557 . . . . 0.37 110.872 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 25.3 t -93.3 99.94 12.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.661 -0.699 . . . . 1.11 109.32 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.77 119.29 36.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.966 0.412 . . . . 1.14 110.642 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 51.5 p90 -122.33 160.74 46.7 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.423 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.514 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.4 Cg_exo -79.01 156.37 91.69 Favored 'Cis proline' 0 CA--C 1.523 -0.07 0 C-N-CA 124.232 -1.153 . . . . 0.48 111.945 -3.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.624 -0.262 . . . . 1.31 110.615 173.656 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.679 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.183 0.516 . . . . 1.13 111.186 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 m -86.0 134.58 33.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.898 -0.592 . . . . 1.12 110.182 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 26.3 p -130.92 165.91 22.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.842 0.353 . . . . 1.01 110.705 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -127.86 112.69 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 0.85 110.826 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 39.1 t -91.25 99.38 12.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.956 -0.757 . . . . 1.2 108.956 174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.44 0.9 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.472 -1.051 . . . . 1.01 110.472 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.44 10.62 2.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.115 0.483 . . . . 3.65 109.995 170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.2 m -94.58 119.63 33.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.679 . . . . 0.72 109.615 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.435 HG12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 tt -74.85 129.01 37.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.444 0.64 . . . . 1.06 111.418 -175.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.17 -175.37 13.88 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.52 -0.764 . . . . 0.36 111.926 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.46 132.63 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.327 0.584 . . . . 0.33 109.46 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 15.6 t80 -88.35 112.49 22.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.668 -0.696 . . . . 0.8 111.353 -173.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -97.41 103.74 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.873 -0.603 . . . . 0.47 110.357 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -86.95 135.31 33.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.557 -0.292 . . . . 0.75 110.229 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.6 -10.81 59.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.525 -0.845 . . . . 1.07 113.334 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -123.92 150.46 44.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.003 0.43 . . . . 0.57 111.022 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.23 4.58 29.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 3.98 110.425 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -135.51 140.71 44.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 1.6 110.14 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 83.2 m -74.66 139.13 73.96 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.91 110.142 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 6.2 Cg_exo -75.37 84.46 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.431 2.088 . . . . 0.82 109.7 172.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -71.68 71.73 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.507 0.67 . . . . 2.07 111.799 -172.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' HB2' HH11 ' A' ' 24' ' ' ARG . 40.6 m-80 -130.97 20.93 4.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.038 -0.983 . . . . 1.83 108.544 172.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.499 HH11 ' HB2' ' A' ' 23' ' ' ASN . 10.8 mpt_? -129.71 -2.57 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.043 -0.98 . . . . 3.39 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.97 30.12 52.35 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.524 -0.846 . . . . 1.1 112.516 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -54.52 133.18 46.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.732 0.301 . . . . 3.45 110.755 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.9 m -103.43 -45.41 4.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.013 -0.54 . . . . 1.33 111.423 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -133.04 171.79 21.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.169 -1.015 . . . . 0.35 112.452 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' HD11 ' A' ' 36' ' ' ILE . 14.8 m -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.96 111.546 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -120.09 108.31 14.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.72 -0.673 . . . . 1.01 109.359 172.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.18 138.57 45.31 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.973 -0.632 . . . . 0.49 112.099 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.05 -178.28 5.13 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.641 -0.329 . . . . 1.75 110.48 -176.111 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -65.04 95.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 1.96 111.766 -172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 62.28 28.07 16.77 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.533 -0.758 . . . . 1.75 110.707 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.65 -176.26 28.53 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.542 -0.837 . . . . 0.34 111.922 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 29' ' ' SER . 15.0 tt -141.35 128.12 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.113 0.483 . . . . 0.37 110.626 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -87.78 101.86 14.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 1.11 109.447 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.9 m -99.06 120.59 39.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.14 110.742 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.546 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 53.3 p90 -119.87 156.56 54.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.259 -0.428 . . . . 0.57 109.981 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 31.7 Cg_exo -61.18 158.71 50.65 Favored 'Cis proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.167 -1.18 . . . . 0.48 114.033 1.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.435 ' HB ' HG12 ' A' ' 10' ' ' ILE . 6.7 p . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.31 -0.859 . . . . 1.31 111.036 172.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.303 0.573 . . . . 1.13 110.579 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.2 m -133.4 139.63 46.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 1.12 111.014 -177.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 p -125.99 171.28 10.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.106 -0.702 . . . . 1.01 109.106 176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -127.55 106.6 9.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.85 110.479 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m -88.2 104.0 16.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.523 -0.917 . . . . 1.2 108.523 174.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.18 -112.46 4.37 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.978 -1.249 . . . . 1.01 109.978 -167.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -114.74 3.15 14.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.26 0.553 . . . . 3.65 109.701 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -86.26 119.29 26.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.72 110.567 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.98 124.98 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.578 -0.737 . . . . 1.06 111.027 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.48 151.03 16.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.852 -0.613 . . . . 0.36 111.976 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.55 130.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.284 0.564 . . . . 0.33 109.532 -178.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 20.0 t80 -87.95 120.6 29.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.75 -0.659 . . . . 0.8 111.426 -174.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.418 ' CH2' ' HG2' ' A' ' 21' ' ' PRO . 96.2 m95 -102.9 125.28 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.47 110.405 177.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HE1' HD23 ' A' ' 34' ' ' LEU . 71.8 t80 -116.7 119.11 34.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.689 -0.687 . . . . 0.75 109.736 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.12 12.81 13.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.513 -0.851 . . . . 1.07 112.198 -178.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -155.55 143.27 19.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.57 110.669 177.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -90.54 -12.36 37.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 3.98 110.077 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -122.45 141.96 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.209 0.528 . . . . 1.6 111.064 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.5 m -72.28 134.71 82.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.631 -0.713 . . . . 0.91 109.981 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HG2' ' CH2' ' A' ' 14' ' ' TRP . 14.7 Cg_exo -67.24 95.36 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.562 2.175 . . . . 0.82 110.294 173.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 t -79.85 66.86 5.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 2.07 111.355 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -141.26 15.04 2.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 1.83 110.76 173.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -108.53 -54.87 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 3.39 109.608 174.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.97 -5.42 0.79 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.282 -0.872 . . . . 1.1 112.049 -175.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 41' ' ' VAL . 17.7 m-85 -52.2 139.19 24.35 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.596 0.358 . . . . 3.45 111.003 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.1 m -132.23 -48.61 0.92 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.291 -0.413 . . . . 1.33 111.163 -176.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.68 159.56 25.93 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.822 -0.704 . . . . 0.35 112.01 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 m -142.38 154.04 44.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.004 0.431 . . . . 0.96 111.282 -177.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.3 120.9 20.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.73 . . . . 1.01 109.138 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.96 124.79 37.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.49 111.333 177.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -127.49 177.86 6.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.994 0.397 . . . . 1.75 110.547 -173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -53.23 101.74 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 123.56 0.537 . . . . 1.96 112.177 -176.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.446 HD23 ' HE1' ' A' ' 15' ' ' PHE . 13.7 tp 56.76 29.51 16.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.249 -0.887 . . . . 1.75 110.986 176.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -169.05 -163.75 23.6 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.129 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -136.02 128.56 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.144 0.497 . . . . 0.37 110.702 -177.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 4.9 t -99.2 116.25 30.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.769 -0.826 . . . . 1.11 108.769 178.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.56 133.45 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.538 -0.301 . . . . 1.14 110.996 -171.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 54.9 p90 -133.5 162.79 55.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.59 -0.277 . . . . 0.57 110.549 -177.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.3 Cg_exo -81.68 150.55 75.48 Favored 'Cis proline' 0 C--N 1.342 0.232 0 C-N-CA 124.47 -1.054 . . . . 0.48 112.306 -3.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HA ' ' HE1' ' A' ' 26' ' ' TYR . 87.4 t . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.193 0.52 . . . . 1.31 111.077 177.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.3 p . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.13 111.521 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 m -99.21 129.64 45.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 1.12 110.302 177.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.4 p -132.08 153.6 50.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.877 0.37 . . . . 1.01 111.337 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 39.7 m-85 -120.61 129.78 53.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.85 110.515 175.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.9 t -123.3 115.81 22.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.585 -0.524 . . . . 1.2 109.585 174.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.85 -91.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.271 -0.732 . . . . 1.01 111.271 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -133.71 -2.31 3.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.975 0.417 . . . . 3.65 110.094 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -100.44 134.97 42.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.72 111.46 -171.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.565 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -93.64 130.18 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 1.06 110.218 177.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.29 -171.32 12.14 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.035 -0.602 . . . . 0.36 112.196 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.25 130.44 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.369 0.604 . . . . 0.33 109.42 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 6.8 t80 -87.6 109.8 19.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.609 -0.723 . . . . 0.8 111.145 -176.547 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -87.79 102.51 14.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.73 -0.668 . . . . 0.47 110.379 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -83.07 105.91 14.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.75 109.727 174.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.49 -61.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.638 -0.792 . . . . 1.07 112.046 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t -86.77 161.03 18.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.003 0.43 . . . . 0.57 110.655 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.1 tmtp? -116.78 11.56 14.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.9 -0.778 . . . . 3.98 108.9 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -139.34 141.06 37.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.694 -0.685 . . . . 1.6 110.278 178.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 90.5 m -77.27 117.98 68.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.477 -0.329 . . . . 0.91 111.079 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.11 85.24 0.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.073 1.848 . . . . 0.82 109.896 172.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -82.15 52.42 2.0 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.746 0.784 . . . . 2.07 110.681 -172.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.54 24.19 8.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.99 -1.004 . . . . 1.83 108.773 172.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -132.74 -76.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.895 -1.048 . . . . 3.39 110.22 -178.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.55 27.59 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.554 -0.831 . . . . 1.1 113.162 176.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -71.43 135.83 47.39 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 122.6 -0.353 . . . . 3.45 110.886 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -104.67 -38.32 6.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.987 0.423 . . . . 1.33 111.071 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 176.26 24.7 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.219 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.564 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 43.7 p -139.44 171.57 14.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.925 0.393 . . . . 0.96 111.251 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 5.5 t -149.75 131.28 14.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.01 109.06 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.21 129.04 34.3 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.599 -0.81 . . . . 0.49 111.855 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.98 168.99 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.858 0.329 . . . . 1.75 110.474 -176.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -53.98 102.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.106 -0.497 . . . . 1.96 111.393 -178.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.92 26.39 14.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.506 0.504 . . . . 1.75 111.621 177.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.29 -170.13 30.8 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.254 -0.974 . . . . 0.34 112.499 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.7 tt -132.62 132.69 59.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.37 111.014 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 52.4 t -92.73 111.56 23.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.824 -0.626 . . . . 1.11 109.4 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.3 m -103.07 120.62 41.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.766 0.317 . . . . 1.14 111.442 -175.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 24.0 p90 -124.92 155.55 70.26 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.343 -0.39 . . . . 0.57 110.905 -177.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.9 Cg_exo -66.75 163.12 72.27 Favored 'Cis proline' 0 N--CA 1.474 0.342 0 C-N-CA 123.697 -1.376 . . . . 0.48 111.947 -2.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.702 0.763 . . . . 1.31 110.203 176.173 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.819 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 19.3 p . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 121.328 0.585 . . . . 1.13 110.619 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -141.16 139.27 33.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.614 -0.721 . . . . 1.12 110.877 -174.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.9 p -122.72 172.05 8.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.26 93.27 3.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.66 -0.496 . . . . 0.85 109.66 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.64 101.47 5.75 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.27 -104.48 1.51 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.799 -1.32 . . . . 1.01 109.799 -168.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -122.36 6.5 9.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.802 0.334 . . . . 3.65 110.205 171.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.37 121.15 31.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.72 110.836 -178.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tt -71.75 121.45 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.695 -0.684 . . . . 1.06 110.738 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.77 154.33 16.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.526 -0.761 . . . . 0.36 111.474 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.45 132.04 56.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.212 0.53 . . . . 0.33 109.691 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.819 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 18.1 t80 -85.12 112.1 20.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.8 111.602 -173.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -95.97 131.51 42.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.47 110.095 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -112.35 138.12 49.53 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.649 -0.5 . . . . 0.75 109.649 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.18 -50.38 0.9 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.668 -0.777 . . . . 1.07 111.903 -178.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -87.17 149.8 24.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.929 0.395 . . . . 0.57 110.428 176.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.3 8.8 16.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 3.98 109.459 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -130.23 141.13 50.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.309 -0.859 . . . . 1.6 110.177 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -72.38 114.74 32.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.089 -0.337 . . . . 0.91 110.089 177.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.31 135.95 52.88 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.521 2.148 . . . . 0.82 112.416 -176.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 56.03 2.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.567 -0.742 . . . . 2.07 110.213 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -119.2 -16.62 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.718 -0.674 . . . . 1.83 111.131 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -124.97 -26.8 3.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 3.39 110.99 175.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 31.29 7.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.418 -0.896 . . . . 1.1 112.202 -177.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -51.17 125.87 15.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.813 0.339 . . . . 3.45 110.458 177.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -106.89 -4.04 19.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.122 0.486 . . . . 1.33 111.183 -169.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -148.46 158.21 27.59 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.704 -0.76 . . . . 0.35 111.678 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 36' ' ' ILE . 50.3 p -137.44 138.43 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.17 0.51 . . . . 0.96 111.766 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 94.0 m -120.84 114.02 20.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.174 172.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.01 141.55 47.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.174 -0.466 . . . . 0.49 113.086 -177.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.81 175.72 9.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.952 -0.388 . . . . 1.75 109.952 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -56.72 98.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.575 0.547 . . . . 1.96 111.724 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt 60.39 18.37 8.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.026 -0.534 . . . . 1.75 111.198 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.63 -174.37 17.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.992 -0.623 . . . . 0.34 111.893 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.8 tt -143.86 126.57 11.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.279 0.561 . . . . 0.37 110.662 -178.166 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 6.5 t -97.08 106.27 18.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.983 -0.747 . . . . 1.11 108.983 178.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.52 136.08 38.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.087 0.47 . . . . 1.14 111.349 -173.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.3 p90 -129.08 159.9 66.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.57 110.286 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 86.6 Cg_endo -90.66 156.74 28.58 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.421 -1.491 . . . . 0.48 112.349 -2.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.065 -0.717 . . . . 1.31 109.065 173.432 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 13' ' ' TYR . 1.9 m . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.436 0.636 . . . . 1.13 109.999 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 10' ' ' ILE . 61.5 m -91.82 128.62 37.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 1.12 112.151 -168.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.83 148.72 34.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.588 -0.523 . . . . 1.01 109.588 172.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.2 125.04 52.91 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.184 -0.206 . . . . 0.85 110.623 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.2 m -89.63 95.42 10.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.386 -0.968 . . . . 1.2 108.386 171.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -83.48 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.053 -0.594 . . . . 1.01 111.795 -177.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -141.76 19.76 2.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 3.65 110.104 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -116.35 131.26 56.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.72 110.586 178.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 3' ' ' THR . 4.6 tp -82.5 115.26 24.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.533 0.683 . . . . 1.06 111.751 -175.111 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.62 173.62 17.03 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.384 -0.826 . . . . 0.36 112.234 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.87 130.33 63.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.493 -0.558 . . . . 0.33 109.493 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 2' ' ' THR . 14.9 t80 -84.07 108.99 17.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.775 . . . . 0.8 111.378 -174.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 98.7 m95 -93.24 102.08 14.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.569 -0.741 . . . . 0.47 110.389 177.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -89.38 121.26 31.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.24 -0.437 . . . . 0.75 110.006 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.56 -29.94 5.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.489 -0.862 . . . . 1.07 112.916 178.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 3.7 t -107.41 149.79 27.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.154 0.502 . . . . 0.57 110.732 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 18' ' ' LYS . 36.5 mtmt -100.88 1.62 40.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.359 -0.837 . . . . 3.98 110.091 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -139.85 152.56 46.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.882 -0.599 . . . . 1.6 110.407 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 85.3 m -83.66 119.86 74.36 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.91 110.666 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.22 96.85 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.88 1.72 . . . . 0.82 109.589 170.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 t -82.17 63.05 6.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.555 0.693 . . . . 2.07 110.631 -172.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -107.67 -1.46 21.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 1.83 110.078 177.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HD2' ' OH ' ' A' ' 26' ' ' TYR . 91.3 mtt180 -125.98 21.25 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 3.39 110.611 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.75 38.08 89.34 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.031 -0.604 . . . . 1.1 113.311 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.488 ' OH ' ' HD2' ' A' ' 24' ' ' ARG . 20.9 m-85 -68.35 120.21 14.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.032 0.416 . . . . 3.45 110.014 177.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 m -94.76 -33.81 12.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.851 -0.613 . . . . 1.33 111.345 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.73 174.07 25.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.218 -0.991 . . . . 0.35 112.311 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.8 p -158.24 159.03 35.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.961 0.41 . . . . 0.96 111.185 -178.378 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 29.8 p -134.45 142.44 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.247 -0.649 . . . . 1.01 109.247 174.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.36 132.57 27.77 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.059 -0.591 . . . . 0.49 112.122 -177.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.27 16.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.816 0.341 . . . . 1.75 110.697 -175.313 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -56.9 106.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.624 . . . . 1.96 111.233 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 58.88 21.86 9.59 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.754 0.659 . . . . 1.75 111.898 177.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -173.08 32.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.436 -0.888 . . . . 0.34 112.134 -177.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.5 134.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.807 0.337 . . . . 0.37 110.65 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 44.1 t -98.86 108.88 21.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.495 -0.558 . . . . 1.11 109.495 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.9 m -104.97 127.3 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.385 -0.37 . . . . 1.14 111.081 -174.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.7 p90 -120.29 159.69 46.62 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.287 -0.415 . . . . 0.57 111.061 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 95.1 Cg_endo -92.04 160.49 25.79 Favored 'Cis proline' 0 C--N 1.344 0.303 0 C-N-CA 124.005 -1.248 . . . . 0.48 113.006 -0.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.31 110.422 173.856 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.066 0.46 . . . . 1.13 111.084 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -76.71 148.69 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.068 0.461 . . . . 1.12 110.075 178.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 11.2 t -150.22 115.4 5.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.914 0.388 . . . . 1.01 110.618 -175.11 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 35.7 m-85 -97.33 109.19 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.479 -0.328 . . . . 0.85 111.041 -178.001 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.2 m -86.81 98.2 11.05 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.545 -0.909 . . . . 1.2 108.545 171.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.81 -111.77 4.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.395 -0.821 . . . . 1.01 111.499 -172.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -89.83 -22.86 21.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.518 0.199 . . . . 3.65 111.287 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -91.82 118.61 30.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.18 0.514 . . . . 0.72 111.639 -168.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 5.4 tt -78.32 123.56 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 1.06 110.859 177.692 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.23 -169.44 12.56 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 111.06 -0.816 . . . . 0.36 111.06 176.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 132.91 68.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.178 0.513 . . . . 0.33 110.02 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 6.7 t80 -88.82 106.17 18.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.554 -0.748 . . . . 0.8 111.068 -176.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 89.8 m95 -87.15 95.91 10.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.47 110.329 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.1 t80 -78.79 109.82 13.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.422 -0.584 . . . . 0.75 109.422 175.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.39 -61.45 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.88 -0.676 . . . . 1.07 112.143 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -86.79 160.19 18.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.88 0.372 . . . . 0.57 110.578 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.39 11.5 14.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 3.98 109.589 178.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.3 t -129.47 145.93 51.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 1.6 110.3 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 70.9 m -82.87 124.76 76.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.91 110.105 178.013 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 33.5 Cg_exo -57.36 113.47 1.51 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.638 2.225 . . . . 0.82 111.104 176.098 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -77.01 43.42 0.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 2.07 111.947 -172.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -128.44 16.75 6.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.928 0.394 . . . . 1.83 110.789 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -123.09 -42.25 2.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.84 0.352 . . . . 3.39 111.102 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.28 32.11 3.57 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.752 -0.737 . . . . 1.1 112.044 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 20' ' ' CYS . 63.9 m-85 -56.25 131.42 47.89 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.879 0.371 . . . . 3.45 110.557 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -85.2 -40.66 16.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.087 -0.506 . . . . 1.33 110.943 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.23 165.31 26.35 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.672 -0.775 . . . . 0.35 111.651 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 36' ' ' ILE . 69.0 p -140.66 134.47 30.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.96 110.989 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 57.0 m -106.07 110.93 23.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.567 -0.742 . . . . 1.01 109.496 178.543 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.6 113.47 3.89 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.171 -0.772 . . . . 0.49 111.171 176.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -112.84 164.47 13.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.041 -0.355 . . . . 1.75 110.041 -172.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -56.9 104.9 0.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.082 -0.508 . . . . 1.96 110.675 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt 65.03 28.62 12.42 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.683 0.614 . . . . 1.75 111.307 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.79 -168.72 35.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.496 -0.859 . . . . 0.34 112.268 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.4 tt -138.13 132.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.37 111.071 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.751 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 48.6 t -94.77 100.58 12.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.674 -0.694 . . . . 1.11 109.751 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.03 121.05 39.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.464 -0.334 . . . . 1.14 110.933 -176.11 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -128.1 153.52 78.56 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.57 110.927 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.83 154.05 46.45 Favored 'Cis proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.286 -1.547 . . . . 0.48 112.498 -1.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 41' ' ' VAL . 6.5 p . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.048 -0.524 . . . . 1.31 110.165 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 111.999 -0.44 . . . . 2.96 111.999 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.4 41.55 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.268 0.556 . . . . 1.13 111.385 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.7 m -103.27 126.86 50.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.12 109.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.13 127.3 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.334 0.588 . . . . 1.01 110.9 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -91.38 119.46 31.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.491 . . . . 0.85 110.812 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -94.8 104.24 16.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.112 -0.699 . . . . 1.2 109.112 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.12 -96.47 0.61 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.511 -0.852 . . . . 1.01 111.075 -173.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -128.84 0.33 5.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 3.65 110.638 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -92.35 130.68 37.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.352 -0.386 . . . . 0.72 110.608 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -79.53 114.31 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 1.06 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.41 165.91 12.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.656 -0.702 . . . . 0.36 111.862 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.56 134.19 54.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.278 0.561 . . . . 0.33 109.866 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -87.29 106.13 17.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.472 -0.786 . . . . 0.8 111.168 -175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -88.47 108.39 19.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.814 -0.63 . . . . 0.47 110.618 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -96.88 114.29 25.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.75 109.815 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.86 -16.58 6.13 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.271 -0.966 . . . . 1.07 113.08 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.4 t -135.55 156.66 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.57 110.87 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.42 0.63 23.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 3.98 109.878 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 m -116.76 118.99 34.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 1.6 111.144 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 71.7 m -61.29 120.51 55.71 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.702 -0.481 . . . . 0.91 109.702 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 47.6 Cg_exo -53.43 108.24 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.652 2.235 . . . . 0.82 111.116 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -79.18 36.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.916 -0.584 . . . . 2.07 111.896 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -123.89 13.68 9.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.386 0.612 . . . . 1.83 109.47 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -108.75 -74.37 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.481 -0.781 . . . . 3.39 110.831 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.1 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.356 -0.838 . . . . 1.1 111.63 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.58 149.58 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 3.45 110.566 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 m -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.091 -0.504 . . . . 1.33 110.549 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.67 160.72 22.81 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.442 -0.885 . . . . 0.35 112.072 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.551 ' HB2' HD11 ' A' ' 36' ' ' ILE . 33.0 p -142.1 136.34 30.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.101 0.476 . . . . 0.96 111.746 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 61.2 m -107.16 128.16 54.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.624 -0.716 . . . . 1.01 109.986 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 105.87 1.69 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.692 -0.766 . . . . 0.49 111.334 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -105.74 173.14 6.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.173 -0.306 . . . . 1.75 110.173 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -54.35 102.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.445 -0.343 . . . . 1.96 111.615 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp 58.33 28.41 16.68 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.019 0.824 . . . . 1.75 111.143 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.27 -173.4 33.81 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.039 -0.601 . . . . 0.34 111.687 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 29' ' ' SER . 16.0 tt -136.25 128.51 45.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.282 0.563 . . . . 0.37 111.416 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 22.1 m -92.05 102.8 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.942 -0.572 . . . . 1.11 110.378 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.3 m -97.92 125.37 42.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.477 -0.329 . . . . 1.14 110.532 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.441 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 45.0 p90 -128.46 156.41 77.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.57 111.111 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -80.16 162.56 83.66 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.669 -1.388 . . . . 0.48 112.377 -2.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.74 96.09 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.238 -0.437 . . . . 1.31 110.385 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.476 -0.773 . . . . 3.08 110.155 -179.515 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.28 -0.328 . . . . 2.96 112.28 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -84.42 65.3 8.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.607 0.718 . . . . 1.13 111.07 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m -146.43 136.39 23.44 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.439 -0.801 . . . . 1.12 109.398 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 p -129.26 161.61 29.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.024 0.44 . . . . 1.01 110.716 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -111.67 93.43 4.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.85 109.598 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.72 107.82 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.89 -100.87 0.73 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.446 -0.662 . . . . 1.01 111.446 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.88 23.18 5.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 3.65 110.16 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -124.2 127.79 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.72 110.778 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tt -83.97 124.24 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.537 0.684 . . . . 1.06 110.683 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -130.67 161.2 23.33 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.464 -0.789 . . . . 0.36 111.864 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.31 132.02 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.33 109.739 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 10.3 t80 -86.92 106.58 17.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 0.8 111.104 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -84.49 107.74 16.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.47 110.121 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -90.35 119.35 30.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.486 -0.561 . . . . 0.75 109.486 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.01 -60.63 0.46 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 1.07 111.862 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -91.89 134.24 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.106 0.479 . . . . 0.57 110.288 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -108.65 23.63 14.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.642 0.734 . . . . 3.98 109.455 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.8 p -124.11 130.18 52.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.875 -1.057 . . . . 1.6 109.916 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 73.9 m -78.7 125.3 84.52 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.576 -0.284 . . . . 0.91 111.054 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.3 Cg_exo -66.09 110.5 1.76 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.878 2.386 . . . . 0.82 111.272 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -79.6 66.08 4.96 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.315 0.579 . . . . 2.07 110.981 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -157.66 23.74 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 1.83 110.357 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.2 mmp_? -130.21 -49.82 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 3.39 111.538 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.01 10.01 1.4 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.981 -0.628 . . . . 1.1 111.971 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 23.5 m-85 -69.62 120.83 15.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.919 -0.4 . . . . 3.45 109.919 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -115.68 -24.19 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.099 0.476 . . . . 1.33 110.889 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 158.48 22.55 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.942 -0.863 . . . . 0.35 110.942 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.806 ' HB3' HD11 ' A' ' 36' ' ' ILE . 13.3 m -132.03 139.4 48.56 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.313 0.556 . . . . 0.96 111.738 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -115.77 95.3 5.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.447 -0.946 . . . . 1.01 108.447 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.67 131.17 39.69 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.407 -0.425 . . . . 0.49 112.317 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -132.42 169.11 17.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.961 0.41 . . . . 1.75 111.066 -173.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -59.67 111.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 1.96 111.118 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.2 mt 64.88 24.44 12.74 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.748 0.655 . . . . 1.75 111.57 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.8 -159.76 23.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.704 -1.236 . . . . 0.34 112.936 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 29' ' ' SER . 17.0 tt -144.45 125.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.37 110.85 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 t -92.43 94.66 9.22 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.744 -0.836 . . . . 1.11 108.744 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 1.5 t -93.48 136.53 33.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.161 -0.472 . . . . 1.14 110.405 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 36.1 p90 -134.03 161.14 65.52 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.57 111.232 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 2.3 Cg_endo -82.32 154.94 77.39 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.613 -1.411 . . . . 0.48 111.555 -3.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.07 61.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 122.211 1.005 . . . . 1.31 109.437 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 114.796 -1.093 . . . . 3.08 110.672 -173.184 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 112.02 -0.432 . . . . 2.96 112.02 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.2 p -90.04 48.73 1.61 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.28 0.562 . . . . 1.13 110.938 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 10' ' ' ILE . 53.0 m -106.15 127.77 53.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.12 111.368 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 7.2 p -145.82 136.08 23.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.972 0.415 . . . . 1.01 110.9 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.42 136.42 38.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.85 111.66 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.8 m -119.14 105.05 11.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.316 -0.856 . . . . 1.2 108.737 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.95 -115.36 7.16 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.806 -0.917 . . . . 1.01 110.806 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -102.0 -12.89 17.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.654 -0.499 . . . . 3.65 109.654 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 39' ' ' TYR . 7.3 m -83.21 119.65 24.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.523 -0.762 . . . . 0.72 111.241 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 3' ' ' THR . 4.1 tp -73.98 121.86 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.06 110.286 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.05 159.07 15.15 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.667 -0.697 . . . . 0.36 112.011 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.1 130.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.478 0.656 . . . . 0.33 109.741 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.406 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 12.0 t80 -84.36 97.67 9.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.207 -0.906 . . . . 0.8 110.88 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -79.9 88.98 5.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.694 -0.684 . . . . 0.47 110.181 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -84.17 104.13 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.186 -0.672 . . . . 0.75 109.186 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.86 -48.33 0.64 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.953 -0.642 . . . . 1.07 111.707 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -107.57 165.73 11.2 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.907 -0.405 . . . . 0.57 109.907 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -122.22 11.05 10.06 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.975 -0.75 . . . . 3.98 108.975 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -127.44 125.29 40.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.431 -0.804 . . . . 1.6 110.55 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.5 m -67.9 123.58 87.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.109 -0.33 . . . . 0.91 110.109 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 108.05 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.589 2.192 . . . . 0.82 111.275 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.4 m -79.75 58.62 2.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.03 0.443 . . . . 2.07 111.888 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -149.23 22.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 1.83 111.153 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 62.4 mtt180 -133.46 -49.17 0.84 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.862 0.363 . . . . 3.39 111.323 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.99 22.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.738 -0.744 . . . . 1.1 112.718 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -70.23 111.8 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.841 -0.429 . . . . 3.45 109.841 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 m -93.33 -28.52 16.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.0 -0.546 . . . . 1.33 110.94 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.22 167.48 24.68 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.55 -0.833 . . . . 0.35 112.33 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 44.5 p -144.41 144.47 31.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.143 0.496 . . . . 0.96 110.908 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 76.0 m -121.32 129.18 52.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 1.01 109.719 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.39 115.26 6.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.896 -0.882 . . . . 0.49 110.896 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -117.78 167.74 11.1 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.724 -0.473 . . . . 1.75 109.724 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -54.39 101.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.93 -0.577 . . . . 1.96 111.408 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.3 mt 63.77 22.29 13.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.522 -0.763 . . . . 1.75 111.905 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.89 -178.98 35.35 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.573 -0.822 . . . . 0.34 112.123 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.9 126.58 62.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.214 0.531 . . . . 0.37 111.128 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 57.2 m -90.25 107.61 19.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.1 -0.5 . . . . 1.11 110.559 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.1 125.77 46.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.939 -0.393 . . . . 1.14 109.939 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 9' ' ' THR . 45.1 p90 -128.62 155.37 79.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.528 -0.306 . . . . 0.57 110.82 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.38 161.66 92.09 Favored 'Cis proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.996 -1.252 . . . . 0.48 112.568 -1.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 10' ' ' ILE . 97.9 t -61.05 104.21 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 121.023 0.439 . . . . 1.31 111.262 174.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 22.6 t70 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.223 -0.894 . . . . 3.08 109.248 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.197 -0.361 . . . . 2.96 112.197 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -93.29 23.82 4.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.04 0.448 . . . . 1.13 111.926 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 m -76.37 117.9 18.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.764 -0.458 . . . . 1.12 109.764 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 34.1 t -121.77 109.09 14.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.137 0.494 . . . . 1.01 111.754 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 55.4 m-85 -85.77 109.7 18.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.85 110.2 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.51 101.86 13.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.2 108.09 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.51 -118.12 8.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.613 -0.803 . . . . 1.01 111.102 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -107.04 10.33 30.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.857 0.361 . . . . 3.65 110.997 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 39' ' ' TYR . 11.9 m -108.82 117.23 33.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.362 -0.535 . . . . 0.72 110.476 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.4 tt -81.27 123.28 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.679 . . . . 1.06 110.851 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -131.39 -172.83 13.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.723 -0.671 . . . . 0.36 111.706 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.2 131.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.399 0.618 . . . . 0.33 109.843 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HE1' ' HA3' ' A' ' 35' ' ' GLY . 11.2 t80 -86.4 106.75 17.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.296 -0.865 . . . . 0.8 110.833 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' HB2' HG23 ' A' ' 36' ' ' ILE . 98.8 m95 -88.17 112.8 23.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.47 110.049 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.407 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 91.7 t80 -89.91 135.98 33.32 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.964 -0.384 . . . . 0.75 109.964 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.5 -53.51 0.77 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 1.07 112.654 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -83.36 154.11 24.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.57 110.422 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.5 mptt -109.63 -2.88 17.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 3.98 109.257 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -130.24 159.0 38.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.524 -0.762 . . . . 1.6 110.012 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.5 m -88.07 121.83 70.33 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.536 -0.302 . . . . 0.91 110.941 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -63.11 105.75 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.078 1.852 . . . . 0.82 110.459 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.5 m -79.08 68.72 5.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.987 -0.551 . . . . 2.07 111.128 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.56 13.46 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 1.83 111.341 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 3.5 mpt_? -128.64 -82.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 3.39 110.958 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.67 27.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.621 -0.718 . . . . 1.1 111.924 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 18.3 m-85 -70.48 153.2 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.145 -0.317 . . . . 3.45 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.1 m -129.66 -55.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.012 -0.275 . . . . 1.33 111.504 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.68 17.4 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.799 . . . . 0.35 111.716 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 p -138.18 140.14 39.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.281 0.562 . . . . 0.96 111.655 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 61.1 m -116.92 136.95 52.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.631 -0.713 . . . . 1.01 109.473 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.44 127.15 28.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.684 -0.77 . . . . 0.49 111.506 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -129.29 171.37 12.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.804 -0.443 . . . . 1.75 109.804 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -54.48 103.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.455 0.472 . . . . 1.96 111.49 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 56.92 25.35 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.391 -0.822 . . . . 1.75 111.857 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . -161.53 177.15 37.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.075 -1.059 . . . . 0.34 112.604 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 14' ' ' TRP . 11.8 tt -118.37 124.2 72.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.579 0.704 . . . . 0.37 110.94 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 49.8 t -88.43 95.51 10.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.414 -0.812 . . . . 1.11 109.694 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 3.1 t -101.11 124.49 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.907 0.384 . . . . 1.14 111.056 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.696 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 28.3 p90 -126.46 162.04 48.93 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.57 110.571 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -82.66 167.0 68.05 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 124.481 -1.05 . . . . 0.48 112.835 -1.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 93.8 t -64.29 101.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 1.31 110.832 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 25.9 t70 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.526 -0.916 . . . . 3.08 108.526 169.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.747 -0.541 . . . . 2.96 111.747 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -69.13 115.87 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.469 . . . . 1.13 110.69 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.1 m -75.76 124.99 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.484 -0.78 . . . . 1.12 111.516 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 50.4 t -138.55 154.53 48.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.697 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -133.42 129.0 36.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.85 111.563 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -112.33 102.53 10.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.607 -0.724 . . . . 1.2 109.202 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.8 -86.79 0.45 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -138.1 -0.51 2.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 3.65 109.937 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -85.7 124.97 32.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.72 110.381 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG13 ' CG1' ' A' ' 41' ' ' VAL . 3.6 tp -79.75 121.84 33.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.491 0.662 . . . . 1.06 110.827 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.1 -176.01 14.26 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.49 -0.777 . . . . 0.36 111.708 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.5 134.04 61.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.479 0.657 . . . . 0.33 110.238 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 16.4 t80 -89.6 102.51 15.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.364 -0.835 . . . . 0.8 111.176 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -83.2 98.23 9.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.025 -0.534 . . . . 0.47 110.777 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.61 102.35 14.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.896 0.379 . . . . 0.75 110.184 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.84 -51.22 0.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.782 -0.723 . . . . 1.07 111.708 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 t -90.44 158.1 17.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.899 0.381 . . . . 0.57 110.337 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.6 mptt -116.52 17.99 15.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.646 . . . . 3.98 109.502 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -147.17 146.94 30.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.114 -0.493 . . . . 1.6 110.553 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 71.0 m -80.11 124.33 82.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.148 -0.478 . . . . 0.91 110.685 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 24.3 Cg_exo -62.12 130.13 29.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.87 2.38 . . . . 0.82 112.012 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 m -83.74 55.3 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.299 -0.41 . . . . 2.07 111.548 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -141.8 0.53 1.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.741 0.305 . . . . 1.83 111.476 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 1.028 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.6 -44.78 3.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.983 0.42 . . . . 3.39 111.627 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 38.46 1.68 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.464 -0.654 . . . . 1.1 111.464 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -71.09 138.39 49.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.622 0.248 . . . . 3.45 110.69 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.516 HG22 ' HD3' ' A' ' 40' ' ' PRO . 14.5 t -106.78 -12.87 15.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.442 -0.344 . . . . 1.33 110.713 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.67 170.47 38.23 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.745 -1.217 . . . . 0.35 113.027 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 9.3 p -143.05 144.78 32.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.936 0.398 . . . . 0.96 111.013 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 63.1 m -125.28 134.61 52.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.026 -0.534 . . . . 1.01 110.173 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 121.76 7.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.638 -0.792 . . . . 0.49 112.119 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.12 171.94 9.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.455 0.169 . . . . 1.75 110.722 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -56.2 104.32 0.14 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 1.96 111.714 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.95 27.09 14.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.307 -0.86 . . . . 1.75 112.028 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.56 170.68 35.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.374 -0.917 . . . . 0.34 112.761 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 tt -116.55 130.81 70.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.37 110.339 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.7 t -96.23 102.23 13.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.113 -0.494 . . . . 1.11 110.05 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.05 122.19 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.816 0.341 . . . . 1.14 110.681 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -122.18 151.19 58.39 Favored Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.225 -0.443 . . . . 0.57 110.321 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 27' ' ' THR . 73.1 Cg_endo -86.16 160.41 56.81 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.063 -1.641 . . . . 0.48 112.045 0.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' CG1' HG13 ' A' ' 10' ' ' ILE . 5.6 p -73.2 91.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.734 0.778 . . . . 1.31 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.028 ' HB3' ' HG3' ' A' ' 24' ' ' ARG . 24.6 t70 . . . . . 0 C--O 1.246 0.87 0 CA-C-N 115.208 -0.906 . . . . 3.08 110.442 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 111.853 -0.499 . . . . 2.96 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p -112.41 30.64 6.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.069 0.461 . . . . 1.13 111.129 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.1 m -74.38 121.91 22.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.5 . . . . 1.12 110.742 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 t -121.82 157.27 31.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.657 -0.701 . . . . 1.01 110.068 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -132.05 124.5 29.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.936 0.398 . . . . 0.85 111.344 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -100.53 92.56 5.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.69 -95.31 0.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.97 -0.852 . . . . 1.01 110.97 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -121.71 -2.03 9.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.829 0.347 . . . . 3.65 110.33 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.466 HG21 ' CD1' ' A' ' 39' ' ' TYR . 6.0 m -87.46 129.34 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.72 110.717 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 tt -86.36 113.45 24.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.885 0.85 . . . . 1.06 111.669 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.0 -174.22 14.58 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.029 -0.987 . . . . 0.36 111.528 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.93 134.48 66.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.43 0.633 . . . . 0.33 110.204 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -83.77 104.4 13.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.262 -0.881 . . . . 0.8 111.174 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 90.0 m95 -89.16 98.36 11.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.47 110.822 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.939 -0.573 . . . . 0.75 109.949 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.89 14.79 6.51 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.358 -0.925 . . . . 1.07 113.387 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -151.42 146.12 25.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.57 110.664 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -97.51 -8.67 28.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.378 -0.828 . . . . 3.98 109.603 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 p -118.75 139.43 51.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.679 . . . . 1.6 111.404 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 72.8 m -75.9 129.06 82.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.131 -0.486 . . . . 0.91 109.75 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 31.3 Cg_exo -58.11 97.59 0.09 OUTLIER 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.555 2.17 . . . . 0.82 110.782 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -79.61 51.92 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.524 0.678 . . . . 2.07 111.316 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.87 0.39 1.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.934 -1.03 . . . . 1.83 109.785 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -103.99 -46.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 3.39 110.906 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.07 14.95 0.94 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.747 -0.739 . . . . 1.1 112.683 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -70.7 137.92 50.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 3.45 110.385 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 m -115.23 -32.78 5.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.92 0.39 . . . . 1.33 110.659 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.48 176.97 18.61 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.858 -0.687 . . . . 0.35 111.796 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.4 p -162.66 148.89 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.116 0.484 . . . . 0.96 111.598 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 58.3 m -125.53 151.13 46.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.506 -0.77 . . . . 1.01 109.426 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.46 125.89 7.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.49 111.659 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.98 162.97 24.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.75 110.469 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 106.61 0.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 1.96 111.545 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 63.53 20.48 12.26 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.929 0.768 . . . . 1.75 112.087 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.92 175.73 39.26 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.28 -0.962 . . . . 0.34 112.85 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.58 133.69 68.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.199 0.523 . . . . 0.37 110.285 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' SER . 52.2 t -95.02 95.69 8.76 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.813 -0.44 . . . . 1.11 109.813 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.41 128.29 40.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.397 -0.365 . . . . 1.14 110.752 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 41.0 p90 -129.54 159.74 67.94 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.512 -0.313 . . . . 0.57 110.759 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 83.7 Cg_endo -91.41 162.6 28.71 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.677 -1.384 . . . . 0.48 112.789 -1.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.53 92.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.099 -0.5 . . . . 1.31 109.78 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.306 -0.854 . . . . 3.08 109.916 -177.89 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.982 0 N-CA-C 111.494 -0.643 . . . . 2.96 111.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.8 p -86.68 42.32 1.01 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.548 0.69 . . . . 1.13 110.165 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 m -76.88 109.02 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.145 -0.934 . . . . 1.12 110.303 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.67 151.23 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.694 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -129.06 115.51 17.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.85 111.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.7 m -99.88 95.54 6.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.85 -107.34 2.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.62 -0.8 . . . . 1.01 111.268 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -107.78 -5.03 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.042 0.448 . . . . 3.65 110.524 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -99.95 117.38 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.72 110.788 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tt -82.23 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.514 0.673 . . . . 1.06 110.996 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.55 -170.28 11.85 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.201 -0.909 . . . . 0.36 111.204 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.92 137.7 52.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.295 0.569 . . . . 0.33 109.553 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 36.8 t80 -87.56 107.27 18.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.8 111.475 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.531 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 82.0 m95 -90.64 100.51 13.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.129 -0.487 . . . . 0.47 109.861 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.7 t80 -83.76 132.54 34.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.491 -0.322 . . . . 0.75 110.303 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.01 -18.69 39.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.639 -0.791 . . . . 1.07 113.233 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -118.29 151.83 36.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.581 . . . . 0.57 111.359 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -102.32 3.1 37.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.303 -0.862 . . . . 3.98 110.527 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -134.87 146.27 49.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.224 0.535 . . . . 1.6 111.368 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 94.5 m -80.9 127.99 72.93 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.702 -0.681 . . . . 0.91 111.208 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 17.1 Cg_exo -62.54 116.18 3.36 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.514 2.143 . . . . 0.82 110.553 173.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.1 m -84.08 24.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 2.07 112.12 -170.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.27 16.32 24.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.135 0.493 . . . . 1.83 110.147 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -119.38 -60.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.714 -0.676 . . . . 3.39 110.943 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.02 40.54 0.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.828 -0.624 . . . . 1.1 111.678 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 48.3 m-85 -70.39 132.58 45.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 3.45 111.245 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -89.16 -27.8 20.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.537 -0.756 . . . . 1.33 110.592 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.62 171.68 34.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.37 -0.919 . . . . 0.35 112.337 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.518 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 17.6 p -140.68 151.97 44.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.898 0.38 . . . . 0.96 111.505 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -124.02 140.93 52.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.01 109.778 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.91 126.49 7.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.785 -0.722 . . . . 0.49 111.783 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -129.13 169.02 15.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 1.75 109.058 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -62.55 97.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 1.96 111.924 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.4 mp 63.5 27.32 15.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.337 -0.847 . . . . 1.75 111.266 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . -154.11 165.71 31.82 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.34 111.566 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.34 129.35 74.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.359 0.599 . . . . 0.37 110.559 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.7 t -92.53 105.86 17.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.325 -0.62 . . . . 1.11 109.325 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.8 m -103.76 123.08 46.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.922 0.391 . . . . 1.14 110.807 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -125.32 153.86 72.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.978 -0.556 . . . . 0.57 110.634 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.38 158.72 73.68 Favored 'Cis proline' 0 C--O 1.235 0.331 0 C-N-CA 123.518 -1.451 . . . . 0.48 111.852 -1.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 41' ' ' VAL . 5.8 p -75.76 86.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.849 0.833 . . . . 1.31 110.612 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.288 -0.863 . . . . 3.08 110.503 -179.468 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.088 -0.405 . . . . 2.96 112.088 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p -100.93 30.8 3.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.09 0.471 . . . . 1.13 111.433 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -96.14 139.82 31.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.44 -0.345 . . . . 1.12 110.532 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.58 161.05 30.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.303 -0.408 . . . . 1.01 110.707 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.37 106.72 10.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.565 -0.289 . . . . 0.85 110.558 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.2 m -85.04 93.28 8.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.24 -0.652 . . . . 1.2 109.24 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.27 -93.1 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.442 -0.799 . . . . 1.01 111.865 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.56 0.29 8.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.645 0.259 . . . . 3.65 110.805 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 m -106.42 122.94 47.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.72 110.774 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 9.6 tt -76.31 123.26 32.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.405 -0.816 . . . . 1.06 111.256 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.02 171.77 18.6 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.36 111.653 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.95 131.55 65.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.201 0.524 . . . . 0.33 109.776 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 7.6 t80 -87.34 100.6 12.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.541 -0.754 . . . . 0.8 110.66 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -79.51 88.53 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.673 -0.694 . . . . 0.47 109.679 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 78.1 t80 -70.48 122.14 19.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.677 -0.692 . . . . 0.75 109.782 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.07 -32.58 5.06 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.698 -0.763 . . . . 1.07 112.847 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -125.25 151.24 46.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.57 111.194 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.2 tptm -109.76 21.76 16.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.047 0.927 . . . . 3.98 108.615 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -119.44 122.86 42.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 1.6 110.303 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.1 m -72.6 118.96 72.38 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.848 0.356 . . . . 0.91 110.392 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.6 75.86 4.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.745 2.297 . . . . 0.82 109.858 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -78.34 53.12 1.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.865 -1.061 . . . . 2.07 112.913 -168.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -88.36 1.37 54.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.219 -0.66 . . . . 1.83 109.219 170.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HB3' ' OXT' ' A' ' 42' ' ' ASP . 9.7 mpt_? -97.12 -73.44 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.073 -0.967 . . . . 3.39 109.857 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.8 28.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.455 -0.793 . . . . 1.1 112.194 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.02 138.66 43.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 3.45 110.978 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -109.11 -45.98 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.209 0.528 . . . . 1.33 111.027 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.1 -179.48 16.06 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.83 -0.908 . . . . 0.35 110.83 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.461 ' OG ' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -157.71 164.29 37.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.655 0.728 . . . . 0.96 111.655 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -133.17 125.12 28.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.83 . . . . 1.01 109.74 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HE3' ' A' ' 18' ' ' LYS . . . -66.88 127.15 27.63 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.818 -0.706 . . . . 0.49 112.082 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -123.11 165.14 17.33 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.734 -0.274 . . . . 1.75 111.235 -176.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -39.23 -55.78 1.62 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.359 1.037 . . . . 1.96 113.021 -168.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 5.8 mp -134.27 45.71 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.951 -0.389 . . . . 1.75 109.951 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.6 -164.7 33.4 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.702 -1.237 . . . . 0.34 112.7 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 18' ' ' LYS . 16.1 tt -133.89 130.08 55.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.093 0.473 . . . . 0.37 111.146 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.8 t -95.88 92.44 6.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.201 -0.454 . . . . 1.11 109.971 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.7 124.51 33.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 1.14 110.55 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -126.97 153.48 76.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.57 111.036 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 2.4 Cg_endo -82.82 172.13 50.23 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.621 -1.408 . . . . 0.48 111.3 -3.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.14 46.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.137 0.494 . . . . 1.31 110.771 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.549 ' OXT' ' HB3' ' A' ' 24' ' ' ARG . 18.4 m-20 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.263 -0.875 . . . . 3.08 109.596 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 111.752 -0.539 . . . . 2.96 111.752 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 15.4 p -84.29 59.03 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.464 0.649 . . . . 1.13 110.371 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 10' ' ' ILE . 3.6 m -104.27 123.79 48.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.416 -0.811 . . . . 1.12 110.195 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' O ' HD12 ' A' ' 10' ' ' ILE . 8.0 p -135.65 159.96 40.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.873 0.368 . . . . 1.01 111.316 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.471 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 88.6 m-85 -119.61 143.91 47.41 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.78 -0.452 . . . . 0.85 109.78 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.3 t -119.91 101.75 8.08 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.49 -91.54 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.778 -0.646 . . . . 1.01 111.872 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -122.49 -9.95 8.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.887 0.375 . . . . 3.65 110.684 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -95.6 128.53 42.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.117 -0.492 . . . . 0.72 111.067 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 3' ' ' THR . 5.1 tp -82.22 132.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.978 -0.555 . . . . 1.06 110.003 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.46 179.78 19.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.13 -0.557 . . . . 0.36 112.627 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.871 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.62 137.71 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.228 0.537 . . . . 0.33 109.76 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 2.0 t80 -89.64 101.09 13.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.724 -0.671 . . . . 0.8 111.443 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -82.85 83.28 7.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.871 -0.604 . . . . 0.47 109.42 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -73.37 96.91 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.178 -0.465 . . . . 0.75 110.337 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.33 -61.37 0.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.725 -0.67 . . . . 1.07 111.903 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -87.11 161.82 17.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.729 0.299 . . . . 0.57 110.627 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -113.51 11.18 18.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.165 -0.68 . . . . 3.98 109.165 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -128.77 135.78 49.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.595 . . . . 1.6 110.562 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 93.9 m -80.01 127.41 77.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.745 0.307 . . . . 0.91 111.292 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 2.9 Cg_exo -74.23 78.32 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.558 2.172 . . . . 0.82 110.194 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -78.62 63.04 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.556 0.693 . . . . 2.07 111.141 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.43 4.71 10.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.33 -0.85 . . . . 1.83 109.687 171.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.04 -81.77 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.29 -0.633 . . . . 3.39 109.29 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.49 4.23 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.977 -0.63 . . . . 1.1 113.146 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -62.06 127.31 30.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.077 0.438 . . . . 3.45 110.273 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 p -114.74 -39.07 3.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.933 0.397 . . . . 1.33 110.888 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.91 157.85 14.95 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.956 -0.64 . . . . 0.35 112.188 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.2 p -124.55 149.97 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.376 . . . . 0.96 111.103 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.9 t -133.4 114.66 13.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.119 -0.491 . . . . 1.01 109.969 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 127.16 42.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.416 -0.421 . . . . 0.49 113.196 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -128.21 174.43 9.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.644 0.259 . . . . 1.75 110.56 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -65.52 95.41 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 1.96 111.506 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt 64.42 27.31 13.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.745 -0.661 . . . . 1.75 110.536 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.34 -175.83 29.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.822 -0.704 . . . . 0.34 111.874 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 29' ' ' SER . 12.3 tt -136.44 130.09 46.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.233 0.539 . . . . 0.37 110.958 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 45.0 t -93.3 103.52 15.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.062 -0.718 . . . . 1.11 109.062 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.1 m -91.76 124.43 35.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 1.14 110.928 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 47.0 p90 -127.08 150.11 71.24 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.025 -0.534 . . . . 0.57 111.117 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 16.5 Cg_exo -68.49 165.78 71.56 Favored 'Cis proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.56 -1.433 . . . . 0.48 111.933 -4.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' HB ' ' A' ' 12' ' ' ILE . 7.3 p -72.5 68.65 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 122.32 1.057 . . . . 1.31 110.712 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.996 -179.281 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.889 -0.485 . . . . 2.96 111.889 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.8 p -92.43 18.07 9.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.723 0.297 . . . . 1.13 111.43 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -69.69 115.83 9.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 1.12 110.023 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -122.51 154.7 37.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.451 . . . . 1.01 110.651 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 54.7 m-85 -131.67 121.94 25.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.755 0.312 . . . . 0.85 110.941 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -102.92 99.47 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.979 -0.749 . . . . 1.2 108.979 171.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.75 -97.55 0.35 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.921 -0.657 . . . . 1.01 111.767 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -106.84 -25.15 11.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.694 0.283 . . . . 3.65 110.825 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -88.39 123.68 33.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.209 0.528 . . . . 0.72 111.64 -170.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 tt -78.73 131.84 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.706 -0.679 . . . . 1.06 110.615 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.68 -174.06 13.33 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.702 -0.681 . . . . 0.36 111.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -117.16 133.19 64.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.353 0.596 . . . . 0.33 109.928 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 15.3 t80 -84.44 100.1 11.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.8 110.928 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -80.17 94.37 6.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.47 110.373 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.5 t80 -79.56 109.87 14.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.523 -0.547 . . . . 0.75 109.523 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.26 -21.32 4.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.453 -0.88 . . . . 1.07 112.884 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -135.05 151.99 51.27 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.765 -0.256 . . . . 0.57 110.497 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -115.94 8.08 14.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.386 -0.598 . . . . 3.98 109.386 174.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 p -120.98 126.73 50.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 1.6 109.786 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 88.9 m -74.52 136.25 74.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.91 111.686 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 6.0 Cg_exo -79.48 100.69 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.091 2.527 . . . . 0.82 110.126 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 t -80.97 20.4 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 2.07 111.2 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -86.84 -8.7 57.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.471 -0.566 . . . . 1.83 109.471 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 11.0 mmt180 -89.41 -58.15 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 3.39 109.98 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.9 30.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.588 -0.733 . . . . 1.1 112.149 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -72.17 152.2 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 3.45 111.256 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -118.37 -41.09 2.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.118 -0.492 . . . . 1.33 111.149 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.5 165.41 23.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.71 -0.757 . . . . 0.35 111.959 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.826 ' HB2' HD11 ' A' ' 36' ' ' ILE . 34.5 p -143.09 143.72 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.093 0.473 . . . . 0.96 111.888 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 42.8 m -122.49 125.6 46.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 1.01 109.764 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.04 132.44 45.95 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.531 -0.842 . . . . 0.49 111.585 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.34 166.36 21.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.97 0.385 . . . . 1.75 110.884 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -59.0 100.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.96 111.197 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp 64.36 29.33 13.61 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.767 0.667 . . . . 1.75 111.207 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.57 -168.87 33.75 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.394 -0.907 . . . . 0.34 112.306 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.0 tt -136.28 130.3 47.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.437 0.637 . . . . 0.37 111.166 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 47.5 t -89.26 96.36 10.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.751 . . . . 1.11 108.971 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -100.27 130.9 46.44 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.66 -0.416 . . . . 1.14 110.146 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 55.1 p90 -131.27 157.91 76.75 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.787 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.6 Cg_exo -74.0 157.2 99.5 Favored 'Cis proline' 0 C--O 1.231 0.152 0 C-N-CA 123.611 -1.412 . . . . 0.48 111.674 -2.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.7 p -66.14 97.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.711 0.767 . . . . 1.31 110.144 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.395 -0.82 . . . . 3.08 110.444 -177.151 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 N-CA-C 112.015 -0.434 . . . . 2.96 112.015 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 11.9 p -80.79 77.27 7.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 1.13 110.861 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -107.09 128.09 54.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.865 -0.607 . . . . 1.12 110.719 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -135.17 119.07 17.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.01 111.132 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 45.6 m-85 -80.7 117.81 21.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.85 111.182 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.1 m -91.53 87.55 6.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.102 -0.703 . . . . 1.2 109.102 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.03 -102.87 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.868 -0.605 . . . . 1.01 112.047 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -100.38 -19.98 16.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.569 0.223 . . . . 3.65 111.327 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -97.16 118.37 33.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.898 0.38 . . . . 0.72 110.732 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 7.4 tt -79.82 131.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 1.06 110.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.33 173.75 19.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.736 -0.745 . . . . 0.36 112.608 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.97 135.04 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.513 -0.551 . . . . 0.33 109.513 -178.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.87 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 25.4 t80 -87.28 113.78 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.8 111.701 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.403 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 88.1 m95 -92.68 102.81 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.469 -0.787 . . . . 0.47 109.596 173.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -73.15 130.83 41.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.033 -0.358 . . . . 0.75 110.033 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.39 -82.62 0.31 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.031 -0.604 . . . . 1.07 111.995 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.5 t -63.81 151.63 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.57 111.67 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -112.44 12.08 19.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.883 -0.784 . . . . 3.98 108.883 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -127.93 130.09 47.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.114 -0.948 . . . . 1.6 110.108 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.7 m -68.28 128.15 93.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.508 -0.314 . . . . 0.91 111.022 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 52.4 Cg_exo -53.36 109.7 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.477 2.118 . . . . 0.82 110.454 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -83.42 48.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.432 0.634 . . . . 2.07 111.093 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -144.39 25.82 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 1.83 110.262 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.42 -54.67 2.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.901 -0.591 . . . . 3.39 111.016 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.81 22.28 1.05 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.507 -0.769 . . . . 1.1 111.851 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -63.78 147.82 50.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.849 0.357 . . . . 3.45 110.916 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -108.76 -43.35 4.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.86 -0.609 . . . . 1.33 110.832 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -133.85 175.23 20.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.798 -0.715 . . . . 0.35 112.288 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.709 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.4 p -152.1 140.73 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.986 0.422 . . . . 0.96 111.817 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 59.3 m -116.69 133.51 55.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.243 -0.651 . . . . 1.01 109.243 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.59 133.09 17.05 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.532 -0.842 . . . . 0.49 111.177 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -130.21 165.22 22.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.626 -0.509 . . . . 1.75 109.626 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HB3' HD12 ' A' ' 34' ' ' LEU . 54.6 m-85 -37.53 -69.43 0.12 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.177 0.806 . . . . 1.96 113.177 -167.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 33' ' ' PHE . 7.2 mp -120.76 43.52 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.735 -0.386 . . . . 1.75 110.157 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.0 -158.08 22.77 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.146 -1.026 . . . . 0.34 112.694 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' SER . 13.3 tt -137.37 133.92 46.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.39 0.614 . . . . 0.37 111.133 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 28.0 m -93.46 101.26 13.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.11 110.135 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -94.1 130.35 40.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.076 -0.511 . . . . 1.14 110.907 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.8 p90 -130.14 157.98 75.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.263 -0.426 . . . . 0.57 110.314 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.2 Cg_exo -74.85 153.03 98.95 Favored 'Cis proline' 0 C--O 1.231 0.154 0 C-N-CA 123.863 -1.307 . . . . 0.48 111.944 -0.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.2 p -72.02 98.35 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.472 0.653 . . . . 1.31 111.078 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.023 -0.99 . . . . 3.08 111.117 177.828 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.161 -0.376 . . . . 2.96 112.161 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.1 p -90.69 48.19 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.038 0.447 . . . . 1.13 111.86 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m -69.7 131.28 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 1.12 110.012 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -135.3 153.26 51.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.797 0.332 . . . . 1.01 110.903 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -136.44 125.3 24.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 0.85 110.463 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.22 86.93 2.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.201 -1.037 . . . . 1.2 108.201 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.93 -102.12 1.11 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.224 -0.898 . . . . 1.01 111.654 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.42 -11.39 17.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.468 0.175 . . . . 3.65 110.678 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -95.91 118.03 31.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.72 110.993 -175.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 41' ' ' VAL . 11.0 tt -79.7 130.43 36.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.312 0.577 . . . . 1.06 111.189 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -173.45 12.9 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.543 -0.753 . . . . 0.36 111.934 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.67 136.1 60.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.142 0.496 . . . . 0.33 109.942 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 1.6 t80 -86.28 105.91 16.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.831 -0.622 . . . . 0.8 110.516 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.38 104.48 13.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.47 109.982 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 61.2 t80 -94.31 103.58 15.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.662 -0.699 . . . . 0.75 109.192 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.33 -6.7 5.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.412 -0.899 . . . . 1.07 112.242 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -143.54 152.48 41.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.955 -0.387 . . . . 0.57 109.955 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.82 12.54 19.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.331 0.586 . . . . 3.98 109.584 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 p -134.35 146.33 49.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 1.6 110.055 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 77.5 m -79.58 116.59 61.85 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.91 110.364 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.75 126.29 16.42 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.485 2.123 . . . . 0.82 111.697 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.0 m -76.06 110.39 10.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 2.07 110.517 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -169.95 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.83 111.922 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.66 ' HD3' ' OXT' ' A' ' 42' ' ' ASP . 72.4 mtt180 -122.27 -69.38 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.795 -0.362 . . . . 3.39 111.583 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.77 36.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.237 -0.982 . . . . 1.1 112.959 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.08 130.58 44.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.859 0.361 . . . . 3.45 110.178 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.2 m -101.2 -40.35 7.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.228 -0.442 . . . . 1.33 110.78 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -124.4 169.92 16.48 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.581 -0.818 . . . . 0.35 112.229 -177.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.3 p -154.06 133.19 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.39 0.615 . . . . 0.96 111.87 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 65.3 m -115.3 120.85 41.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.42 -0.809 . . . . 1.01 109.68 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.24 133.42 48.54 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.49 111.842 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -129.92 164.44 24.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.864 0.332 . . . . 1.75 110.865 -176.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HB3' HD22 ' A' ' 34' ' ' LEU . 70.7 m-85 -39.37 -59.66 1.04 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.863 1.06 . . . . 1.96 113.863 -170.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 33' ' ' PHE . 3.1 mm? -123.34 28.47 7.05 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.439 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.98 -151.31 9.23 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.514 -1.327 . . . . 0.34 113.246 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.817 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.1 tt -139.25 135.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.37 111.178 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 42.5 t -94.2 101.65 13.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.681 -0.69 . . . . 1.11 109.576 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.5 m -95.58 129.19 42.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 1.14 110.817 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 42.4 p90 -130.22 157.39 77.34 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.57 110.468 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.4 Cg_exo -81.89 171.63 55.41 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 123.707 -1.372 . . . . 0.48 111.931 -1.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 77.3 t -62.94 95.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 1.31 110.962 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.66 ' OXT' ' HD3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.632 -0.699 . . . . 3.08 109.406 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.993 -0.443 . . . . 2.96 111.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p -96.26 53.98 1.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 1.13 111.43 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.7 m -110.25 127.83 55.19 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.611 . . . . 1.12 109.349 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.36 139.14 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.125 0.488 . . . . 1.01 111.887 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 62.5 m-85 -103.26 111.74 24.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.073 -0.512 . . . . 0.85 110.019 173.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.04 100.47 12.58 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.479 -0.563 . . . . 1.2 109.479 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.97 -85.29 0.38 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 1.01 112.003 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -134.23 -0.71 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.799 0.333 . . . . 3.65 111.065 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 m -108.39 135.09 50.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.805 0.336 . . . . 0.72 110.887 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.9 tt -93.87 128.11 45.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.601 0.715 . . . . 1.06 111.654 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 -178.4 15.95 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.471 -0.786 . . . . 0.36 111.826 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.816 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.52 136.78 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.439 -0.578 . . . . 0.33 109.439 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 26.4 t80 -89.85 115.92 27.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.8 111.648 -173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HZ2' ' HH ' ' A' ' 26' ' ' TYR . 87.1 m95 -99.12 110.68 23.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.842 -0.617 . . . . 0.47 110.427 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -103.22 122.13 44.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.189 -0.671 . . . . 0.75 109.189 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 125.4 -32.1 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.183 -0.767 . . . . 1.07 111.183 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 t -121.4 146.39 46.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.951 -0.389 . . . . 0.57 109.951 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 18' ' ' LYS . 14.2 ptmt -108.73 14.78 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.348 0.594 . . . . 3.98 109.885 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -128.91 137.07 51.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.532 -0.758 . . . . 1.6 109.527 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.3 m -80.34 125.75 80.44 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.91 110.612 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.11 97.53 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.726 2.284 . . . . 0.82 110.766 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -71.74 4.16 3.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.23 0.538 . . . . 2.07 112.329 -173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -79.73 -16.59 55.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.827 -0.624 . . . . 1.83 109.358 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 16.7 mmt180 -87.19 -11.95 48.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.51 -0.768 . . . . 3.39 110.931 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.31 33.23 23.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.944 -0.646 . . . . 1.1 113.202 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 35.8 m-85 -70.82 137.29 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.84 0.352 . . . . 3.45 110.224 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.7 m -100.32 -43.1 6.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 1.33 111.078 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.93 165.99 24.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.742 -0.742 . . . . 0.35 112.21 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -137.05 160.74 38.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.879 0.371 . . . . 0.96 111.26 -176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.593 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 97.8 m -141.77 145.48 34.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.026 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.59 131.33 11.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.008 -0.615 . . . . 0.49 112.337 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 2.0 t80 -127.75 174.06 9.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.331 -0.618 . . . . 1.75 109.331 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.61 92.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.674 0.609 . . . . 1.96 111.972 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt 59.67 33.08 21.84 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.566 -0.743 . . . . 1.75 110.657 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.99 178.26 36.13 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 0.34 111.583 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.47 135.28 64.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.379 0.609 . . . . 0.37 111.039 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.76 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.721 -0.672 . . . . 1.11 109.367 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.3 m -105.82 121.96 45.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.612 -0.267 . . . . 1.14 111.049 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.3 p90 -129.27 157.11 77.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.57 110.982 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.0 Cg_exo -65.28 151.51 76.99 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 123.774 -1.344 . . . . 0.48 112.323 -1.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.816 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.6 p -61.59 96.84 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.123 0.487 . . . . 1.31 111.486 178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--O 1.245 0.862 0 CA-C-N 115.044 -0.98 . . . . 3.08 111.857 176.582 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.265 -0.334 . . . . 2.96 112.265 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -80.99 61.86 4.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.12 0.486 . . . . 1.13 110.959 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -142.97 141.88 31.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.775 -0.648 . . . . 1.12 109.905 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.6 p -131.45 159.64 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 1.01 110.819 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.66 102.23 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.85 110.574 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -89.28 90.49 8.36 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.755 -0.831 . . . . 1.2 108.755 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.68 -117.07 7.36 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 1.01 111.49 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -88.63 -18.38 28.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.552 0.215 . . . . 3.65 110.534 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.46 117.23 29.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.142 0.496 . . . . 0.72 111.18 -170.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 41' ' ' VAL . 6.7 tt -86.81 129.75 37.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.579 -0.737 . . . . 1.06 110.028 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.77 162.48 22.9 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.021 -0.609 . . . . 0.36 112.131 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.858 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.84 132.81 41.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.364 -0.606 . . . . 0.33 109.364 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.1 t80 -89.04 103.45 16.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.064 -0.516 . . . . 0.8 111.283 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 97.6 m95 -84.44 81.24 8.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.773 -0.648 . . . . 0.47 110.337 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -75.25 118.16 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.738 -0.664 . . . . 0.75 109.895 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.01 8.14 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.443 -0.884 . . . . 1.07 112.414 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 36' ' ' ILE . 10.2 t -132.5 153.6 50.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.62 0.248 . . . . 0.57 110.571 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 6.88 23.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.208 0.527 . . . . 3.98 109.615 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.0 m -107.23 118.11 35.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.618 -0.719 . . . . 1.6 110.393 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -68.48 116.63 42.08 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.91 109.531 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 Cg_exo -56.92 120.22 7.99 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.804 2.336 . . . . 0.82 111.41 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -84.86 49.39 1.71 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.638 0.732 . . . . 2.07 110.732 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -128.22 13.36 6.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.586 -0.734 . . . . 1.83 110.007 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.75 ' HG2' ' HA ' ' A' ' 42' ' ' ASP . 8.6 mpt_? -117.94 -55.84 2.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 3.39 110.988 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.72 38.2 0.67 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.69 -0.686 . . . . 1.1 111.677 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -67.49 141.95 56.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.408 . . . . 3.45 110.869 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -112.38 -35.32 5.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.066 -0.516 . . . . 1.33 110.63 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.97 175.27 21.21 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.586 -0.816 . . . . 0.35 111.494 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 p -156.73 158.28 36.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.96 111.509 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 74.3 m -123.45 114.69 20.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.104 -0.702 . . . . 1.01 109.104 174.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.88 131.52 25.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.766 -0.73 . . . . 0.49 111.936 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 32.6 m-85 -135.71 -178.96 5.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.472 0.136 . . . . 1.75 110.933 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -57.66 102.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.632 0.605 . . . . 1.96 112.632 -172.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.0 mm? 59.83 26.27 15.44 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.562 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.93 173.42 35.82 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.508 -0.853 . . . . 0.34 111.975 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 17' ' ' THR . 16.6 tt -132.61 124.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.445 0.64 . . . . 0.37 110.241 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 8.0 t -94.74 98.55 10.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.123 -0.695 . . . . 1.11 109.123 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 m -93.76 140.33 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 1.14 111.365 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 15.1 p90 -134.23 159.63 71.58 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 116.372 -0.377 . . . . 0.57 111.165 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 33.6 Cg_exo -63.32 154.59 70.84 Favored 'Cis proline' 0 N--CA 1.479 0.643 0 C-N-CA 124.107 -1.205 . . . . 0.48 112.494 -0.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.1 p -64.41 98.35 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.504 0.668 . . . . 1.31 111.853 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.75 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 26.2 t70 . . . . . 0 C--O 1.243 0.746 0 CA-C-N 114.758 -1.11 . . . . 3.08 111.274 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.601 0 N-CA-C 112.177 -0.369 . . . . 2.96 112.177 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.1 m -94.23 125.36 38.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.96 -0.385 . . . . 1.13 109.96 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 m -102.1 142.0 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.546 -0.297 . . . . 1.12 110.42 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.57 152.42 51.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.437 . . . . 1.01 111.086 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.0 m-85 -113.6 138.71 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.057 0.456 . . . . 0.85 110.581 174.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.3 t -121.57 102.21 8.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.615 -0.883 . . . . 1.2 108.615 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -101.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.151 -0.78 . . . . 1.01 111.151 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -119.64 -1.88 10.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.576 0.227 . . . . 3.65 111.094 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 39' ' ' TYR . 3.5 m -97.96 136.38 38.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.72 111.006 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 tt -96.31 125.15 49.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.689 0.757 . . . . 1.06 111.475 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.01 178.65 17.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.16 -0.927 . . . . 0.36 112.131 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 135.96 49.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.659 -0.496 . . . . 0.33 109.659 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 11.7 t80 -87.59 104.58 16.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.446 -0.797 . . . . 0.8 111.21 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 94.6 m95 -87.36 90.11 8.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.47 110.522 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.435 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.2 t80 -79.5 123.46 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.398 -0.593 . . . . 0.75 109.398 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.31 -24.72 8.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.415 -0.898 . . . . 1.07 112.597 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 6.9 t -126.08 155.04 42.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.99 0.424 . . . . 0.57 110.667 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 15.94 16.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.644 -0.707 . . . . 3.98 109.806 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -131.76 128.08 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.6 110.7 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 99.7 m -72.38 126.35 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.258 -0.428 . . . . 0.91 111.159 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 12.4 Cg_exo -67.4 101.39 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.763 2.309 . . . . 0.82 110.905 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 p -79.27 26.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 2.07 111.805 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -91.27 -11.07 39.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.331 -0.395 . . . . 1.83 110.649 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 58.7 mtt180 -102.35 -74.06 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.418 -0.355 . . . . 3.39 111.185 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.22 33.07 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.531 -0.842 . . . . 1.1 112.392 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -71.9 125.73 27.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.384 -0.228 . . . . 3.45 110.384 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 m -100.86 -49.44 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.085 -0.507 . . . . 1.33 110.842 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -112.4 157.13 15.15 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.622 -0.799 . . . . 0.35 112.061 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.543 ' HB3' HD11 ' A' ' 36' ' ' ILE . 11.6 m -139.64 136.29 34.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.858 0.361 . . . . 0.96 110.907 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 81.8 m -129.64 132.88 46.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 1.01 109.689 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 145.78 49.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.149 -0.548 . . . . 0.49 112.99 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -136.48 165.46 25.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.886 -0.783 . . . . 1.75 108.886 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -60.26 99.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.052 0.22 . . . . 1.96 110.725 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.0 mt 63.09 32.15 15.44 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.825 0.703 . . . . 1.75 111.102 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.22 178.21 39.64 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.89 -0.671 . . . . 0.34 111.707 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 29' ' ' SER . 16.8 tt -128.93 131.57 68.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.294 0.569 . . . . 0.37 110.93 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.14 105.29 17.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 1.11 109.308 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -101.93 123.37 45.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 1.14 110.869 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 42.6 p90 -128.44 158.06 72.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.485 -0.325 . . . . 0.57 111.248 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.8 Cg_exo -78.77 161.16 89.64 Favored 'Cis proline' 0 C--O 1.233 0.267 0 C-N-CA 124.058 -1.226 . . . . 0.48 112.204 -2.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.7 97.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.142 -0.481 . . . . 1.31 111.105 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 33.5 t70 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.494 -0.765 . . . . 3.08 109.563 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.3 -0.72 . . . . 2.96 111.3 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 13' ' ' TYR . 3.9 m -80.13 105.32 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.216 0.531 . . . . 1.13 110.58 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.5 m -87.61 137.29 32.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.739 -0.664 . . . . 1.12 112.055 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 p -140.07 155.72 46.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.702 -0.481 . . . . 1.01 109.702 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 0.85 111.268 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.9 m -110.92 87.67 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.807 -0.812 . . . . 1.2 108.807 170.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.81 -97.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.361 -0.836 . . . . 1.01 111.479 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -108.51 -18.88 13.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.49 0.186 . . . . 3.65 111.109 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -90.09 119.31 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.434 -0.506 . . . . 0.72 110.731 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tt -82.26 128.29 38.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.603 . . . . 1.06 110.379 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.61 -171.53 12.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.933 -0.576 . . . . 0.36 112.294 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.728 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -121.88 132.7 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.33 109.785 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' HD2' HG21 ' A' ' 2' ' ' THR . 14.4 t80 -89.99 109.38 20.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.8 110.972 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.04 119.34 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.477 -0.783 . . . . 0.47 110.456 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 44.0 t80 -104.13 118.02 35.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.003 -0.74 . . . . 0.75 109.003 170.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.72 -21.37 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.284 -0.726 . . . . 1.07 111.284 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 t -141.12 161.9 36.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.336 -0.616 . . . . 0.57 109.336 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -121.09 20.7 11.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.184 -0.462 . . . . 3.98 110.06 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -135.95 152.83 51.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 1.6 109.789 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 83.9 m -84.79 116.37 64.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.502 -0.317 . . . . 0.91 111.022 -177.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 18.9 Cg_endo -63.94 134.79 44.82 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.684 2.256 . . . . 0.82 111.562 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 t -85.9 45.06 1.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.75 0.786 . . . . 2.07 110.037 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -97.2 -16.38 20.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.295 -0.866 . . . . 1.83 110.091 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 42' ' ' ASP . 1.2 mpt_? -121.18 -80.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 3.39 111.211 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 1.1 111.053 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.649 ' HE1' ' H ' ' A' ' 42' ' ' ASP . 49.2 m-85 -67.87 112.06 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 3.45 110.021 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HD3' ' A' ' 40' ' ' PRO . 8.9 t -100.53 -26.32 13.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 1.33 110.721 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -124.41 157.33 18.73 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.263 -0.97 . . . . 0.35 111.859 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.643 ' HB2' HD11 ' A' ' 36' ' ' ILE . 30.0 p -145.05 137.27 25.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.205 0.526 . . . . 0.96 111.716 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 74.3 m -117.46 129.41 55.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.616 -0.72 . . . . 1.01 109.448 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.3 118.08 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.736 -0.745 . . . . 0.49 111.759 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -116.79 172.92 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.435 -0.209 . . . . 1.75 110.435 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -54.46 104.58 0.11 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.96 111.542 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.2 mp 56.65 26.92 11.78 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.812 0.695 . . . . 1.75 111.432 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.36 -173.5 32.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.551 -0.833 . . . . 0.34 112.225 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.5 tt -135.38 132.03 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.147 0.499 . . . . 0.37 111.387 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.5 t -93.74 106.99 18.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.277 -0.638 . . . . 1.11 109.277 176.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 99.7 m -104.34 126.9 51.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.365 -0.38 . . . . 1.14 111.166 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 44.1 p90 -124.84 155.68 69.8 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.852 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD3' HG22 ' A' ' 27' ' ' THR . 21.1 Cg_exo -67.45 161.22 78.59 Favored 'Cis proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.958 -1.268 . . . . 0.48 112.882 -1.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.4 p -66.67 95.27 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.82 -0.627 . . . . 1.31 112.211 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.649 ' H ' ' HE1' ' A' ' 26' ' ' TYR . 22.9 t70 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.001 -0.999 . . . . 3.08 111.867 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.875 -0.49 . . . . 2.96 111.875 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -97.72 112.87 24.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.894 -0.41 . . . . 1.13 109.894 178.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -127.59 144.15 51.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.799 0.333 . . . . 1.12 111.556 -171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.64 164.15 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.85 115.97 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.918 0.39 . . . . 0.85 110.619 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.19 103.49 15.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.986 -0.746 . . . . 1.2 108.986 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 -93.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.334 -1.106 . . . . 1.01 110.334 -171.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 20.8 ptmt -133.22 5.02 3.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.033 0.444 . . . . 3.65 110.249 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 m -87.38 129.17 35.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.886 -0.597 . . . . 0.72 110.281 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tt -85.08 115.85 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.37 0.605 . . . . 1.06 110.754 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.71 173.66 16.13 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.548 -0.751 . . . . 0.36 112.042 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.27 127.0 68.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.408 0.623 . . . . 0.33 109.738 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t80 -86.2 109.34 18.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 0.8 111.005 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.495 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 91.9 m95 -89.83 117.02 28.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.516 -0.765 . . . . 0.47 110.266 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -112.52 114.19 26.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.491 -0.559 . . . . 0.75 109.491 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.5 -9.53 6.51 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.871 -0.68 . . . . 1.07 111.976 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 t -133.06 160.43 37.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.795 0.331 . . . . 0.57 110.563 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -116.71 8.61 13.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.474 -0.565 . . . . 3.98 109.474 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.8 m -134.93 132.74 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 1.6 111.302 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 86.6 m -67.79 120.62 74.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.91 110.315 174.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 43.9 Cg_exo -55.75 116.1 2.92 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.915 2.41 . . . . 0.82 111.97 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.8 t -84.84 14.92 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.457 0.646 . . . . 2.07 111.3 -174.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -97.35 -1.96 43.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.459 0.647 . . . . 1.83 109.267 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -100.0 -59.94 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 3.39 110.436 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.43 40.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.86 -0.686 . . . . 1.1 112.564 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' HE2' ' HD2' ' A' ' 21' ' ' PRO . 57.4 m-85 -69.88 146.36 51.32 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.883 -0.186 . . . . 3.45 110.74 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.406 ' OG1' ' HD3' ' A' ' 40' ' ' PRO . 46.6 p -106.98 -14.41 14.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.906 0.384 . . . . 1.33 111.061 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.39 170.74 36.46 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.884 -0.674 . . . . 0.35 111.74 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.514 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 57.4 p -145.77 150.05 35.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 0.96 111.386 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.8 m -123.45 118.29 27.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.838 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.67 111.17 3.91 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.437 -0.665 . . . . 0.49 111.437 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.1 178.22 4.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.064 -0.347 . . . . 1.75 110.064 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -52.31 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.201 0.313 . . . . 1.96 111.541 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 57.04 25.4 10.7 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.703 -0.681 . . . . 1.75 111.655 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.07 26.93 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.534 -0.841 . . . . 0.34 112.281 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 tt -136.11 122.84 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.232 0.539 . . . . 0.37 110.616 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 14.0 t -99.76 109.51 21.94 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.618 -0.512 . . . . 1.11 109.618 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.3 m -97.66 130.87 44.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.147 -0.479 . . . . 1.14 110.369 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.5 p90 -122.81 154.67 63.97 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.52 -0.309 . . . . 0.57 110.779 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 8.3 Cg_exo -72.42 174.43 48.42 Favored 'Cis proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.604 -1.415 . . . . 0.48 112.036 -1.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.8 p -67.72 95.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.748 0.785 . . . . 1.31 110.849 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.457 ' H ' ' HE1' ' A' ' 26' ' ' TYR . 1.6 m-20 . . . . . 0 C--O 1.245 0.833 0 CA-C-N 115.383 -0.826 . . . . 3.08 110.323 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.136 -0.386 . . . . 2.96 112.136 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.7 p -89.0 85.0 6.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.433 0.635 . . . . 1.13 111.462 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -101.92 136.85 41.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.783 -0.644 . . . . 1.12 109.928 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 9.3 p -145.44 149.72 35.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 1.01 111.347 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 78.2 m-85 -107.33 127.64 53.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.85 110.047 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 t -97.79 95.88 7.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.333 -0.988 . . . . 1.2 108.333 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.98 -92.95 0.56 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.75 -0.94 . . . . 1.01 110.75 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -120.18 -14.28 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.582 0.23 . . . . 3.65 110.577 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' CD1' ' A' ' 39' ' ' TYR . 1.3 m -78.3 115.19 17.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.88 0.372 . . . . 0.72 110.913 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 5.7 tp -74.71 125.44 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.902 -0.59 . . . . 1.06 110.862 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.29 -176.39 17.29 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.899 -0.667 . . . . 0.36 112.126 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 134.13 62.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.304 0.573 . . . . 0.33 109.699 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.611 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 10.4 t80 -85.38 101.76 12.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.8 110.612 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m95 -82.22 107.6 15.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.715 -0.675 . . . . 0.47 109.921 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -96.65 101.31 12.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.179 -0.464 . . . . 0.75 109.854 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.15 -41.57 1.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.728 -0.748 . . . . 1.07 112.83 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -96.44 155.0 16.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.57 110.61 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -102.36 -4.94 24.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.791 . . . . 3.98 109.713 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -126.37 133.36 51.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.6 111.145 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.0 m -70.58 121.15 82.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.824 -0.626 . . . . 0.91 110.469 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 53.0 Cg_exo -53.06 108.6 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.96 2.44 . . . . 0.82 111.934 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.1 t -74.88 -0.89 20.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.516 0.675 . . . . 2.07 111.452 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.05 -13.37 57.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.364 -0.834 . . . . 1.83 109.808 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HD2' ' OXT' ' A' ' 42' ' ' ASP . 13.3 mmt85 -89.28 -55.26 3.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.81 -0.632 . . . . 3.39 110.162 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.12 1.84 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.851 -0.69 . . . . 1.1 112.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 63.9 m-85 -63.36 132.66 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.378 . . . . 3.45 110.357 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 m -93.65 -26.62 16.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.848 -0.615 . . . . 1.33 110.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.34 170.18 27.48 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.708 -0.758 . . . . 0.35 111.848 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.667 ' HB2' HD11 ' A' ' 36' ' ' ILE . 13.9 p -139.16 133.9 32.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.44 0.638 . . . . 0.96 111.227 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 2.4 t -110.52 106.61 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.568 -0.742 . . . . 1.01 109.458 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.99 123.85 33.78 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.147 -0.549 . . . . 0.49 111.876 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.45 170.75 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.04 -0.355 . . . . 1.75 110.04 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -54.42 104.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.664 0.386 . . . . 1.96 111.758 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 56.1 28.81 13.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.791 0.682 . . . . 1.75 111.64 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -172.44 34.29 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.759 -0.734 . . . . 0.34 111.798 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.2 tt -138.8 121.45 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.422 0.63 . . . . 0.37 111.581 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 15.1 m -83.43 96.3 8.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 1.11 110.254 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 83.7 m -86.61 130.15 34.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.262 -0.426 . . . . 1.14 110.924 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 9' ' ' THR . 34.1 p90 -135.63 157.43 76.3 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.123 -0.49 . . . . 0.57 111.063 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.1 Cg_exo -76.79 151.11 93.86 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.603 -1.415 . . . . 0.48 111.577 -2.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 10' ' ' ILE . 7.5 p -66.15 96.63 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 122.021 0.915 . . . . 1.31 111.099 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' OXT' ' HD2' ' A' ' 24' ' ' ARG . 32.0 t70 . . . . . 0 C--O 1.244 0.793 0 CA-C-N 115.242 -0.89 . . . . 3.08 109.292 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 112.119 -0.392 . . . . 2.96 112.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p -109.05 55.36 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 1.13 111.361 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.1 m -134.6 140.04 45.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.385 -0.371 . . . . 1.12 110.426 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.77 175.49 9.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.764 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 70.9 m-85 -134.76 132.55 38.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.85 110.893 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.07 106.86 14.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.152 -0.685 . . . . 1.2 109.152 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.33 -97.06 0.66 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.752 -0.939 . . . . 1.01 110.752 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -130.47 3.4 4.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.924 0.392 . . . . 3.65 110.424 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.7 m -93.18 133.08 36.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.216 -0.447 . . . . 0.72 110.341 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.5 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 tt -85.48 126.0 40.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.438 0.637 . . . . 1.06 110.628 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.19 162.3 16.03 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.351 -0.84 . . . . 0.36 111.386 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 131.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.382 -0.599 . . . . 0.33 109.382 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -86.84 98.07 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.8 110.911 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 99.9 m95 -82.83 98.86 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.81 -0.632 . . . . 0.47 110.075 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -81.26 127.77 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.603 -0.517 . . . . 0.75 109.603 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.28 -68.5 0.25 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.689 -0.767 . . . . 1.07 111.886 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 t -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.57 110.518 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.637 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.3 tmtt? -97.3 -0.68 46.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.237 -1.023 . . . . 3.98 108.237 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -96.64 107.31 19.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.664 -0.698 . . . . 1.6 110.337 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.6 m -59.75 113.4 7.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.872 -0.418 . . . . 0.91 109.872 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 77.4 Cg_exo -49.89 114.28 1.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.762 2.308 . . . . 0.82 112.252 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -76.95 47.99 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.057 0.932 . . . . 2.07 109.604 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -111.75 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.304 -1.316 . . . . 1.83 108.927 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.614 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.88 -52.38 10.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.795 -1.093 . . . . 3.39 111.111 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.0 25.15 0.83 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.566 -0.826 . . . . 1.1 113.133 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -56.81 131.32 49.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.997 -0.371 . . . . 3.45 109.997 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -114.03 -37.18 4.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 1.33 111.346 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -102.94 151.46 18.02 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.422 -0.894 . . . . 0.35 111.524 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.873 ' HB2' HD11 ' A' ' 36' ' ' ILE . 19.8 p -143.46 137.33 28.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.093 0.473 . . . . 0.96 111.788 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 59.1 m -123.87 132.44 53.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.708 . . . . 1.01 109.687 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.11 134.33 34.13 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.49 112.232 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 171.66 14.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.887 0.343 . . . . 1.75 110.99 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -60.66 96.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.473 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.991 -0.549 . . . . 1.75 110.697 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.76 -176.16 35.39 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.332 -0.937 . . . . 0.34 112.073 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 29' ' ' SER . 19.2 tt -136.53 137.02 48.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.27 0.557 . . . . 0.37 110.872 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 25.3 t -93.3 99.94 12.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.661 -0.699 . . . . 1.11 109.32 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.77 119.29 36.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.966 0.412 . . . . 1.14 110.642 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 51.5 p90 -122.33 160.74 46.7 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.423 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.514 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.4 Cg_exo -79.01 156.37 91.69 Favored 'Cis proline' 0 CA--C 1.523 -0.07 0 C-N-CA 124.232 -1.153 . . . . 0.48 111.945 -3.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.92 101.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.624 -0.262 . . . . 1.31 110.615 173.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 13.2 m-20 . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.772 -0.632 . . . . 3.08 110.265 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.5 0 N-CA-C 111.934 -0.466 . . . . 2.96 111.934 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.679 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 7.9 p -90.59 77.74 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.183 0.516 . . . . 1.13 111.186 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 m -86.0 134.58 33.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.898 -0.592 . . . . 1.12 110.182 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 26.3 p -130.92 165.91 22.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.842 0.353 . . . . 1.01 110.705 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -127.86 112.69 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 0.85 110.826 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 39.1 t -91.25 99.38 12.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.956 -0.757 . . . . 1.2 108.956 174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.44 0.9 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.472 -1.051 . . . . 1.01 110.472 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.44 10.62 2.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.115 0.483 . . . . 3.65 109.995 170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.2 m -94.58 119.63 33.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.679 . . . . 0.72 109.615 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.435 HG12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 tt -74.85 129.01 37.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.444 0.64 . . . . 1.06 111.418 -175.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.17 -175.37 13.88 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.52 -0.764 . . . . 0.36 111.926 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.46 132.63 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.327 0.584 . . . . 0.33 109.46 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 15.6 t80 -88.35 112.49 22.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.668 -0.696 . . . . 0.8 111.353 -173.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -97.41 103.74 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.873 -0.603 . . . . 0.47 110.357 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -86.95 135.31 33.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.557 -0.292 . . . . 0.75 110.229 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.6 -10.81 59.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.525 -0.845 . . . . 1.07 113.334 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -123.92 150.46 44.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.003 0.43 . . . . 0.57 111.022 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.23 4.58 29.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 3.98 110.425 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -135.51 140.71 44.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 1.6 110.14 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 83.2 m -74.66 139.13 73.96 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.91 110.142 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 6.2 Cg_exo -75.37 84.46 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.431 2.088 . . . . 0.82 109.7 172.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -71.68 71.73 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.507 0.67 . . . . 2.07 111.799 -172.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' HB2' HH11 ' A' ' 24' ' ' ARG . 40.6 m-80 -130.97 20.93 4.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.038 -0.983 . . . . 1.83 108.544 172.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.499 HH11 ' HB2' ' A' ' 23' ' ' ASN . 10.8 mpt_? -129.71 -2.57 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.043 -0.98 . . . . 3.39 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.97 30.12 52.35 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.524 -0.846 . . . . 1.1 112.516 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -54.52 133.18 46.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.732 0.301 . . . . 3.45 110.755 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.9 m -103.43 -45.41 4.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.013 -0.54 . . . . 1.33 111.423 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -133.04 171.79 21.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.169 -1.015 . . . . 0.35 112.452 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' HD11 ' A' ' 36' ' ' ILE . 14.8 m -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.96 111.546 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -120.09 108.31 14.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.72 -0.673 . . . . 1.01 109.359 172.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.18 138.57 45.31 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.973 -0.632 . . . . 0.49 112.099 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.05 -178.28 5.13 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.641 -0.329 . . . . 1.75 110.48 -176.111 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -65.04 95.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 1.96 111.766 -172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 62.28 28.07 16.77 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.533 -0.758 . . . . 1.75 110.707 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.65 -176.26 28.53 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.542 -0.837 . . . . 0.34 111.922 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 29' ' ' SER . 15.0 tt -141.35 128.12 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.113 0.483 . . . . 0.37 110.626 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -87.78 101.86 14.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 1.11 109.447 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.9 m -99.06 120.59 39.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.14 110.742 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.546 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 53.3 p90 -119.87 156.56 54.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.259 -0.428 . . . . 0.57 109.981 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 31.7 Cg_exo -61.18 158.71 50.65 Favored 'Cis proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.167 -1.18 . . . . 0.48 114.033 1.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.435 ' HB ' HG12 ' A' ' 10' ' ' ILE . 6.7 p -57.79 111.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.31 -0.859 . . . . 1.31 111.036 172.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 24' ' ' ARG . 7.5 t70 . . . . . 0 C--O 1.25 1.084 0 CA-C-N 114.31 -1.314 . . . . 3.08 111.452 171.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.07 -0.412 . . . . 2.96 112.07 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 p -99.08 68.69 1.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.303 0.573 . . . . 1.13 110.579 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.2 m -133.4 139.63 46.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 1.12 111.014 -177.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 p -125.99 171.28 10.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.106 -0.702 . . . . 1.01 109.106 176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -127.55 106.6 9.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.85 110.479 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m -88.2 104.0 16.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.523 -0.917 . . . . 1.2 108.523 174.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.18 -112.46 4.37 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.978 -1.249 . . . . 1.01 109.978 -167.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -114.74 3.15 14.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.26 0.553 . . . . 3.65 109.701 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -86.26 119.29 26.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.72 110.567 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.98 124.98 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.578 -0.737 . . . . 1.06 111.027 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.48 151.03 16.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.852 -0.613 . . . . 0.36 111.976 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.55 130.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.284 0.564 . . . . 0.33 109.532 -178.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 20.0 t80 -87.95 120.6 29.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.75 -0.659 . . . . 0.8 111.426 -174.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.418 ' CH2' ' HG2' ' A' ' 21' ' ' PRO . 96.2 m95 -102.9 125.28 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.47 110.405 177.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HE1' HD23 ' A' ' 34' ' ' LEU . 71.8 t80 -116.7 119.11 34.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.689 -0.687 . . . . 0.75 109.736 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.12 12.81 13.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.513 -0.851 . . . . 1.07 112.198 -178.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -155.55 143.27 19.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.57 110.669 177.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -90.54 -12.36 37.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 3.98 110.077 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -122.45 141.96 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.209 0.528 . . . . 1.6 111.064 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.5 m -72.28 134.71 82.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.631 -0.713 . . . . 0.91 109.981 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HG2' ' CH2' ' A' ' 14' ' ' TRP . 14.7 Cg_exo -67.24 95.36 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.562 2.175 . . . . 0.82 110.294 173.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 t -79.85 66.86 5.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 2.07 111.355 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -141.26 15.04 2.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 1.83 110.76 173.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -108.53 -54.87 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 3.39 109.608 174.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.97 -5.42 0.79 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.282 -0.872 . . . . 1.1 112.049 -175.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 41' ' ' VAL . 17.7 m-85 -52.2 139.19 24.35 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.596 0.358 . . . . 3.45 111.003 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.1 m -132.23 -48.61 0.92 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.291 -0.413 . . . . 1.33 111.163 -176.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.68 159.56 25.93 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.822 -0.704 . . . . 0.35 112.01 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 m -142.38 154.04 44.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.004 0.431 . . . . 0.96 111.282 -177.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.3 120.9 20.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.73 . . . . 1.01 109.138 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.96 124.79 37.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.49 111.333 177.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -127.49 177.86 6.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.994 0.397 . . . . 1.75 110.547 -173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -53.23 101.74 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 123.56 0.537 . . . . 1.96 112.177 -176.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD23 ' HE1' ' A' ' 15' ' ' PHE . 13.7 tp 56.76 29.51 16.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.249 -0.887 . . . . 1.75 110.986 176.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -169.05 -163.75 23.6 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.129 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -136.02 128.56 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.144 0.497 . . . . 0.37 110.702 -177.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 4.9 t -99.2 116.25 30.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.769 -0.826 . . . . 1.11 108.769 178.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.56 133.45 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.538 -0.301 . . . . 1.14 110.996 -171.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 54.9 p90 -133.5 162.79 55.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.59 -0.277 . . . . 0.57 110.549 -177.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.3 Cg_exo -81.68 150.55 75.48 Favored 'Cis proline' 0 C--N 1.342 0.232 0 C-N-CA 124.47 -1.054 . . . . 0.48 112.306 -3.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HA ' ' HE1' ' A' ' 26' ' ' TYR . 87.4 t -63.13 97.69 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.193 0.52 . . . . 1.31 111.077 177.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.253 1.256 0 CA-C-N 115.331 -0.849 . . . . 3.08 109.531 177.837 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.607 -0.597 . . . . 2.96 111.607 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.3 p -84.83 81.67 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.251 0.548 . . . . 1.13 111.521 -178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 m -99.21 129.64 45.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 1.12 110.302 177.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.4 p -132.08 153.6 50.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.877 0.37 . . . . 1.01 111.337 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 39.7 m-85 -120.61 129.78 53.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.85 110.515 175.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.9 t -123.3 115.81 22.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.585 -0.524 . . . . 1.2 109.585 174.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.85 -91.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.271 -0.732 . . . . 1.01 111.271 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -133.71 -2.31 3.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.975 0.417 . . . . 3.65 110.094 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -100.44 134.97 42.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.72 111.46 -171.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.565 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -93.64 130.18 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 1.06 110.218 177.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.29 -171.32 12.14 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.035 -0.602 . . . . 0.36 112.196 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.25 130.44 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.369 0.604 . . . . 0.33 109.42 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 6.8 t80 -87.6 109.8 19.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.609 -0.723 . . . . 0.8 111.145 -176.547 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -87.79 102.51 14.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.73 -0.668 . . . . 0.47 110.379 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -83.07 105.91 14.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.75 109.727 174.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.49 -61.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.638 -0.792 . . . . 1.07 112.046 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t -86.77 161.03 18.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.003 0.43 . . . . 0.57 110.655 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.1 tmtp? -116.78 11.56 14.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.9 -0.778 . . . . 3.98 108.9 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -139.34 141.06 37.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.694 -0.685 . . . . 1.6 110.278 178.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 90.5 m -77.27 117.98 68.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.477 -0.329 . . . . 0.91 111.079 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.11 85.24 0.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.073 1.848 . . . . 0.82 109.896 172.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -82.15 52.42 2.0 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.746 0.784 . . . . 2.07 110.681 -172.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.54 24.19 8.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.99 -1.004 . . . . 1.83 108.773 172.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 83.1 mtt85 -132.74 -76.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.895 -1.048 . . . . 3.39 110.22 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.55 27.59 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.554 -0.831 . . . . 1.1 113.162 176.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -71.43 135.83 47.39 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 122.6 -0.353 . . . . 3.45 110.886 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -104.67 -38.32 6.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.987 0.423 . . . . 1.33 111.071 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 176.26 24.7 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.219 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.564 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 43.7 p -139.44 171.57 14.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.925 0.393 . . . . 0.96 111.251 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 5.5 t -149.75 131.28 14.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.01 109.06 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.21 129.04 34.3 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.599 -0.81 . . . . 0.49 111.855 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.98 168.99 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.858 0.329 . . . . 1.75 110.474 -176.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -53.98 102.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.106 -0.497 . . . . 1.96 111.393 -178.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.92 26.39 14.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.506 0.504 . . . . 1.75 111.621 177.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.29 -170.13 30.8 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.254 -0.974 . . . . 0.34 112.499 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.7 tt -132.62 132.69 59.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.37 111.014 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 52.4 t -92.73 111.56 23.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.824 -0.626 . . . . 1.11 109.4 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.3 m -103.07 120.62 41.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.766 0.317 . . . . 1.14 111.442 -175.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 24.0 p90 -124.92 155.55 70.26 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.343 -0.39 . . . . 0.57 110.905 -177.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.9 Cg_exo -66.75 163.12 72.27 Favored 'Cis proline' 0 N--CA 1.474 0.342 0 C-N-CA 123.697 -1.376 . . . . 0.48 111.947 -2.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.3 96.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.702 0.763 . . . . 1.31 110.203 176.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 28.0 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.346 -0.843 . . . . 3.08 110.611 -175.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.994 -0.443 . . . . 2.96 111.994 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.819 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 19.3 p -82.07 93.41 7.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.328 0.585 . . . . 1.13 110.619 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -141.16 139.27 33.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.614 -0.721 . . . . 1.12 110.877 -174.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.9 p -122.72 172.05 8.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.26 93.27 3.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.66 -0.496 . . . . 0.85 109.66 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.64 101.47 5.75 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.27 -104.48 1.51 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.799 -1.32 . . . . 1.01 109.799 -168.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -122.36 6.5 9.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.802 0.334 . . . . 3.65 110.205 171.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.37 121.15 31.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.72 110.836 -178.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tt -71.75 121.45 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.695 -0.684 . . . . 1.06 110.738 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.77 154.33 16.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.526 -0.761 . . . . 0.36 111.474 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.45 132.04 56.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.212 0.53 . . . . 0.33 109.691 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.819 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 18.1 t80 -85.12 112.1 20.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.8 111.602 -173.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -95.97 131.51 42.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.47 110.095 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -112.35 138.12 49.53 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.649 -0.5 . . . . 0.75 109.649 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.18 -50.38 0.9 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.668 -0.777 . . . . 1.07 111.903 -178.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -87.17 149.8 24.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.929 0.395 . . . . 0.57 110.428 176.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.3 8.8 16.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 3.98 109.459 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -130.23 141.13 50.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.309 -0.859 . . . . 1.6 110.177 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -72.38 114.74 32.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.089 -0.337 . . . . 0.91 110.089 177.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.31 135.95 52.88 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.521 2.148 . . . . 0.82 112.416 -176.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 56.03 2.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.567 -0.742 . . . . 2.07 110.213 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -119.2 -16.62 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.718 -0.674 . . . . 1.83 111.131 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -124.97 -26.8 3.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 3.39 110.99 175.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 31.29 7.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.418 -0.896 . . . . 1.1 112.202 -177.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -51.17 125.87 15.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.813 0.339 . . . . 3.45 110.458 177.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -106.89 -4.04 19.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.122 0.486 . . . . 1.33 111.183 -169.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -148.46 158.21 27.59 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.704 -0.76 . . . . 0.35 111.678 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 36' ' ' ILE . 50.3 p -137.44 138.43 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.17 0.51 . . . . 0.96 111.766 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 94.0 m -120.84 114.02 20.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.174 172.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.01 141.55 47.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.174 -0.466 . . . . 0.49 113.086 -177.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.81 175.72 9.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.952 -0.388 . . . . 1.75 109.952 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -56.72 98.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.575 0.547 . . . . 1.96 111.724 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt 60.39 18.37 8.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.026 -0.534 . . . . 1.75 111.198 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.63 -174.37 17.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.992 -0.623 . . . . 0.34 111.893 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.8 tt -143.86 126.57 11.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.279 0.561 . . . . 0.37 110.662 -178.166 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 6.5 t -97.08 106.27 18.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.983 -0.747 . . . . 1.11 108.983 178.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.52 136.08 38.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.087 0.47 . . . . 1.14 111.349 -173.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.3 p90 -129.08 159.9 66.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.57 110.286 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 86.6 Cg_endo -90.66 156.74 28.58 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.421 -1.491 . . . . 0.48 112.349 -2.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.6 74.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.065 -0.717 . . . . 1.31 109.065 173.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.483 -0.77 . . . . 3.08 110.214 -177.908 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.926 -0.47 . . . . 2.96 111.926 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 13' ' ' TYR . 1.9 m -69.36 99.39 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.436 0.636 . . . . 1.13 109.999 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 10' ' ' ILE . 61.5 m -91.82 128.62 37.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 1.12 112.151 -168.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.83 148.72 34.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.588 -0.523 . . . . 1.01 109.588 172.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.2 125.04 52.91 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.184 -0.206 . . . . 0.85 110.623 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.2 m -89.63 95.42 10.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.386 -0.968 . . . . 1.2 108.386 171.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -83.48 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.053 -0.594 . . . . 1.01 111.795 -177.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -141.76 19.76 2.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 3.65 110.104 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -116.35 131.26 56.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.72 110.586 178.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 3' ' ' THR . 4.6 tp -82.5 115.26 24.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.533 0.683 . . . . 1.06 111.751 -175.111 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.62 173.62 17.03 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.384 -0.826 . . . . 0.36 112.234 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.87 130.33 63.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.493 -0.558 . . . . 0.33 109.493 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 2' ' ' THR . 14.9 t80 -84.07 108.99 17.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.775 . . . . 0.8 111.378 -174.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 98.7 m95 -93.24 102.08 14.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.569 -0.741 . . . . 0.47 110.389 177.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -89.38 121.26 31.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.24 -0.437 . . . . 0.75 110.006 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.56 -29.94 5.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.489 -0.862 . . . . 1.07 112.916 178.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 3.7 t -107.41 149.79 27.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.154 0.502 . . . . 0.57 110.732 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 18' ' ' LYS . 36.5 mtmt -100.88 1.62 40.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.359 -0.837 . . . . 3.98 110.091 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -139.85 152.56 46.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.882 -0.599 . . . . 1.6 110.407 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 85.3 m -83.66 119.86 74.36 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.91 110.666 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.22 96.85 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.88 1.72 . . . . 0.82 109.589 170.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 t -82.17 63.05 6.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.555 0.693 . . . . 2.07 110.631 -172.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -107.67 -1.46 21.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 1.83 110.078 177.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HD2' ' OH ' ' A' ' 26' ' ' TYR . 91.3 mtt180 -125.98 21.25 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 3.39 110.611 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.75 38.08 89.34 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.031 -0.604 . . . . 1.1 113.311 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.488 ' OH ' ' HD2' ' A' ' 24' ' ' ARG . 20.9 m-85 -68.35 120.21 14.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.032 0.416 . . . . 3.45 110.014 177.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 m -94.76 -33.81 12.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.851 -0.613 . . . . 1.33 111.345 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.73 174.07 25.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.218 -0.991 . . . . 0.35 112.311 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.8 p -158.24 159.03 35.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.961 0.41 . . . . 0.96 111.185 -178.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 29.8 p -134.45 142.44 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.247 -0.649 . . . . 1.01 109.247 174.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.36 132.57 27.77 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.059 -0.591 . . . . 0.49 112.122 -177.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.27 16.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.816 0.341 . . . . 1.75 110.697 -175.313 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -56.9 106.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.624 . . . . 1.96 111.233 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 58.88 21.86 9.59 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.754 0.659 . . . . 1.75 111.898 177.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -173.08 32.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.436 -0.888 . . . . 0.34 112.134 -177.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.5 134.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.807 0.337 . . . . 0.37 110.65 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 44.1 t -98.86 108.88 21.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.495 -0.558 . . . . 1.11 109.495 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.9 m -104.97 127.3 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.385 -0.37 . . . . 1.14 111.081 -174.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.7 p90 -120.29 159.69 46.62 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.287 -0.415 . . . . 0.57 111.061 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 95.1 Cg_endo -92.04 160.49 25.79 Favored 'Cis proline' 0 C--N 1.344 0.303 0 C-N-CA 124.005 -1.248 . . . . 0.48 113.006 -0.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.29 96.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.31 110.422 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.659 -0.686 . . . . 3.08 110.121 175.419 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.723 -0.551 . . . . 2.96 111.723 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -84.08 85.19 7.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 1.13 111.084 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -76.71 148.69 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.068 0.461 . . . . 1.12 110.075 178.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 11.2 t -150.22 115.4 5.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.914 0.388 . . . . 1.01 110.618 -175.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 35.7 m-85 -97.33 109.19 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.479 -0.328 . . . . 0.85 111.041 -178.001 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.2 m -86.81 98.2 11.05 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.545 -0.909 . . . . 1.2 108.545 171.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.81 -111.77 4.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.395 -0.821 . . . . 1.01 111.499 -172.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -89.83 -22.86 21.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.518 0.199 . . . . 3.65 111.287 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -91.82 118.61 30.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.18 0.514 . . . . 0.72 111.639 -168.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 5.4 tt -78.32 123.56 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 1.06 110.859 177.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.23 -169.44 12.56 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 111.06 -0.816 . . . . 0.36 111.06 176.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 132.91 68.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.178 0.513 . . . . 0.33 110.02 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 6.7 t80 -88.82 106.17 18.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.554 -0.748 . . . . 0.8 111.068 -176.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 89.8 m95 -87.15 95.91 10.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.47 110.329 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.45 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.1 t80 -78.79 109.82 13.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.422 -0.584 . . . . 0.75 109.422 175.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.39 -61.45 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.88 -0.676 . . . . 1.07 112.143 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -86.79 160.19 18.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.88 0.372 . . . . 0.57 110.578 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.39 11.5 14.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 3.98 109.589 178.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.3 t -129.47 145.93 51.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 1.6 110.3 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 70.9 m -82.87 124.76 76.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.91 110.105 178.013 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 33.5 Cg_exo -57.36 113.47 1.51 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.638 2.225 . . . . 0.82 111.104 176.098 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -77.01 43.42 0.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 2.07 111.947 -172.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -128.44 16.75 6.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.928 0.394 . . . . 1.83 110.789 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -123.09 -42.25 2.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.84 0.352 . . . . 3.39 111.102 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.28 32.11 3.57 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.752 -0.737 . . . . 1.1 112.044 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 20' ' ' CYS . 63.9 m-85 -56.25 131.42 47.89 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.879 0.371 . . . . 3.45 110.557 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -85.2 -40.66 16.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.087 -0.506 . . . . 1.33 110.943 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.23 165.31 26.35 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.672 -0.775 . . . . 0.35 111.651 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 36' ' ' ILE . 69.0 p -140.66 134.47 30.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.96 110.989 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 57.0 m -106.07 110.93 23.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.567 -0.742 . . . . 1.01 109.496 178.543 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.6 113.47 3.89 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.171 -0.772 . . . . 0.49 111.171 176.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -112.84 164.47 13.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.041 -0.355 . . . . 1.75 110.041 -172.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -56.9 104.9 0.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.082 -0.508 . . . . 1.96 110.675 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt 65.03 28.62 12.42 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.683 0.614 . . . . 1.75 111.307 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.79 -168.72 35.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.496 -0.859 . . . . 0.34 112.268 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.4 tt -138.13 132.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.37 111.071 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.751 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 48.6 t -94.77 100.58 12.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.674 -0.694 . . . . 1.11 109.751 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.03 121.05 39.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.464 -0.334 . . . . 1.14 110.933 -176.11 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -128.1 153.52 78.56 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.57 110.927 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.83 154.05 46.45 Favored 'Cis proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.286 -1.547 . . . . 0.48 112.498 -1.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 41' ' ' VAL . 6.5 p -85.2 98.2 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.048 -0.524 . . . . 1.31 110.165 177.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.161 -0.927 . . . . 3.08 110.733 178.577 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.268 0.556 . . . . 1.1299999999999999 111.385 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.7 m -103.27 126.86 50.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.1200000000000001 109.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.13 127.3 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.334 0.588 . . . . 1.01 110.9 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -91.38 119.46 31.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.491 . . . . 0.84999999999999998 110.812 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -94.8 104.24 16.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.112 -0.699 . . . . 1.2 109.112 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.12 -96.47 0.61 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.511 -0.852 . . . . 1.01 111.075 -173.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -128.84 0.33 5.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 3.6499999999999999 110.638 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -92.35 130.68 37.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.352 -0.386 . . . . 0.71999999999999997 110.608 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -79.53 114.31 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 1.0600000000000001 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.41 165.91 12.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.656 -0.702 . . . . 0.35999999999999999 111.862 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.56 134.19 54.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.278 0.561 . . . . 0.33000000000000002 109.866 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -87.29 106.13 17.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.472 -0.786 . . . . 0.80000000000000004 111.168 -175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -88.47 108.39 19.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.814 -0.63 . . . . 0.46999999999999997 110.618 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -96.88 114.29 25.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.75 109.815 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.86 -16.58 6.13 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.271 -0.966 . . . . 1.0700000000000001 113.08 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.4 t -135.55 156.66 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 110.87 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.42 0.63 23.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 3.98 109.878 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 m -116.76 118.99 34.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 1.6000000000000001 111.144 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 71.7 m -61.29 120.51 55.71 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 47.6 Cg_exo -53.43 108.24 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.652 2.235 . . . . 0.81999999999999995 111.116 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -79.18 36.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.916 -0.584 . . . . 2.0699999999999998 111.896 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -123.89 13.68 9.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.386 0.612 . . . . 1.8300000000000001 109.47 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -108.75 -74.37 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.481 -0.781 . . . . 3.3900000000000001 110.831 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.1 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.356 -0.838 . . . . 1.1000000000000001 111.63 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.58 149.58 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 3.4500000000000002 110.566 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 m -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.091 -0.504 . . . . 1.3300000000000001 110.549 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.67 160.72 22.81 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.442 -0.885 . . . . 0.34999999999999998 112.072 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.551 ' HB2' HD11 ' A' ' 36' ' ' ILE . 33.0 p -142.1 136.34 30.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.101 0.476 . . . . 0.95999999999999996 111.746 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 61.2 m -107.16 128.16 54.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.624 -0.716 . . . . 1.01 109.986 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 105.87 1.69 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.692 -0.766 . . . . 0.48999999999999999 111.334 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -105.74 173.14 6.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.173 -0.306 . . . . 1.75 110.173 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -54.35 102.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.445 -0.343 . . . . 1.96 111.615 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp 58.33 28.41 16.68 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.019 0.824 . . . . 1.75 111.143 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.27 -173.4 33.81 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.039 -0.601 . . . . 0.34000000000000002 111.687 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 29' ' ' SER . 16.0 tt -136.25 128.51 45.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.282 0.563 . . . . 0.37 111.416 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 22.1 m -92.05 102.8 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 110.378 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.3 m -97.92 125.37 42.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.477 -0.329 . . . . 1.1399999999999999 110.532 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.441 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 45.0 p90 -128.46 156.41 77.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.56999999999999995 111.111 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -80.16 162.56 83.66 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.669 -1.388 . . . . 0.47999999999999998 112.377 -2.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 C--O 1.234 0.241 0 CA-C-N 116.238 -0.437 . . . . 1.3100000000000001 110.385 175.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.607 0.718 . . . . 1.1299999999999999 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m -146.43 136.39 23.44 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.439 -0.801 . . . . 1.1200000000000001 109.398 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 p -129.26 161.61 29.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.024 0.44 . . . . 1.01 110.716 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -111.67 93.43 4.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.84999999999999998 109.598 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.72 107.82 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.89 -100.87 0.73 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.446 -0.662 . . . . 1.01 111.446 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.88 23.18 5.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 110.16 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -124.2 127.79 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.71999999999999997 110.778 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tt -83.97 124.24 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.537 0.684 . . . . 1.0600000000000001 110.683 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -130.67 161.2 23.33 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.464 -0.789 . . . . 0.35999999999999999 111.864 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.31 132.02 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.33000000000000002 109.739 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 10.3 t80 -86.92 106.58 17.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 0.80000000000000004 111.104 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -84.49 107.74 16.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 110.121 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -90.35 119.35 30.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.486 -0.561 . . . . 0.75 109.486 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.01 -60.63 0.46 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 1.0700000000000001 111.862 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -91.89 134.24 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.106 0.479 . . . . 0.56999999999999995 110.288 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -108.65 23.63 14.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.642 0.734 . . . . 3.98 109.455 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.8 p -124.11 130.18 52.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.875 -1.057 . . . . 1.6000000000000001 109.916 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 73.9 m -78.7 125.3 84.52 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.576 -0.284 . . . . 0.91000000000000003 111.054 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.3 Cg_exo -66.09 110.5 1.76 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.878 2.386 . . . . 0.81999999999999995 111.272 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -79.6 66.08 4.96 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.315 0.579 . . . . 2.0699999999999998 110.981 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -157.66 23.74 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 1.8300000000000001 110.357 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.2 mmp_? -130.21 -49.82 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 3.3900000000000001 111.538 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.01 10.01 1.4 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.981 -0.628 . . . . 1.1000000000000001 111.971 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.591 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 23.5 m-85 -69.62 120.83 15.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.919 -0.4 . . . . 3.4500000000000002 109.919 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -115.68 -24.19 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.099 0.476 . . . . 1.3300000000000001 110.889 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 158.48 22.55 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.942 -0.863 . . . . 0.34999999999999998 110.942 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.806 ' HB3' HD11 ' A' ' 36' ' ' ILE . 13.3 m -132.03 139.4 48.56 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.313 0.556 . . . . 0.95999999999999996 111.738 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -115.77 95.3 5.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.447 -0.946 . . . . 1.01 108.447 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.67 131.17 39.69 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.407 -0.425 . . . . 0.48999999999999999 112.317 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -132.42 169.11 17.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.961 0.41 . . . . 1.75 111.066 -173.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -59.67 111.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 1.96 111.118 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.2 mt 64.88 24.44 12.74 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.748 0.655 . . . . 1.75 111.57 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.8 -159.76 23.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.704 -1.236 . . . . 0.34000000000000002 112.936 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 29' ' ' SER . 17.0 tt -144.45 125.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.37 110.85 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 t -92.43 94.66 9.22 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.744 -0.836 . . . . 1.1100000000000001 108.744 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 1.5 t -93.48 136.53 33.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.161 -0.472 . . . . 1.1399999999999999 110.405 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 36.1 p90 -134.03 161.14 65.52 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.56999999999999995 111.232 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 2.3 Cg_endo -82.32 154.94 77.39 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.613 -1.411 . . . . 0.47999999999999998 111.555 -3.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 122.211 1.005 . . . . 1.3100000000000001 109.437 175.194 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.28 0.562 . . . . 1.1299999999999999 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 10' ' ' ILE . 53.0 m -106.15 127.77 53.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.1200000000000001 111.368 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 7.2 p -145.82 136.08 23.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.972 0.415 . . . . 1.01 110.9 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.42 136.42 38.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.84999999999999998 111.66 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.8 m -119.14 105.05 11.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.316 -0.856 . . . . 1.2 108.737 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.95 -115.36 7.16 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.806 -0.917 . . . . 1.01 110.806 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -102.0 -12.89 17.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.654 -0.499 . . . . 3.6499999999999999 109.654 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 39' ' ' TYR . 7.3 m -83.21 119.65 24.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.523 -0.762 . . . . 0.71999999999999997 111.241 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 3' ' ' THR . 4.1 tp -73.98 121.86 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0600000000000001 110.286 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.05 159.07 15.15 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.667 -0.697 . . . . 0.35999999999999999 112.011 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.1 130.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.478 0.656 . . . . 0.33000000000000002 109.741 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.406 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 12.0 t80 -84.36 97.67 9.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.207 -0.906 . . . . 0.80000000000000004 110.88 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -79.9 88.98 5.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.694 -0.684 . . . . 0.46999999999999997 110.181 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -84.17 104.13 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.186 -0.672 . . . . 0.75 109.186 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.86 -48.33 0.64 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.953 -0.642 . . . . 1.0700000000000001 111.707 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -107.57 165.73 11.2 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.907 -0.405 . . . . 0.56999999999999995 109.907 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -122.22 11.05 10.06 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.975 -0.75 . . . . 3.98 108.975 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -127.44 125.29 40.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.431 -0.804 . . . . 1.6000000000000001 110.55 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.5 m -67.9 123.58 87.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.109 -0.33 . . . . 0.91000000000000003 110.109 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 108.05 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.589 2.192 . . . . 0.81999999999999995 111.275 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.4 m -79.75 58.62 2.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.03 0.443 . . . . 2.0699999999999998 111.888 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -149.23 22.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 1.8300000000000001 111.153 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -133.46 -49.17 0.84 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.862 0.363 . . . . 3.3900000000000001 111.323 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.99 22.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.738 -0.744 . . . . 1.1000000000000001 112.718 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -70.23 111.8 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.841 -0.429 . . . . 3.4500000000000002 109.841 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 m -93.33 -28.52 16.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.0 -0.546 . . . . 1.3300000000000001 110.94 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.22 167.48 24.68 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.55 -0.833 . . . . 0.34999999999999998 112.33 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 44.5 p -144.41 144.47 31.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.143 0.496 . . . . 0.95999999999999996 110.908 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 76.0 m -121.32 129.18 52.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 1.01 109.719 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.39 115.26 6.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.896 -0.882 . . . . 0.48999999999999999 110.896 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -117.78 167.74 11.1 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.724 -0.473 . . . . 1.75 109.724 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -54.39 101.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.93 -0.577 . . . . 1.96 111.408 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.3 mt 63.77 22.29 13.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.522 -0.763 . . . . 1.75 111.905 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.89 -178.98 35.35 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.573 -0.822 . . . . 0.34000000000000002 112.123 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.9 126.58 62.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.214 0.531 . . . . 0.37 111.128 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 57.2 m -90.25 107.61 19.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.559 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.1 125.77 46.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.939 -0.393 . . . . 1.1399999999999999 109.939 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 9' ' ' THR . 45.1 p90 -128.62 155.37 79.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.528 -0.306 . . . . 0.56999999999999995 110.82 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.38 161.66 92.09 Favored 'Cis proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.996 -1.252 . . . . 0.47999999999999998 112.568 -1.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 10' ' ' ILE . 97.9 t . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.023 0.439 . . . . 1.3100000000000001 111.262 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.04 0.448 . . . . 1.1299999999999999 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 m -76.37 117.9 18.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.764 -0.458 . . . . 1.1200000000000001 109.764 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 34.1 t -121.77 109.09 14.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.137 0.494 . . . . 1.01 111.754 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 55.4 m-85 -85.77 109.7 18.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.84999999999999998 110.2 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.51 101.86 13.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.2 108.09 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.51 -118.12 8.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.613 -0.803 . . . . 1.01 111.102 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -107.04 10.33 30.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.857 0.361 . . . . 3.6499999999999999 110.997 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 39' ' ' TYR . 11.9 m -108.82 117.23 33.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.362 -0.535 . . . . 0.71999999999999997 110.476 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.4 tt -81.27 123.28 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.679 . . . . 1.0600000000000001 110.851 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -131.39 -172.83 13.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.723 -0.671 . . . . 0.35999999999999999 111.706 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.2 131.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.399 0.618 . . . . 0.33000000000000002 109.843 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HE1' ' HA3' ' A' ' 35' ' ' GLY . 11.2 t80 -86.4 106.75 17.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.296 -0.865 . . . . 0.80000000000000004 110.833 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.432 ' HB2' HG23 ' A' ' 36' ' ' ILE . 98.8 m95 -88.17 112.8 23.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.46999999999999997 110.049 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.407 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 91.7 t80 -89.91 135.98 33.32 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.964 -0.384 . . . . 0.75 109.964 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.5 -53.51 0.77 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 1.0700000000000001 112.654 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -83.36 154.11 24.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.56999999999999995 110.422 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.5 mptt -109.63 -2.88 17.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 3.98 109.257 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -130.24 159.0 38.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.524 -0.762 . . . . 1.6000000000000001 110.012 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.5 m -88.07 121.83 70.33 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.536 -0.302 . . . . 0.91000000000000003 110.941 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -63.11 105.75 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.078 1.852 . . . . 0.81999999999999995 110.459 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.5 m -79.08 68.72 5.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.987 -0.551 . . . . 2.0699999999999998 111.128 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.56 13.46 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 1.8300000000000001 111.341 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -128.64 -82.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 3.3900000000000001 110.958 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.67 27.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.621 -0.718 . . . . 1.1000000000000001 111.924 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 18.3 m-85 -70.48 153.2 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.145 -0.317 . . . . 3.4500000000000002 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.1 m -129.66 -55.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.012 -0.275 . . . . 1.3300000000000001 111.504 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.68 17.4 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.799 . . . . 0.34999999999999998 111.716 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 p -138.18 140.14 39.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.281 0.562 . . . . 0.95999999999999996 111.655 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 61.1 m -116.92 136.95 52.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.631 -0.713 . . . . 1.01 109.473 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.44 127.15 28.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.684 -0.77 . . . . 0.48999999999999999 111.506 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -129.29 171.37 12.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.804 -0.443 . . . . 1.75 109.804 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -54.48 103.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.455 0.472 . . . . 1.96 111.49 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 56.92 25.35 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.391 -0.822 . . . . 1.75 111.857 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . -161.53 177.15 37.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.075 -1.059 . . . . 0.34000000000000002 112.604 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 14' ' ' TRP . 11.8 tt -118.37 124.2 72.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.579 0.704 . . . . 0.37 110.94 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 49.8 t -88.43 95.51 10.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.414 -0.812 . . . . 1.1100000000000001 109.694 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 3.1 t -101.11 124.49 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.907 0.384 . . . . 1.1399999999999999 111.056 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.696 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 28.3 p90 -126.46 162.04 48.93 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.56999999999999995 110.571 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -82.66 167.0 68.05 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 124.481 -1.05 . . . . 0.47999999999999998 112.835 -1.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 93.8 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 1.3100000000000001 110.832 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.084 0.469 . . . . 1.1299999999999999 110.69 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.1 m -75.76 124.99 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.484 -0.78 . . . . 1.1200000000000001 111.516 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 50.4 t -138.55 154.53 48.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.697 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -133.42 129.0 36.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.84999999999999998 111.563 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -112.33 102.53 10.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.607 -0.724 . . . . 1.2 109.202 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.8 -86.79 0.45 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -138.1 -0.51 2.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 3.6499999999999999 109.937 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -85.7 124.97 32.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.71999999999999997 110.381 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG13 ' CG1' ' A' ' 41' ' ' VAL . 3.6 tp -79.75 121.84 33.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.491 0.662 . . . . 1.0600000000000001 110.827 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.1 -176.01 14.26 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.49 -0.777 . . . . 0.35999999999999999 111.708 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.5 134.04 61.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.479 0.657 . . . . 0.33000000000000002 110.238 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 16.4 t80 -89.6 102.51 15.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.364 -0.835 . . . . 0.80000000000000004 111.176 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -83.2 98.23 9.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.025 -0.534 . . . . 0.46999999999999997 110.777 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.61 102.35 14.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.896 0.379 . . . . 0.75 110.184 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.84 -51.22 0.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.782 -0.723 . . . . 1.0700000000000001 111.708 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 t -90.44 158.1 17.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.899 0.381 . . . . 0.56999999999999995 110.337 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.6 mptt -116.52 17.99 15.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.646 . . . . 3.98 109.502 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -147.17 146.94 30.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.114 -0.493 . . . . 1.6000000000000001 110.553 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 71.0 m -80.11 124.33 82.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.148 -0.478 . . . . 0.91000000000000003 110.685 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 24.3 Cg_exo -62.12 130.13 29.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.87 2.38 . . . . 0.81999999999999995 112.012 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 m -83.74 55.3 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.299 -0.41 . . . . 2.0699999999999998 111.548 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -141.8 0.53 1.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.741 0.305 . . . . 1.8300000000000001 111.476 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -44.78 3.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.983 0.42 . . . . 3.3900000000000001 111.627 -174.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 38.46 1.68 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.464 -0.654 . . . . 1.1000000000000001 111.464 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -71.09 138.39 49.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.622 0.248 . . . . 3.4500000000000002 110.69 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.516 HG22 ' HD3' ' A' ' 40' ' ' PRO . 14.5 t -106.78 -12.87 15.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.442 -0.344 . . . . 1.3300000000000001 110.713 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.67 170.47 38.23 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.745 -1.217 . . . . 0.34999999999999998 113.027 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 9.3 p -143.05 144.78 32.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.936 0.398 . . . . 0.95999999999999996 111.013 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 63.1 m -125.28 134.61 52.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.026 -0.534 . . . . 1.01 110.173 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 121.76 7.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.638 -0.792 . . . . 0.48999999999999999 112.119 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.12 171.94 9.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.455 0.169 . . . . 1.75 110.722 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -56.2 104.32 0.14 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 1.96 111.714 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.95 27.09 14.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.307 -0.86 . . . . 1.75 112.028 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.56 170.68 35.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.374 -0.917 . . . . 0.34000000000000002 112.761 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 tt -116.55 130.81 70.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.37 110.339 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.7 t -96.23 102.23 13.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.05 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.05 122.19 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.816 0.341 . . . . 1.1399999999999999 110.681 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -122.18 151.19 58.39 Favored Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 110.321 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 27' ' ' THR . 73.1 Cg_endo -86.16 160.41 56.81 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.063 -1.641 . . . . 0.47999999999999998 112.045 0.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' CG1' HG13 ' A' ' 10' ' ' ILE . 5.6 p . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.734 0.778 . . . . 1.3100000000000001 110.723 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.069 0.461 . . . . 1.1299999999999999 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.1 m -74.38 121.91 22.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.5 . . . . 1.1200000000000001 110.742 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 t -121.82 157.27 31.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.657 -0.701 . . . . 1.01 110.068 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -132.05 124.5 29.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.936 0.398 . . . . 0.84999999999999998 111.344 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -100.53 92.56 5.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.69 -95.31 0.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.97 -0.852 . . . . 1.01 110.97 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -121.71 -2.03 9.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.829 0.347 . . . . 3.6499999999999999 110.33 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.466 HG21 ' CD1' ' A' ' 39' ' ' TYR . 6.0 m -87.46 129.34 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.71999999999999997 110.717 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 tt -86.36 113.45 24.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.885 0.85 . . . . 1.0600000000000001 111.669 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.0 -174.22 14.58 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.029 -0.987 . . . . 0.35999999999999999 111.528 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.93 134.48 66.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.43 0.633 . . . . 0.33000000000000002 110.204 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -83.77 104.4 13.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.262 -0.881 . . . . 0.80000000000000004 111.174 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 90.0 m95 -89.16 98.36 11.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.46999999999999997 110.822 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.939 -0.573 . . . . 0.75 109.949 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.89 14.79 6.51 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.358 -0.925 . . . . 1.0700000000000001 113.387 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -151.42 146.12 25.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.56999999999999995 110.664 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -97.51 -8.67 28.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.378 -0.828 . . . . 3.98 109.603 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 p -118.75 139.43 51.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.679 . . . . 1.6000000000000001 111.404 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 72.8 m -75.9 129.06 82.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 109.75 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 31.3 Cg_exo -58.11 97.59 0.09 OUTLIER 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.555 2.17 . . . . 0.81999999999999995 110.782 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -79.61 51.92 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.524 0.678 . . . . 2.0699999999999998 111.316 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.87 0.39 1.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.934 -1.03 . . . . 1.8300000000000001 109.785 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -103.99 -46.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 3.3900000000000001 110.906 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.07 14.95 0.94 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.747 -0.739 . . . . 1.1000000000000001 112.683 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -70.7 137.92 50.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 3.4500000000000002 110.385 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 m -115.23 -32.78 5.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.92 0.39 . . . . 1.3300000000000001 110.659 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.48 176.97 18.61 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.858 -0.687 . . . . 0.34999999999999998 111.796 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.4 p -162.66 148.89 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.116 0.484 . . . . 0.95999999999999996 111.598 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 58.3 m -125.53 151.13 46.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.506 -0.77 . . . . 1.01 109.426 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.46 125.89 7.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.48999999999999999 111.659 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.98 162.97 24.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.75 110.469 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 106.61 0.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 1.96 111.545 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 63.53 20.48 12.26 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.929 0.768 . . . . 1.75 112.087 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.92 175.73 39.26 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.28 -0.962 . . . . 0.34000000000000002 112.85 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.58 133.69 68.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.199 0.523 . . . . 0.37 110.285 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' SER . 52.2 t -95.02 95.69 8.76 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.813 -0.44 . . . . 1.1100000000000001 109.813 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.41 128.29 40.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.397 -0.365 . . . . 1.1399999999999999 110.752 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 41.0 p90 -129.54 159.74 67.94 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.512 -0.313 . . . . 0.56999999999999995 110.759 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 83.7 Cg_endo -91.41 162.6 28.71 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.677 -1.384 . . . . 0.47999999999999998 112.789 -1.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.235 0.332 0 CA-C-N 116.099 -0.5 . . . . 1.3100000000000001 109.78 173.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.8 p . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.548 0.69 . . . . 1.1299999999999999 110.165 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 m -76.88 109.02 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.145 -0.934 . . . . 1.1200000000000001 110.303 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.67 151.23 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.694 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -129.06 115.51 17.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.84999999999999998 111.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.7 m -99.88 95.54 6.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.85 -107.34 2.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.62 -0.8 . . . . 1.01 111.268 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -107.78 -5.03 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.042 0.448 . . . . 3.6499999999999999 110.524 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -99.95 117.38 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.71999999999999997 110.788 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tt -82.23 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.514 0.673 . . . . 1.0600000000000001 110.996 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.55 -170.28 11.85 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.201 -0.909 . . . . 0.35999999999999999 111.204 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.92 137.7 52.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.295 0.569 . . . . 0.33000000000000002 109.553 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 36.8 t80 -87.56 107.27 18.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.80000000000000004 111.475 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.531 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 82.0 m95 -90.64 100.51 13.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.129 -0.487 . . . . 0.46999999999999997 109.861 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.7 t80 -83.76 132.54 34.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.491 -0.322 . . . . 0.75 110.303 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.01 -18.69 39.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.639 -0.791 . . . . 1.0700000000000001 113.233 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -118.29 151.83 36.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.581 . . . . 0.56999999999999995 111.359 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -102.32 3.1 37.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.303 -0.862 . . . . 3.98 110.527 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -134.87 146.27 49.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.224 0.535 . . . . 1.6000000000000001 111.368 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 94.5 m -80.9 127.99 72.93 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.702 -0.681 . . . . 0.91000000000000003 111.208 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 17.1 Cg_exo -62.54 116.18 3.36 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.514 2.143 . . . . 0.81999999999999995 110.553 173.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.1 m -84.08 24.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 2.0699999999999998 112.12 -170.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.27 16.32 24.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.135 0.493 . . . . 1.8300000000000001 110.147 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -119.38 -60.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.714 -0.676 . . . . 3.3900000000000001 110.943 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.02 40.54 0.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.828 -0.624 . . . . 1.1000000000000001 111.678 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 48.3 m-85 -70.39 132.58 45.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 3.4500000000000002 111.245 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -89.16 -27.8 20.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.537 -0.756 . . . . 1.3300000000000001 110.592 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.62 171.68 34.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.37 -0.919 . . . . 0.34999999999999998 112.337 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.518 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 17.6 p -140.68 151.97 44.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.898 0.38 . . . . 0.95999999999999996 111.505 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -124.02 140.93 52.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.01 109.778 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.91 126.49 7.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.785 -0.722 . . . . 0.48999999999999999 111.783 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -129.13 169.02 15.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 1.75 109.058 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -62.55 97.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 1.96 111.924 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.4 mp 63.5 27.32 15.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.337 -0.847 . . . . 1.75 111.266 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . -154.11 165.71 31.82 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.34000000000000002 111.566 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.34 129.35 74.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.359 0.599 . . . . 0.37 110.559 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.7 t -92.53 105.86 17.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.325 -0.62 . . . . 1.1100000000000001 109.325 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.8 m -103.76 123.08 46.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.922 0.391 . . . . 1.1399999999999999 110.807 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -125.32 153.86 72.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.978 -0.556 . . . . 0.56999999999999995 110.634 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.38 158.72 73.68 Favored 'Cis proline' 0 C--O 1.235 0.331 0 C-N-CA 123.518 -1.451 . . . . 0.47999999999999998 111.852 -1.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 41' ' ' VAL . 5.8 p . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.849 0.833 . . . . 1.3100000000000001 110.612 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.09 0.471 . . . . 1.1299999999999999 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -96.14 139.82 31.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.44 -0.345 . . . . 1.1200000000000001 110.532 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.58 161.05 30.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.303 -0.408 . . . . 1.01 110.707 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.37 106.72 10.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.565 -0.289 . . . . 0.84999999999999998 110.558 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.2 m -85.04 93.28 8.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.24 -0.652 . . . . 1.2 109.24 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.27 -93.1 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.442 -0.799 . . . . 1.01 111.865 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.56 0.29 8.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.645 0.259 . . . . 3.6499999999999999 110.805 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 m -106.42 122.94 47.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.71999999999999997 110.774 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 9.6 tt -76.31 123.26 32.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.405 -0.816 . . . . 1.0600000000000001 111.256 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.02 171.77 18.6 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.35999999999999999 111.653 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.95 131.55 65.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.201 0.524 . . . . 0.33000000000000002 109.776 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 7.6 t80 -87.34 100.6 12.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.541 -0.754 . . . . 0.80000000000000004 110.66 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -79.51 88.53 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.673 -0.694 . . . . 0.46999999999999997 109.679 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 78.1 t80 -70.48 122.14 19.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.677 -0.692 . . . . 0.75 109.782 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.07 -32.58 5.06 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.698 -0.763 . . . . 1.0700000000000001 112.847 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -125.25 151.24 46.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.56999999999999995 111.194 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.2 tptm -109.76 21.76 16.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.047 0.927 . . . . 3.98 108.615 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -119.44 122.86 42.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 1.6000000000000001 110.303 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.1 m -72.6 118.96 72.38 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.848 0.356 . . . . 0.91000000000000003 110.392 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.6 75.86 4.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.745 2.297 . . . . 0.81999999999999995 109.858 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -78.34 53.12 1.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.865 -1.061 . . . . 2.0699999999999998 112.913 -168.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -88.36 1.37 54.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.219 -0.66 . . . . 1.8300000000000001 109.219 170.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -97.12 -73.44 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.073 -0.967 . . . . 3.3900000000000001 109.857 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.8 28.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.455 -0.793 . . . . 1.1000000000000001 112.194 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.02 138.66 43.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 3.4500000000000002 110.978 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -109.11 -45.98 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.209 0.528 . . . . 1.3300000000000001 111.027 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.1 -179.48 16.06 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.83 -0.908 . . . . 0.34999999999999998 110.83 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.461 ' OG ' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -157.71 164.29 37.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.655 0.728 . . . . 0.95999999999999996 111.655 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -133.17 125.12 28.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.83 . . . . 1.01 109.74 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HE3' ' A' ' 18' ' ' LYS . . . -66.88 127.15 27.63 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.818 -0.706 . . . . 0.48999999999999999 112.082 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -123.11 165.14 17.33 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.734 -0.274 . . . . 1.75 111.235 -176.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -39.23 -55.78 1.62 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.359 1.037 . . . . 1.96 113.021 -168.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 5.8 mp -134.27 45.71 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.951 -0.389 . . . . 1.75 109.951 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.6 -164.7 33.4 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.702 -1.237 . . . . 0.34000000000000002 112.7 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 18' ' ' LYS . 16.1 tt -133.89 130.08 55.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.093 0.473 . . . . 0.37 111.146 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.8 t -95.88 92.44 6.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.201 -0.454 . . . . 1.1100000000000001 109.971 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.7 124.51 33.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 1.1399999999999999 110.55 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -126.97 153.48 76.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.56999999999999995 111.036 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 2.4 Cg_endo -82.82 172.13 50.23 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.621 -1.408 . . . . 0.47999999999999998 111.3 -3.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.137 0.494 . . . . 1.3100000000000001 110.771 178.236 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 15.4 p . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.464 0.649 . . . . 1.1299999999999999 110.371 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 10' ' ' ILE . 3.6 m -104.27 123.79 48.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.416 -0.811 . . . . 1.1200000000000001 110.195 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' O ' HD12 ' A' ' 10' ' ' ILE . 8.0 p -135.65 159.96 40.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.873 0.368 . . . . 1.01 111.316 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.471 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 88.6 m-85 -119.61 143.91 47.41 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.78 -0.452 . . . . 0.84999999999999998 109.78 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.3 t -119.91 101.75 8.08 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.49 -91.54 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.778 -0.646 . . . . 1.01 111.872 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -122.49 -9.95 8.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.887 0.375 . . . . 3.6499999999999999 110.684 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -95.6 128.53 42.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.117 -0.492 . . . . 0.71999999999999997 111.067 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 3' ' ' THR . 5.1 tp -82.22 132.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.978 -0.555 . . . . 1.0600000000000001 110.003 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.46 179.78 19.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.13 -0.557 . . . . 0.35999999999999999 112.627 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.871 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.62 137.71 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.228 0.537 . . . . 0.33000000000000002 109.76 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 2.0 t80 -89.64 101.09 13.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.724 -0.671 . . . . 0.80000000000000004 111.443 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -82.85 83.28 7.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.871 -0.604 . . . . 0.46999999999999997 109.42 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -73.37 96.91 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.178 -0.465 . . . . 0.75 110.337 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.33 -61.37 0.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.725 -0.67 . . . . 1.0700000000000001 111.903 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -87.11 161.82 17.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.729 0.299 . . . . 0.56999999999999995 110.627 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -113.51 11.18 18.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.165 -0.68 . . . . 3.98 109.165 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -128.77 135.78 49.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.595 . . . . 1.6000000000000001 110.562 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 93.9 m -80.01 127.41 77.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.745 0.307 . . . . 0.91000000000000003 111.292 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 2.9 Cg_exo -74.23 78.32 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.558 2.172 . . . . 0.81999999999999995 110.194 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -78.62 63.04 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.556 0.693 . . . . 2.0699999999999998 111.141 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.43 4.71 10.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.33 -0.85 . . . . 1.8300000000000001 109.687 171.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.04 -81.77 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.29 -0.633 . . . . 3.3900000000000001 109.29 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.49 4.23 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.977 -0.63 . . . . 1.1000000000000001 113.146 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -62.06 127.31 30.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.077 0.438 . . . . 3.4500000000000002 110.273 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 p -114.74 -39.07 3.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.933 0.397 . . . . 1.3300000000000001 110.888 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.91 157.85 14.95 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.956 -0.64 . . . . 0.34999999999999998 112.188 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.2 p -124.55 149.97 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.376 . . . . 0.95999999999999996 111.103 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.9 t -133.4 114.66 13.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.119 -0.491 . . . . 1.01 109.969 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 127.16 42.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.416 -0.421 . . . . 0.48999999999999999 113.196 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -128.21 174.43 9.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.644 0.259 . . . . 1.75 110.56 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -65.52 95.41 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 1.96 111.506 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt 64.42 27.31 13.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.745 -0.661 . . . . 1.75 110.536 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.34 -175.83 29.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.822 -0.704 . . . . 0.34000000000000002 111.874 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 29' ' ' SER . 12.3 tt -136.44 130.09 46.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.233 0.539 . . . . 0.37 110.958 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 45.0 t -93.3 103.52 15.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.062 -0.718 . . . . 1.1100000000000001 109.062 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.1 m -91.76 124.43 35.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 1.1399999999999999 110.928 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 47.0 p90 -127.08 150.11 71.24 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.025 -0.534 . . . . 0.56999999999999995 111.117 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 16.5 Cg_exo -68.49 165.78 71.56 Favored 'Cis proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.56 -1.433 . . . . 0.47999999999999998 111.933 -4.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' HB ' ' A' ' 12' ' ' ILE . 7.3 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 122.32 1.057 . . . . 1.3100000000000001 110.712 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.723 0.297 . . . . 1.1299999999999999 111.43 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -69.69 115.83 9.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 1.1200000000000001 110.023 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -122.51 154.7 37.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.451 . . . . 1.01 110.651 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 54.7 m-85 -131.67 121.94 25.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.755 0.312 . . . . 0.84999999999999998 110.941 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -102.92 99.47 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.979 -0.749 . . . . 1.2 108.979 171.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.75 -97.55 0.35 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.921 -0.657 . . . . 1.01 111.767 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -106.84 -25.15 11.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.694 0.283 . . . . 3.6499999999999999 110.825 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -88.39 123.68 33.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.209 0.528 . . . . 0.71999999999999997 111.64 -170.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 tt -78.73 131.84 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.706 -0.679 . . . . 1.0600000000000001 110.615 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.68 -174.06 13.33 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.702 -0.681 . . . . 0.35999999999999999 111.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -117.16 133.19 64.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.353 0.596 . . . . 0.33000000000000002 109.928 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 15.3 t80 -84.44 100.1 11.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.80000000000000004 110.928 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -80.17 94.37 6.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.46999999999999997 110.373 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.5 t80 -79.56 109.87 14.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.523 -0.547 . . . . 0.75 109.523 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.26 -21.32 4.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.453 -0.88 . . . . 1.0700000000000001 112.884 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -135.05 151.99 51.27 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.765 -0.256 . . . . 0.56999999999999995 110.497 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -115.94 8.08 14.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.386 -0.598 . . . . 3.98 109.386 174.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 p -120.98 126.73 50.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 1.6000000000000001 109.786 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 88.9 m -74.52 136.25 74.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.91000000000000003 111.686 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 6.0 Cg_exo -79.48 100.69 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.091 2.527 . . . . 0.81999999999999995 110.126 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 t -80.97 20.4 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 2.0699999999999998 111.2 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -86.84 -8.7 57.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.471 -0.566 . . . . 1.8300000000000001 109.471 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 11.0 mmt180 -89.41 -58.15 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 3.3900000000000001 109.98 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.9 30.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.588 -0.733 . . . . 1.1000000000000001 112.149 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -72.17 152.2 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 3.4500000000000002 111.256 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -118.37 -41.09 2.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.118 -0.492 . . . . 1.3300000000000001 111.149 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.5 165.41 23.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.71 -0.757 . . . . 0.34999999999999998 111.959 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.826 ' HB2' HD11 ' A' ' 36' ' ' ILE . 34.5 p -143.09 143.72 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.093 0.473 . . . . 0.95999999999999996 111.888 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 42.8 m -122.49 125.6 46.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 1.01 109.764 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.04 132.44 45.95 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.531 -0.842 . . . . 0.48999999999999999 111.585 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.34 166.36 21.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.97 0.385 . . . . 1.75 110.884 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -59.0 100.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.96 111.197 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp 64.36 29.33 13.61 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.767 0.667 . . . . 1.75 111.207 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.57 -168.87 33.75 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.394 -0.907 . . . . 0.34000000000000002 112.306 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.0 tt -136.28 130.3 47.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.437 0.637 . . . . 0.37 111.166 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 47.5 t -89.26 96.36 10.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.751 . . . . 1.1100000000000001 108.971 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -100.27 130.9 46.44 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.66 -0.416 . . . . 1.1399999999999999 110.146 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 55.1 p90 -131.27 157.91 76.75 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.787 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.6 Cg_exo -74.0 157.2 99.5 Favored 'Cis proline' 0 C--O 1.231 0.152 0 C-N-CA 123.611 -1.412 . . . . 0.47999999999999998 111.674 -2.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.7 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.711 0.767 . . . . 1.3100000000000001 110.144 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 11.9 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.33 0.586 . . . . 1.1299999999999999 110.861 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -107.09 128.09 54.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.865 -0.607 . . . . 1.1200000000000001 110.719 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -135.17 119.07 17.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.01 111.132 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 45.6 m-85 -80.7 117.81 21.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.84999999999999998 111.182 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.1 m -91.53 87.55 6.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.102 -0.703 . . . . 1.2 109.102 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.03 -102.87 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.868 -0.605 . . . . 1.01 112.047 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -100.38 -19.98 16.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.569 0.223 . . . . 3.6499999999999999 111.327 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -97.16 118.37 33.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.898 0.38 . . . . 0.71999999999999997 110.732 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 7.4 tt -79.82 131.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 1.0600000000000001 110.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.33 173.75 19.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.736 -0.745 . . . . 0.35999999999999999 112.608 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.97 135.04 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.513 -0.551 . . . . 0.33000000000000002 109.513 -178.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.87 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 25.4 t80 -87.28 113.78 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.80000000000000004 111.701 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.403 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 88.1 m95 -92.68 102.81 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.469 -0.787 . . . . 0.46999999999999997 109.596 173.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -73.15 130.83 41.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.033 -0.358 . . . . 0.75 110.033 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.39 -82.62 0.31 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.031 -0.604 . . . . 1.0700000000000001 111.995 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.5 t -63.81 151.63 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.56999999999999995 111.67 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -112.44 12.08 19.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.883 -0.784 . . . . 3.98 108.883 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -127.93 130.09 47.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.114 -0.948 . . . . 1.6000000000000001 110.108 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.7 m -68.28 128.15 93.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.508 -0.314 . . . . 0.91000000000000003 111.022 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 52.4 Cg_exo -53.36 109.7 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.477 2.118 . . . . 0.81999999999999995 110.454 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -83.42 48.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.432 0.634 . . . . 2.0699999999999998 111.093 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -144.39 25.82 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 1.8300000000000001 110.262 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.42 -54.67 2.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.901 -0.591 . . . . 3.3900000000000001 111.016 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.81 22.28 1.05 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.507 -0.769 . . . . 1.1000000000000001 111.851 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -63.78 147.82 50.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.849 0.357 . . . . 3.4500000000000002 110.916 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -108.76 -43.35 4.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 110.832 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -133.85 175.23 20.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.798 -0.715 . . . . 0.34999999999999998 112.288 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.709 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.4 p -152.1 140.73 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.986 0.422 . . . . 0.95999999999999996 111.817 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 59.3 m -116.69 133.51 55.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.243 -0.651 . . . . 1.01 109.243 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.59 133.09 17.05 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.532 -0.842 . . . . 0.48999999999999999 111.177 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -130.21 165.22 22.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.626 -0.509 . . . . 1.75 109.626 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HB3' HD12 ' A' ' 34' ' ' LEU . 54.6 m-85 -37.53 -69.43 0.12 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.177 0.806 . . . . 1.96 113.177 -167.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 33' ' ' PHE . 7.2 mp -120.76 43.52 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.735 -0.386 . . . . 1.75 110.157 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.0 -158.08 22.77 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.146 -1.026 . . . . 0.34000000000000002 112.694 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' SER . 13.3 tt -137.37 133.92 46.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.39 0.614 . . . . 0.37 111.133 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 28.0 m -93.46 101.26 13.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.1100000000000001 110.135 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -94.1 130.35 40.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.076 -0.511 . . . . 1.1399999999999999 110.907 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.8 p90 -130.14 157.98 75.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 110.314 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.2 Cg_exo -74.85 153.03 98.95 Favored 'Cis proline' 0 C--O 1.231 0.154 0 C-N-CA 123.863 -1.307 . . . . 0.47999999999999998 111.944 -0.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.2 p . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.472 0.653 . . . . 1.3100000000000001 111.078 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.1 p . . . . . 0 C--O 1.234 0.277 0 CA-C-O 121.038 0.447 . . . . 1.1299999999999999 111.86 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m -69.7 131.28 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 110.012 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -135.3 153.26 51.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.797 0.332 . . . . 1.01 110.903 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -136.44 125.3 24.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 0.84999999999999998 110.463 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.22 86.93 2.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.201 -1.037 . . . . 1.2 108.201 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.93 -102.12 1.11 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.224 -0.898 . . . . 1.01 111.654 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.42 -11.39 17.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.468 0.175 . . . . 3.6499999999999999 110.678 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -95.91 118.03 31.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.71999999999999997 110.993 -175.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 41' ' ' VAL . 11.0 tt -79.7 130.43 36.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.312 0.577 . . . . 1.0600000000000001 111.189 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -173.45 12.9 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.543 -0.753 . . . . 0.35999999999999999 111.934 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.67 136.1 60.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.142 0.496 . . . . 0.33000000000000002 109.942 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 1.6 t80 -86.28 105.91 16.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.831 -0.622 . . . . 0.80000000000000004 110.516 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.38 104.48 13.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.46999999999999997 109.982 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 61.2 t80 -94.31 103.58 15.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.662 -0.699 . . . . 0.75 109.192 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.33 -6.7 5.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.412 -0.899 . . . . 1.0700000000000001 112.242 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -143.54 152.48 41.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.955 -0.387 . . . . 0.56999999999999995 109.955 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.82 12.54 19.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.331 0.586 . . . . 3.98 109.584 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 p -134.35 146.33 49.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 1.6000000000000001 110.055 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 77.5 m -79.58 116.59 61.85 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.91000000000000003 110.364 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.75 126.29 16.42 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.485 2.123 . . . . 0.81999999999999995 111.697 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.0 m -76.06 110.39 10.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 2.0699999999999998 110.517 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -169.95 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.8300000000000001 111.922 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -122.27 -69.38 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.795 -0.362 . . . . 3.3900000000000001 111.583 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.77 36.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.237 -0.982 . . . . 1.1000000000000001 112.959 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.08 130.58 44.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.859 0.361 . . . . 3.4500000000000002 110.178 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.2 m -101.2 -40.35 7.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.228 -0.442 . . . . 1.3300000000000001 110.78 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -124.4 169.92 16.48 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.581 -0.818 . . . . 0.34999999999999998 112.229 -177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.3 p -154.06 133.19 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.39 0.615 . . . . 0.95999999999999996 111.87 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 65.3 m -115.3 120.85 41.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.42 -0.809 . . . . 1.01 109.68 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.24 133.42 48.54 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.48999999999999999 111.842 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -129.92 164.44 24.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.864 0.332 . . . . 1.75 110.865 -176.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HB3' HD22 ' A' ' 34' ' ' LEU . 70.7 m-85 -39.37 -59.66 1.04 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.863 1.06 . . . . 1.96 113.863 -170.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 33' ' ' PHE . 3.1 mm? -123.34 28.47 7.05 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.439 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.98 -151.31 9.23 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.514 -1.327 . . . . 0.34000000000000002 113.246 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.817 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.1 tt -139.25 135.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.37 111.178 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 42.5 t -94.2 101.65 13.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.681 -0.69 . . . . 1.1100000000000001 109.576 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.5 m -95.58 129.19 42.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 1.1399999999999999 110.817 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 42.4 p90 -130.22 157.39 77.34 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.56999999999999995 110.468 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.4 Cg_exo -81.89 171.63 55.41 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 123.707 -1.372 . . . . 0.47999999999999998 111.931 -1.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 77.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 1.3100000000000001 110.962 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.097 0.475 . . . . 1.1299999999999999 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.7 m -110.25 127.83 55.19 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.611 . . . . 1.1200000000000001 109.349 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.36 139.14 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.125 0.488 . . . . 1.01 111.887 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 62.5 m-85 -103.26 111.74 24.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.073 -0.512 . . . . 0.84999999999999998 110.019 173.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.04 100.47 12.58 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.479 -0.563 . . . . 1.2 109.479 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.97 -85.29 0.38 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 1.01 112.003 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -134.23 -0.71 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.799 0.333 . . . . 3.6499999999999999 111.065 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 m -108.39 135.09 50.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.805 0.336 . . . . 0.71999999999999997 110.887 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.9 tt -93.87 128.11 45.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.601 0.715 . . . . 1.0600000000000001 111.654 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 -178.4 15.95 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.471 -0.786 . . . . 0.35999999999999999 111.826 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.816 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.52 136.78 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.439 -0.578 . . . . 0.33000000000000002 109.439 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 26.4 t80 -89.85 115.92 27.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.80000000000000004 111.648 -173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HZ2' ' HH ' ' A' ' 26' ' ' TYR . 87.1 m95 -99.12 110.68 23.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.842 -0.617 . . . . 0.46999999999999997 110.427 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -103.22 122.13 44.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.189 -0.671 . . . . 0.75 109.189 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 125.4 -32.1 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.183 -0.767 . . . . 1.0700000000000001 111.183 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 t -121.4 146.39 46.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.951 -0.389 . . . . 0.56999999999999995 109.951 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 14.2 ptmt -108.73 14.78 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.348 0.594 . . . . 3.98 109.885 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -128.91 137.07 51.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.532 -0.758 . . . . 1.6000000000000001 109.527 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.3 m -80.34 125.75 80.44 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.612 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.11 97.53 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.726 2.284 . . . . 0.81999999999999995 110.766 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -71.74 4.16 3.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.23 0.538 . . . . 2.0699999999999998 112.329 -173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -79.73 -16.59 55.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.827 -0.624 . . . . 1.8300000000000001 109.358 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 16.7 mmt180 -87.19 -11.95 48.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.51 -0.768 . . . . 3.3900000000000001 110.931 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.31 33.23 23.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.944 -0.646 . . . . 1.1000000000000001 113.202 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 35.8 m-85 -70.82 137.29 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.84 0.352 . . . . 3.4500000000000002 110.224 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.7 m -100.32 -43.1 6.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 1.3300000000000001 111.078 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.93 165.99 24.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.742 -0.742 . . . . 0.34999999999999998 112.21 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -137.05 160.74 38.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.879 0.371 . . . . 0.95999999999999996 111.26 -176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.593 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 97.8 m -141.77 145.48 34.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.026 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.59 131.33 11.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.008 -0.615 . . . . 0.48999999999999999 112.337 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 2.0 t80 -127.75 174.06 9.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.331 -0.618 . . . . 1.75 109.331 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.61 92.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.674 0.609 . . . . 1.96 111.972 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt 59.67 33.08 21.84 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.566 -0.743 . . . . 1.75 110.657 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.99 178.26 36.13 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 0.34000000000000002 111.583 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.47 135.28 64.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.379 0.609 . . . . 0.37 111.039 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.76 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.721 -0.672 . . . . 1.1100000000000001 109.367 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.3 m -105.82 121.96 45.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.612 -0.267 . . . . 1.1399999999999999 111.049 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.3 p90 -129.27 157.11 77.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.56999999999999995 110.982 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.0 Cg_exo -65.28 151.51 76.99 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 123.774 -1.344 . . . . 0.47999999999999998 112.323 -1.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.816 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.6 p . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.123 0.487 . . . . 1.3100000000000001 111.486 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.12 0.486 . . . . 1.1299999999999999 110.959 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -142.97 141.88 31.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 109.905 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.6 p -131.45 159.64 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 1.01 110.819 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.66 102.23 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.84999999999999998 110.574 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -89.28 90.49 8.36 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.755 -0.831 . . . . 1.2 108.755 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.68 -117.07 7.36 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 1.01 111.49 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -88.63 -18.38 28.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.552 0.215 . . . . 3.6499999999999999 110.534 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.46 117.23 29.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.142 0.496 . . . . 0.71999999999999997 111.18 -170.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 41' ' ' VAL . 6.7 tt -86.81 129.75 37.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.579 -0.737 . . . . 1.0600000000000001 110.028 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.77 162.48 22.9 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.021 -0.609 . . . . 0.35999999999999999 112.131 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.858 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.84 132.81 41.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.364 -0.606 . . . . 0.33000000000000002 109.364 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.1 t80 -89.04 103.45 16.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.064 -0.516 . . . . 0.80000000000000004 111.283 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 97.6 m95 -84.44 81.24 8.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.773 -0.648 . . . . 0.46999999999999997 110.337 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -75.25 118.16 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.738 -0.664 . . . . 0.75 109.895 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.01 8.14 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.443 -0.884 . . . . 1.0700000000000001 112.414 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 36' ' ' ILE . 10.2 t -132.5 153.6 50.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.62 0.248 . . . . 0.56999999999999995 110.571 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 6.88 23.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.208 0.527 . . . . 3.98 109.615 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.0 m -107.23 118.11 35.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.618 -0.719 . . . . 1.6000000000000001 110.393 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -68.48 116.63 42.08 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.91000000000000003 109.531 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 Cg_exo -56.92 120.22 7.99 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.804 2.336 . . . . 0.81999999999999995 111.41 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -84.86 49.39 1.71 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.638 0.732 . . . . 2.0699999999999998 110.732 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -128.22 13.36 6.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.586 -0.734 . . . . 1.8300000000000001 110.007 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -117.94 -55.84 2.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 3.3900000000000001 110.988 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.72 38.2 0.67 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.69 -0.686 . . . . 1.1000000000000001 111.677 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -67.49 141.95 56.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.408 . . . . 3.4500000000000002 110.869 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -112.38 -35.32 5.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.066 -0.516 . . . . 1.3300000000000001 110.63 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.97 175.27 21.21 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.586 -0.816 . . . . 0.34999999999999998 111.494 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 p -156.73 158.28 36.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.95999999999999996 111.509 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 74.3 m -123.45 114.69 20.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.104 -0.702 . . . . 1.01 109.104 174.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.88 131.52 25.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.766 -0.73 . . . . 0.48999999999999999 111.936 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 32.6 m-85 -135.71 -178.96 5.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.472 0.136 . . . . 1.75 110.933 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -57.66 102.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.632 0.605 . . . . 1.96 112.632 -172.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.0 mm? 59.83 26.27 15.44 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.562 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.93 173.42 35.82 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.508 -0.853 . . . . 0.34000000000000002 111.975 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 17' ' ' THR . 16.6 tt -132.61 124.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.445 0.64 . . . . 0.37 110.241 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 8.0 t -94.74 98.55 10.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.123 -0.695 . . . . 1.1100000000000001 109.123 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 m -93.76 140.33 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 1.1399999999999999 111.365 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 15.1 p90 -134.23 159.63 71.58 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 116.372 -0.377 . . . . 0.56999999999999995 111.165 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 33.6 Cg_exo -63.32 154.59 70.84 Favored 'Cis proline' 0 N--CA 1.479 0.643 0 C-N-CA 124.107 -1.205 . . . . 0.47999999999999998 112.494 -0.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.1 p . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.504 0.668 . . . . 1.3100000000000001 111.853 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.1 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.96 -0.385 . . . . 1.1299999999999999 109.96 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 m -102.1 142.0 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.546 -0.297 . . . . 1.1200000000000001 110.42 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.57 152.42 51.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.437 . . . . 1.01 111.086 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.0 m-85 -113.6 138.71 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.057 0.456 . . . . 0.84999999999999998 110.581 174.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.3 t -121.57 102.21 8.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.615 -0.883 . . . . 1.2 108.615 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -101.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.151 -0.78 . . . . 1.01 111.151 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -119.64 -1.88 10.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.576 0.227 . . . . 3.6499999999999999 111.094 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 39' ' ' TYR . 3.5 m -97.96 136.38 38.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.71999999999999997 111.006 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 tt -96.31 125.15 49.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.689 0.757 . . . . 1.0600000000000001 111.475 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.01 178.65 17.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.16 -0.927 . . . . 0.35999999999999999 112.131 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 135.96 49.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.659 -0.496 . . . . 0.33000000000000002 109.659 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 11.7 t80 -87.59 104.58 16.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.446 -0.797 . . . . 0.80000000000000004 111.21 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 94.6 m95 -87.36 90.11 8.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.46999999999999997 110.522 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.435 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.2 t80 -79.5 123.46 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.398 -0.593 . . . . 0.75 109.398 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.31 -24.72 8.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.415 -0.898 . . . . 1.0700000000000001 112.597 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 6.9 t -126.08 155.04 42.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.99 0.424 . . . . 0.56999999999999995 110.667 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 15.94 16.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.644 -0.707 . . . . 3.98 109.806 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -131.76 128.08 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.6000000000000001 110.7 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 99.7 m -72.38 126.35 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.258 -0.428 . . . . 0.91000000000000003 111.159 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 12.4 Cg_exo -67.4 101.39 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.763 2.309 . . . . 0.81999999999999995 110.905 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 p -79.27 26.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 2.0699999999999998 111.805 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -91.27 -11.07 39.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.331 -0.395 . . . . 1.8300000000000001 110.649 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -102.35 -74.06 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.418 -0.355 . . . . 3.3900000000000001 111.185 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.22 33.07 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.531 -0.842 . . . . 1.1000000000000001 112.392 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -71.9 125.73 27.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.384 -0.228 . . . . 3.4500000000000002 110.384 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 m -100.86 -49.44 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.085 -0.507 . . . . 1.3300000000000001 110.842 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -112.4 157.13 15.15 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.622 -0.799 . . . . 0.34999999999999998 112.061 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.543 ' HB3' HD11 ' A' ' 36' ' ' ILE . 11.6 m -139.64 136.29 34.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.858 0.361 . . . . 0.95999999999999996 110.907 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 81.8 m -129.64 132.88 46.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 1.01 109.689 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 145.78 49.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.149 -0.548 . . . . 0.48999999999999999 112.99 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -136.48 165.46 25.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.886 -0.783 . . . . 1.75 108.886 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -60.26 99.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.052 0.22 . . . . 1.96 110.725 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.0 mt 63.09 32.15 15.44 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.825 0.703 . . . . 1.75 111.102 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.22 178.21 39.64 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.89 -0.671 . . . . 0.34000000000000002 111.707 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 29' ' ' SER . 16.8 tt -128.93 131.57 68.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.294 0.569 . . . . 0.37 110.93 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.14 105.29 17.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 109.308 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -101.93 123.37 45.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 1.1399999999999999 110.869 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 42.6 p90 -128.44 158.06 72.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.485 -0.325 . . . . 0.56999999999999995 111.248 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.8 Cg_exo -78.77 161.16 89.64 Favored 'Cis proline' 0 C--O 1.233 0.267 0 C-N-CA 124.058 -1.226 . . . . 0.47999999999999998 112.204 -2.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.142 -0.481 . . . . 1.3100000000000001 111.105 176.459 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 13' ' ' TYR . 3.9 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.216 0.531 . . . . 1.1299999999999999 110.58 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.5 m -87.61 137.29 32.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.739 -0.664 . . . . 1.1200000000000001 112.055 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 p -140.07 155.72 46.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.702 -0.481 . . . . 1.01 109.702 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 0.84999999999999998 111.268 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.9 m -110.92 87.67 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.807 -0.812 . . . . 1.2 108.807 170.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.81 -97.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.361 -0.836 . . . . 1.01 111.479 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -108.51 -18.88 13.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.49 0.186 . . . . 3.6499999999999999 111.109 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -90.09 119.31 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.434 -0.506 . . . . 0.71999999999999997 110.731 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tt -82.26 128.29 38.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.603 . . . . 1.0600000000000001 110.379 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.61 -171.53 12.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.933 -0.576 . . . . 0.35999999999999999 112.294 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.728 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -121.88 132.7 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.33000000000000002 109.785 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.414 ' HD2' HG21 ' A' ' 2' ' ' THR . 14.4 t80 -89.99 109.38 20.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.80000000000000004 110.972 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.04 119.34 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.477 -0.783 . . . . 0.46999999999999997 110.456 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 44.0 t80 -104.13 118.02 35.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.003 -0.74 . . . . 0.75 109.003 170.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.72 -21.37 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.284 -0.726 . . . . 1.0700000000000001 111.284 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 t -141.12 161.9 36.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.336 -0.616 . . . . 0.56999999999999995 109.336 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -121.09 20.7 11.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.184 -0.462 . . . . 3.98 110.06 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -135.95 152.83 51.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 1.6000000000000001 109.789 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 83.9 m -84.79 116.37 64.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.502 -0.317 . . . . 0.91000000000000003 111.022 -177.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 18.9 Cg_endo -63.94 134.79 44.82 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.684 2.256 . . . . 0.81999999999999995 111.562 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 t -85.9 45.06 1.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.75 0.786 . . . . 2.0699999999999998 110.037 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -97.2 -16.38 20.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 110.091 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -121.18 -80.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 3.3900000000000001 111.211 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 1.1000000000000001 111.053 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 49.2 m-85 -67.87 112.06 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 3.4500000000000002 110.021 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HD3' ' A' ' 40' ' ' PRO . 8.9 t -100.53 -26.32 13.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 1.3300000000000001 110.721 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -124.41 157.33 18.73 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.263 -0.97 . . . . 0.34999999999999998 111.859 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.643 ' HB2' HD11 ' A' ' 36' ' ' ILE . 30.0 p -145.05 137.27 25.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.205 0.526 . . . . 0.95999999999999996 111.716 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 74.3 m -117.46 129.41 55.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.616 -0.72 . . . . 1.01 109.448 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.3 118.08 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.736 -0.745 . . . . 0.48999999999999999 111.759 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -116.79 172.92 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.435 -0.209 . . . . 1.75 110.435 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -54.46 104.58 0.11 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.96 111.542 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.2 mp 56.65 26.92 11.78 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.812 0.695 . . . . 1.75 111.432 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.36 -173.5 32.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.551 -0.833 . . . . 0.34000000000000002 112.225 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.5 tt -135.38 132.03 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.147 0.499 . . . . 0.37 111.387 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.5 t -93.74 106.99 18.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.277 -0.638 . . . . 1.1100000000000001 109.277 176.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 99.7 m -104.34 126.9 51.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.365 -0.38 . . . . 1.1399999999999999 111.166 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 44.1 p90 -124.84 155.68 69.8 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 116.048 -0.524 . . . . 0.56999999999999995 110.852 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD3' HG22 ' A' ' 27' ' ' THR . 21.1 Cg_exo -67.45 161.22 78.59 Favored 'Cis proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.958 -1.268 . . . . 0.47999999999999998 112.882 -1.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.4 p . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 115.82 -0.627 . . . . 1.3100000000000001 112.211 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.894 -0.41 . . . . 1.1299999999999999 109.894 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -127.59 144.15 51.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.799 0.333 . . . . 1.1200000000000001 111.556 -171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.64 164.15 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.85 115.97 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.918 0.39 . . . . 0.84999999999999998 110.619 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.19 103.49 15.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.986 -0.746 . . . . 1.2 108.986 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 -93.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.334 -1.106 . . . . 1.01 110.334 -171.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 20.8 ptmt -133.22 5.02 3.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.033 0.444 . . . . 3.6499999999999999 110.249 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 m -87.38 129.17 35.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.886 -0.597 . . . . 0.71999999999999997 110.281 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tt -85.08 115.85 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.37 0.605 . . . . 1.0600000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.71 173.66 16.13 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.548 -0.751 . . . . 0.35999999999999999 112.042 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.27 127.0 68.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.408 0.623 . . . . 0.33000000000000002 109.738 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t80 -86.2 109.34 18.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 0.80000000000000004 111.005 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.495 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 91.9 m95 -89.83 117.02 28.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.516 -0.765 . . . . 0.46999999999999997 110.266 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -112.52 114.19 26.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.491 -0.559 . . . . 0.75 109.491 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.5 -9.53 6.51 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.871 -0.68 . . . . 1.0700000000000001 111.976 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 t -133.06 160.43 37.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.795 0.331 . . . . 0.56999999999999995 110.563 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -116.71 8.61 13.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.474 -0.565 . . . . 3.98 109.474 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.8 m -134.93 132.74 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 1.6000000000000001 111.302 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 86.6 m -67.79 120.62 74.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.91000000000000003 110.315 174.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 43.9 Cg_exo -55.75 116.1 2.92 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.915 2.41 . . . . 0.81999999999999995 111.97 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.8 t -84.84 14.92 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.457 0.646 . . . . 2.0699999999999998 111.3 -174.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -97.35 -1.96 43.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.459 0.647 . . . . 1.8300000000000001 109.267 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -100.0 -59.94 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 3.3900000000000001 110.436 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.43 40.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.86 -0.686 . . . . 1.1000000000000001 112.564 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.47 ' HE2' ' HD2' ' A' ' 21' ' ' PRO . 57.4 m-85 -69.88 146.36 51.32 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.883 -0.186 . . . . 3.4500000000000002 110.74 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.406 ' OG1' ' HD3' ' A' ' 40' ' ' PRO . 46.6 p -106.98 -14.41 14.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.906 0.384 . . . . 1.3300000000000001 111.061 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.39 170.74 36.46 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.884 -0.674 . . . . 0.34999999999999998 111.74 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 57.4 p -145.77 150.05 35.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 0.95999999999999996 111.386 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.8 m -123.45 118.29 27.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.838 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.67 111.17 3.91 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.437 -0.665 . . . . 0.48999999999999999 111.437 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.1 178.22 4.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.064 -0.347 . . . . 1.75 110.064 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -52.31 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.201 0.313 . . . . 1.96 111.541 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 57.04 25.4 10.7 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.703 -0.681 . . . . 1.75 111.655 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.07 26.93 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.534 -0.841 . . . . 0.34000000000000002 112.281 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 tt -136.11 122.84 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.232 0.539 . . . . 0.37 110.616 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 14.0 t -99.76 109.51 21.94 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.618 -0.512 . . . . 1.1100000000000001 109.618 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.3 m -97.66 130.87 44.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.147 -0.479 . . . . 1.1399999999999999 110.369 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.5 p90 -122.81 154.67 63.97 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.52 -0.309 . . . . 0.56999999999999995 110.779 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 8.3 Cg_exo -72.42 174.43 48.42 Favored 'Cis proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.604 -1.415 . . . . 0.47999999999999998 112.036 -1.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.8 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.748 0.785 . . . . 1.3100000000000001 110.849 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.7 p . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.433 0.635 . . . . 1.1299999999999999 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -101.92 136.85 41.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.783 -0.644 . . . . 1.1200000000000001 109.928 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 9.3 p -145.44 149.72 35.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 1.01 111.347 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 78.2 m-85 -107.33 127.64 53.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.84999999999999998 110.047 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 t -97.79 95.88 7.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.333 -0.988 . . . . 1.2 108.333 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.98 -92.95 0.56 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.75 -0.94 . . . . 1.01 110.75 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -120.18 -14.28 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.582 0.23 . . . . 3.6499999999999999 110.577 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' CD1' ' A' ' 39' ' ' TYR . 1.3 m -78.3 115.19 17.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.88 0.372 . . . . 0.71999999999999997 110.913 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.517 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 5.7 tp -74.71 125.44 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.902 -0.59 . . . . 1.0600000000000001 110.862 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.29 -176.39 17.29 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.899 -0.667 . . . . 0.35999999999999999 112.126 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 134.13 62.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.304 0.573 . . . . 0.33000000000000002 109.699 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.611 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 10.4 t80 -85.38 101.76 12.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.80000000000000004 110.612 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m95 -82.22 107.6 15.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.715 -0.675 . . . . 0.46999999999999997 109.921 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -96.65 101.31 12.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.179 -0.464 . . . . 0.75 109.854 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.15 -41.57 1.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.728 -0.748 . . . . 1.0700000000000001 112.83 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -96.44 155.0 16.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.56999999999999995 110.61 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -102.36 -4.94 24.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.791 . . . . 3.98 109.713 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -126.37 133.36 51.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 111.145 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.0 m -70.58 121.15 82.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.824 -0.626 . . . . 0.91000000000000003 110.469 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 53.0 Cg_exo -53.06 108.6 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.96 2.44 . . . . 0.81999999999999995 111.934 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.1 t -74.88 -0.89 20.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.516 0.675 . . . . 2.0699999999999998 111.452 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.05 -13.37 57.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.364 -0.834 . . . . 1.8300000000000001 109.808 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -89.28 -55.26 3.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.81 -0.632 . . . . 3.3900000000000001 110.162 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.12 1.84 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.851 -0.69 . . . . 1.1000000000000001 112.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 63.9 m-85 -63.36 132.66 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.378 . . . . 3.4500000000000002 110.357 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 m -93.65 -26.62 16.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.848 -0.615 . . . . 1.3300000000000001 110.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.34 170.18 27.48 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.708 -0.758 . . . . 0.34999999999999998 111.848 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.667 ' HB2' HD11 ' A' ' 36' ' ' ILE . 13.9 p -139.16 133.9 32.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.44 0.638 . . . . 0.95999999999999996 111.227 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 2.4 t -110.52 106.61 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.568 -0.742 . . . . 1.01 109.458 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.99 123.85 33.78 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.147 -0.549 . . . . 0.48999999999999999 111.876 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.45 170.75 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.04 -0.355 . . . . 1.75 110.04 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -54.42 104.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.664 0.386 . . . . 1.96 111.758 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 56.1 28.81 13.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.791 0.682 . . . . 1.75 111.64 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -172.44 34.29 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.759 -0.734 . . . . 0.34000000000000002 111.798 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.2 tt -138.8 121.45 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.422 0.63 . . . . 0.37 111.581 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 15.1 m -83.43 96.3 8.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 1.1100000000000001 110.254 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 83.7 m -86.61 130.15 34.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.262 -0.426 . . . . 1.1399999999999999 110.924 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 9' ' ' THR . 34.1 p90 -135.63 157.43 76.3 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.123 -0.49 . . . . 0.56999999999999995 111.063 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.1 Cg_exo -76.79 151.11 93.86 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.603 -1.415 . . . . 0.47999999999999998 111.577 -2.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 10' ' ' ILE . 7.5 p . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 122.021 0.915 . . . . 1.3100000000000001 111.099 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 111.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.1 m -134.6 140.04 45.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.385 -0.371 . . . . 1.1200000000000001 110.426 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.77 175.49 9.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.764 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 70.9 m-85 -134.76 132.55 38.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.84999999999999998 110.893 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.07 106.86 14.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.152 -0.685 . . . . 1.2 109.152 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.33 -97.06 0.66 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.752 -0.939 . . . . 1.01 110.752 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -130.47 3.4 4.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.924 0.392 . . . . 3.6499999999999999 110.424 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.7 m -93.18 133.08 36.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.216 -0.447 . . . . 0.71999999999999997 110.341 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.5 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 tt -85.48 126.0 40.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.438 0.637 . . . . 1.0600000000000001 110.628 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.19 162.3 16.03 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.351 -0.84 . . . . 0.35999999999999999 111.386 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 131.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.382 -0.599 . . . . 0.33000000000000002 109.382 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -86.84 98.07 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.80000000000000004 110.911 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 99.9 m95 -82.83 98.86 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.81 -0.632 . . . . 0.46999999999999997 110.075 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -81.26 127.77 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.603 -0.517 . . . . 0.75 109.603 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.28 -68.5 0.25 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.689 -0.767 . . . . 1.0700000000000001 111.886 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 t -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.56999999999999995 110.518 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.637 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.3 tmtt? -97.3 -0.68 46.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.237 -1.023 . . . . 3.98 108.237 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -96.64 107.31 19.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.664 -0.698 . . . . 1.6000000000000001 110.337 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.6 m -59.75 113.4 7.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.872 -0.418 . . . . 0.91000000000000003 109.872 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 77.4 Cg_exo -49.89 114.28 1.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.762 2.308 . . . . 0.81999999999999995 112.252 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -76.95 47.99 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.057 0.932 . . . . 2.0699999999999998 109.604 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -111.75 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.304 -1.316 . . . . 1.8300000000000001 108.927 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -75.88 -52.38 10.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.795 -1.093 . . . . 3.3900000000000001 111.111 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.0 25.15 0.83 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.566 -0.826 . . . . 1.1000000000000001 113.133 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -56.81 131.32 49.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.997 -0.371 . . . . 3.4500000000000002 109.997 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -114.03 -37.18 4.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 111.346 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -102.94 151.46 18.02 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.422 -0.894 . . . . 0.34999999999999998 111.524 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.873 ' HB2' HD11 ' A' ' 36' ' ' ILE . 19.8 p -143.46 137.33 28.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.093 0.473 . . . . 0.95999999999999996 111.788 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 59.1 m -123.87 132.44 53.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.708 . . . . 1.01 109.687 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.11 134.33 34.13 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.48999999999999999 112.232 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 171.66 14.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.887 0.343 . . . . 1.75 110.99 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -60.66 96.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.473 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.991 -0.549 . . . . 1.75 110.697 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.76 -176.16 35.39 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.332 -0.937 . . . . 0.34000000000000002 112.073 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 29' ' ' SER . 19.2 tt -136.53 137.02 48.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.27 0.557 . . . . 0.37 110.872 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 25.3 t -93.3 99.94 12.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.661 -0.699 . . . . 1.1100000000000001 109.32 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.77 119.29 36.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.966 0.412 . . . . 1.1399999999999999 110.642 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 51.5 p90 -122.33 160.74 46.7 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.048 -0.524 . . . . 0.56999999999999995 110.423 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.514 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.4 Cg_exo -79.01 156.37 91.69 Favored 'Cis proline' 0 CA--C 1.523 -0.07 0 C-N-CA 124.232 -1.153 . . . . 0.47999999999999998 111.945 -3.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.624 -0.262 . . . . 1.3100000000000001 110.615 173.656 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.679 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.183 0.516 . . . . 1.1299999999999999 111.186 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 m -86.0 134.58 33.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.898 -0.592 . . . . 1.1200000000000001 110.182 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 26.3 p -130.92 165.91 22.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.842 0.353 . . . . 1.01 110.705 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -127.86 112.69 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 0.84999999999999998 110.826 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 39.1 t -91.25 99.38 12.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.956 -0.757 . . . . 1.2 108.956 174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.44 0.9 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.472 -1.051 . . . . 1.01 110.472 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.44 10.62 2.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 109.995 170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.2 m -94.58 119.63 33.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.679 . . . . 0.71999999999999997 109.615 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.435 HG12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 tt -74.85 129.01 37.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.444 0.64 . . . . 1.0600000000000001 111.418 -175.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.17 -175.37 13.88 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.52 -0.764 . . . . 0.35999999999999999 111.926 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.46 132.63 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.327 0.584 . . . . 0.33000000000000002 109.46 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 15.6 t80 -88.35 112.49 22.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.668 -0.696 . . . . 0.80000000000000004 111.353 -173.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -97.41 103.74 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.873 -0.603 . . . . 0.46999999999999997 110.357 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -86.95 135.31 33.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.557 -0.292 . . . . 0.75 110.229 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.6 -10.81 59.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.525 -0.845 . . . . 1.0700000000000001 113.334 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -123.92 150.46 44.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.003 0.43 . . . . 0.56999999999999995 111.022 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.23 4.58 29.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 3.98 110.425 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -135.51 140.71 44.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 1.6000000000000001 110.14 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 83.2 m -74.66 139.13 73.96 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.91000000000000003 110.142 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 6.2 Cg_exo -75.37 84.46 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.431 2.088 . . . . 0.81999999999999995 109.7 172.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -71.68 71.73 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.507 0.67 . . . . 2.0699999999999998 111.799 -172.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' HB2' HH11 ' A' ' 24' ' ' ARG . 40.6 m-80 -130.97 20.93 4.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.038 -0.983 . . . . 1.8300000000000001 108.544 172.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.499 HH11 ' HB2' ' A' ' 23' ' ' ASN . 10.8 mpt_? -129.71 -2.57 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.043 -0.98 . . . . 3.3900000000000001 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.97 30.12 52.35 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.524 -0.846 . . . . 1.1000000000000001 112.516 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -54.52 133.18 46.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.732 0.301 . . . . 3.4500000000000002 110.755 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.9 m -103.43 -45.41 4.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.013 -0.54 . . . . 1.3300000000000001 111.423 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -133.04 171.79 21.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.169 -1.015 . . . . 0.34999999999999998 112.452 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' HD11 ' A' ' 36' ' ' ILE . 14.8 m -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.95999999999999996 111.546 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -120.09 108.31 14.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.72 -0.673 . . . . 1.01 109.359 172.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.18 138.57 45.31 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.973 -0.632 . . . . 0.48999999999999999 112.099 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.05 -178.28 5.13 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.641 -0.329 . . . . 1.75 110.48 -176.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -65.04 95.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 1.96 111.766 -172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 62.28 28.07 16.77 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.533 -0.758 . . . . 1.75 110.707 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.65 -176.26 28.53 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.542 -0.837 . . . . 0.34000000000000002 111.922 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 29' ' ' SER . 15.0 tt -141.35 128.12 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.113 0.483 . . . . 0.37 110.626 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -87.78 101.86 14.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 1.1100000000000001 109.447 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.9 m -99.06 120.59 39.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.1399999999999999 110.742 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.546 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 53.3 p90 -119.87 156.56 54.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.259 -0.428 . . . . 0.56999999999999995 109.981 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 31.7 Cg_exo -61.18 158.71 50.65 Favored 'Cis proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.167 -1.18 . . . . 0.47999999999999998 114.033 1.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.435 ' HB ' HG12 ' A' ' 10' ' ' ILE . 6.7 p . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.31 -0.859 . . . . 1.3100000000000001 111.036 172.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.303 0.573 . . . . 1.1299999999999999 110.579 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.2 m -133.4 139.63 46.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 1.1200000000000001 111.014 -177.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 p -125.99 171.28 10.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.106 -0.702 . . . . 1.01 109.106 176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -127.55 106.6 9.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.84999999999999998 110.479 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m -88.2 104.0 16.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.523 -0.917 . . . . 1.2 108.523 174.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.18 -112.46 4.37 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.978 -1.249 . . . . 1.01 109.978 -167.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -114.74 3.15 14.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.26 0.553 . . . . 3.6499999999999999 109.701 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -86.26 119.29 26.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.71999999999999997 110.567 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.98 124.98 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.578 -0.737 . . . . 1.0600000000000001 111.027 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.48 151.03 16.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.852 -0.613 . . . . 0.35999999999999999 111.976 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.55 130.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.284 0.564 . . . . 0.33000000000000002 109.532 -178.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 20.0 t80 -87.95 120.6 29.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.75 -0.659 . . . . 0.80000000000000004 111.426 -174.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.418 ' CH2' ' HG2' ' A' ' 21' ' ' PRO . 96.2 m95 -102.9 125.28 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.46999999999999997 110.405 177.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HE1' HD23 ' A' ' 34' ' ' LEU . 71.8 t80 -116.7 119.11 34.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.689 -0.687 . . . . 0.75 109.736 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.12 12.81 13.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.513 -0.851 . . . . 1.0700000000000001 112.198 -178.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -155.55 143.27 19.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.56999999999999995 110.669 177.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -90.54 -12.36 37.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 3.98 110.077 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -122.45 141.96 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.209 0.528 . . . . 1.6000000000000001 111.064 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.5 m -72.28 134.71 82.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.631 -0.713 . . . . 0.91000000000000003 109.981 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HG2' ' CH2' ' A' ' 14' ' ' TRP . 14.7 Cg_exo -67.24 95.36 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.562 2.175 . . . . 0.81999999999999995 110.294 173.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 t -79.85 66.86 5.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 2.0699999999999998 111.355 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -141.26 15.04 2.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 1.8300000000000001 110.76 173.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -108.53 -54.87 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 3.3900000000000001 109.608 174.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.97 -5.42 0.79 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.282 -0.872 . . . . 1.1000000000000001 112.049 -175.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 41' ' ' VAL . 17.7 m-85 -52.2 139.19 24.35 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.596 0.358 . . . . 3.4500000000000002 111.003 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.1 m -132.23 -48.61 0.92 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.291 -0.413 . . . . 1.3300000000000001 111.163 -176.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.68 159.56 25.93 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.822 -0.704 . . . . 0.34999999999999998 112.01 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 m -142.38 154.04 44.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.004 0.431 . . . . 0.95999999999999996 111.282 -177.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.3 120.9 20.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.73 . . . . 1.01 109.138 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.96 124.79 37.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.48999999999999999 111.333 177.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -127.49 177.86 6.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.994 0.397 . . . . 1.75 110.547 -173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -53.23 101.74 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 123.56 0.537 . . . . 1.96 112.177 -176.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.446 HD23 ' HE1' ' A' ' 15' ' ' PHE . 13.7 tp 56.76 29.51 16.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.249 -0.887 . . . . 1.75 110.986 176.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -169.05 -163.75 23.6 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.689 -0.767 . . . . 0.34000000000000002 112.129 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -136.02 128.56 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.144 0.497 . . . . 0.37 110.702 -177.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 4.9 t -99.2 116.25 30.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.769 -0.826 . . . . 1.1100000000000001 108.769 178.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.56 133.45 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.538 -0.301 . . . . 1.1399999999999999 110.996 -171.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 54.9 p90 -133.5 162.79 55.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.59 -0.277 . . . . 0.56999999999999995 110.549 -177.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.3 Cg_exo -81.68 150.55 75.48 Favored 'Cis proline' 0 C--N 1.342 0.232 0 C-N-CA 124.47 -1.054 . . . . 0.47999999999999998 112.306 -3.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HA ' ' HE1' ' A' ' 26' ' ' TYR . 87.4 t . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.193 0.52 . . . . 1.3100000000000001 111.077 177.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.3 p . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.1299999999999999 111.521 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 m -99.21 129.64 45.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 1.1200000000000001 110.302 177.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.4 p -132.08 153.6 50.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.877 0.37 . . . . 1.01 111.337 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 39.7 m-85 -120.61 129.78 53.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.84999999999999998 110.515 175.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.9 t -123.3 115.81 22.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.585 -0.524 . . . . 1.2 109.585 174.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.85 -91.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.271 -0.732 . . . . 1.01 111.271 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -133.71 -2.31 3.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.975 0.417 . . . . 3.6499999999999999 110.094 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -100.44 134.97 42.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.71999999999999997 111.46 -171.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.565 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -93.64 130.18 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 1.0600000000000001 110.218 177.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.29 -171.32 12.14 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.035 -0.602 . . . . 0.35999999999999999 112.196 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.25 130.44 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.369 0.604 . . . . 0.33000000000000002 109.42 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 6.8 t80 -87.6 109.8 19.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.609 -0.723 . . . . 0.80000000000000004 111.145 -176.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -87.79 102.51 14.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.73 -0.668 . . . . 0.46999999999999997 110.379 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -83.07 105.91 14.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.75 109.727 174.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.49 -61.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.638 -0.792 . . . . 1.0700000000000001 112.046 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t -86.77 161.03 18.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.003 0.43 . . . . 0.56999999999999995 110.655 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.1 tmtp? -116.78 11.56 14.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.9 -0.778 . . . . 3.98 108.9 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -139.34 141.06 37.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.694 -0.685 . . . . 1.6000000000000001 110.278 178.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 90.5 m -77.27 117.98 68.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.477 -0.329 . . . . 0.91000000000000003 111.079 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.11 85.24 0.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.073 1.848 . . . . 0.81999999999999995 109.896 172.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -82.15 52.42 2.0 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.746 0.784 . . . . 2.0699999999999998 110.681 -172.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.54 24.19 8.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.99 -1.004 . . . . 1.8300000000000001 108.773 172.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -132.74 -76.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.895 -1.048 . . . . 3.3900000000000001 110.22 -178.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.55 27.59 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.554 -0.831 . . . . 1.1000000000000001 113.162 176.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -71.43 135.83 47.39 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 122.6 -0.353 . . . . 3.4500000000000002 110.886 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -104.67 -38.32 6.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.987 0.423 . . . . 1.3300000000000001 111.071 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 176.26 24.7 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.764 -0.731 . . . . 0.34999999999999998 112.219 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.564 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 43.7 p -139.44 171.57 14.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.925 0.393 . . . . 0.95999999999999996 111.251 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 5.5 t -149.75 131.28 14.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.01 109.06 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.21 129.04 34.3 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.599 -0.81 . . . . 0.48999999999999999 111.855 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.98 168.99 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.858 0.329 . . . . 1.75 110.474 -176.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -53.98 102.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.106 -0.497 . . . . 1.96 111.393 -178.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.92 26.39 14.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.506 0.504 . . . . 1.75 111.621 177.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.29 -170.13 30.8 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.254 -0.974 . . . . 0.34000000000000002 112.499 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.7 tt -132.62 132.69 59.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.37 111.014 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 52.4 t -92.73 111.56 23.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.4 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.3 m -103.07 120.62 41.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.766 0.317 . . . . 1.1399999999999999 111.442 -175.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 24.0 p90 -124.92 155.55 70.26 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.343 -0.39 . . . . 0.56999999999999995 110.905 -177.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.9 Cg_exo -66.75 163.12 72.27 Favored 'Cis proline' 0 N--CA 1.474 0.342 0 C-N-CA 123.697 -1.376 . . . . 0.47999999999999998 111.947 -2.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.702 0.763 . . . . 1.3100000000000001 110.203 176.173 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.819 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 19.3 p . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 121.328 0.585 . . . . 1.1299999999999999 110.619 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -141.16 139.27 33.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.614 -0.721 . . . . 1.1200000000000001 110.877 -174.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.9 p -122.72 172.05 8.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.26 93.27 3.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.66 -0.496 . . . . 0.84999999999999998 109.66 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.64 101.47 5.75 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.27 -104.48 1.51 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.799 -1.32 . . . . 1.01 109.799 -168.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -122.36 6.5 9.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.802 0.334 . . . . 3.6499999999999999 110.205 171.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.37 121.15 31.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.71999999999999997 110.836 -178.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tt -71.75 121.45 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.695 -0.684 . . . . 1.0600000000000001 110.738 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.77 154.33 16.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.526 -0.761 . . . . 0.35999999999999999 111.474 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.45 132.04 56.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.212 0.53 . . . . 0.33000000000000002 109.691 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.819 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 18.1 t80 -85.12 112.1 20.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.80000000000000004 111.602 -173.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -95.97 131.51 42.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.46999999999999997 110.095 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -112.35 138.12 49.53 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.649 -0.5 . . . . 0.75 109.649 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.18 -50.38 0.9 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.668 -0.777 . . . . 1.0700000000000001 111.903 -178.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -87.17 149.8 24.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.929 0.395 . . . . 0.56999999999999995 110.428 176.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.3 8.8 16.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 3.98 109.459 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -130.23 141.13 50.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.309 -0.859 . . . . 1.6000000000000001 110.177 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -72.38 114.74 32.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.089 -0.337 . . . . 0.91000000000000003 110.089 177.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.31 135.95 52.88 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.521 2.148 . . . . 0.81999999999999995 112.416 -176.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 56.03 2.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.567 -0.742 . . . . 2.0699999999999998 110.213 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -119.2 -16.62 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.718 -0.674 . . . . 1.8300000000000001 111.131 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -124.97 -26.8 3.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 3.3900000000000001 110.99 175.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 31.29 7.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.418 -0.896 . . . . 1.1000000000000001 112.202 -177.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -51.17 125.87 15.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.813 0.339 . . . . 3.4500000000000002 110.458 177.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -106.89 -4.04 19.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.122 0.486 . . . . 1.3300000000000001 111.183 -169.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -148.46 158.21 27.59 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.704 -0.76 . . . . 0.34999999999999998 111.678 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 36' ' ' ILE . 50.3 p -137.44 138.43 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.17 0.51 . . . . 0.95999999999999996 111.766 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 94.0 m -120.84 114.02 20.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.174 172.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.01 141.55 47.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.174 -0.466 . . . . 0.48999999999999999 113.086 -177.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.81 175.72 9.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.952 -0.388 . . . . 1.75 109.952 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -56.72 98.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.575 0.547 . . . . 1.96 111.724 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt 60.39 18.37 8.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.026 -0.534 . . . . 1.75 111.198 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.63 -174.37 17.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.992 -0.623 . . . . 0.34000000000000002 111.893 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.8 tt -143.86 126.57 11.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.279 0.561 . . . . 0.37 110.662 -178.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 6.5 t -97.08 106.27 18.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.983 -0.747 . . . . 1.1100000000000001 108.983 178.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.52 136.08 38.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.087 0.47 . . . . 1.1399999999999999 111.349 -173.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.3 p90 -129.08 159.9 66.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.56999999999999995 110.286 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 86.6 Cg_endo -90.66 156.74 28.58 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.421 -1.491 . . . . 0.47999999999999998 112.349 -2.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.065 -0.717 . . . . 1.3100000000000001 109.065 173.432 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 13' ' ' TYR . 1.9 m . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.436 0.636 . . . . 1.1299999999999999 109.999 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 10' ' ' ILE . 61.5 m -91.82 128.62 37.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 1.1200000000000001 112.151 -168.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.83 148.72 34.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.588 -0.523 . . . . 1.01 109.588 172.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.2 125.04 52.91 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.184 -0.206 . . . . 0.84999999999999998 110.623 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.2 m -89.63 95.42 10.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.386 -0.968 . . . . 1.2 108.386 171.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -83.48 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.053 -0.594 . . . . 1.01 111.795 -177.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -141.76 19.76 2.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 3.6499999999999999 110.104 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -116.35 131.26 56.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.71999999999999997 110.586 178.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 3' ' ' THR . 4.6 tp -82.5 115.26 24.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.533 0.683 . . . . 1.0600000000000001 111.751 -175.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.62 173.62 17.03 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.384 -0.826 . . . . 0.35999999999999999 112.234 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.87 130.33 63.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.493 -0.558 . . . . 0.33000000000000002 109.493 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 2' ' ' THR . 14.9 t80 -84.07 108.99 17.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.775 . . . . 0.80000000000000004 111.378 -174.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 98.7 m95 -93.24 102.08 14.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 110.389 177.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -89.38 121.26 31.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.24 -0.437 . . . . 0.75 110.006 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.56 -29.94 5.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.489 -0.862 . . . . 1.0700000000000001 112.916 178.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 3.7 t -107.41 149.79 27.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.154 0.502 . . . . 0.56999999999999995 110.732 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 36.5 mtmt -100.88 1.62 40.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.359 -0.837 . . . . 3.98 110.091 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -139.85 152.56 46.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.882 -0.599 . . . . 1.6000000000000001 110.407 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 85.3 m -83.66 119.86 74.36 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.91000000000000003 110.666 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.22 96.85 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.88 1.72 . . . . 0.81999999999999995 109.589 170.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 t -82.17 63.05 6.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.555 0.693 . . . . 2.0699999999999998 110.631 -172.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -107.67 -1.46 21.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 1.8300000000000001 110.078 177.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HD2' ' OH ' ' A' ' 26' ' ' TYR . 91.3 mtt180 -125.98 21.25 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 3.3900000000000001 110.611 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.75 38.08 89.34 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.031 -0.604 . . . . 1.1000000000000001 113.311 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.488 ' OH ' ' HD2' ' A' ' 24' ' ' ARG . 20.9 m-85 -68.35 120.21 14.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.032 0.416 . . . . 3.4500000000000002 110.014 177.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 m -94.76 -33.81 12.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.851 -0.613 . . . . 1.3300000000000001 111.345 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.73 174.07 25.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.218 -0.991 . . . . 0.34999999999999998 112.311 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.8 p -158.24 159.03 35.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.961 0.41 . . . . 0.95999999999999996 111.185 -178.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 29.8 p -134.45 142.44 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.247 -0.649 . . . . 1.01 109.247 174.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.36 132.57 27.77 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.059 -0.591 . . . . 0.48999999999999999 112.122 -177.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.27 16.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.816 0.341 . . . . 1.75 110.697 -175.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -56.9 106.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.624 . . . . 1.96 111.233 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 58.88 21.86 9.59 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.754 0.659 . . . . 1.75 111.898 177.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -173.08 32.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.436 -0.888 . . . . 0.34000000000000002 112.134 -177.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.5 134.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.807 0.337 . . . . 0.37 110.65 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 44.1 t -98.86 108.88 21.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.495 -0.558 . . . . 1.1100000000000001 109.495 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.9 m -104.97 127.3 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.385 -0.37 . . . . 1.1399999999999999 111.081 -174.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.7 p90 -120.29 159.69 46.62 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.287 -0.415 . . . . 0.56999999999999995 111.061 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 95.1 Cg_endo -92.04 160.49 25.79 Favored 'Cis proline' 0 C--N 1.344 0.303 0 C-N-CA 124.005 -1.248 . . . . 0.47999999999999998 113.006 -0.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.3100000000000001 110.422 173.856 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.066 0.46 . . . . 1.1299999999999999 111.084 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -76.71 148.69 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.068 0.461 . . . . 1.1200000000000001 110.075 178.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 11.2 t -150.22 115.4 5.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.914 0.388 . . . . 1.01 110.618 -175.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 35.7 m-85 -97.33 109.19 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.479 -0.328 . . . . 0.84999999999999998 111.041 -178.001 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.2 m -86.81 98.2 11.05 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.545 -0.909 . . . . 1.2 108.545 171.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.81 -111.77 4.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.395 -0.821 . . . . 1.01 111.499 -172.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -89.83 -22.86 21.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.518 0.199 . . . . 3.6499999999999999 111.287 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -91.82 118.61 30.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.18 0.514 . . . . 0.71999999999999997 111.639 -168.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 5.4 tt -78.32 123.56 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 1.0600000000000001 110.859 177.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.23 -169.44 12.56 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 111.06 -0.816 . . . . 0.35999999999999999 111.06 176.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 132.91 68.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.178 0.513 . . . . 0.33000000000000002 110.02 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 6.7 t80 -88.82 106.17 18.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.554 -0.748 . . . . 0.80000000000000004 111.068 -176.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 89.8 m95 -87.15 95.91 10.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.46999999999999997 110.329 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.1 t80 -78.79 109.82 13.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.422 -0.584 . . . . 0.75 109.422 175.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.39 -61.45 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.88 -0.676 . . . . 1.0700000000000001 112.143 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -86.79 160.19 18.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.88 0.372 . . . . 0.56999999999999995 110.578 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.39 11.5 14.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 3.98 109.589 178.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.3 t -129.47 145.93 51.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 1.6000000000000001 110.3 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 70.9 m -82.87 124.76 76.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.91000000000000003 110.105 178.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 33.5 Cg_exo -57.36 113.47 1.51 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.638 2.225 . . . . 0.81999999999999995 111.104 176.098 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -77.01 43.42 0.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 2.0699999999999998 111.947 -172.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -128.44 16.75 6.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.928 0.394 . . . . 1.8300000000000001 110.789 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -123.09 -42.25 2.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.84 0.352 . . . . 3.3900000000000001 111.102 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.28 32.11 3.57 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.752 -0.737 . . . . 1.1000000000000001 112.044 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 20' ' ' CYS . 63.9 m-85 -56.25 131.42 47.89 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.879 0.371 . . . . 3.4500000000000002 110.557 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -85.2 -40.66 16.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.087 -0.506 . . . . 1.3300000000000001 110.943 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.23 165.31 26.35 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.672 -0.775 . . . . 0.34999999999999998 111.651 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 36' ' ' ILE . 69.0 p -140.66 134.47 30.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.95999999999999996 110.989 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 57.0 m -106.07 110.93 23.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.567 -0.742 . . . . 1.01 109.496 178.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.6 113.47 3.89 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.171 -0.772 . . . . 0.48999999999999999 111.171 176.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -112.84 164.47 13.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.041 -0.355 . . . . 1.75 110.041 -172.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -56.9 104.9 0.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.082 -0.508 . . . . 1.96 110.675 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt 65.03 28.62 12.42 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.683 0.614 . . . . 1.75 111.307 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.79 -168.72 35.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.496 -0.859 . . . . 0.34000000000000002 112.268 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.4 tt -138.13 132.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.37 111.071 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.751 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 48.6 t -94.77 100.58 12.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.674 -0.694 . . . . 1.1100000000000001 109.751 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.03 121.05 39.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.464 -0.334 . . . . 1.1399999999999999 110.933 -176.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -128.1 153.52 78.56 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.56999999999999995 110.927 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.83 154.05 46.45 Favored 'Cis proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.286 -1.547 . . . . 0.47999999999999998 112.498 -1.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 41' ' ' VAL . 6.5 p . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.048 -0.524 . . . . 1.3100000000000001 110.165 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 111.999 -0.44 . . . . 2.96 111.999 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.4 41.55 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.268 0.556 . . . . 1.1299999999999999 111.385 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.7 m -103.27 126.86 50.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.1200000000000001 109.972 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.13 127.3 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.334 0.588 . . . . 1.01 110.9 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -91.38 119.46 31.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.491 . . . . 0.84999999999999998 110.812 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -94.8 104.24 16.14 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.112 -0.699 . . . . 1.2 109.112 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.12 -96.47 0.61 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.511 -0.852 . . . . 1.01 111.075 -173.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -128.84 0.33 5.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 3.6499999999999999 110.638 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -92.35 130.68 37.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.352 -0.386 . . . . 0.71999999999999997 110.608 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -79.53 114.31 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 1.0600000000000001 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.41 165.91 12.86 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.656 -0.702 . . . . 0.35999999999999999 111.862 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.56 134.19 54.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.278 0.561 . . . . 0.33000000000000002 109.866 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -87.29 106.13 17.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.472 -0.786 . . . . 0.80000000000000004 111.168 -175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -88.47 108.39 19.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.814 -0.63 . . . . 0.46999999999999997 110.618 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -96.88 114.29 25.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.75 109.815 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.86 -16.58 6.13 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.271 -0.966 . . . . 1.0700000000000001 113.08 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.4 t -135.55 156.66 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 110.87 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.42 0.63 23.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 3.98 109.878 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 m -116.76 118.99 34.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 1.6000000000000001 111.144 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 71.7 m -61.29 120.51 55.71 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.702 -0.481 . . . . 0.91000000000000003 109.702 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 47.6 Cg_exo -53.43 108.24 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.652 2.235 . . . . 0.81999999999999995 111.116 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -79.18 36.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.916 -0.584 . . . . 2.0699999999999998 111.896 -172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -123.89 13.68 9.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.386 0.612 . . . . 1.8300000000000001 109.47 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -108.75 -74.37 0.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.481 -0.781 . . . . 3.3900000000000001 110.831 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.1 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.356 -0.838 . . . . 1.1000000000000001 111.63 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.58 149.58 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 3.4500000000000002 110.566 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 m -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.091 -0.504 . . . . 1.3300000000000001 110.549 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.67 160.72 22.81 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.442 -0.885 . . . . 0.34999999999999998 112.072 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.551 ' HB2' HD11 ' A' ' 36' ' ' ILE . 33.0 p -142.1 136.34 30.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.101 0.476 . . . . 0.95999999999999996 111.746 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 61.2 m -107.16 128.16 54.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.624 -0.716 . . . . 1.01 109.986 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 105.87 1.69 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.692 -0.766 . . . . 0.48999999999999999 111.334 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -105.74 173.14 6.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.173 -0.306 . . . . 1.75 110.173 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -54.35 102.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.445 -0.343 . . . . 1.96 111.615 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp 58.33 28.41 16.68 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.019 0.824 . . . . 1.75 111.143 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.27 -173.4 33.81 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.039 -0.601 . . . . 0.34000000000000002 111.687 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 29' ' ' SER . 16.0 tt -136.25 128.51 45.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.282 0.563 . . . . 0.37 111.416 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 22.1 m -92.05 102.8 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 110.378 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.3 m -97.92 125.37 42.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.477 -0.329 . . . . 1.1399999999999999 110.532 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.441 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 45.0 p90 -128.46 156.41 77.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.56999999999999995 111.111 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -80.16 162.56 83.66 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.669 -1.388 . . . . 0.47999999999999998 112.377 -2.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.74 96.09 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.238 -0.437 . . . . 1.3100000000000001 110.385 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.476 -0.773 . . . . 3.0800000000000001 110.155 -179.515 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.28 -0.328 . . . . 2.96 112.28 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 p -84.42 65.3 8.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.607 0.718 . . . . 1.1299999999999999 111.07 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m -146.43 136.39 23.44 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.439 -0.801 . . . . 1.1200000000000001 109.398 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 p -129.26 161.61 29.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.024 0.44 . . . . 1.01 110.716 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -111.67 93.43 4.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.84999999999999998 109.598 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.72 107.82 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.89 -100.87 0.73 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.446 -0.662 . . . . 1.01 111.446 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.88 23.18 5.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 110.16 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -124.2 127.79 48.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.71999999999999997 110.778 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tt -83.97 124.24 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.537 0.684 . . . . 1.0600000000000001 110.683 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -130.67 161.2 23.33 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.464 -0.789 . . . . 0.35999999999999999 111.864 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.31 132.02 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.33000000000000002 109.739 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 10.3 t80 -86.92 106.58 17.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 0.80000000000000004 111.104 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -84.49 107.74 16.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 110.121 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -90.35 119.35 30.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.486 -0.561 . . . . 0.75 109.486 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.01 -60.63 0.46 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 1.0700000000000001 111.862 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -91.89 134.24 34.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.106 0.479 . . . . 0.56999999999999995 110.288 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -108.65 23.63 14.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.642 0.734 . . . . 3.98 109.455 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.8 p -124.11 130.18 52.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.875 -1.057 . . . . 1.6000000000000001 109.916 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 73.9 m -78.7 125.3 84.52 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.576 -0.284 . . . . 0.91000000000000003 111.054 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 18.3 Cg_exo -66.09 110.5 1.76 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.878 2.386 . . . . 0.81999999999999995 111.272 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -79.6 66.08 4.96 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.315 0.579 . . . . 2.0699999999999998 110.981 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -157.66 23.74 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 1.8300000000000001 110.357 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.2 mmp_? -130.21 -49.82 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 3.3900000000000001 111.538 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.01 10.01 1.4 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.981 -0.628 . . . . 1.1000000000000001 111.971 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 23.5 m-85 -69.62 120.83 15.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.919 -0.4 . . . . 3.4500000000000002 109.919 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -115.68 -24.19 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.099 0.476 . . . . 1.3300000000000001 110.889 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 158.48 22.55 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.942 -0.863 . . . . 0.34999999999999998 110.942 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.806 ' HB3' HD11 ' A' ' 36' ' ' ILE . 13.3 m -132.03 139.4 48.56 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.313 0.556 . . . . 0.95999999999999996 111.738 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.8 t -115.77 95.3 5.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.447 -0.946 . . . . 1.01 108.447 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.67 131.17 39.69 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.407 -0.425 . . . . 0.48999999999999999 112.317 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -132.42 169.11 17.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.961 0.41 . . . . 1.75 111.066 -173.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -59.67 111.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 1.96 111.118 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.2 mt 64.88 24.44 12.74 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.748 0.655 . . . . 1.75 111.57 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.8 -159.76 23.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.704 -1.236 . . . . 0.34000000000000002 112.936 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 29' ' ' SER . 17.0 tt -144.45 125.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.37 110.85 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 t -92.43 94.66 9.22 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.744 -0.836 . . . . 1.1100000000000001 108.744 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 1.5 t -93.48 136.53 33.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.161 -0.472 . . . . 1.1399999999999999 110.405 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 36.1 p90 -134.03 161.14 65.52 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.56999999999999995 111.232 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 2.3 Cg_endo -82.32 154.94 77.39 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.613 -1.411 . . . . 0.47999999999999998 111.555 -3.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.07 61.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 122.211 1.005 . . . . 1.3100000000000001 109.437 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 114.796 -1.093 . . . . 3.0800000000000001 110.672 -173.184 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 112.02 -0.432 . . . . 2.96 112.02 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.2 p -90.04 48.73 1.61 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.28 0.562 . . . . 1.1299999999999999 110.938 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 10' ' ' ILE . 53.0 m -106.15 127.77 53.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.1200000000000001 111.368 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 7.2 p -145.82 136.08 23.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.972 0.415 . . . . 1.01 110.9 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.42 136.42 38.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.84999999999999998 111.66 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.8 m -119.14 105.05 11.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.316 -0.856 . . . . 1.2 108.737 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.95 -115.36 7.16 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.806 -0.917 . . . . 1.01 110.806 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -102.0 -12.89 17.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.654 -0.499 . . . . 3.6499999999999999 109.654 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 39' ' ' TYR . 7.3 m -83.21 119.65 24.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.523 -0.762 . . . . 0.71999999999999997 111.241 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 3' ' ' THR . 4.1 tp -73.98 121.86 25.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0600000000000001 110.286 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.05 159.07 15.15 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.667 -0.697 . . . . 0.35999999999999999 112.011 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.1 130.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.478 0.656 . . . . 0.33000000000000002 109.741 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.406 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 12.0 t80 -84.36 97.67 9.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.207 -0.906 . . . . 0.80000000000000004 110.88 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -79.9 88.98 5.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.694 -0.684 . . . . 0.46999999999999997 110.181 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -84.17 104.13 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.186 -0.672 . . . . 0.75 109.186 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.86 -48.33 0.64 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.953 -0.642 . . . . 1.0700000000000001 111.707 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -107.57 165.73 11.2 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.907 -0.405 . . . . 0.56999999999999995 109.907 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -122.22 11.05 10.06 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.975 -0.75 . . . . 3.98 108.975 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -127.44 125.29 40.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.431 -0.804 . . . . 1.6000000000000001 110.55 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.5 m -67.9 123.58 87.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.109 -0.33 . . . . 0.91000000000000003 110.109 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 108.05 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.589 2.192 . . . . 0.81999999999999995 111.275 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.4 m -79.75 58.62 2.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.03 0.443 . . . . 2.0699999999999998 111.888 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -149.23 22.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 1.8300000000000001 111.153 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 62.4 mtt180 -133.46 -49.17 0.84 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.862 0.363 . . . . 3.3900000000000001 111.323 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.99 22.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.738 -0.744 . . . . 1.1000000000000001 112.718 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -70.23 111.8 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.841 -0.429 . . . . 3.4500000000000002 109.841 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 m -93.33 -28.52 16.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.0 -0.546 . . . . 1.3300000000000001 110.94 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.22 167.48 24.68 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.55 -0.833 . . . . 0.34999999999999998 112.33 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 44.5 p -144.41 144.47 31.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.143 0.496 . . . . 0.95999999999999996 110.908 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 76.0 m -121.32 129.18 52.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.006 -0.543 . . . . 1.01 109.719 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.39 115.26 6.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.896 -0.882 . . . . 0.48999999999999999 110.896 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -117.78 167.74 11.1 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.724 -0.473 . . . . 1.75 109.724 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -54.39 101.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.93 -0.577 . . . . 1.96 111.408 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.3 mt 63.77 22.29 13.01 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.522 -0.763 . . . . 1.75 111.905 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.89 -178.98 35.35 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.573 -0.822 . . . . 0.34000000000000002 112.123 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.9 126.58 62.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.214 0.531 . . . . 0.37 111.128 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 57.2 m -90.25 107.61 19.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.559 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.1 125.77 46.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.939 -0.393 . . . . 1.1399999999999999 109.939 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 9' ' ' THR . 45.1 p90 -128.62 155.37 79.09 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.528 -0.306 . . . . 0.56999999999999995 110.82 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.38 161.66 92.09 Favored 'Cis proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.996 -1.252 . . . . 0.47999999999999998 112.568 -1.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.506 ' CG2' HG13 ' A' ' 10' ' ' ILE . 97.9 t -61.05 104.21 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 121.023 0.439 . . . . 1.3100000000000001 111.262 174.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 22.6 t70 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.223 -0.894 . . . . 3.0800000000000001 109.248 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.197 -0.361 . . . . 2.96 112.197 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -93.29 23.82 4.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.04 0.448 . . . . 1.1299999999999999 111.926 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 m -76.37 117.9 18.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.764 -0.458 . . . . 1.1200000000000001 109.764 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 34.1 t -121.77 109.09 14.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.137 0.494 . . . . 1.01 111.754 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 55.4 m-85 -85.77 109.7 18.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.84999999999999998 110.2 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 t -96.51 101.86 13.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.09 -1.078 . . . . 1.2 108.09 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.51 -118.12 8.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.613 -0.803 . . . . 1.01 111.102 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -107.04 10.33 30.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.857 0.361 . . . . 3.6499999999999999 110.997 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 39' ' ' TYR . 11.9 m -108.82 117.23 33.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.362 -0.535 . . . . 0.71999999999999997 110.476 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.4 tt -81.27 123.28 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.679 . . . . 1.0600000000000001 110.851 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 39' ' ' TYR . . . -131.39 -172.83 13.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.723 -0.671 . . . . 0.35999999999999999 111.706 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.2 131.89 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.399 0.618 . . . . 0.33000000000000002 109.843 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HE1' ' HA3' ' A' ' 35' ' ' GLY . 11.2 t80 -86.4 106.75 17.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.296 -0.865 . . . . 0.80000000000000004 110.833 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' HB2' HG23 ' A' ' 36' ' ' ILE . 98.8 m95 -88.17 112.8 23.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.543 -0.753 . . . . 0.46999999999999997 110.049 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.407 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 91.7 t80 -89.91 135.98 33.32 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.964 -0.384 . . . . 0.75 109.964 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.5 -53.51 0.77 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 1.0700000000000001 112.654 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -83.36 154.11 24.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.56999999999999995 110.422 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.5 mptt -109.63 -2.88 17.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 3.98 109.257 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -130.24 159.0 38.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.524 -0.762 . . . . 1.6000000000000001 110.012 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.5 m -88.07 121.83 70.33 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.536 -0.302 . . . . 0.91000000000000003 110.941 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -63.11 105.75 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.078 1.852 . . . . 0.81999999999999995 110.459 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.5 m -79.08 68.72 5.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.987 -0.551 . . . . 2.0699999999999998 111.128 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.56 13.46 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 1.8300000000000001 111.341 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 3.5 mpt_? -128.64 -82.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 3.3900000000000001 110.958 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.67 27.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.621 -0.718 . . . . 1.1000000000000001 111.924 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 18.3 m-85 -70.48 153.2 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.145 -0.317 . . . . 3.4500000000000002 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.1 m -129.66 -55.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.012 -0.275 . . . . 1.3300000000000001 111.504 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.68 17.4 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.799 . . . . 0.34999999999999998 111.716 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 p -138.18 140.14 39.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.281 0.562 . . . . 0.95999999999999996 111.655 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 61.1 m -116.92 136.95 52.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.631 -0.713 . . . . 1.01 109.473 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.44 127.15 28.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.684 -0.77 . . . . 0.48999999999999999 111.506 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -129.29 171.37 12.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.804 -0.443 . . . . 1.75 109.804 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -54.48 103.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.455 0.472 . . . . 1.96 111.49 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 56.92 25.35 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.391 -0.822 . . . . 1.75 111.857 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . -161.53 177.15 37.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.075 -1.059 . . . . 0.34000000000000002 112.604 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 14' ' ' TRP . 11.8 tt -118.37 124.2 72.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.579 0.704 . . . . 0.37 110.94 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 49.8 t -88.43 95.51 10.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.414 -0.812 . . . . 1.1100000000000001 109.694 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 26' ' ' TYR . 3.1 t -101.11 124.49 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.907 0.384 . . . . 1.1399999999999999 111.056 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.696 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 28.3 p90 -126.46 162.04 48.93 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.56999999999999995 110.571 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 6.3 Cg_exo -82.66 167.0 68.05 Favored 'Cis proline' 0 C--N 1.343 0.243 0 C-N-CA 124.481 -1.05 . . . . 0.47999999999999998 112.835 -1.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 93.8 t -64.29 101.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 1.3100000000000001 110.832 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 25.9 t70 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.526 -0.916 . . . . 3.0800000000000001 108.526 169.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.747 -0.541 . . . . 2.96 111.747 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -69.13 115.87 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.469 . . . . 1.1299999999999999 110.69 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.1 m -75.76 124.99 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.484 -0.78 . . . . 1.1200000000000001 111.516 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 50.4 t -138.55 154.53 48.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.697 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -133.42 129.0 36.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.84999999999999998 111.563 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -112.33 102.53 10.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.607 -0.724 . . . . 1.2 109.202 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.8 -86.79 0.45 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -138.1 -0.51 2.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 3.6499999999999999 109.937 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -85.7 124.97 32.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.71999999999999997 110.381 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG13 ' CG1' ' A' ' 41' ' ' VAL . 3.6 tp -79.75 121.84 33.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.491 0.662 . . . . 1.0600000000000001 110.827 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.1 -176.01 14.26 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.49 -0.777 . . . . 0.35999999999999999 111.708 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.5 134.04 61.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.479 0.657 . . . . 0.33000000000000002 110.238 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 16.4 t80 -89.6 102.51 15.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.364 -0.835 . . . . 0.80000000000000004 111.176 -177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -83.2 98.23 9.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.025 -0.534 . . . . 0.46999999999999997 110.777 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -87.61 102.35 14.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.896 0.379 . . . . 0.75 110.184 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.84 -51.22 0.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.782 -0.723 . . . . 1.0700000000000001 111.708 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 t -90.44 158.1 17.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.899 0.381 . . . . 0.56999999999999995 110.337 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 10.6 mptt -116.52 17.99 15.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.646 . . . . 3.98 109.502 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -147.17 146.94 30.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.114 -0.493 . . . . 1.6000000000000001 110.553 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 71.0 m -80.11 124.33 82.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.148 -0.478 . . . . 0.91000000000000003 110.685 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 24.3 Cg_exo -62.12 130.13 29.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.87 2.38 . . . . 0.81999999999999995 112.012 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 m -83.74 55.3 3.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.299 -0.41 . . . . 2.0699999999999998 111.548 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -141.8 0.53 1.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.741 0.305 . . . . 1.8300000000000001 111.476 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 1.028 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.6 -44.78 3.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.983 0.42 . . . . 3.3900000000000001 111.627 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 38.46 1.68 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.464 -0.654 . . . . 1.1000000000000001 111.464 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -71.09 138.39 49.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.622 0.248 . . . . 3.4500000000000002 110.69 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.516 HG22 ' HD3' ' A' ' 40' ' ' PRO . 14.5 t -106.78 -12.87 15.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.442 -0.344 . . . . 1.3300000000000001 110.713 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.67 170.47 38.23 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.745 -1.217 . . . . 0.34999999999999998 113.027 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' CYS . 9.3 p -143.05 144.78 32.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.936 0.398 . . . . 0.95999999999999996 111.013 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 63.1 m -125.28 134.61 52.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.026 -0.534 . . . . 1.01 110.173 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 121.76 7.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.638 -0.792 . . . . 0.48999999999999999 112.119 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.12 171.94 9.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.455 0.169 . . . . 1.75 110.722 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -56.2 104.32 0.14 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 1.96 111.714 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.95 27.09 14.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.307 -0.86 . . . . 1.75 112.028 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.56 170.68 35.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.374 -0.917 . . . . 0.34000000000000002 112.761 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 tt -116.55 130.81 70.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.37 110.339 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.7 t -96.23 102.23 13.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.05 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.05 122.19 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.816 0.341 . . . . 1.1399999999999999 110.681 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -122.18 151.19 58.39 Favored Pre-proline 0 C--O 1.239 0.502 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 110.321 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 27' ' ' THR . 73.1 Cg_endo -86.16 160.41 56.81 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.063 -1.641 . . . . 0.47999999999999998 112.045 0.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' CG1' HG13 ' A' ' 10' ' ' ILE . 5.6 p -73.2 91.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.734 0.778 . . . . 1.3100000000000001 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.028 ' HB3' ' HG3' ' A' ' 24' ' ' ARG . 24.6 t70 . . . . . 0 C--O 1.246 0.87 0 CA-C-N 115.208 -0.906 . . . . 3.0800000000000001 110.442 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 111.853 -0.499 . . . . 2.96 111.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p -112.41 30.64 6.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.069 0.461 . . . . 1.1299999999999999 111.129 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.1 m -74.38 121.91 22.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.5 . . . . 1.1200000000000001 110.742 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 t -121.82 157.27 31.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.657 -0.701 . . . . 1.01 110.068 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -132.05 124.5 29.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.936 0.398 . . . . 0.84999999999999998 111.344 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -100.53 92.56 5.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.69 -95.31 0.62 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.97 -0.852 . . . . 1.01 110.97 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -121.71 -2.03 9.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.829 0.347 . . . . 3.6499999999999999 110.33 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.466 HG21 ' CD1' ' A' ' 39' ' ' TYR . 6.0 m -87.46 129.34 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.71999999999999997 110.717 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 tt -86.36 113.45 24.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.885 0.85 . . . . 1.0600000000000001 111.669 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.0 -174.22 14.58 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.029 -0.987 . . . . 0.35999999999999999 111.528 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.93 134.48 66.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.43 0.633 . . . . 0.33000000000000002 110.204 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -83.77 104.4 13.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.262 -0.881 . . . . 0.80000000000000004 111.174 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 90.0 m95 -89.16 98.36 11.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.46999999999999997 110.822 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.939 -0.573 . . . . 0.75 109.949 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.89 14.79 6.51 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.358 -0.925 . . . . 1.0700000000000001 113.387 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -151.42 146.12 25.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.56999999999999995 110.664 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -97.51 -8.67 28.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.378 -0.828 . . . . 3.98 109.603 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 p -118.75 139.43 51.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.679 . . . . 1.6000000000000001 111.404 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 72.8 m -75.9 129.06 82.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 109.75 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 31.3 Cg_exo -58.11 97.59 0.09 OUTLIER 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.555 2.17 . . . . 0.81999999999999995 110.782 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -79.61 51.92 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.524 0.678 . . . . 2.0699999999999998 111.316 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.87 0.39 1.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.934 -1.03 . . . . 1.8300000000000001 109.785 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -103.99 -46.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 3.3900000000000001 110.906 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.07 14.95 0.94 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.747 -0.739 . . . . 1.1000000000000001 112.683 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -70.7 137.92 50.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 3.4500000000000002 110.385 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 m -115.23 -32.78 5.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.92 0.39 . . . . 1.3300000000000001 110.659 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.48 176.97 18.61 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.858 -0.687 . . . . 0.34999999999999998 111.796 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.4 p -162.66 148.89 12.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.116 0.484 . . . . 0.95999999999999996 111.598 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 58.3 m -125.53 151.13 46.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.506 -0.77 . . . . 1.01 109.426 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.46 125.89 7.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.48999999999999999 111.659 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.98 162.97 24.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.75 110.469 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 106.61 0.27 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 1.96 111.545 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 63.53 20.48 12.26 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.929 0.768 . . . . 1.75 112.087 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.92 175.73 39.26 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.28 -0.962 . . . . 0.34000000000000002 112.85 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -122.58 133.69 68.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.199 0.523 . . . . 0.37 110.285 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' SER . 52.2 t -95.02 95.69 8.76 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.813 -0.44 . . . . 1.1100000000000001 109.813 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.41 128.29 40.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.397 -0.365 . . . . 1.1399999999999999 110.752 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 41.0 p90 -129.54 159.74 67.94 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.512 -0.313 . . . . 0.56999999999999995 110.759 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 83.7 Cg_endo -91.41 162.6 28.71 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.677 -1.384 . . . . 0.47999999999999998 112.789 -1.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.53 92.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.099 -0.5 . . . . 1.3100000000000001 109.78 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.306 -0.854 . . . . 3.0800000000000001 109.916 -177.89 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.982 0 N-CA-C 111.494 -0.643 . . . . 2.96 111.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.8 p -86.68 42.32 1.01 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.548 0.69 . . . . 1.1299999999999999 110.165 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 m -76.88 109.02 10.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.145 -0.934 . . . . 1.1200000000000001 110.303 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.67 151.23 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.694 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -129.06 115.51 17.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.84999999999999998 111.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.7 m -99.88 95.54 6.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.85 -107.34 2.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.62 -0.8 . . . . 1.01 111.268 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -107.78 -5.03 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.042 0.448 . . . . 3.6499999999999999 110.524 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -99.95 117.38 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.71999999999999997 110.788 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tt -82.23 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.514 0.673 . . . . 1.0600000000000001 110.996 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.55 -170.28 11.85 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.201 -0.909 . . . . 0.35999999999999999 111.204 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.92 137.7 52.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.295 0.569 . . . . 0.33000000000000002 109.553 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 36.8 t80 -87.56 107.27 18.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.80000000000000004 111.475 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.531 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 82.0 m95 -90.64 100.51 13.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.129 -0.487 . . . . 0.46999999999999997 109.861 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.7 t80 -83.76 132.54 34.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.491 -0.322 . . . . 0.75 110.303 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.01 -18.69 39.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.639 -0.791 . . . . 1.0700000000000001 113.233 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -118.29 151.83 36.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.581 . . . . 0.56999999999999995 111.359 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -102.32 3.1 37.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.303 -0.862 . . . . 3.98 110.527 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -134.87 146.27 49.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.224 0.535 . . . . 1.6000000000000001 111.368 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 94.5 m -80.9 127.99 72.93 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.702 -0.681 . . . . 0.91000000000000003 111.208 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 17.1 Cg_exo -62.54 116.18 3.36 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.514 2.143 . . . . 0.81999999999999995 110.553 173.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.1 m -84.08 24.81 0.89 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 2.0699999999999998 112.12 -170.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.27 16.32 24.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.135 0.493 . . . . 1.8300000000000001 110.147 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -119.38 -60.0 1.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.714 -0.676 . . . . 3.3900000000000001 110.943 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.02 40.54 0.55 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.828 -0.624 . . . . 1.1000000000000001 111.678 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 48.3 m-85 -70.39 132.58 45.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 3.4500000000000002 111.245 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -89.16 -27.8 20.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.537 -0.756 . . . . 1.3300000000000001 110.592 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.62 171.68 34.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.37 -0.919 . . . . 0.34999999999999998 112.337 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.518 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 17.6 p -140.68 151.97 44.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.898 0.38 . . . . 0.95999999999999996 111.505 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -124.02 140.93 52.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.01 109.778 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.91 126.49 7.45 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.785 -0.722 . . . . 0.48999999999999999 111.783 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -129.13 169.02 15.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.058 -0.719 . . . . 1.75 109.058 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -62.55 97.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 1.96 111.924 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.4 mp 63.5 27.32 15.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.337 -0.847 . . . . 1.75 111.266 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . -154.11 165.71 31.82 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.34000000000000002 111.566 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.34 129.35 74.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.359 0.599 . . . . 0.37 110.559 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.7 t -92.53 105.86 17.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.325 -0.62 . . . . 1.1100000000000001 109.325 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.8 m -103.76 123.08 46.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.922 0.391 . . . . 1.1399999999999999 110.807 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -125.32 153.86 72.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.978 -0.556 . . . . 0.56999999999999995 110.634 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.38 158.72 73.68 Favored 'Cis proline' 0 C--O 1.235 0.331 0 C-N-CA 123.518 -1.451 . . . . 0.47999999999999998 111.852 -1.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 41' ' ' VAL . 5.8 p -75.76 86.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.849 0.833 . . . . 1.3100000000000001 110.612 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.288 -0.863 . . . . 3.0800000000000001 110.503 -179.468 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.088 -0.405 . . . . 2.96 112.088 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 p -100.93 30.8 3.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.09 0.471 . . . . 1.1299999999999999 111.433 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -96.14 139.82 31.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.44 -0.345 . . . . 1.1200000000000001 110.532 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.58 161.05 30.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.303 -0.408 . . . . 1.01 110.707 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.37 106.72 10.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.565 -0.289 . . . . 0.84999999999999998 110.558 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.2 m -85.04 93.28 8.56 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.24 -0.652 . . . . 1.2 109.24 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.27 -93.1 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.442 -0.799 . . . . 1.01 111.865 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.56 0.29 8.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.645 0.259 . . . . 3.6499999999999999 110.805 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 m -106.42 122.94 47.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.71999999999999997 110.774 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 9.6 tt -76.31 123.26 32.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.405 -0.816 . . . . 1.0600000000000001 111.256 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.02 171.77 18.6 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.35999999999999999 111.653 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.95 131.55 65.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.201 0.524 . . . . 0.33000000000000002 109.776 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 7.6 t80 -87.34 100.6 12.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.541 -0.754 . . . . 0.80000000000000004 110.66 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -79.51 88.53 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.673 -0.694 . . . . 0.46999999999999997 109.679 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 78.1 t80 -70.48 122.14 19.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.677 -0.692 . . . . 0.75 109.782 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.07 -32.58 5.06 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.698 -0.763 . . . . 1.0700000000000001 112.847 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -125.25 151.24 46.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.56999999999999995 111.194 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.2 tptm -109.76 21.76 16.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.047 0.927 . . . . 3.98 108.615 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -119.44 122.86 42.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 1.6000000000000001 110.303 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.1 m -72.6 118.96 72.38 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.848 0.356 . . . . 0.91000000000000003 110.392 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.6 75.86 4.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.745 2.297 . . . . 0.81999999999999995 109.858 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -78.34 53.12 1.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.865 -1.061 . . . . 2.0699999999999998 112.913 -168.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -88.36 1.37 54.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.219 -0.66 . . . . 1.8300000000000001 109.219 170.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HB3' ' OXT' ' A' ' 42' ' ' ASP . 9.7 mpt_? -97.12 -73.44 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.073 -0.967 . . . . 3.3900000000000001 109.857 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.8 28.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.455 -0.793 . . . . 1.1000000000000001 112.194 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.02 138.66 43.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 3.4500000000000002 110.978 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -109.11 -45.98 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.209 0.528 . . . . 1.3300000000000001 111.027 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.1 -179.48 16.06 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.83 -0.908 . . . . 0.34999999999999998 110.83 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.461 ' OG ' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -157.71 164.29 37.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.655 0.728 . . . . 0.95999999999999996 111.655 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -133.17 125.12 28.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.373 -0.83 . . . . 1.01 109.74 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HE3' ' A' ' 18' ' ' LYS . . . -66.88 127.15 27.63 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.818 -0.706 . . . . 0.48999999999999999 112.082 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -123.11 165.14 17.33 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.734 -0.274 . . . . 1.75 111.235 -176.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -39.23 -55.78 1.62 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.359 1.037 . . . . 1.96 113.021 -168.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 5.8 mp -134.27 45.71 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.951 -0.389 . . . . 1.75 109.951 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.6 -164.7 33.4 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.702 -1.237 . . . . 0.34000000000000002 112.7 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 18' ' ' LYS . 16.1 tt -133.89 130.08 55.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.093 0.473 . . . . 0.37 111.146 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 53.8 t -95.88 92.44 6.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.201 -0.454 . . . . 1.1100000000000001 109.971 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.7 124.51 33.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.274 -0.421 . . . . 1.1399999999999999 110.55 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -126.97 153.48 76.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.56999999999999995 111.036 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 2.4 Cg_endo -82.82 172.13 50.23 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.621 -1.408 . . . . 0.47999999999999998 111.3 -3.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.14 46.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.137 0.494 . . . . 1.3100000000000001 110.771 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.549 ' OXT' ' HB3' ' A' ' 24' ' ' ARG . 18.4 m-20 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.263 -0.875 . . . . 3.0800000000000001 109.596 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 111.752 -0.539 . . . . 2.96 111.752 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 15.4 p -84.29 59.03 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.464 0.649 . . . . 1.1299999999999999 110.371 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.523 HG22 HD11 ' A' ' 10' ' ' ILE . 3.6 m -104.27 123.79 48.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.416 -0.811 . . . . 1.1200000000000001 110.195 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' O ' HD12 ' A' ' 10' ' ' ILE . 8.0 p -135.65 159.96 40.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.873 0.368 . . . . 1.01 111.316 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.471 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 88.6 m-85 -119.61 143.91 47.41 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.78 -0.452 . . . . 0.84999999999999998 109.78 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.3 t -119.91 101.75 8.08 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.49 -91.54 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.778 -0.646 . . . . 1.01 111.872 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -122.49 -9.95 8.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.887 0.375 . . . . 3.6499999999999999 110.684 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -95.6 128.53 42.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.117 -0.492 . . . . 0.71999999999999997 111.067 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 3' ' ' THR . 5.1 tp -82.22 132.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.978 -0.555 . . . . 1.0600000000000001 110.003 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.46 179.78 19.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.13 -0.557 . . . . 0.35999999999999999 112.627 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.871 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.62 137.71 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.228 0.537 . . . . 0.33000000000000002 109.76 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.509 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 2.0 t80 -89.64 101.09 13.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.724 -0.671 . . . . 0.80000000000000004 111.443 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -82.85 83.28 7.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.871 -0.604 . . . . 0.46999999999999997 109.42 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -73.37 96.91 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.178 -0.465 . . . . 0.75 110.337 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.33 -61.37 0.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.725 -0.67 . . . . 1.0700000000000001 111.903 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.9 t -87.11 161.82 17.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.729 0.299 . . . . 0.56999999999999995 110.627 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -113.51 11.18 18.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.165 -0.68 . . . . 3.98 109.165 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -128.77 135.78 49.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.595 . . . . 1.6000000000000001 110.562 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 93.9 m -80.01 127.41 77.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.745 0.307 . . . . 0.91000000000000003 111.292 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 2.9 Cg_exo -74.23 78.32 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.558 2.172 . . . . 0.81999999999999995 110.194 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.8 t -78.62 63.04 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.556 0.693 . . . . 2.0699999999999998 111.141 -172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.43 4.71 10.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.33 -0.85 . . . . 1.8300000000000001 109.687 171.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.04 -81.77 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.29 -0.633 . . . . 3.3900000000000001 109.29 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.49 4.23 0.13 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.977 -0.63 . . . . 1.1000000000000001 113.146 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -62.06 127.31 30.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.077 0.438 . . . . 3.4500000000000002 110.273 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 p -114.74 -39.07 3.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.933 0.397 . . . . 1.3300000000000001 110.888 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.91 157.85 14.95 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.956 -0.64 . . . . 0.34999999999999998 112.188 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.2 p -124.55 149.97 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.376 . . . . 0.95999999999999996 111.103 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.9 t -133.4 114.66 13.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.119 -0.491 . . . . 1.01 109.969 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.79 127.16 42.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.416 -0.421 . . . . 0.48999999999999999 113.196 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -128.21 174.43 9.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.644 0.259 . . . . 1.75 110.56 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -65.52 95.41 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 1.96 111.506 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt 64.42 27.31 13.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.745 -0.661 . . . . 1.75 110.536 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.34 -175.83 29.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.822 -0.704 . . . . 0.34000000000000002 111.874 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 29' ' ' SER . 12.3 tt -136.44 130.09 46.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.233 0.539 . . . . 0.37 110.958 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 45.0 t -93.3 103.52 15.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.062 -0.718 . . . . 1.1100000000000001 109.062 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.1 m -91.76 124.43 35.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 1.1399999999999999 110.928 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 47.0 p90 -127.08 150.11 71.24 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.025 -0.534 . . . . 0.56999999999999995 111.117 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 16.5 Cg_exo -68.49 165.78 71.56 Favored 'Cis proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.56 -1.433 . . . . 0.47999999999999998 111.933 -4.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.871 HG23 ' HB ' ' A' ' 12' ' ' ILE . 7.3 p -72.5 68.65 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 122.32 1.057 . . . . 1.3100000000000001 110.712 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.199 -0.91 . . . . 3.0800000000000001 109.996 -179.281 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.889 -0.485 . . . . 2.96 111.889 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.8 p -92.43 18.07 9.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.723 0.297 . . . . 1.1299999999999999 111.43 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -69.69 115.83 9.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 1.1200000000000001 110.023 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -122.51 154.7 37.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.451 . . . . 1.01 110.651 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 54.7 m-85 -131.67 121.94 25.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.755 0.312 . . . . 0.84999999999999998 110.941 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -102.92 99.47 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.979 -0.749 . . . . 1.2 108.979 171.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.75 -97.55 0.35 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.921 -0.657 . . . . 1.01 111.767 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -106.84 -25.15 11.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.694 0.283 . . . . 3.6499999999999999 110.825 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -88.39 123.68 33.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.209 0.528 . . . . 0.71999999999999997 111.64 -170.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 tt -78.73 131.84 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.706 -0.679 . . . . 1.0600000000000001 110.615 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.68 -174.06 13.33 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.702 -0.681 . . . . 0.35999999999999999 111.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -117.16 133.19 64.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.353 0.596 . . . . 0.33000000000000002 109.928 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 15.3 t80 -84.44 100.1 11.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.382 -0.826 . . . . 0.80000000000000004 110.928 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -80.17 94.37 6.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.46999999999999997 110.373 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.5 t80 -79.56 109.87 14.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.523 -0.547 . . . . 0.75 109.523 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.26 -21.32 4.11 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.453 -0.88 . . . . 1.0700000000000001 112.884 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -135.05 151.99 51.27 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.765 -0.256 . . . . 0.56999999999999995 110.497 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -115.94 8.08 14.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.386 -0.598 . . . . 3.98 109.386 174.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 p -120.98 126.73 50.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 1.6000000000000001 109.786 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 88.9 m -74.52 136.25 74.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.91000000000000003 111.686 -175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 6.0 Cg_exo -79.48 100.69 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.091 2.527 . . . . 0.81999999999999995 110.126 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 t -80.97 20.4 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 2.0699999999999998 111.2 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -86.84 -8.7 57.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.471 -0.566 . . . . 1.8300000000000001 109.471 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 11.0 mmt180 -89.41 -58.15 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 3.3900000000000001 109.98 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.9 30.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.588 -0.733 . . . . 1.1000000000000001 112.149 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -72.17 152.2 42.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.755 0.312 . . . . 3.4500000000000002 111.256 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -118.37 -41.09 2.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.118 -0.492 . . . . 1.3300000000000001 111.149 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.5 165.41 23.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.71 -0.757 . . . . 0.34999999999999998 111.959 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.826 ' HB2' HD11 ' A' ' 36' ' ' ILE . 34.5 p -143.09 143.72 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.093 0.473 . . . . 0.95999999999999996 111.888 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 42.8 m -122.49 125.6 46.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 1.01 109.764 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.04 132.44 45.95 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.531 -0.842 . . . . 0.48999999999999999 111.585 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.34 166.36 21.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.97 0.385 . . . . 1.75 110.884 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -59.0 100.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.96 111.197 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp 64.36 29.33 13.61 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.767 0.667 . . . . 1.75 111.207 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.57 -168.87 33.75 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.394 -0.907 . . . . 0.34000000000000002 112.306 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.0 tt -136.28 130.3 47.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.437 0.637 . . . . 0.37 111.166 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 47.5 t -89.26 96.36 10.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.751 . . . . 1.1100000000000001 108.971 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -100.27 130.9 46.44 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.66 -0.416 . . . . 1.1399999999999999 110.146 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 55.1 p90 -131.27 157.91 76.75 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.787 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.6 Cg_exo -74.0 157.2 99.5 Favored 'Cis proline' 0 C--O 1.231 0.152 0 C-N-CA 123.611 -1.412 . . . . 0.47999999999999998 111.674 -2.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.7 p -66.14 97.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.711 0.767 . . . . 1.3100000000000001 110.144 177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.395 -0.82 . . . . 3.0800000000000001 110.444 -177.151 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 N-CA-C 112.015 -0.434 . . . . 2.96 112.015 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 11.9 p -80.79 77.27 7.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.33 0.586 . . . . 1.1299999999999999 110.861 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -107.09 128.09 54.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.865 -0.607 . . . . 1.1200000000000001 110.719 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -135.17 119.07 17.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.01 111.132 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 45.6 m-85 -80.7 117.81 21.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.84999999999999998 111.182 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.1 m -91.53 87.55 6.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.102 -0.703 . . . . 1.2 109.102 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.03 -102.87 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.868 -0.605 . . . . 1.01 112.047 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -100.38 -19.98 16.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.569 0.223 . . . . 3.6499999999999999 111.327 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -97.16 118.37 33.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.898 0.38 . . . . 0.71999999999999997 110.732 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 7.4 tt -79.82 131.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 1.0600000000000001 110.857 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.33 173.75 19.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.736 -0.745 . . . . 0.35999999999999999 112.608 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.97 135.04 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.513 -0.551 . . . . 0.33000000000000002 109.513 -178.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.87 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 25.4 t80 -87.28 113.78 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.977 -0.556 . . . . 0.80000000000000004 111.701 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.403 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 88.1 m95 -92.68 102.81 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.469 -0.787 . . . . 0.46999999999999997 109.596 173.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -73.15 130.83 41.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.033 -0.358 . . . . 0.75 110.033 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.39 -82.62 0.31 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.031 -0.604 . . . . 1.0700000000000001 111.995 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.5 t -63.81 151.63 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.295 0.569 . . . . 0.56999999999999995 111.67 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -112.44 12.08 19.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.883 -0.784 . . . . 3.98 108.883 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -127.93 130.09 47.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.114 -0.948 . . . . 1.6000000000000001 110.108 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.7 m -68.28 128.15 93.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.508 -0.314 . . . . 0.91000000000000003 111.022 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 52.4 Cg_exo -53.36 109.7 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.477 2.118 . . . . 0.81999999999999995 110.454 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -83.42 48.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.432 0.634 . . . . 2.0699999999999998 111.093 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -144.39 25.82 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 1.8300000000000001 110.262 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.42 -54.67 2.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.901 -0.591 . . . . 3.3900000000000001 111.016 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.81 22.28 1.05 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.507 -0.769 . . . . 1.1000000000000001 111.851 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -63.78 147.82 50.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.849 0.357 . . . . 3.4500000000000002 110.916 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -108.76 -43.35 4.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 110.832 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -133.85 175.23 20.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.798 -0.715 . . . . 0.34999999999999998 112.288 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.709 ' HB2' HD11 ' A' ' 36' ' ' ILE . 16.4 p -152.1 140.73 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.986 0.422 . . . . 0.95999999999999996 111.817 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 59.3 m -116.69 133.51 55.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.243 -0.651 . . . . 1.01 109.243 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.59 133.09 17.05 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.532 -0.842 . . . . 0.48999999999999999 111.177 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -130.21 165.22 22.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.626 -0.509 . . . . 1.75 109.626 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HB3' HD12 ' A' ' 34' ' ' LEU . 54.6 m-85 -37.53 -69.43 0.12 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.177 0.806 . . . . 1.96 113.177 -167.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 33' ' ' PHE . 7.2 mp -120.76 43.52 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.735 -0.386 . . . . 1.75 110.157 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.0 -158.08 22.77 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.146 -1.026 . . . . 0.34000000000000002 112.694 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' SER . 13.3 tt -137.37 133.92 46.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.39 0.614 . . . . 0.37 111.133 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 28.0 m -93.46 101.26 13.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.1100000000000001 110.135 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -94.1 130.35 40.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.076 -0.511 . . . . 1.1399999999999999 110.907 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.8 p90 -130.14 157.98 75.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 110.314 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 7.2 Cg_exo -74.85 153.03 98.95 Favored 'Cis proline' 0 C--O 1.231 0.154 0 C-N-CA 123.863 -1.307 . . . . 0.47999999999999998 111.944 -0.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.2 p -72.02 98.35 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.472 0.653 . . . . 1.3100000000000001 111.078 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.023 -0.99 . . . . 3.0800000000000001 111.117 177.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.161 -0.376 . . . . 2.96 112.161 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.1 p -90.69 48.19 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.038 0.447 . . . . 1.1299999999999999 111.86 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.1 m -69.7 131.28 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 110.012 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -135.3 153.26 51.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.797 0.332 . . . . 1.01 110.903 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -136.44 125.3 24.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 0.84999999999999998 110.463 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.22 86.93 2.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.201 -1.037 . . . . 1.2 108.201 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.93 -102.12 1.11 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.224 -0.898 . . . . 1.01 111.654 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -104.42 -11.39 17.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.468 0.175 . . . . 3.6499999999999999 110.678 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -95.91 118.03 31.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.71999999999999997 110.993 -175.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 41' ' ' VAL . 11.0 tt -79.7 130.43 36.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.312 0.577 . . . . 1.0600000000000001 111.189 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -173.45 12.9 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.543 -0.753 . . . . 0.35999999999999999 111.934 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.67 136.1 60.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.142 0.496 . . . . 0.33000000000000002 109.942 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.464 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 1.6 t80 -86.28 105.91 16.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.831 -0.622 . . . . 0.80000000000000004 110.516 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.38 104.48 13.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.46999999999999997 109.982 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 61.2 t80 -94.31 103.58 15.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.662 -0.699 . . . . 0.75 109.192 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.33 -6.7 5.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.412 -0.899 . . . . 1.0700000000000001 112.242 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 t -143.54 152.48 41.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.955 -0.387 . . . . 0.56999999999999995 109.955 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.82 12.54 19.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.331 0.586 . . . . 3.98 109.584 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 p -134.35 146.33 49.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 1.6000000000000001 110.055 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 77.5 m -79.58 116.59 61.85 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.91000000000000003 110.364 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.75 126.29 16.42 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.485 2.123 . . . . 0.81999999999999995 111.697 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.0 m -76.06 110.39 10.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 2.0699999999999998 110.517 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -169.95 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.8300000000000001 111.922 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.66 ' HD3' ' OXT' ' A' ' 42' ' ' ASP . 72.4 mtt180 -122.27 -69.38 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.795 -0.362 . . . . 3.3900000000000001 111.583 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.77 36.3 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.237 -0.982 . . . . 1.1000000000000001 112.959 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.08 130.58 44.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.859 0.361 . . . . 3.4500000000000002 110.178 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.2 m -101.2 -40.35 7.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.228 -0.442 . . . . 1.3300000000000001 110.78 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -124.4 169.92 16.48 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.581 -0.818 . . . . 0.34999999999999998 112.229 -177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.817 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.3 p -154.06 133.19 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.39 0.615 . . . . 0.95999999999999996 111.87 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 65.3 m -115.3 120.85 41.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.42 -0.809 . . . . 1.01 109.68 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.24 133.42 48.54 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.721 -0.752 . . . . 0.48999999999999999 111.842 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -129.92 164.44 24.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.864 0.332 . . . . 1.75 110.865 -176.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HB3' HD22 ' A' ' 34' ' ' LEU . 70.7 m-85 -39.37 -59.66 1.04 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.863 1.06 . . . . 1.96 113.863 -170.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 33' ' ' PHE . 3.1 mm? -123.34 28.47 7.05 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.439 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.98 -151.31 9.23 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.514 -1.327 . . . . 0.34000000000000002 113.246 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.817 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.1 tt -139.25 135.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.37 111.178 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 42.5 t -94.2 101.65 13.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.681 -0.69 . . . . 1.1100000000000001 109.576 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.5 m -95.58 129.19 42.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 1.1399999999999999 110.817 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 42.4 p90 -130.22 157.39 77.34 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.56999999999999995 110.468 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.4 Cg_exo -81.89 171.63 55.41 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 123.707 -1.372 . . . . 0.47999999999999998 111.931 -1.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HG12 ' A' ' 10' ' ' ILE . 77.3 t -62.94 95.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 1.3100000000000001 110.962 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.66 ' OXT' ' HD3' ' A' ' 24' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.632 -0.699 . . . . 3.0800000000000001 109.406 173.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.993 -0.443 . . . . 2.96 111.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p -96.26 53.98 1.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 1.1299999999999999 111.43 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.7 m -110.25 127.83 55.19 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.611 . . . . 1.1200000000000001 109.349 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.36 139.14 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.125 0.488 . . . . 1.01 111.887 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.433 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 62.5 m-85 -103.26 111.74 24.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.073 -0.512 . . . . 0.84999999999999998 110.019 173.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.04 100.47 12.58 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.479 -0.563 . . . . 1.2 109.479 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.97 -85.29 0.38 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 1.01 112.003 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -134.23 -0.71 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.799 0.333 . . . . 3.6499999999999999 111.065 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 m -108.39 135.09 50.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.805 0.336 . . . . 0.71999999999999997 110.887 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.9 tt -93.87 128.11 45.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.601 0.715 . . . . 1.0600000000000001 111.654 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 -178.4 15.95 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.471 -0.786 . . . . 0.35999999999999999 111.826 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.816 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.52 136.78 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.439 -0.578 . . . . 0.33000000000000002 109.439 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 32' ' ' TYR . 26.4 t80 -89.85 115.92 27.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.80000000000000004 111.648 -173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HZ2' ' HH ' ' A' ' 26' ' ' TYR . 87.1 m95 -99.12 110.68 23.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.842 -0.617 . . . . 0.46999999999999997 110.427 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -103.22 122.13 44.12 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.189 -0.671 . . . . 0.75 109.189 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 125.4 -32.1 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.183 -0.767 . . . . 1.0700000000000001 111.183 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 t -121.4 146.39 46.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.951 -0.389 . . . . 0.56999999999999995 109.951 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 14.2 ptmt -108.73 14.78 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.348 0.594 . . . . 3.98 109.885 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -128.91 137.07 51.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.532 -0.758 . . . . 1.6000000000000001 109.527 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.3 m -80.34 125.75 80.44 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.612 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.11 97.53 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.726 2.284 . . . . 0.81999999999999995 110.766 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -71.74 4.16 3.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.23 0.538 . . . . 2.0699999999999998 112.329 -173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -79.73 -16.59 55.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.827 -0.624 . . . . 1.8300000000000001 109.358 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 16.7 mmt180 -87.19 -11.95 48.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.51 -0.768 . . . . 3.3900000000000001 110.931 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.31 33.23 23.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.944 -0.646 . . . . 1.1000000000000001 113.202 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HH ' ' HZ2' ' A' ' 14' ' ' TRP . 35.8 m-85 -70.82 137.29 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.84 0.352 . . . . 3.4500000000000002 110.224 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.7 m -100.32 -43.1 6.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 1.3300000000000001 111.078 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.93 165.99 24.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.742 -0.742 . . . . 0.34999999999999998 112.21 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -137.05 160.74 38.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.879 0.371 . . . . 0.95999999999999996 111.26 -176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.593 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 97.8 m -141.77 145.48 34.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.026 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.59 131.33 11.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.008 -0.615 . . . . 0.48999999999999999 112.337 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 2.0 t80 -127.75 174.06 9.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.331 -0.618 . . . . 1.75 109.331 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.61 92.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.674 0.609 . . . . 1.96 111.972 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt 59.67 33.08 21.84 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.566 -0.743 . . . . 1.75 110.657 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.99 178.26 36.13 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 0.34000000000000002 111.583 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.47 135.28 64.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.379 0.609 . . . . 0.37 111.039 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.76 110.54 23.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.721 -0.672 . . . . 1.1100000000000001 109.367 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.3 m -105.82 121.96 45.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.612 -0.267 . . . . 1.1399999999999999 111.049 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 33.3 p90 -129.27 157.11 77.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.372 -0.376 . . . . 0.56999999999999995 110.982 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.0 Cg_exo -65.28 151.51 76.99 Favored 'Cis proline' 0 C--N 1.344 0.311 0 C-N-CA 123.774 -1.344 . . . . 0.47999999999999998 112.323 -1.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.816 HG23 ' HB ' ' A' ' 12' ' ' ILE . 3.6 p -61.59 96.84 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.123 0.487 . . . . 1.3100000000000001 111.486 178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--O 1.245 0.862 0 CA-C-N 115.044 -0.98 . . . . 3.0800000000000001 111.857 176.582 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.265 -0.334 . . . . 2.96 112.265 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -80.99 61.86 4.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.12 0.486 . . . . 1.1299999999999999 110.959 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -142.97 141.88 31.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 109.905 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.6 p -131.45 159.64 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 1.01 110.819 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -114.66 102.23 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.84999999999999998 110.574 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -89.28 90.49 8.36 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.755 -0.831 . . . . 1.2 108.755 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.68 -117.07 7.36 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 1.01 111.49 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -88.63 -18.38 28.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.552 0.215 . . . . 3.6499999999999999 110.534 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -93.46 117.23 29.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.142 0.496 . . . . 0.71999999999999997 111.18 -170.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 41' ' ' VAL . 6.7 tt -86.81 129.75 37.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.579 -0.737 . . . . 1.0600000000000001 110.028 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.77 162.48 22.9 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.021 -0.609 . . . . 0.35999999999999999 112.131 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.858 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.84 132.81 41.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.364 -0.606 . . . . 0.33000000000000002 109.364 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.1 t80 -89.04 103.45 16.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.064 -0.516 . . . . 0.80000000000000004 111.283 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 97.6 m95 -84.44 81.24 8.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.773 -0.648 . . . . 0.46999999999999997 110.337 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -75.25 118.16 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.738 -0.664 . . . . 0.75 109.895 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.01 8.14 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.443 -0.884 . . . . 1.0700000000000001 112.414 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 36' ' ' ILE . 10.2 t -132.5 153.6 50.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.62 0.248 . . . . 0.56999999999999995 110.571 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 6.88 23.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.208 0.527 . . . . 3.98 109.615 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.0 m -107.23 118.11 35.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.618 -0.719 . . . . 1.6000000000000001 110.393 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -68.48 116.63 42.08 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.91000000000000003 109.531 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 Cg_exo -56.92 120.22 7.99 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.804 2.336 . . . . 0.81999999999999995 111.41 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -84.86 49.39 1.71 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.638 0.732 . . . . 2.0699999999999998 110.732 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -128.22 13.36 6.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.586 -0.734 . . . . 1.8300000000000001 110.007 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.75 ' HG2' ' HA ' ' A' ' 42' ' ' ASP . 8.6 mpt_? -117.94 -55.84 2.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 3.3900000000000001 110.988 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.72 38.2 0.67 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.69 -0.686 . . . . 1.1000000000000001 111.677 -175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -67.49 141.95 56.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.408 . . . . 3.4500000000000002 110.869 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -112.38 -35.32 5.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.066 -0.516 . . . . 1.3300000000000001 110.63 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.97 175.27 21.21 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.586 -0.816 . . . . 0.34999999999999998 111.494 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 p -156.73 158.28 36.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.95999999999999996 111.509 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 74.3 m -123.45 114.69 20.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.104 -0.702 . . . . 1.01 109.104 174.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.88 131.52 25.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.766 -0.73 . . . . 0.48999999999999999 111.936 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 32.6 m-85 -135.71 -178.96 5.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.472 0.136 . . . . 1.75 110.933 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -57.66 102.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.632 0.605 . . . . 1.96 112.632 -172.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.0 mm? 59.83 26.27 15.44 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.562 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.93 173.42 35.82 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.508 -0.853 . . . . 0.34000000000000002 111.975 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 17' ' ' THR . 16.6 tt -132.61 124.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.445 0.64 . . . . 0.37 110.241 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 8.0 t -94.74 98.55 10.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.123 -0.695 . . . . 1.1100000000000001 109.123 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 m -93.76 140.33 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 1.1399999999999999 111.365 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 15.1 p90 -134.23 159.63 71.58 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 116.372 -0.377 . . . . 0.56999999999999995 111.165 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 33.6 Cg_exo -63.32 154.59 70.84 Favored 'Cis proline' 0 N--CA 1.479 0.643 0 C-N-CA 124.107 -1.205 . . . . 0.47999999999999998 112.494 -0.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.858 HG23 ' HB ' ' A' ' 12' ' ' ILE . 6.1 p -64.41 98.35 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.504 0.668 . . . . 1.3100000000000001 111.853 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.75 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 26.2 t70 . . . . . 0 C--O 1.243 0.746 0 CA-C-N 114.758 -1.11 . . . . 3.0800000000000001 111.274 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.601 0 N-CA-C 112.177 -0.369 . . . . 2.96 112.177 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.1 m -94.23 125.36 38.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.96 -0.385 . . . . 1.1299999999999999 109.96 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 m -102.1 142.0 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.546 -0.297 . . . . 1.1200000000000001 110.42 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.57 152.42 51.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.437 . . . . 1.01 111.086 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 65.0 m-85 -113.6 138.71 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.057 0.456 . . . . 0.84999999999999998 110.581 174.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.3 t -121.57 102.21 8.1 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.615 -0.883 . . . . 1.2 108.615 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -101.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.151 -0.78 . . . . 1.01 111.151 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -119.64 -1.88 10.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.576 0.227 . . . . 3.6499999999999999 111.094 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 39' ' ' TYR . 3.5 m -97.96 136.38 38.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.944 -0.302 . . . . 0.71999999999999997 111.006 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HB ' ' CE1' ' A' ' 5' ' ' TYR . 12.4 tt -96.31 125.15 49.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 121.689 0.757 . . . . 1.0600000000000001 111.475 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.01 178.65 17.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.16 -0.927 . . . . 0.35999999999999999 112.131 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 135.96 49.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.659 -0.496 . . . . 0.33000000000000002 109.659 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' OH ' ' HD1' ' A' ' 15' ' ' PHE . 11.7 t80 -87.59 104.58 16.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.446 -0.797 . . . . 0.80000000000000004 111.21 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 94.6 m95 -87.36 90.11 8.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.46999999999999997 110.522 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.435 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 89.2 t80 -79.5 123.46 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.398 -0.593 . . . . 0.75 109.398 174.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.31 -24.72 8.55 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.415 -0.898 . . . . 1.0700000000000001 112.597 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 6.9 t -126.08 155.04 42.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.99 0.424 . . . . 0.56999999999999995 110.667 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 15.94 16.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.644 -0.707 . . . . 3.98 109.806 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 m -131.76 128.08 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.6000000000000001 110.7 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 99.7 m -72.38 126.35 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.258 -0.428 . . . . 0.91000000000000003 111.159 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' CYS . 12.4 Cg_exo -67.4 101.39 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.763 2.309 . . . . 0.81999999999999995 110.905 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 p -79.27 26.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 2.0699999999999998 111.805 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -91.27 -11.07 39.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.331 -0.395 . . . . 1.8300000000000001 110.649 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 58.7 mtt180 -102.35 -74.06 0.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.418 -0.355 . . . . 3.3900000000000001 111.185 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.22 33.07 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.531 -0.842 . . . . 1.1000000000000001 112.392 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -71.9 125.73 27.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.384 -0.228 . . . . 3.4500000000000002 110.384 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 m -100.86 -49.44 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.085 -0.507 . . . . 1.3300000000000001 110.842 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -112.4 157.13 15.15 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.622 -0.799 . . . . 0.34999999999999998 112.061 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.543 ' HB3' HD11 ' A' ' 36' ' ' ILE . 11.6 m -139.64 136.29 34.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.858 0.361 . . . . 0.95999999999999996 110.907 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 81.8 m -129.64 132.88 46.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 1.01 109.689 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 145.78 49.88 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.149 -0.548 . . . . 0.48999999999999999 112.99 -175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -136.48 165.46 25.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.886 -0.783 . . . . 1.75 108.886 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -60.26 99.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.052 0.22 . . . . 1.96 110.725 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.0 mt 63.09 32.15 15.44 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.825 0.703 . . . . 1.75 111.102 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.22 178.21 39.64 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.89 -0.671 . . . . 0.34000000000000002 111.707 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 29' ' ' SER . 16.8 tt -128.93 131.57 68.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.294 0.569 . . . . 0.37 110.93 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 47.0 t -92.14 105.29 17.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 109.308 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -101.93 123.37 45.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 1.1399999999999999 110.869 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 42.6 p90 -128.44 158.06 72.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.485 -0.325 . . . . 0.56999999999999995 111.248 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.8 Cg_exo -78.77 161.16 89.64 Favored 'Cis proline' 0 C--O 1.233 0.267 0 C-N-CA 124.058 -1.226 . . . . 0.47999999999999998 112.204 -2.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.7 97.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.142 -0.481 . . . . 1.3100000000000001 111.105 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 33.5 t70 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.494 -0.765 . . . . 3.0800000000000001 109.563 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.3 -0.72 . . . . 2.96 111.3 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 13' ' ' TYR . 3.9 m -80.13 105.32 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.216 0.531 . . . . 1.1299999999999999 110.58 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.5 m -87.61 137.29 32.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.739 -0.664 . . . . 1.1200000000000001 112.055 -172.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.8 p -140.07 155.72 46.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.702 -0.481 . . . . 1.01 109.702 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 0.84999999999999998 111.268 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.9 m -110.92 87.67 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.807 -0.812 . . . . 1.2 108.807 170.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.81 -97.36 0.49 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.361 -0.836 . . . . 1.01 111.479 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -108.51 -18.88 13.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.49 0.186 . . . . 3.6499999999999999 111.109 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -90.09 119.31 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.434 -0.506 . . . . 0.71999999999999997 110.731 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tt -82.26 128.29 38.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.603 . . . . 1.0600000000000001 110.379 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.61 -171.53 12.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.933 -0.576 . . . . 0.35999999999999999 112.294 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.728 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -121.88 132.7 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.33000000000000002 109.785 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' HD2' HG21 ' A' ' 2' ' ' THR . 14.4 t80 -89.99 109.38 20.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.80000000000000004 110.972 -176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.04 119.34 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.477 -0.783 . . . . 0.46999999999999997 110.456 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' HD2' ' OH ' ' A' ' 13' ' ' TYR . 44.0 t80 -104.13 118.02 35.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.003 -0.74 . . . . 0.75 109.003 170.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.72 -21.37 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.284 -0.726 . . . . 1.0700000000000001 111.284 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 t -141.12 161.9 36.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.336 -0.616 . . . . 0.56999999999999995 109.336 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -121.09 20.7 11.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.184 -0.462 . . . . 3.98 110.06 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -135.95 152.83 51.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 1.6000000000000001 109.789 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 83.9 m -84.79 116.37 64.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.502 -0.317 . . . . 0.91000000000000003 111.022 -177.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 18.9 Cg_endo -63.94 134.79 44.82 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.684 2.256 . . . . 0.81999999999999995 111.562 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.2 t -85.9 45.06 1.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.75 0.786 . . . . 2.0699999999999998 110.037 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -97.2 -16.38 20.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 110.091 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 42' ' ' ASP . 1.2 mpt_? -121.18 -80.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 3.3900000000000001 111.211 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.58 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 1.1000000000000001 111.053 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.649 ' HE1' ' H ' ' A' ' 42' ' ' ASP . 49.2 m-85 -67.87 112.06 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 3.4500000000000002 110.021 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HD3' ' A' ' 40' ' ' PRO . 8.9 t -100.53 -26.32 13.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 1.3300000000000001 110.721 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -124.41 157.33 18.73 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.263 -0.97 . . . . 0.34999999999999998 111.859 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.643 ' HB2' HD11 ' A' ' 36' ' ' ILE . 30.0 p -145.05 137.27 25.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.205 0.526 . . . . 0.95999999999999996 111.716 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 74.3 m -117.46 129.41 55.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.616 -0.72 . . . . 1.01 109.448 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.3 118.08 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.736 -0.745 . . . . 0.48999999999999999 111.759 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -116.79 172.92 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.435 -0.209 . . . . 1.75 110.435 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -54.46 104.58 0.11 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.96 111.542 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.2 mp 56.65 26.92 11.78 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.812 0.695 . . . . 1.75 111.432 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.36 -173.5 32.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.551 -0.833 . . . . 0.34000000000000002 112.225 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.5 tt -135.38 132.03 51.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.147 0.499 . . . . 0.37 111.387 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 52.5 t -93.74 106.99 18.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.277 -0.638 . . . . 1.1100000000000001 109.277 176.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 99.7 m -104.34 126.9 51.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.365 -0.38 . . . . 1.1399999999999999 111.166 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 44.1 p90 -124.84 155.68 69.8 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 116.048 -0.524 . . . . 0.56999999999999995 110.852 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD3' HG22 ' A' ' 27' ' ' THR . 21.1 Cg_exo -67.45 161.22 78.59 Favored 'Cis proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.958 -1.268 . . . . 0.47999999999999998 112.882 -1.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.4 p -66.67 95.27 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.82 -0.627 . . . . 1.3100000000000001 112.211 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.649 ' H ' ' HE1' ' A' ' 26' ' ' TYR . 22.9 t70 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.001 -0.999 . . . . 3.0800000000000001 111.867 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.875 -0.49 . . . . 2.96 111.875 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -97.72 112.87 24.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.894 -0.41 . . . . 1.1299999999999999 109.894 178.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -127.59 144.15 51.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.799 0.333 . . . . 1.1200000000000001 111.556 -171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.64 164.15 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.85 115.97 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.918 0.39 . . . . 0.84999999999999998 110.619 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.19 103.49 15.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.986 -0.746 . . . . 1.2 108.986 173.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 -93.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.334 -1.106 . . . . 1.01 110.334 -171.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 20.8 ptmt -133.22 5.02 3.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.033 0.444 . . . . 3.6499999999999999 110.249 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 m -87.38 129.17 35.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.886 -0.597 . . . . 0.71999999999999997 110.281 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tt -85.08 115.85 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.37 0.605 . . . . 1.0600000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.71 173.66 16.13 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.548 -0.751 . . . . 0.35999999999999999 112.042 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.27 127.0 68.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.408 0.623 . . . . 0.33000000000000002 109.738 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t80 -86.2 109.34 18.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 0.80000000000000004 111.005 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.495 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 91.9 m95 -89.83 117.02 28.35 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.516 -0.765 . . . . 0.46999999999999997 110.266 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -112.52 114.19 26.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.491 -0.559 . . . . 0.75 109.491 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.5 -9.53 6.51 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.871 -0.68 . . . . 1.0700000000000001 111.976 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 t -133.06 160.43 37.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.795 0.331 . . . . 0.56999999999999995 110.563 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -116.71 8.61 13.8 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.474 -0.565 . . . . 3.98 109.474 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.8 m -134.93 132.74 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 1.6000000000000001 111.302 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 86.6 m -67.79 120.62 74.95 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.91000000000000003 110.315 174.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 43.9 Cg_exo -55.75 116.1 2.92 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.915 2.41 . . . . 0.81999999999999995 111.97 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.8 t -84.84 14.92 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.457 0.646 . . . . 2.0699999999999998 111.3 -174.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -97.35 -1.96 43.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.459 0.647 . . . . 1.8300000000000001 109.267 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -100.0 -59.94 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 3.3900000000000001 110.436 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.43 40.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.86 -0.686 . . . . 1.1000000000000001 112.564 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' HE2' ' HD2' ' A' ' 21' ' ' PRO . 57.4 m-85 -69.88 146.36 51.32 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.883 -0.186 . . . . 3.4500000000000002 110.74 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.406 ' OG1' ' HD3' ' A' ' 40' ' ' PRO . 46.6 p -106.98 -14.41 14.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.906 0.384 . . . . 1.3300000000000001 111.061 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.39 170.74 36.46 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.884 -0.674 . . . . 0.34999999999999998 111.74 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.514 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 57.4 p -145.77 150.05 35.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 0.95999999999999996 111.386 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.8 m -123.45 118.29 27.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.838 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.67 111.17 3.91 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.437 -0.665 . . . . 0.48999999999999999 111.437 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.1 178.22 4.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.064 -0.347 . . . . 1.75 110.064 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -52.31 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.201 0.313 . . . . 1.96 111.541 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp 57.04 25.4 10.7 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.703 -0.681 . . . . 1.75 111.655 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.07 26.93 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.534 -0.841 . . . . 0.34000000000000002 112.281 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 tt -136.11 122.84 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.232 0.539 . . . . 0.37 110.616 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 14.0 t -99.76 109.51 21.94 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.618 -0.512 . . . . 1.1100000000000001 109.618 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.3 m -97.66 130.87 44.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.147 -0.479 . . . . 1.1399999999999999 110.369 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.5 p90 -122.81 154.67 63.97 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.52 -0.309 . . . . 0.56999999999999995 110.779 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 8.3 Cg_exo -72.42 174.43 48.42 Favored 'Cis proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.604 -1.415 . . . . 0.47999999999999998 112.036 -1.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 12' ' ' ILE . 4.8 p -67.72 95.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.748 0.785 . . . . 1.3100000000000001 110.849 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.457 ' H ' ' HE1' ' A' ' 26' ' ' TYR . 1.6 m-20 . . . . . 0 C--O 1.245 0.833 0 CA-C-N 115.383 -0.826 . . . . 3.0800000000000001 110.323 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.136 -0.386 . . . . 2.96 112.136 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 4.7 p -89.0 85.0 6.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.433 0.635 . . . . 1.1299999999999999 111.462 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -101.92 136.85 41.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.783 -0.644 . . . . 1.1200000000000001 109.928 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 13' ' ' TYR . 9.3 p -145.44 149.72 35.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 1.01 111.347 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 10' ' ' ILE . 78.2 m-85 -107.33 127.64 53.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.84999999999999998 110.047 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 t -97.79 95.88 7.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.333 -0.988 . . . . 1.2 108.333 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.98 -92.95 0.56 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.75 -0.94 . . . . 1.01 110.75 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -120.18 -14.28 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.582 0.23 . . . . 3.6499999999999999 110.577 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.521 HG21 ' CD1' ' A' ' 39' ' ' TYR . 1.3 m -78.3 115.19 17.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.88 0.372 . . . . 0.71999999999999997 110.913 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 5.7 tp -74.71 125.44 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.902 -0.59 . . . . 1.0600000000000001 110.862 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.29 -176.39 17.29 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.899 -0.667 . . . . 0.35999999999999999 112.126 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 134.13 62.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.304 0.573 . . . . 0.33000000000000002 109.699 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.611 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 10.4 t80 -85.38 101.76 12.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.80000000000000004 110.612 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m95 -82.22 107.6 15.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.715 -0.675 . . . . 0.46999999999999997 109.921 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -96.65 101.31 12.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.179 -0.464 . . . . 0.75 109.854 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.15 -41.57 1.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.728 -0.748 . . . . 1.0700000000000001 112.83 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -96.44 155.0 16.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.56999999999999995 110.61 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -102.36 -4.94 24.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.461 -0.791 . . . . 3.98 109.713 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -126.37 133.36 51.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 111.145 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 84.0 m -70.58 121.15 82.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.824 -0.626 . . . . 0.91000000000000003 110.469 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 53.0 Cg_exo -53.06 108.6 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.96 2.44 . . . . 0.81999999999999995 111.934 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.1 t -74.88 -0.89 20.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.516 0.675 . . . . 2.0699999999999998 111.452 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.05 -13.37 57.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.364 -0.834 . . . . 1.8300000000000001 109.808 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HD2' ' OXT' ' A' ' 42' ' ' ASP . 13.3 mmt85 -89.28 -55.26 3.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.81 -0.632 . . . . 3.3900000000000001 110.162 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.12 1.84 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.851 -0.69 . . . . 1.1000000000000001 112.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 63.9 m-85 -63.36 132.66 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.895 0.378 . . . . 3.4500000000000002 110.357 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 m -93.65 -26.62 16.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.848 -0.615 . . . . 1.3300000000000001 110.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.34 170.18 27.48 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.708 -0.758 . . . . 0.34999999999999998 111.848 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.667 ' HB2' HD11 ' A' ' 36' ' ' ILE . 13.9 p -139.16 133.9 32.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.44 0.638 . . . . 0.95999999999999996 111.227 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 2.4 t -110.52 106.61 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.568 -0.742 . . . . 1.01 109.458 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.99 123.85 33.78 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.147 -0.549 . . . . 0.48999999999999999 111.876 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.45 170.75 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.04 -0.355 . . . . 1.75 110.04 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -54.42 104.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.664 0.386 . . . . 1.96 111.758 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 56.1 28.81 13.5 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.791 0.682 . . . . 1.75 111.64 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -172.44 34.29 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.759 -0.734 . . . . 0.34000000000000002 111.798 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 29' ' ' SER . 15.2 tt -138.8 121.45 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.422 0.63 . . . . 0.37 111.581 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 15.1 m -83.43 96.3 8.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 1.1100000000000001 110.254 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 26' ' ' TYR . 83.7 m -86.61 130.15 34.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.262 -0.426 . . . . 1.1399999999999999 110.924 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' A' ' 9' ' ' THR . 34.1 p90 -135.63 157.43 76.3 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.123 -0.49 . . . . 0.56999999999999995 111.063 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 3.1 Cg_exo -76.79 151.11 93.86 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.603 -1.415 . . . . 0.47999999999999998 111.577 -2.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 10' ' ' ILE . 7.5 p -66.15 96.63 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 122.021 0.915 . . . . 1.3100000000000001 111.099 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' OXT' ' HD2' ' A' ' 24' ' ' ARG . 32.0 t70 . . . . . 0 C--O 1.244 0.793 0 CA-C-N 115.242 -0.89 . . . . 3.0800000000000001 109.292 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 112.119 -0.392 . . . . 2.96 112.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p -109.05 55.36 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 111.361 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.1 m -134.6 140.04 45.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.385 -0.371 . . . . 1.1200000000000001 110.426 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.77 175.49 9.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.194 -0.457 . . . . 1.01 110.764 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 70.9 m-85 -134.76 132.55 38.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.84999999999999998 110.893 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.07 106.86 14.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.152 -0.685 . . . . 1.2 109.152 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.33 -97.06 0.66 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.752 -0.939 . . . . 1.01 110.752 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -130.47 3.4 4.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.924 0.392 . . . . 3.6499999999999999 110.424 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.7 m -93.18 133.08 36.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.216 -0.447 . . . . 0.71999999999999997 110.341 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.5 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 tt -85.48 126.0 40.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.438 0.637 . . . . 1.0600000000000001 110.628 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.19 162.3 16.03 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.351 -0.84 . . . . 0.35999999999999999 111.386 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 131.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.382 -0.599 . . . . 0.33000000000000002 109.382 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -86.84 98.07 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.80000000000000004 110.911 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 99.9 m95 -82.83 98.86 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.81 -0.632 . . . . 0.46999999999999997 110.075 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -81.26 127.77 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.603 -0.517 . . . . 0.75 109.603 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.28 -68.5 0.25 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.689 -0.767 . . . . 1.0700000000000001 111.886 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 t -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.083 0.468 . . . . 0.56999999999999995 110.518 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.637 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.3 tmtt? -97.3 -0.68 46.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.237 -1.023 . . . . 3.98 108.237 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -96.64 107.31 19.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.664 -0.698 . . . . 1.6000000000000001 110.337 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.6 m -59.75 113.4 7.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.872 -0.418 . . . . 0.91000000000000003 109.872 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 77.4 Cg_exo -49.89 114.28 1.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.762 2.308 . . . . 0.81999999999999995 112.252 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -76.95 47.99 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.057 0.932 . . . . 2.0699999999999998 109.604 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -111.75 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.304 -1.316 . . . . 1.8300000000000001 108.927 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.614 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.88 -52.38 10.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.795 -1.093 . . . . 3.3900000000000001 111.111 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.0 25.15 0.83 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.566 -0.826 . . . . 1.1000000000000001 113.133 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -56.81 131.32 49.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.997 -0.371 . . . . 3.4500000000000002 109.997 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -114.03 -37.18 4.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 111.346 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 39' ' ' TYR . . . -102.94 151.46 18.02 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.422 -0.894 . . . . 0.34999999999999998 111.524 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.873 ' HB2' HD11 ' A' ' 36' ' ' ILE . 19.8 p -143.46 137.33 28.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.093 0.473 . . . . 0.95999999999999996 111.788 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 59.1 m -123.87 132.44 53.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.708 . . . . 1.01 109.687 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.11 134.33 34.13 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.48999999999999999 112.232 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 171.66 14.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.887 0.343 . . . . 1.75 110.99 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -60.66 96.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.473 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.991 -0.549 . . . . 1.75 110.697 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.76 -176.16 35.39 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.332 -0.937 . . . . 0.34000000000000002 112.073 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 29' ' ' SER . 19.2 tt -136.53 137.02 48.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.27 0.557 . . . . 0.37 110.872 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 25.3 t -93.3 99.94 12.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.661 -0.699 . . . . 1.1100000000000001 109.32 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.77 119.29 36.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.966 0.412 . . . . 1.1399999999999999 110.642 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' HA3' ' A' ' 28' ' ' GLY . 51.5 p90 -122.33 160.74 46.7 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.048 -0.524 . . . . 0.56999999999999995 110.423 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.514 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.4 Cg_exo -79.01 156.37 91.69 Favored 'Cis proline' 0 CA--C 1.523 -0.07 0 C-N-CA 124.232 -1.153 . . . . 0.47999999999999998 111.945 -3.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.92 101.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.624 -0.262 . . . . 1.3100000000000001 110.615 173.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 13.2 m-20 . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.772 -0.632 . . . . 3.0800000000000001 110.265 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.5 0 N-CA-C 111.934 -0.466 . . . . 2.96 111.934 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.679 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 7.9 p -90.59 77.74 6.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.183 0.516 . . . . 1.1299999999999999 111.186 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 m -86.0 134.58 33.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.898 -0.592 . . . . 1.1200000000000001 110.182 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 26.3 p -130.92 165.91 22.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.842 0.353 . . . . 1.01 110.705 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -127.86 112.69 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 0.84999999999999998 110.826 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 39.1 t -91.25 99.38 12.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.956 -0.757 . . . . 1.2 108.956 174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.44 0.9 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.472 -1.051 . . . . 1.01 110.472 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.44 10.62 2.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.115 0.483 . . . . 3.6499999999999999 109.995 170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.2 m -94.58 119.63 33.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.679 . . . . 0.71999999999999997 109.615 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.435 HG12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 tt -74.85 129.01 37.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.444 0.64 . . . . 1.0600000000000001 111.418 -175.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.17 -175.37 13.88 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.52 -0.764 . . . . 0.35999999999999999 111.926 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.46 132.63 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.327 0.584 . . . . 0.33000000000000002 109.46 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 15.6 t80 -88.35 112.49 22.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.668 -0.696 . . . . 0.80000000000000004 111.353 -173.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 95.2 m95 -97.41 103.74 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.873 -0.603 . . . . 0.46999999999999997 110.357 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -86.95 135.31 33.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.557 -0.292 . . . . 0.75 110.229 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.6 -10.81 59.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.525 -0.845 . . . . 1.0700000000000001 113.334 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -123.92 150.46 44.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.003 0.43 . . . . 0.56999999999999995 111.022 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.23 4.58 29.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 3.98 110.425 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -135.51 140.71 44.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 1.6000000000000001 110.14 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 83.2 m -74.66 139.13 73.96 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.91000000000000003 110.142 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 6.2 Cg_exo -75.37 84.46 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.431 2.088 . . . . 0.81999999999999995 109.7 172.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.4 m -71.68 71.73 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.507 0.67 . . . . 2.0699999999999998 111.799 -172.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' HB2' HH11 ' A' ' 24' ' ' ARG . 40.6 m-80 -130.97 20.93 4.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.038 -0.983 . . . . 1.8300000000000001 108.544 172.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.499 HH11 ' HB2' ' A' ' 23' ' ' ASN . 10.8 mpt_? -129.71 -2.57 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.043 -0.98 . . . . 3.3900000000000001 110.736 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.97 30.12 52.35 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.524 -0.846 . . . . 1.1000000000000001 112.516 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -54.52 133.18 46.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.732 0.301 . . . . 3.4500000000000002 110.755 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.9 m -103.43 -45.41 4.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.013 -0.54 . . . . 1.3300000000000001 111.423 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' CZ ' ' A' ' 39' ' ' TYR . . . -133.04 171.79 21.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.169 -1.015 . . . . 0.34999999999999998 112.452 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' HD11 ' A' ' 36' ' ' ILE . 14.8 m -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.906 0.384 . . . . 0.95999999999999996 111.546 -176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -120.09 108.31 14.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.72 -0.673 . . . . 1.01 109.359 172.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.18 138.57 45.31 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.973 -0.632 . . . . 0.48999999999999999 112.099 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.05 -178.28 5.13 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.641 -0.329 . . . . 1.75 110.48 -176.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -65.04 95.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 1.96 111.766 -172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 62.28 28.07 16.77 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.533 -0.758 . . . . 1.75 110.707 -176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.65 -176.26 28.53 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.542 -0.837 . . . . 0.34000000000000002 111.922 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 29' ' ' SER . 15.0 tt -141.35 128.12 20.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.113 0.483 . . . . 0.37 110.626 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -87.78 101.86 14.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 1.1100000000000001 109.447 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.9 m -99.06 120.59 39.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.1399999999999999 110.742 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.546 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 53.3 p90 -119.87 156.56 54.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.259 -0.428 . . . . 0.56999999999999995 109.981 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 31.7 Cg_exo -61.18 158.71 50.65 Favored 'Cis proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.167 -1.18 . . . . 0.47999999999999998 114.033 1.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.435 ' HB ' HG12 ' A' ' 10' ' ' ILE . 6.7 p -57.79 111.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.31 -0.859 . . . . 1.3100000000000001 111.036 172.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 24' ' ' ARG . 7.5 t70 . . . . . 0 C--O 1.25 1.084 0 CA-C-N 114.31 -1.314 . . . . 3.0800000000000001 111.452 171.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.07 -0.412 . . . . 2.96 112.07 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 p -99.08 68.69 1.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.303 0.573 . . . . 1.1299999999999999 110.579 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.2 m -133.4 139.63 46.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 1.1200000000000001 111.014 -177.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 p -125.99 171.28 10.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.106 -0.702 . . . . 1.01 109.106 176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -127.55 106.6 9.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.84999999999999998 110.479 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.3 m -88.2 104.0 16.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.523 -0.917 . . . . 1.2 108.523 174.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.18 -112.46 4.37 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.978 -1.249 . . . . 1.01 109.978 -167.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -114.74 3.15 14.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.26 0.553 . . . . 3.6499999999999999 109.701 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -86.26 119.29 26.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.71999999999999997 110.567 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.98 124.98 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.578 -0.737 . . . . 1.0600000000000001 111.027 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.48 151.03 16.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.852 -0.613 . . . . 0.35999999999999999 111.976 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.55 130.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.284 0.564 . . . . 0.33000000000000002 109.532 -178.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 20.0 t80 -87.95 120.6 29.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.75 -0.659 . . . . 0.80000000000000004 111.426 -174.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.418 ' CH2' ' HG2' ' A' ' 21' ' ' PRO . 96.2 m95 -102.9 125.28 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.46999999999999997 110.405 177.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HE1' HD23 ' A' ' 34' ' ' LEU . 71.8 t80 -116.7 119.11 34.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.689 -0.687 . . . . 0.75 109.736 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.12 12.81 13.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.513 -0.851 . . . . 1.0700000000000001 112.198 -178.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -155.55 143.27 19.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.56999999999999995 110.669 177.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -90.54 -12.36 37.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.427 -0.806 . . . . 3.98 110.077 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -122.45 141.96 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.209 0.528 . . . . 1.6000000000000001 111.064 -175.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.5 m -72.28 134.71 82.44 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.631 -0.713 . . . . 0.91000000000000003 109.981 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HG2' ' CH2' ' A' ' 14' ' ' TRP . 14.7 Cg_exo -67.24 95.36 0.37 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.562 2.175 . . . . 0.81999999999999995 110.294 173.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 t -79.85 66.86 5.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 2.0699999999999998 111.355 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -141.26 15.04 2.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 1.8300000000000001 110.76 173.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -108.53 -54.87 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 3.3900000000000001 109.608 174.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.97 -5.42 0.79 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.282 -0.872 . . . . 1.1000000000000001 112.049 -175.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 41' ' ' VAL . 17.7 m-85 -52.2 139.19 24.35 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.596 0.358 . . . . 3.4500000000000002 111.003 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.1 m -132.23 -48.61 0.92 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.291 -0.413 . . . . 1.3300000000000001 111.163 -176.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.68 159.56 25.93 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.822 -0.704 . . . . 0.34999999999999998 112.01 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.7 m -142.38 154.04 44.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.004 0.431 . . . . 0.95999999999999996 111.282 -177.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.3 120.9 20.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.593 -0.73 . . . . 1.01 109.138 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.96 124.79 37.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.48999999999999999 111.333 177.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -127.49 177.86 6.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.994 0.397 . . . . 1.75 110.547 -173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -53.23 101.74 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 123.56 0.537 . . . . 1.96 112.177 -176.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD23 ' HE1' ' A' ' 15' ' ' PHE . 13.7 tp 56.76 29.51 16.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.249 -0.887 . . . . 1.75 110.986 176.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -169.05 -163.75 23.6 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.689 -0.767 . . . . 0.34000000000000002 112.129 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 tt -136.02 128.56 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.144 0.497 . . . . 0.37 110.702 -177.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 4.9 t -99.2 116.25 30.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.769 -0.826 . . . . 1.1100000000000001 108.769 178.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.56 133.45 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.538 -0.301 . . . . 1.1399999999999999 110.996 -171.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 54.9 p90 -133.5 162.79 55.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.59 -0.277 . . . . 0.56999999999999995 110.549 -177.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 5.3 Cg_exo -81.68 150.55 75.48 Favored 'Cis proline' 0 C--N 1.342 0.232 0 C-N-CA 124.47 -1.054 . . . . 0.47999999999999998 112.306 -3.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HA ' ' HE1' ' A' ' 26' ' ' TYR . 87.4 t -63.13 97.69 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.193 0.52 . . . . 1.3100000000000001 111.077 177.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.253 1.256 0 CA-C-N 115.331 -0.849 . . . . 3.0800000000000001 109.531 177.837 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.607 -0.597 . . . . 2.96 111.607 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 18.3 p -84.83 81.67 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.251 0.548 . . . . 1.1299999999999999 111.521 -178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.6 m -99.21 129.64 45.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 1.1200000000000001 110.302 177.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.4 p -132.08 153.6 50.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.877 0.37 . . . . 1.01 111.337 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 39.7 m-85 -120.61 129.78 53.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.84999999999999998 110.515 175.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.9 t -123.3 115.81 22.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.585 -0.524 . . . . 1.2 109.585 174.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.85 -91.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.271 -0.732 . . . . 1.01 111.271 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -133.71 -2.31 3.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.975 0.417 . . . . 3.6499999999999999 110.094 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -100.44 134.97 42.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.71999999999999997 111.46 -171.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.565 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -93.64 130.18 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 1.0600000000000001 110.218 177.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.29 -171.32 12.14 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.035 -0.602 . . . . 0.35999999999999999 112.196 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.25 130.44 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.369 0.604 . . . . 0.33000000000000002 109.42 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 6.8 t80 -87.6 109.8 19.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.609 -0.723 . . . . 0.80000000000000004 111.145 -176.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -87.79 102.51 14.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.73 -0.668 . . . . 0.46999999999999997 110.379 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -83.07 105.91 14.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.75 109.727 174.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.49 -61.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.638 -0.792 . . . . 1.0700000000000001 112.046 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t -86.77 161.03 18.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.003 0.43 . . . . 0.56999999999999995 110.655 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.1 tmtp? -116.78 11.56 14.57 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.9 -0.778 . . . . 3.98 108.9 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -139.34 141.06 37.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.694 -0.685 . . . . 1.6000000000000001 110.278 178.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 90.5 m -77.27 117.98 68.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.477 -0.329 . . . . 0.91000000000000003 111.079 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.11 85.24 0.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.073 1.848 . . . . 0.81999999999999995 109.896 172.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -82.15 52.42 2.0 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.746 0.784 . . . . 2.0699999999999998 110.681 -172.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.54 24.19 8.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.99 -1.004 . . . . 1.8300000000000001 108.773 172.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 83.1 mtt85 -132.74 -76.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.895 -1.048 . . . . 3.3900000000000001 110.22 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -176.55 27.59 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.554 -0.831 . . . . 1.1000000000000001 113.162 176.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -71.43 135.83 47.39 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 122.6 -0.353 . . . . 3.4500000000000002 110.886 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -104.67 -38.32 6.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.987 0.423 . . . . 1.3300000000000001 111.071 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 176.26 24.7 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.764 -0.731 . . . . 0.34999999999999998 112.219 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.564 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 43.7 p -139.44 171.57 14.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.925 0.393 . . . . 0.95999999999999996 111.251 -177.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 5.5 t -149.75 131.28 14.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.01 109.06 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.21 129.04 34.3 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.599 -0.81 . . . . 0.48999999999999999 111.855 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.98 168.99 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.858 0.329 . . . . 1.75 110.474 -176.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -53.98 102.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.106 -0.497 . . . . 1.96 111.393 -178.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.92 26.39 14.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.506 0.504 . . . . 1.75 111.621 177.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.29 -170.13 30.8 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.254 -0.974 . . . . 0.34000000000000002 112.499 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.7 tt -132.62 132.69 59.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.37 111.014 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 52.4 t -92.73 111.56 23.21 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.4 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.3 m -103.07 120.62 41.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.766 0.317 . . . . 1.1399999999999999 111.442 -175.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HA ' ' C ' ' A' ' 40' ' ' PRO . 24.0 p90 -124.92 155.55 70.26 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.343 -0.39 . . . . 0.56999999999999995 110.905 -177.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 39' ' ' TYR . 23.9 Cg_exo -66.75 163.12 72.27 Favored 'Cis proline' 0 N--CA 1.474 0.342 0 C-N-CA 123.697 -1.376 . . . . 0.47999999999999998 111.947 -2.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.3 96.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.702 0.763 . . . . 1.3100000000000001 110.203 176.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 24' ' ' ARG . 28.0 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.346 -0.843 . . . . 3.0800000000000001 110.611 -175.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.994 -0.443 . . . . 2.96 111.994 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.819 ' HB ' ' HB3' ' A' ' 13' ' ' TYR . 19.3 p -82.07 93.41 7.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.328 0.585 . . . . 1.1299999999999999 110.619 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -141.16 139.27 33.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.614 -0.721 . . . . 1.1200000000000001 110.877 -174.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.9 p -122.72 172.05 8.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.26 93.27 3.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.66 -0.496 . . . . 0.84999999999999998 109.66 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.64 101.47 5.75 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.27 -104.48 1.51 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.799 -1.32 . . . . 1.01 109.799 -168.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -122.36 6.5 9.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.802 0.334 . . . . 3.6499999999999999 110.205 171.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.37 121.15 31.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.71999999999999997 110.836 -178.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tt -71.75 121.45 21.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.695 -0.684 . . . . 1.0600000000000001 110.738 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.77 154.33 16.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.526 -0.761 . . . . 0.35999999999999999 111.474 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.45 132.04 56.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.212 0.53 . . . . 0.33000000000000002 109.691 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.819 ' HB3' ' HB ' ' A' ' 2' ' ' THR . 18.1 t80 -85.12 112.1 20.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.80000000000000004 111.602 -173.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -95.97 131.51 42.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.46999999999999997 110.095 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -112.35 138.12 49.53 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.649 -0.5 . . . . 0.75 109.649 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.18 -50.38 0.9 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.668 -0.777 . . . . 1.0700000000000001 111.903 -178.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -87.17 149.8 24.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.929 0.395 . . . . 0.56999999999999995 110.428 176.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -114.3 8.8 16.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 3.98 109.459 177.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -130.23 141.13 50.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.309 -0.859 . . . . 1.6000000000000001 110.177 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -72.38 114.74 32.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.089 -0.337 . . . . 0.91000000000000003 110.089 177.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.31 135.95 52.88 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.521 2.148 . . . . 0.81999999999999995 112.416 -176.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 56.03 2.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.567 -0.742 . . . . 2.0699999999999998 110.213 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -119.2 -16.62 9.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.718 -0.674 . . . . 1.8300000000000001 111.131 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -124.97 -26.8 3.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 3.3900000000000001 110.99 175.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 31.29 7.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.418 -0.896 . . . . 1.1000000000000001 112.202 -177.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -51.17 125.87 15.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.813 0.339 . . . . 3.4500000000000002 110.458 177.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -106.89 -4.04 19.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.122 0.486 . . . . 1.3300000000000001 111.183 -169.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -148.46 158.21 27.59 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.704 -0.76 . . . . 0.34999999999999998 111.678 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 36' ' ' ILE . 50.3 p -137.44 138.43 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.17 0.51 . . . . 0.95999999999999996 111.766 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' A' ' 39' ' ' TYR . 94.0 m -120.84 114.02 20.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.651 -0.704 . . . . 1.01 109.174 172.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.01 141.55 47.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.174 -0.466 . . . . 0.48999999999999999 113.086 -177.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.81 175.72 9.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.952 -0.388 . . . . 1.75 109.952 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -56.72 98.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.575 0.547 . . . . 1.96 111.724 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt 60.39 18.37 8.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.026 -0.534 . . . . 1.75 111.198 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.63 -174.37 17.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.992 -0.623 . . . . 0.34000000000000002 111.893 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 29' ' ' SER . 14.8 tt -143.86 126.57 11.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.279 0.561 . . . . 0.37 110.662 -178.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 6.5 t -97.08 106.27 18.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.983 -0.747 . . . . 1.1100000000000001 108.983 178.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.52 136.08 38.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.087 0.47 . . . . 1.1399999999999999 111.349 -173.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 48.3 p90 -129.08 159.9 66.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.56999999999999995 110.286 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 86.6 Cg_endo -90.66 156.74 28.58 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.421 -1.491 . . . . 0.47999999999999998 112.349 -2.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.6 74.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.065 -0.717 . . . . 1.3100000000000001 109.065 173.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.483 -0.77 . . . . 3.0800000000000001 110.214 -177.908 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.926 -0.47 . . . . 2.96 111.926 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 13' ' ' TYR . 1.9 m -69.36 99.39 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.436 0.636 . . . . 1.1299999999999999 109.999 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 10' ' ' ILE . 61.5 m -91.82 128.62 37.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 1.1200000000000001 112.151 -168.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.83 148.72 34.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.588 -0.523 . . . . 1.01 109.588 172.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.2 125.04 52.91 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.184 -0.206 . . . . 0.84999999999999998 110.623 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.2 m -89.63 95.42 10.25 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.386 -0.968 . . . . 1.2 108.386 171.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.79 -83.48 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.053 -0.594 . . . . 1.01 111.795 -177.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -141.76 19.76 2.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 3.6499999999999999 110.104 178.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -116.35 131.26 56.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.71999999999999997 110.586 178.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 3' ' ' THR . 4.6 tp -82.5 115.26 24.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.533 0.683 . . . . 1.0600000000000001 111.751 -175.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.62 173.62 17.03 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.384 -0.826 . . . . 0.35999999999999999 112.234 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.87 130.33 63.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.493 -0.558 . . . . 0.33000000000000002 109.493 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 2' ' ' THR . 14.9 t80 -84.07 108.99 17.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.775 . . . . 0.80000000000000004 111.378 -174.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 98.7 m95 -93.24 102.08 14.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 110.389 177.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -89.38 121.26 31.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.24 -0.437 . . . . 0.75 110.006 176.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.56 -29.94 5.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.489 -0.862 . . . . 1.0700000000000001 112.916 178.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 14' ' ' TRP . 3.7 t -107.41 149.79 27.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.154 0.502 . . . . 0.56999999999999995 110.732 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 36.5 mtmt -100.88 1.62 40.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.359 -0.837 . . . . 3.98 110.091 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -139.85 152.56 46.58 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.882 -0.599 . . . . 1.6000000000000001 110.407 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 85.3 m -83.66 119.86 74.36 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.91000000000000003 110.666 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.22 96.85 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.88 1.72 . . . . 0.81999999999999995 109.589 170.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 t -82.17 63.05 6.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.555 0.693 . . . . 2.0699999999999998 110.631 -172.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -107.67 -1.46 21.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 1.8300000000000001 110.078 177.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HD2' ' OH ' ' A' ' 26' ' ' TYR . 91.3 mtt180 -125.98 21.25 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 3.3900000000000001 110.611 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.75 38.08 89.34 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.031 -0.604 . . . . 1.1000000000000001 113.311 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.488 ' OH ' ' HD2' ' A' ' 24' ' ' ARG . 20.9 m-85 -68.35 120.21 14.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.032 0.416 . . . . 3.4500000000000002 110.014 177.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 m -94.76 -33.81 12.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.851 -0.613 . . . . 1.3300000000000001 111.345 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.73 174.07 25.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.218 -0.991 . . . . 0.34999999999999998 112.311 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.442 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 5.8 p -158.24 159.03 35.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.961 0.41 . . . . 0.95999999999999996 111.185 -178.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 29.8 p -134.45 142.44 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.247 -0.649 . . . . 1.01 109.247 174.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.36 132.57 27.77 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 121.059 -0.591 . . . . 0.48999999999999999 112.122 -177.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.27 16.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.816 0.341 . . . . 1.75 110.697 -175.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -56.9 106.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.624 . . . . 1.96 111.233 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 58.88 21.86 9.59 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.754 0.659 . . . . 1.75 111.898 177.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -173.08 32.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.436 -0.888 . . . . 0.34000000000000002 112.134 -177.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.5 134.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.807 0.337 . . . . 0.37 110.65 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.616 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 44.1 t -98.86 108.88 21.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.495 -0.558 . . . . 1.1100000000000001 109.495 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.9 m -104.97 127.3 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.385 -0.37 . . . . 1.1399999999999999 111.081 -174.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 33.7 p90 -120.29 159.69 46.62 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.287 -0.415 . . . . 0.56999999999999995 111.061 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 39' ' ' TYR . 95.1 Cg_endo -92.04 160.49 25.79 Favored 'Cis proline' 0 C--N 1.344 0.303 0 C-N-CA 124.005 -1.248 . . . . 0.47999999999999998 113.006 -0.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.3 t -71.29 96.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.3100000000000001 110.422 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.659 -0.686 . . . . 3.0800000000000001 110.121 175.419 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.723 -0.551 . . . . 2.96 111.723 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -84.08 85.19 7.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 1.1299999999999999 111.084 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -76.71 148.69 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.068 0.461 . . . . 1.1200000000000001 110.075 178.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . 11.2 t -150.22 115.4 5.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.914 0.388 . . . . 1.01 110.618 -175.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.511 ' CE2' ' HB ' ' A' ' 10' ' ' ILE . 35.7 m-85 -97.33 109.19 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.479 -0.328 . . . . 0.84999999999999998 111.041 -178.001 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.2 m -86.81 98.2 11.05 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.545 -0.909 . . . . 1.2 108.545 171.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.81 -111.77 4.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.395 -0.821 . . . . 1.01 111.499 -172.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -89.83 -22.86 21.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.518 0.199 . . . . 3.6499999999999999 111.287 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -91.82 118.61 30.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.18 0.514 . . . . 0.71999999999999997 111.639 -168.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.511 ' HB ' ' CE2' ' A' ' 5' ' ' TYR . 5.4 tt -78.32 123.56 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 1.0600000000000001 110.859 177.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.23 -169.44 12.56 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 111.06 -0.816 . . . . 0.35999999999999999 111.06 176.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 132.91 68.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.178 0.513 . . . . 0.33000000000000002 110.02 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 6.7 t80 -88.82 106.17 18.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.554 -0.748 . . . . 0.80000000000000004 111.068 -176.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 21' ' ' PRO . 89.8 m95 -87.15 95.91 10.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.46999999999999997 110.329 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.45 ' HD1' ' OH ' ' A' ' 13' ' ' TYR . 90.1 t80 -78.79 109.82 13.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.422 -0.584 . . . . 0.75 109.422 175.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.39 -61.45 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.88 -0.676 . . . . 1.0700000000000001 112.143 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -86.79 160.19 18.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.88 0.372 . . . . 0.56999999999999995 110.578 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.39 11.5 14.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 3.98 109.589 178.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.3 t -129.47 145.93 51.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 1.6000000000000001 110.3 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 29' ' ' SER . 70.9 m -82.87 124.76 76.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.91000000000000003 110.105 178.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HG2' ' CZ2' ' A' ' 14' ' ' TRP . 33.5 Cg_exo -57.36 113.47 1.51 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.638 2.225 . . . . 0.81999999999999995 111.104 176.098 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -77.01 43.42 0.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 2.0699999999999998 111.947 -172.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -128.44 16.75 6.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.928 0.394 . . . . 1.8300000000000001 110.789 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -123.09 -42.25 2.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.84 0.352 . . . . 3.3900000000000001 111.102 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.28 32.11 3.57 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.752 -0.737 . . . . 1.1000000000000001 112.044 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 20' ' ' CYS . 63.9 m-85 -56.25 131.42 47.89 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.879 0.371 . . . . 3.4500000000000002 110.557 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -85.2 -40.66 16.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.087 -0.506 . . . . 1.3300000000000001 110.943 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.23 165.31 26.35 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.672 -0.775 . . . . 0.34999999999999998 111.651 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.601 ' HB2' HD11 ' A' ' 36' ' ' ILE . 69.0 p -140.66 134.47 30.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.267 0.556 . . . . 0.95999999999999996 110.989 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 57.0 m -106.07 110.93 23.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.567 -0.742 . . . . 1.01 109.496 178.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.6 113.47 3.89 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.171 -0.772 . . . . 0.48999999999999999 111.171 176.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -112.84 164.47 13.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.041 -0.355 . . . . 1.75 110.041 -172.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -56.9 104.9 0.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.082 -0.508 . . . . 1.96 110.675 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt 65.03 28.62 12.42 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.683 0.614 . . . . 1.75 111.307 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.79 -168.72 35.18 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.496 -0.859 . . . . 0.34000000000000002 112.268 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 29' ' ' SER . 17.4 tt -138.13 132.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.37 111.071 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.751 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 48.6 t -94.77 100.58 12.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.674 -0.694 . . . . 1.1100000000000001 109.751 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.03 121.05 39.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.464 -0.334 . . . . 1.1399999999999999 110.933 -176.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -128.1 153.52 78.56 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.56999999999999995 110.927 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.83 154.05 46.45 Favored 'Cis proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.286 -1.547 . . . . 0.47999999999999998 112.498 -1.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 41' ' ' VAL . 6.5 p -85.2 98.2 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.048 -0.524 . . . . 1.3100000000000001 110.165 177.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.161 -0.927 . . . . 3.0800000000000001 110.733 178.577 . . . . . . . . 0 0 . 1 stop_ save_